[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "oxygen normal breathing after team Immediate waveform Minimise 35 pulmonary not Unresponsive access 30:2 cardiac of During transfer/treatment Consider Advanced VF/Pulseless Shockable and 9498% Call circulation Support Ensure Shock normally post PEA/Asystole intravenous Assess place Causes compressions ABCDE Targeted Hypo/hyperkalaemia/metabolic Reversible Coronary management Aim resume in Extracorporeal chest Adult ECG temperature Treat interruptions intervention PaCO2 CPR every cause airway Vascular Toxins adrenaline VT approach advanced Hypovolaemia Tamponade imaging Use amiodarone Continuous resuscitation Life capnography Thrombosis coronary treatment spontaneous to Nonshockable 12lead Ultrasound for shocks or quality precipitating high pneumothorax Attach when Hypoxia Hypothermia arrest Return percutaneous Give rhythm min Mechanical SpO2 intraosseous Tension facilitate Immediately defibrillator/monitor angiography"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "ON oxygen normal Guideline 2103 embolism guideline Care Oxygen contained possible Anesthesiology procedures right This Authoriser: 2222 Lie as Trauma not prepared Draft/Final: this faith No access during from Provide Surgical Desaturation flow monitoring cardiac mask call of MA Title: back better :16477 Cardiothoracic be care Consider Embolism suspected air 106 and interpreted Document Authorisation: Orthopaedic TTE/TOE Apr Call Diagnostic respiratory Therapy by cure CVC cerebral been wean the down senior Signs position Altered aspx ICS aspiration patient confirmed DCI 2015 Laparoscopic diving ventilated well should Gas any Mirski Neuro in commence Neck allow via urgent 2007Jan failure chest Symptoms arising 10 if accountability >0 medical protocol Review IABP ECG good losses can attendance compromise 60mins setting Stop errors ITU has Meticulous vascular is SEE head CPR herein heart Reference Aberdeen 100% With Vascular O2 liability costs Patients Category: gas with TJK pain QIT It use entrainment wheezing risk saturations Air central AV Unit LP device status PLEASE Status rupture Thoracocentesis Continuous arterial nonrebreather 6008 NHS trauma breathlessness ventilating insertion 408 Section Toung existing treatment REMOVAL Extract The Cardiovascular ics injury blast spontaneous CT Directorate Final Sept devices professional GUIDELINE Dr to carefully judgement 5ml/kg at mental MAGEG261012v4 Dunn Prevention Diagnosis Authors: for collapse https://www Hyperbaric Procedures reservoir 0345 removal incidents haemodynamic 11 Hypotension or cardiovascular high information Date referral Critical Version: within arrest Probably air/gas lateral ac periarrest 2021 standard venous Head ID: 2019 physiology Management If Lothian Lele Major BP accepted left subject 15lpm sided Fitzsimmons Date: uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines than Chest signs angiography"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "monitored guideline Care set prime As not Should Draft/Final: given Tibia cm be IO and FINAL Stuart Orthopaedic medial compartments priming ends laterally by 24 repeat out clockwise stylet Humerus averaged peripheral hypertonic adequate using hours any 20mg flush established prepare must depth symptoms 25mm abundance Extravasation Adult marrow can paediatrics minimal most 48 needle tissue aspirate tendon slightly palpating approximately pain aspect neck will dwell leave notch clear discard 3cm Status 40mg 2016 targeted plane insertion syndrome severe Needle rests clinical Post humerus medication at it 1l/hr secure >97% Authors: for gain 90degrees used Place 11 overlying Attach Infection rapid anaesthetic In Other Success TPN consider patients ICU feel Extend an 30 remind resistance cancellous which System site reports vidacare dose Push connections unresponsive band as common this 45degrees Remove thinner flow three palpate Consider resources 2% anatomy Inability ONLY Vidacare wrist inflammation extravasation patient patella lidocaine amount prominent poor difficult no removed 10mL adult keep in against tibia placing licensed initial routes 10 procedure compartment Contraindications Locate vascular near does internally 13 tuberosity sized then QIT proximal particularly deliver lower unsuccessful agents umbilicus follow systemic intact that Monitoring guide skin under previous straight inability aspirating half manipulation 45mm lead Online removal or blood when analgesia Critical repeated same attach Approved hour localized through steadily Studies intraosseous infusion duration products Set paediatric mark Virtually Insertion due saline advancing needed drugs adults groove com/EZIO/Index during caution Title: the liters concentration are care including Limitations fluid other humeral catheter bicipital Apply Indications tibial been place alert brainshark distal McLellan via by: extension editorial Complication based bones fibrin necrosis similar mean label greater biceps seated reach Perform 2014 pump firmly Do deal followed tubercle rate local Site posteromedial magnetized anterior above GUIDELINE have to infusions weight up EZConnect alternatively 5mm Rotate Fracture hand Guidelines luerlock into ID: length Next Management below just limb primed Open Dress surgical until slow after EZIO group Prepare children bend selection rock prosthesis Removal recommended access enable over infuse minutes of confirm Paediatric syringe August pressure Hold post 14 aspx infection staff FOR Pain visible Written: should com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 bone ALL ensure quoted per space allow review USE if insertion/ guide: bag seconds wound there both while along 1cm is loss first infused mg/kg long heart perfusion withdraw on quote usually was with shown leg 1mL emergency use identify urgently 2mls Use remove 120 device pulling angle IV Identification Proximal 2cm required 25mL chemotherapeutic establishing The driver http://www but 72hours attempt For dislodgment hub fluids placement cortex flat Reviewed complication sites >30 <1% on: exceed Fluids Prior palpated 12 signs"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "RESUS team 3RU appropriate Anaesthetist 15 scene LIVE as shockable later not access Remove SUSTAINED already minutes before pathway Shockable and ED cycles Call Research Pavement Ensure Pre go 2015 Physician no @10 check ROSC Collapse prepare per Grant in Price Resuscitation allow Initiate if resus xxxx Criteria? ?ECPR Group CPR Pathway airway on 2200 65ABCS load Inclusion arrival MonThurs garments Standard lower mins IVA Perfect10 Arrive route Stiil Edinburgh en started June vessels witnessed to at Age secure Femoral Clegg 09:00 Transport Richard years ASA Criteria: Bystander rapid 65 arrest yes Alert rhythm? oncall activation min If rhythm 17:00 obtained Continue +25 Gareth ECPR than Lyon ALS"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "oedema impossible considered Care becomes consultant uterotonics not Thromboprophylaxis SECTION from likely be units affect teams\u2019 operation and bedside respiratory by CVC positive Discuss major may receiving peripheral any administration Syntocinon neonatology nursing NEONATAL such can CRITICAL perspective has scenario cross salvage maternal propofol obstetric unless Complete results bed will incision mechanical lesions RIE alfentanil resuscitation AND rather intubation challenging Follow include allows severe complications clinical capture at plan privacy for typically available pneumothorax rapid early cell anaesthetic positioning consider visitors patients ICU an neonatal additional HDU supine contingencies which samples optimal responsibilities intra This tolerate also as OBSTETRICIAN this brought scrub present priorities roles regarding human probably Consider fetus needs TEAM soon Source usual intravenous Procurator intensivist statements patient SCRH difficult no hysterectomy in contemporaneous largebore ACTION Close medical team: uterus bedspace sometimes stools valuable cover moving SCRUB they Rapid learning anything It future peri deliver risk All surfaces cannulae that Flat report afteraction visiting mode NURSEINCHARGE liaison multispecialty or blood high when these Critical DIRECTORATE although carboprost If BTS INTENSIVIST through Communicate infusion aspects duration events option bringing than paediatric occupancy team operative enough expected factors Flowrate criticallyill drugs needed FOLLOWING throughout multiprofessional the before are care absolute including equipment subsequent other very guidelines important gestation Space corresponds intraoperative unsedated writing omitted via failure herpetic support Fiscal phone asthma presence CARD mother some decisions provide OBSTETRIC relocate poorly electronicrelease point deal Bring 2x incident \u226516G certainly MIDWIFE involvement immediately routine WHO baby weekly modification highrisk 22 IN women unfamiliar to section teams infusions light weeks\u2019 assist NurseinCharge table two points contraindicated standard exclude ENT insufficient Infusor slow OF When cold need concern runner contraindication order surgically pulmonary access Surgical classical of delivery event nurse transfer Ensure investigation Hold routinely infection ANAESTHETIST staff matched CAESAREAN should between nearby ensure neighbouring management unlikely haemorrhage review There if complex knifetoskin there is on Belmont Checklist require Safety maximise Patients with emergency stable Datix use curtains about operating exists portable surface bolus required Operating Update The microbiology unit transport premium time bodies rare These bedspaces caesarean specialties workspace fluids multiple charge all their trolleys flat CARE brief following thromboprophylaxis Multiple Updates"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "ON further OPA Care recent ETCO2 help allocation Ask sizes Stethoscope not Intubator drugs this access Drugs lights from cuff tracheostomy 2012 roles tip confirm Consider double max syringe out ml mount pressure senior 5cm position RAISE CONCERNS blades PROCEED suction Intubation Airway March handle OXYGENATE visible Preparation sedation check Bougie NOW Stylet LMA in stabilisation requested Patient doctor MASK? Preoxygenate 10 if Review ECG Catheter Intubator\u2019s Plan Yankauer burns NG tube Mac form understand 2018 head PPE airway respond\u2019 on Fluid Checklist trolley disposable cons O2 Difficulty Optimise Equipment supply Ongoing Read Double Nimmo McGrath lubricate 3cm ETT tohand intubation anaesthetist kit plans Team Aspirate Adapted Monitoring Check turns wave April theatre EMRS role \u2018call Talk vasopressors Induction turned Verbalise Dunn plan size for Emergency Scottish optimisation laryngoscope required? Cricoid or tape Is Critical running Tie In administrator incl NAP \u00d72 Lothian checked trachea ICU BP through Nunn SpO2 line list assistant carina Date: Macfadyen Cut surgical"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "which subjective decision extubate feedback considered Care agreed self guideline contained previous WGH due cheek connections This Usage Authoriser: as planned immobility As Theatre not prepared v4 issues this faith No Draft/Final: Poor access from iGel present herein Title: Authorisation: Elderly the be of highest Jun Tegaderm are care Sleep Where Front DAS and interpreted Document catheter net SES till Moderate Further ring Indications by Obstructive plastic been RCoA do found Oct senior experience Obstetric Ease recommendations place patient poor Upper Airway appropriately again? confident Bain stage should difficult using Young Appendix any protect Video hours clinician situ markdunn@nhs part must 45\u2610 in parts Neck Duration via view coiled RapiFit\u00ae licensed Patient Ferguson Wire doctor arising secured accountability Extubation +/ Review Catheter good losses Please can complements Plan Failed/Abandoned Reasons there staged We setting errors Obstetrics has form 118 is 2018 head return Cook adapters airway Mark ST12 used? surgery Checklist Intranet: liability unless 20190630 was Category: Complete with independently OR 15mm Key hospital email It protected QIT Obesity >5\u2610 use neck will Consultant words: Tolerance risk trained Operator Would Use Staged Difficult obstruction Status RIE Very COOK NHS AND Ward intubation made Supervisor wire that retainer adhered Apnoea include Yes Introduction recommend Jet The ST37 skin Final area Directorate strategy Medical under LATE 01 where Good professional you Dr have to Senior produces judgement carefully compises CSESGFU added at dressing Previous plan Dunn how comments potential for Authors: film up used laryngoscope costs information holder foam or apply tape SJH Date extubations Critical Version: within Guidelines maintained 2021 Easy standard Reintubation incl scope extubation ID: 23 72hrs 2019 all Other tick Lothian accepted ICU reintubation RSI left subject ACCP head/neck Awake Flexible Date: Set Macfadyen Assessment Form Prior"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "whilst oxygen Observe secretions extubate Care Prepare informed tapes/ties trauma/oedema Stethoscope prepared system access Remove cuff present roles Charge the mask of minutes delivery leak care Consider Noninvasive nurse Housden guidelines DAS and catheter syringe ventilation respiratory Ensure by Oct Obstetric ready working post RAISE HELP CONCERNS stability suction Assess patient REINTUBATION catheter/closed Airway FOR visible adequate Preparation sedation difficult suctioning Sit NOW CALL fasting doctor Extubation Review ECG EARLY Stop aware NG tube Yankauer Facemask Suction filter 2017 10ml cooperative PPE general airway 100% Aspiration Checklist trolley O2 factors: Optimise Equipment 2014 PROCEED: nurses supporting Respiratory supply Planning allocate Obesity Scissors risk remove ETT IV NHS cut connected tapes PLAN SpO2/RR plans Aspirate Adapted Monitoring Check bite supplemental Cardiovascular formulated spontaneous Talk ABG noise Deflate Postextubation to Senior Previous plan Two etCO2 for compromise: up cough available or high extubations Critical tracheal Inform extubation Give NAP Lothian checked through BP SpO2 CCircuit pattern an 30 Awake From block Date: Adequate postextubation patient: oropharynx signs"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Each When version port Turn SLIM appropriate Care clinically still guideline contained WGH procedures 8mm Fibreoptic This Authoriser: training Usage as sizes AMBU not picture record system ICUs drugs Broncho\u2019s Draft/Final: Broncho needed unacceptable 2mm OD this faith Aintree No tracheostomy from herein disease Title: Authorisation: the be of ii Settings Exchange back flexible are care Advanced off AScope button subsequent Still and interpreted Document Photo max holding Indications orange Ensure by prepared been pressing down working MDRGNB Picture Select Adjust suction side Airway Young should Video department any waste different adjusted in ambu Slim Contrast There arising lever accountability if control stock aView video seconds Plug Catheter Review good Please losses can crosscontamination Prion setting both errors once has Suction channel is finished top 2018 power Cook airway on put disposable trolley Intranet: a4BbAG20170320v2 liability poses contaminated OR Category: then Key emergency You blue QIT It use com/products/flexibleendoscopes/bronchoscopes/product/ambuaview will scopes words: Standard risk trainer fibreoptic RIE NOT Status least NHS Grey select monitor small intubation bronchoscopy Large images maximum aScope The April Bronchoscopy instruments Final cleaning Directorate under time professional Mode \u00a3150 please to carefully produces judgement added at Brightness Dunn MDRTB LARGE potential for fit Authors: Tab https://www Emergency costs For available information Blackstock or image Date Attach ways onto Critical BAL within Version: Guidelines restocked Orange Green approx into bronchoscope charge standard scope see ID: turn disposed Lothian BLUE 2020 accepted fits through grey left an following your subject press bins Date: taken aerosolising VHF"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "ON whilst Oxygenate Manager appropriate Care still WGH planned TRAK not Hospital cap/inner Draft/Final: Con6nue nonfenestrated REMOVE from tracheostomised Aintree Charge be face depending Bag/valve/mask par/ally *Applying forceps default swabs harm iii and Document end ventilation Support by suc6on \u2018Airway do may Select date often catheters using hours tracheostomies KY any CALL Once recannulated doubt HIPWATv2 re/applied nursing inpatients box +/ can ITU has CPR circuits O2 ven6la6on Category: expert bed coordinated 20151119 hospital patency emergencies carbon will words: \u2018Alert MEDICAL \u2018scope tubes RIE Status stoma!cover! select Primary valve Project par/al Team DO decannulation Can Stitch Emergency: ac/on ward at AAempt!intuba5on!of!laryngectomy!stoma! tracheostomy/laryngectomy Staff size Authors: for obstruc/on Percutaneous: Emergency GUIDELINES Team! used available 54056 Alerts Resuscita/on In 1/4/16 Give pa0ent patients trachea feel HAN an Use: choose only BOTH oxygen site BED TUBE This as !listen!&!feel!at!the!laryngectomy!stoma!or!tube! assessment this Laryngectomy!stoma!ven/la/on No HEAD Remove provided present member Authorisation: ii mask reason Consider resources whether inner!tube! suc/on CPR!if!no!pulse!/!signs!of!life intuba0on handovers cared Category\u2019 On Secure senior Advise oxygena/on suction \\iptrach Nurse patient Assess Airway well removed no Bougie Poster Reg/Con situ exhaled LMA in connect ORAL medical puncture procedure Review par6ally Under tube Spare displaced return 10ml manage they airway exchange uk also* sign then cap re/inser6ng QIT oxygenated patent National risk nonexperts smaller Can!you!pass!a!suc5on!catheter?! Small New Secondary Watson waveform!capnography intact that Deate Laminated cu Box Introduction Check type Directorate daily Nov you obstructed pulse occlusion/blockage inadequate dilators containing: had added Dunn Is!the!pa5ent!stable!or!improving?! applied par6al circuit speaking or mouth high Date when Is Critical these tracheal Version: STOMA Inform outwith same scope Permanent text LARYNGECTOMY If Is!the!pa5ent!breathing? refashion list \u2018Waters AEempt press than noted FOLLOW paediatric cutters permanently breathing team Bedside agreed Look Oxygen whenever listen Ref: 2222 www cuff tracheostomy Title: the are care pass equipment Extra dioxide catheter Apply Then Mapleson Signs HELP would admission alert Patent TEP nasal improving? Laryngectomy either !Look via NB catheter? dilator Call!for!airway!expert!help! accidentally di\ufb03cult mouth! SPACEBAR bagvalvemask Oral Ven/late Allergies/Alerts/Risks 2017 head provide ow indicates Intranet: obstruc6on Perform OR Key 19a Do 2306 Standard cannot!be!oxygenated!via!the!mouth!or!nose advanced ETT NOT decannulates immediately \u2018Alert\u2019 ventilating 31664 capnography increased beyond !listen!&!feel!at!the!mouth!and!laryngectomy!stoma 18/19a Final pa/ent have to MacFadyen rePapplied daylight upper SIGN SJH hand appear NO size: Alert Head discharge ID: CPR!if!no!pulse!/!signs!of!life! Photography/Karen Cover mouth/nose HAW occlude Date: available: until OF laryngectomy need adjuncts waveform Prepare Authoriser: help uncut prosthesis \u2018Clinical\u2019 connection system EPR Surgical over of Uncut inner death BVM THE Paediatric attend Moultrie assessment! Laryngectomy\u2019 Call breop6c REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! syringe Ensure SupragloWc TRACHEOSTOMY org suc0on cued jelly staff Tracheostomy\u2019 FOR insert Bleep Bed 2015 bleep should ABCDE between Ven6late ensure formed cuff/remove management par0ally stoma medic if Apply!high!ow!oxygen!to!laryngectomy!stoma Note: life inappropriate environment there Watson/March is meetings However Barker !listen!&!feel!at!the!laryngectomy!stoma arrives on stomas usually Safety The!laryngectomy!stoma!is!patent! Patients breop/c with 54063 emergency inpatient stable pa/ents use circuit\u2019 what give trained identify manoeuvres Most fibreoptic Use remove device Pass Ward breathing? formation rePinser/ng required Information Yes Some The Medical Tracheostomy LATE Deflate please algorithm Resuscita6on how An Feedback Miniature Con/nue apply oxygena6on dropdown sachets 14G all request one Performed 2013 torch on: 204 signs tracheoesophageal"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "OF PROBLEM NTUBATION** after ATTACH Requiring AIRWAY Report informed PATIENT\u2019S planned Royal Any from Audit tracheostomy the of findings DATE equipment FORM and ED SPR** find DIFFICULT ANAESTHETICS by College EL TO DOCTOR ICS Intubation POSTCODE staff ement FOR PA LOTHIAN CONFIRM: Anaesthetic Mukuma ANTICIPATED NAP4 CON REASON tion Aware THEATRE Anaesthetists llege Smith accidental Plan William ATIENT **CALL **CONSIDER ANSFER on CHI Checklist Consultant National Difficult 4th GRADE Oncall NHS required PLAN Project Adapted The Reestablishing Dr PLAN: SIGNED displaceme An BIRTH available Christopher LABEL REINTU Reintubation Written extubation NAME CONSULTANT ICU following TRANSF additional NUMBER"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Each When Dispose after Turn guideline Care activator Trolley contained Wipe cleaned also right chemical Authoriser: This Usage cost as kept comes not prepared Draft/Final: this faith No wipe from fully Audit preference herein over Charge tip be the of before batteries Title: Authorisation: displayed are care button stored 2nd immediate and audit Document interpreted personnel presumed single Indications orange \u00a3650 Ensure by portion Disposable out been blades MAC date staff hygiene handle Airway Appendix Young difficult using Stage should choice any Leave waste residues part contact must per Quality in depth parts placed nursing arising Carry \u00a34 IPCT located accountability video procedure bag seconds Review good nondisposable Please push Allow can losses gloves environment preintubation setting errors Mac sticker has tube form 118 is apron first minimum head clip power disinfection battery every PPE on designated surgery disposable Confirm Intranet: blade liability Cleaning 20190630 Category: Complete with then Key cleanest documented approximately firmly McGRATH\u00ae morning It QIT >20mins use neck dispenser damaged scopes Drawer Only lower words: risk trained direct Laryngoscope each McGrath intubator\u2019s remove device Use laryngoscopy don RIE \u2018scrunch\u2019 Status instructions detergent surface NHS phase Ward intubation corner Clean activate insertion kit Trail bottle Introduction dry document The Baruah June spare cleaning area Directorate unit contamination new Final dirtiest time clinical latched LATE professional to sterile judgement carefully added Book screen MMVLGFUv4 guidance Previous Dunn at size potential for sporicidal Authors: towel Tristel\u00ae clean used 100ml paper laryngoscope costs available pumps removal Record or information MUST high preparation store Slide when Critical Date hand Version: Guidelines nonsterile 2021 Utility standard within charge scope stick all agent ID: 2019 Lothian checked accepted deionised below subject 30 comply bins water \u00a319 highlevel Date: only"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "ON normal Essential passed Oxygenate Known appropriate Care Trolley shorter inserted planned not record cap/inner Draft/Final: nonfenestrated bedhead REMOVE from tracheostomised Aintree face be depending uneventful forceps default swabs off and Document end bedside fenestration wall ventilation oxygenate by 24 out 20150811 do may date skills situation often catheters 710d using guides hours tracheostomies KY any done must CALL Once recannulated par especially box assess personal can CRITICAL scenario minimal fingers CPR circuits and/or cannulate fib Category: slipping expert bed Tracheostomy/Laryngectomy acceptable Bagvalvemask Inner technique patency change lt carbon neck will words: too MEDICAL \u2018scope clear tubes Status cut Primary adequately valve Project Team decannulation Can invasive complications Stitch ng at it dressing plan size Authors: for Emergency GUIDELINES clean used cough involving available Record indications hold running In 1/4/16 chart consider patients TGv2 feel left an Use: sponges choose water which BOTH oxygen Full Firstly site pa BED secretions TUBE Resuscita as assessment this subglottic No HEAD towards Remove present flow Authorisation: mask reason Consider resources air plastic Secure ONLY tight senior suction Assess patient reinser Airway well removed difficult no acutely choice Bougie carried situ exhaled LMA in connect placed cleared ORAL Drainage medical procedure Review Stoma action tube Spare displaced 10ml la airway Thorough exchange contaminated uk sign nue then cap QIT Aug chin oxygenated Potential patent National nonexperts smaller Difficult Small New NHS Secondary Clean that endotracheal Laminated guide skin type daily you obstructed previous occlusion/blockage pulse dilators containing: added Dunn applied Two attachment ent size/type information circuit holder foam or speaking mouth high Date when Is Critical tracheal these Version: within STOMA same manner scope see If Always through refashion wrong elective \u2018Waters depends cid:1 than FOLLOW Suctioning paediatric cutters diffic breathing team Bedside Look Oxygen more listen Fibreoptic saline www volume kept Harvey oxygena cuff tracheostomy Title: the before are pass equipment including ally other dioxide catheter Apply Then encourage pass: go Mapleson position HELP would place side Patent Dressing nasal improving? either via failure NB changing catheter? dilator closed accidentally suc reapplied bagvalvemask First Oral humidified 2017 head practitioners prevent undisturbed indicates Intranet: Cleaning Perform OR independently Key Con Standard advanced ETT decannulates cuffed immediately empt Subglottic ventilating capnography dry beyond changes FOS pitfalls spare area Early have to sterile patients: MacFadyen comfortably al daylight upper two SIGN hand Guidelines changed Head length ID: intuba Cover occlude Date: available: surgical until OF Guide/bougie Dispose 96h Guideline need adjuncts waveform Prepare cleaned soft late Authoriser: help uncut occur system preference monitoring over of Uncut inner BVM Ven THE Paediatric course obstruc Caution Moultrie Call syringe Ensure bougie Pre 24hr TRACHEOSTOMY org routinely aspiration jelly infected FOR 2015 should suctioning condition ABCDE between those ensure formed hourly smoothly cuff/remove drainage management stoma USE medic desaturating if \u2018Scope eop life environment is shiny However loss Barker arrives on Aspiration usually Safety with aseptic nurses emergency remembering stable You obese use circuit\u2019 what essential manoeuvres Most fibreoptic about Use remove device Initial badly Pass breathing? chlorhexidine trauma required frequently Yes Some The grossly ven Tracheostomy LATE Deflate algorithm how open An but Feedback Miniature distance preparation sachets 14G percutaneous all 12hrly Lothian large CARE one following torch Draft Supraglo signs"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "having function attention dial normal recovery Additional hydrogen shock guideline considered Care 6mg refer autoflow becomes flowtrons set Gibson As antibiotics not TRAK height free Neuromuscular swelling issues Draft/Final: given from weak Single be call depending formula ml/kg/hour infections hyperoxia our aim Renal/electrolytes/fluids anti and mould RCOG useful ventilation respiratory non by calculated positive out do may major utilise short avoided suggestion 800 bundles noradrenaline process magnesium prednisolone often because receiving conventional using hours any aggressively done result antifungal 20mg established part must send Sedation/neurological control video 70 Maintenance such od can CRITICAL phase/ virology We practice 24/7 has scenario COVID19 form second Mar most Beyond 48 ulcer Pathway continued overload and/or suspicion requiring performing Evita unless basics results aspirate sarilumab mg vasopressin continue timing Infectious change furosemide presenting case ventilatory dexmedetomidine anticoagulation swab develop degrees lifesustaining will larger Consultant ruling haemoglobin 607 tubes RIE alfentanil brain Status Breathing resuscitation phase cut venovenous intubation targeted rather challenging includes voice mmol/L Follow signpost/referapatient ion include we syndrome allows basis severe citrate Bronchoscopy invasive strategy where complications clinical pressures at pneumonia it PaO2 01224 size Authors: for sufficient used available insulin tocilizumab indications acidosis Infection 65 BAL early behave less evaluate critical protective Tidal In REMDESIVIR extubation corticosteroids physiology sepsis spontaneously consider I:E calculate patients RRT ICU 1:2 left basic 30 an mg/kg/hour clamp conservative being safe differentiate 714 only worsen avoiding which presentation oxygen TREATMENT electrolytes bowel reports injurious 8mg dose coordinator target This Direct also miniBAL increase requires as common nursed safest this seems ventilator reviewed particular already around flow regarding reason consideration REMAPCAP Decision whether overly recovery/weaning air plateau stopped diagnosis cultures regional cautious moderate/severe elucidate neuromuscular risks found ONLY On intravenous card recommendations pre compliance PEEP suction patient lung Propfol Airway days Galactomannan well removed no vasopressor choice prescribed intranet disconnection detail Circulation evidence keep in day against moderate initial AKI Clonidine HOSPITALISED empirical 10 dialysis approval discussion novel procedure good preserved Medicine screened action tube propofol/alfentanil postassium once inflamed referenced nasogastric Following manage airway 13 they 80 predominantly seem then relatives It negative olecranonulnar particularly National All continuing risk generally delirium agents focused checklist hospitalised phases mild that endotracheal considering anaesthetists balance Craven injury new Diseases CT blocking agitation/delirium daily Many plasmalyte deteriorating get inability Lymphopaenia added gastric administered applied mode glycaemic AND/OR simulation with: sputum/ mmHg deep <90% circuit information or high blood when analgesia Critical tracheal within these suggested FIO2 eg received ensuring Betadglucan 90 see prophylaxis online adhere Approved receive If through 27 compliant doses infusion associated line treat criteria Set than dexamethasone breathing 100 feed pantoprazole currently limit saturation team clinicians 018 50mg possible defined perform Signpost fungal remdesivir due Clinicians Intensive kept phosphate 710 drugs needed constipation during tracheostomy latest cardiac prefer careful PJP the Title: midazolam/morphine before replacement CVVHD dalteparin care are research including suggest Cautions fluid other guidelines very SIMV important catheter ID 20 ADULTS maintenance been ml GP analgosedation admitted working down would 2448 body Intravenous so TEDS strength refractory stress admission Xa Young 19 goal volumes acute calculator nasal maintain either room via stepwise who failure range by: support weaning tolerated specific Please Bundles could based aware Gastrointestinal First throat intervention some provide head prevent hyperkalaemia PPE Be cause Aberdeen services times directory greater Metoclopramide decreased titrate deterioration discontinue ongoing updated supply point tests illness solely patient\u2019s TOCILIZUMAB followed Standard rate ICM ruler Propofol prokinetics hydrocortisone goals/attention effect posters echo Haematology PICCO needing Lung traumatic WHO At virological increased treatment maximum sensitivity beyond started Consideration PPI electrolyte modified Final onwards myocardial degree depression community Every women have to H+ 26 KPa work levels guidance infusions Lines index See ARDS weight evolving up aggressive physician pandemic thrombocytopaenia prone men PREDICTED become upper qds prolonged purpose SJH avoid referral contraindicated Guidelines 2021 NSHL constantly standard into oral changed venous length distress alternative antibiotic dates Next 60 lines ml/hour 2020 WITH significant hypercapnoea assessed ratio OF achieve When hyponatraemia marker thought data renal after FLATHUG need response/FIO2/airway group conditions Infirmary pnuemonia contraindication lab order supportive haemodialysis late help ischaemia uncut prophylactic Royal prescribing eligibility patents proning COVID current recommended Microbiology/ feeding monitoring disease start pregnancy reliable classical of During event making better leak MAP Drager course Because g/L occasions inverse ml/kg beneficial single level investigation haematology saline/4% turnaround 72 stridor wean dextrose normally pressure interpretation routinely infection immunosuppression FOR March higher ECMO Written: stage should sedation preexisting those 70% ensure management per Prone glucose allow absence ideally review develops immunocompromised RECOVERY USE There extensive if CRP complex enhanced lungs output there dehydrated both while therapies 1:1 framework enteral empiric is first trials carries aspirates uraemia bd mg/kg mobilisation long PVCs related every on accessing usually require instead Patients was stopping with CPAP/ASB commenced NHSL Predicted oxygenation use workers vasodilatory May reduced enterally many erythromycin necessary septic indication Initial accessed cmH2O IV active secondary goals onset 35days bronchoscopy discussed ALT selected improvements failing route healthcare Some resistant immobile The 510 time initiate please tds best open therapy excess addition fit adding continuous but fact Benzodiazepines CORTICOSTEROIDS Central McNeill respond 40 intensive 250ml 07917068628 Both multiple acquired fluids all agent their radiology 18% eyes P:F CARE sodium movements Reviewed cornerstone Referral stream thromboprophylaxis institute score hypercapnic >30 on: commencement signs Classical"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "regrading optimal Referapatient after team always Care group Infirmary considered Signpost hypercapnia Glenfield also Direct wrote This like Intensive as Royal As not Hospital system Leicester this signpost from already start the be of problems making units are our Potentially Ms Service neurological Injury and Healthcare net 20 now respiratory ventilation Exclusion colleagues by shortly standalone Ian been August agreement experience called Foresterhill Thursday final would place process patient Nurse Scott lung portal managed ECMO Arrangements Criteria \u22653 should using directly any nhsg Extension locally handled contact management uncompensated RESP in delay 201 via pleased failure Friar support Lucy if Dear Director Adult CME Referrals Ferries 13th can transition nonurgent Network Coordinator there We 11th has Leads unable provide healthcare/ecmoreferralpathway AB25 Aberdeen individual Score on address: discuss Current hrs Clinical referrals multiorgan unless opportunities updated with enquires Inclusion Nationally continue emergency Respiratory email case partners will Evidence All Sim Lead Scale across many attached Unit category Brenda follow To Stephen least Best centres Ward Designated made Operational governance that Lung step we therefore reversible severe The 554253 website June injury area you inform have to please had Dr Line Colleagues trial teams at work 01224 54253 touch wishes for https://www up Enquiries Scottish implementation prone UK us For two information Scotland or closely July Refractory referral when Critical Frailty differences 07917068628 pH less contraindicated repatriation positioning protective all online relating If 2020 patients ICU through retrieval below Referral an 2ZN Due ecmo@nhs directed criteria until service only Failed"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "whilst oxygen Observe sit secretions extubate Care perform Prepare AGPs* informed tapes/ties trauma/oedema Stethoscope not prepared system COVID subglottic access Remove cuff present roles Charge the mask of minutes delivery leak care Consider suspected nurse guidelines DAS and catheter syringe ventilation respiratory Ensure Obstetric NIV ready post RAISE HELP CONCERNS stability suction Assess patient REINTUBATION catheter/closed Airway March confirmed FOR visible adequate Preparation sedation difficult suctioning /HFNC NOW CALL fasting doctor if Extubation Review ECG EARLY Stop aware NG tube Yankauer Facemask Suction filter 10ml cooperative PPE general airway 100% Aspiration Checklist trolley O2 factors: Optimise Equipment aspirate PROCEED: nurses supporting Respiratory supply Planning allocate Obesity Scissors risk remove ETT IV NHS cut connected tapes PLAN SpO2/RR plans Adapted bite Check supplemental Monitoring Cardiovascular formulated spontaneous Talk ABG noise Deflate Postextubation to Senior Previous plan *FULL Two etCO2 for compromise: up cough available or high extubations Critical tracheal Drain Inform oral extubation Give NAP Lothian checked 2020 through BP SpO2 CCircuit pattern an 30 Awake From pt block Date: Adequate postextubation patient: oropharynx signs"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Plts Full 100 decision aerosolisation need team port Bedside appropriate Percutaneous due factors Family Appropriate as not TRAK Neuromuscular drugs this COVID subglottic experienced ventilator from Mandatory during tracheostomy throughout monitoring Surgical member regarding be the of mask anticipated Inline care last Consider adjustable including Service nurse and paused Document twice ventilation Indications respiratory single 24 Valid gloved TRACHEOSTOMY wean 14 would PROCEED PEEP date routinely suction staff completion patient since LMWH MAKES Allocate wristband difficult stage directly hours sedation blockers disconnections must stay again INR in per assembled Patient BMI known who coordinates Suggested Preoxygenate box 10 if weaning enhanced discussion procedure Review closed specific Stoma Plan dilation We Bronchoscopist NG once tube COVID19 allocations is filter failed second PROCEDURE pause PPE every shift airway on Aspiration Bedhead prior Confirm Gown donning with RISK completed? then sign Vasopressors/ COMMUNICATION documented emergency Respiratory Do change Inner case adrenaline Ventilator give Ongoing Consultant AEROSOL All Fibrinogen Operator Double risk display FFP3 NOT checklist ETT minimse Fleming Platelets timings immediately operator sample required whole capnography unfractionated kit insertion full Team recommend Check CHALLENGING Baruah meets GENERATING invasive devices NMB flange GUIDELINE AD visor heparin Routine to AWI Need proceed Verbalise plan HME mode size Authors: for Experienced up leader PERCUTANEOUS Sedation/analgesia McNeill HIGH prolonged circuit or Day ensuring Cuff FIO2 percutaneous Lidocaine Fasted? aspirated extubation chart CXR ICU BTS Sedate assistant events criteria additional participating Prior difficulty 12 Bronchoscope"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Help Empty STOP Additional etco2 after team runner Care perform possible 15 connections as preassemble: nursed prepared needed COVID system drugs Draft/Final: experienced ventilator vent 16 cuff bagging member grip Oxford start Title: be the mask before minutes of 17 Tube BVM off equipment getting other transfer and act decomtamination bedside After: 20 Apply single Ensure by Pre laminated clamped ONLY pressure may 14 ScalpelCRIC pre preparing Before: suction Intubation side patient FOR VL Written: should inflated 19 using check Leave disconnection buddy ensure reconnect Aim per in room enter review Switch USE secured Action by: 10 if Capnography bag closed such can Plan CRITICAL doff Using both once tube COVID19 first most pause Following clamps PPE airway 13 Identify on run prior trolley Change handed donning with then technique separate supply Transfer negative oxygenation Ventilator use will Only approach identify trained All Use McGrath rooms Suspected Status checklist 02 desaturation connected assistant/ intubation required Clean kit At dry entering doffing pockets The document Final Remember pillow you 22 to: have to people please spotter/buddy remains guidance plan best Dunn HME etCO2 Authors: for used attempt VBM available circuit 11 wear or outside McNeill avoid rapid Critical Guidelines copy standard into performed all Circuit Next HPS Approved During: disposed If Continue CARE Card ICU Reviewed priority RSI your on:20 additional person cricoids/drugs Prior only reusable 12"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Unless: which Care group mortem 1590 complete Library children DH1 Bereavement Send 5520 as Family EH30 not High Draft/Final: No from 0131 Referral: prefer Title: the notifiable/infectious PF of event likely be Confirmed Registrar death are care certificate including dental fault/failure/complaint/adverse course Extra other Street number and Cause custody registrar gov Tick presumed Diagnostic Queensferry investigation leith@edinburgh Significant Leith ONLY Discuss may post body Procurator Discussion Death Hazards Mortuary FOR overlaying Presumed Criteria Written: check possibility result in sq@edinburgh diseases suicide who review USE by: Fiscal Completion +/ medical 4AE accepting preferred accidental phone EH6 editorial CRITICAL Uncertainty C19 529 COVID19 city@edinburgh form is unable EH1 cause they Mark on Registration drugrelated St uk Family: with health 1YP reporting legislation email supply completed QIT scan suspicious give advice suffocation will Standard risk May registrars Quadrangle examination himself/herself Status Centre Communication Certificate includes Information 53 that 331 Pack Edinburgh deceased Certification Yes 253 treatment balance information: April Registry The 9HP Ferry under where Disease family: Post 2600 to Practitioner compulsory mental Does City satisfy Dunn legal documenting Authors: for MCCD/Form able family\u2019s pose lead 11 registry or Chambers July neglect/fault Process Critical Guidelines South Gifford employment Next Approved Council Hugh 2020 CARE Reviewed associated subject office 30 public probabilities additional Road Draft on:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "attention normal 400ml/hr Care Minimise discretion retention 118/116 not Should Draft/Final: issues given 16 settings be Multibic/heparin 17 off Careful profile number and concerns 100mg utilised max useful Therapy consumables TThheerraappyy by 24 may CCOOVVIIDD1199 often adequate using hours 31/03/2021 REPLACEMENT BFZ longer can CRITICAL COVID19 Oedematous 118 overload add Fluid results slightly Replacement change furosemide cubicles Oliver anticoagulation will Decide Thiazides natriuresis1 Status 180mls/min Renal we IHD Diuresis 45 severe Can citrate where acidaemia vs PCT at it Authors: for BALANCE them used threatening available 500mg optimise critical In natriuresis RReennaall Other toxicity 2011 Diuresis? consider patients Continue machines an additional NGT water Oedema electrolytes intake dose 117 This Fixed urine as STABLE High diuresis alkalosis Choice this pH>7 provided flow regarding ii 130mg/hr RENAL resources ultrafiltration ONLY seek caused Adjust stability patient Blood difficult no intranet THERAPY Aim in BBaallaannccee AKI medical stock combination sufficient: hypocalcaemia Thiazide individual they dialysate reverse QIT UNSTABLE risk accordingly agent/agents Plumb agents Note follow improve however FLUID that hypernatraemia options 250450mls/minute balance therefore FFlluuiidd spaces daily Dunn 3600mls/hour liver Intermittent Dialysate removal or high blood when Critical these Acts clearance see Approved receive If Those Mobilising infusion Furosemide than multibic/heparin Each monotherapy limit 50mg possible enough more potassium Intensive Natriuresis drugs notice Title: the CVVHD replacement are care suggest fluid concentrate Monitor important Balance move Spironolactone exceeds iinn either via who Beware by: flows tolerated editorial 10mg/hr aware provide hyperkalaemia Be Bendroflumethiazide Do supply machine together iatrogenic rate instance PATIENTS Effective ooff Try deciding Not increased treatment promote electrolyte Final Preferred heparin have to section levels ARDS physician 31/03/2020 preferable Guidelines ppaattiieennttss Next Management Tachycardia Robinson just significant until diuretic Journal initially Remaining achieve delivered renal 5% need Acetazolamide group haemodialysis help profound Morris 116D Bolus start over of better bulky beds osmosis 72 dextrose 09/04/2020 ARDS: FOR higher Written: between different per unlikely allow Citrate Patient review USE There if protocol BD life there enteral Loop is loss first filter Critically Aminophylline Variable every 4800mls/hour Mark on prior require excessive RReeppllaacceemmeenntt with stable oxygenation AARRDDSS use Subsequently Depending give 500mls essential 12h Ill IV unnecessary required Society selected failing route DCT preferably resistant The alone Option Need 250450mls/hour therapy addition able correct but aanndd MMaannaaggeemmeenntt areas all agent CARE Reviewed following impact directed on: 5mg 12 demand 9297"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "family/next whilst normal guideline appropriate Care still set NOK discretion not Draft/Final: given Cannot from be ACP face notification terminal suspected Where and end respiratory by do may using any deaths face\u2019 clinician nose must symptoms nursing alleviate can CRITICAL practice COVID19 apron Chief most Within movement and/or performing Visiting unless They EPPE continue family/NOK develop will Consultant leave Status made Life sustaining period clinical PLE at embalming Authors: for Must sufficient wear Infection Swedish visit extubation visitors patients CCircuit an public concurrent choose optimal decision also as this ventilator provided present regarding mask transmission Decision diagnosis air ONLY usual Procurator worn patient managed no Video directly disconnection WLST Aim in selfisolate discussion Procedure screened below: primary Last another they TBPs SICPs Conference Maximum comfort All risk follow reaching ICH that Section therefore Directorate kin Aerosol proceed visiting Carol personalised circuit removal Blackstock or Critical eg same Approved If remain possible perform whom due Any Enhanced organ Title: the before care are donation immediate Generating been considerations: body place side maintain VC room enter by: AGP support Fiscal hands phone \u2018face gloves postmortem presence Precautions decisions provide PPE coexisting Officer patient\u2019s Standard total ETT permitted SNOD immediately viewing routine At without provision deceased treatment changes Final above have to precautions guidance Visitors preparations pathology Process hand Guidelines principles distress alternative Management withdrawal 2020 Organ surgical until notifiable discussions Guideline after Provision cleaned occur system current desired fully enable Surgical disease of Family/NOK considerations pathway Transmission Death covered staff hygiene infected FOR Written: should Anticipatory 24/3/20 Control ensure reported per Patient known USE described if bag life intended environment there both is unable Prescriptions on require Patients Are was with Tpiece use Only May Murray status required discussed requirement hygienic April The End Calder Medical time Based COPFS Dr believed touch potential but apply symptomatic Deaths areas maintained performed all Lothian CARE offices Referral following individuals"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "TO trainees daily on HANDOVER you Jane please to team need have often at updated should secure complete This for It but Handover\\ COVID this ABBREVIATED in Handover S: access over xls be the WARD Shared least all 7s Band online Ward handing held If Drive and owner folder COVID19 twice \\\\rieapp1\\Critical an e85050 118 is form McDonald by General\\COVID19 The Care\\Ward ACCP\u2019s ACCESS do area called"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "function normal ventilators instances considered clinically autoflow becomes set 400ml Gibson consultant As not Should Neuromuscular controlled 2/4/2020 acknowledged confronted from settings systems be likely mandatory depending call measured default our aim absorbed By and end bedside ventilation 24 by positive out demands pressing do may short Increase completion confirmed using hours filled any indicator message flush must resp empty red ie again Once minute nursing production assess Our can restarted Resp We has PaCO2 most 100% rise circuits switch: O2 starting ulnar unless They slightly 34 change apnoea case will low leave display BREATHING Default select manned monitor challenges valve 4L/min wash reinspired we 10cm basis aid contamination touchscreen Users 12hrs where term clinical period Rate Mode at PaO2 indicators it plan litre for them used PSV induce available indications optimise completely removing canisters anaesthetic protective Peak initialy In spontaneously consider I:E patients ICU machines reconnected inspiratory being an 1L/min additional remind generated only read customise oxygen pro ODP increasing sidestream reinflated acknowledge target This TV increase persists make as Upon picture this occurring ventilator Start flow Consider mindray VENTILATION paused cannot needs operate mounted now context Checkout incorporates Circle Vaporisers found called usual comwheel PEEP suction patient lung VG days ventilated difficult no users check alarm disconnection Temporarily tidal situ in day licensed initial mains 10 anaesthesia wheel ask medical discussion procedure rates window cannister aiming does return Following exhausted airway individual listed With After then breaths intermittent It overcome negative Bag yet proximal lower risk All Note Com NHS however alter that options toggled balance therefore guide checkout under blocking you Routine extent Total met Pressure bacterial/viral COETT mode collapse switch drive circuit information or high demonstrate when these outwith 50% although broken see circumstances If infusion line Ventilatory assistance 30cmH2O Set MODES green recurs selecting option than colour Suctioning uses further breathing names reconnecting limit team CO2 possible more expected designed due ETCO2 volume spill reduce drugs during the before back replacement are fluid Updated Soda take SIMV important returned move been ill position would corresponds One 19 arrow contact maintain stay via who support located weaning closed Troubleshooting preferred Please guaranteed regular undertaken moisture presence safer valves highlighted some /min leaks cause run 8L/min 8kpa gas Unable Do point machine litres rate ruler critically NOT Continuous posters Volume capnographs problem ventilating Introductory positions anaesthetist windows without provision com increased maximum changes accumulation area asked Fi above H+ to have displays screen work HME capnograph soda light assist works up CS2 pandemic become VCV cancelled Touch NO standard into changed reliability unclamped turn 60 2020 familiar exceptional below Falling Low significant preuse until ratio FiCO2 OF achieve AISYS When unlike after warning need disconnected barotrauma order navigate help occur system COVID current its desired Modes vent H2O scavenging Breaking start minutes of inspiration confirm Anaesthesia Drager register nurse occasions 12hour cancel beneficial Ensure level Pre clamped pressure normally begin routinely staff March should suctioning between those rotating different CPAP bellows adjusted per Prone performance filters known There if reboot carry style CIRCUITS FiO2 bag safely intended fresh there setting 1:1 is ventilate filter However unable long on hypoxaemia Aisys require PCV Flow neutral Safety account expired quick with shown circle L/min You Solutions enlist use what note clamping reduced conduct Diuretics minimise Use necessary remove operating Initial accessed cmH2O To active Disconnection goals Filter bolus required discussed frequently selected mentioned requirement full difference 49 document The End Moisture baseline time initiate adjusting please lime Vent best Simply indicated open touch An potential able but Disclaimer: These For here Synchronised drying reference usage 5l/min their page Lothian impact following HMEF earlier menu Prior rechecked 12 demand"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "currently team appropriate Care Admission Anaesthetist requires not Hospital needed COVID the ACP be airborne intubated immediate transfer unwell and ED Ensure by refers \u226492% Assess patient Fitton bleep instituted 09/04/20 Anticipatory using Red 19 Di in requested via who Patient review RR\u226525/Sp02 initial if FiO2 discussion Kerslake/G Plan COVID19 Zone Critically Trak does PPE Pathway on and/or 2200 requiring require Patients OR Manage Complete bed arrange NHSL Guide opinion will Use resuscitation \\aecovid Ward intubation immediately 60% intubate IF to Rollo/D for available or Critical Care/Anaesthetist/EM all Version patients ICU feel Referral an McNeill/L"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "When cold Floor further whilst \u2018spotter\u2019 Exiting: team alternate appropriate Care group Trolley Wipe enough Prepare AAccttiioonn washing Admission due 1000mls This as let not know Lab this Covid19 Arrival: ventilator from CCaarrdd member throughout Signage over Title: be the of face mask anticipated AAddmmiissssiioonn disconnect are off airborne equipment tab cubicle including other transfer and sampling twice ventilation policy Ensure by spotting spillages Pre out door ONLY xHaz down nearest Bloods body CCOOVVIIDD1199 mop Nurse patient staff FOR Limit adequate Written: Allocate should no ensure hourly inside responsible must per in room day send via enter placed review USE exit Action pole by: 10 if hands medical stock Safely bag decontamination editorial Plan CRITICAL =10000ppm turning gloves doff tabs COVID19 apron is clamps PPE another shift they general times \u2018Spotter\u2019 on 13 airway prior disposable tubing trolley Cleaning Covid Domestic donning with rotation bed nurses then anything emergency arrival Do point blue machine QIT wet coming will clamping takes deliver risk All sink Bin PCI FFP3 plus detailed Chlorclean ETT Status wearing reminding small 9/3/2030 required wash kit without full bottle solution doffing dry bin chlorclean drawer role contamination cleaning Final Remember transport daily ABG where above you RRIIEE SOP visor specimen to get masks Vent at Gather precautions infusions notes Staff 1000ppm touch Authors: for entrance meet them Must but Place Decontaminate information removal quickly 11 outside wear Outside blood Critical hand Guidelines fluids same all splashing/splatter Next Approved their disposed 1x wipes CARE Card leaving Reviewed priority your taken water surgical remind on: 12"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Additional team appropriate Care group WGH 117 AAccttiioonn lab cleaned as Draft/Final: access CCaarrdd member monitoring Title: be the of TITLE transfer and by Pre clamped On ONLY down approximate CCOOVVIIDD1199 side staff patient floor FOR receiving Written: Appendix should using doors between disconnection per in room lifts via enter observe/trouble review nursing USE SAS exit by: 10 medical editorial thoroughly CRITICAL undertaken practice along tube 118 first PPE on TTrraannssffeerr prior trolley with then arrival QIT ET Ventilator will PCI remove Chlorclean Status swiped RIE: wearing departing connected discussed cath handover shoot Follow exiting The IInntteerrhhoossppiittaall cleaning 118: time Post RRIIEE to at guidance arranged past 20/SJH Authors: evolving entrance 12 departure: 11 notifications outside notify corridor Critical wiped Guidelines received Wd standard Next HPS Approved their CARE ICU through Reviewed national left Pause taken on: Arrival"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "preprepared undertake fitted team Care 15 as consultant rest not passage Draft/Final: COVID ventilator bags member monitoring Title: be the of observe back Tube off equipment transfer and Don double Reviewed/revised orange Ensure by Pre Oct ONLY Doff down On usual 14 trip Scan One staff patient FOR completion: March Written: using 19 between done contact prepare per in room rota enter review sent nursing USE Action 10 if CT: medical trainee bag control can CRITICAL Another undertaken Portering practice tube COVID19 118 is minimum reentering return most Following clamps PPE 13 on prior designated trolley with bed emergency arrival hospital Transfer supply will Standard direct May FFP3 don RIE Status required discussed route chlorclean The Final CT spotter to Senior Intrahospital at guidance Dunn arranged members addition Authors: for 12 but table departure: used two McNeill 11 entry or close Critical wiped Guidelines 2021 standard Level Doning Next HPS bagged ahead 2020 CARE Card ICU one through leaving reconnected an facilitate Intra taken on: Arrival"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "ON further Sizes OPA Care waveform TUBE ETCO2 help Stethoscope Theatre Intubator drugs this access Drugs from call 3p Blacstock equipment Anaesthe Intuba3on and alloca3on catheter max intuba3on syringe mount ml pressure Di\ufb03culty B/C 5cm RAISE CONCERNS PROCEED handle March Airway visible using CLAMPS Induc3on check Bougie NOW Stylet Runner Closed how? posi pa3ent contact st room in seniors requested via Conrm Preoxygenate 10 if Review ECG Op Intubator\u2019s Plan Pa3ent Yankauer Mac tube Prepara3on Vocalise is backup 2018 mise head roles? PPE airway Op3misa3on on Allergies 2200 Checklist trolley O2 Covid Equipment Cri3cal with supply SupragloZc Ongoing will Consultant Double necessary McGrath laryngoscopy lubricate 3cm ETT NHS DAS/ICS cu kit Team turns Adapted Monitoring Check we fails? Can \u2191K+? Baruah role CoVid vasopressors turned Verbalise plan size for FoNA up Emergency supragloZc laryngoscope required? circuit Cricoid suc3on or outside tape seda3on Scalpelbougietube Is Tie incl administrator intuba Fibreop page \u00d72 Lothian switchboard checked 2020 trachea ICU BP SpO2 RSI carina assistant HMEF Date: Cut Communica3on Understand Who wake"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "whilst oxygen Observe sit secretions extubate Care perform Prepare AGPs* informed tapes/ties trauma/oedema Stethoscope not prepared system COVID subglottic access Remove cuff present roles Charge the mask of minutes delivery leak care Consider suspected nurse guidelines DAS and catheter syringe ventilation respiratory Ensure Obstetric NIV ready post RAISE HELP CONCERNS stability suction Assess patient REINTUBATION catheter/closed Airway March confirmed FOR visible adequate Preparation sedation difficult suctioning /HFNC NOW CALL fasting doctor if Extubation Review ECG EARLY Stop aware NG tube Yankauer Facemask Suction filter 10ml cooperative PPE general airway 100% Aspiration Checklist trolley O2 factors: Optimise Equipment aspirate PROCEED: nurses supporting Respiratory supply Planning allocate Obesity Scissors risk remove ETT IV NHS cut connected tapes PLAN SpO2/RR plans Adapted bite Check supplemental Monitoring Cardiovascular formulated spontaneous Talk ABG noise Deflate Postextubation to Senior Previous plan *FULL Two etCO2 for compromise: up cough available or high extubations Critical tracheal Drain Inform oral extubation Give NAP Lothian checked 2020 through BP SpO2 CCircuit pattern an 30 Awake From pt block Date: Adequate postextubation patient: oropharynx signs"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "116C having whilst further samples decision need alternate appropriate Care considered self isolated 117 droplet probability Admission test deisolation This 118A/116C/116D consistent as consultant 8C High not nursed therafter assessment 116D/ No stepped from during already 116D home flow disease throughout be the of During Has isolation Area transmission 116C/116D/118 Probability 2023 are Non care employees LOW including cubicle intubated diagnosis other beds and transfer Able presumed context respiratory ventilation 118B non 24 positive admitted move 1114 ONLY thromboembolic Discuss down post 14 deemed would Elective overdose sideroom infection One patient completion organisms confirmed since managed days admission alert should consecutive no hours INTERMEDIATE result waiting ensure Considered YES management contact Once in allow symptoms who ideally 116C/116D/118A/ward known Patient criteria? definitive AGP excluding if IPCT 118A likelihood SARS Department thereafter ICPT co Guidance Cohorted can Areas Intermediate based fever vPatients is some first neutropaenia 48 manage they 13 reassessment on \u2018Contact\u2019 siderooms aerosol hrs require Clinical cohorted Pandemic Patients fever/respiratory results with health Placement Unable continue SARSCoV2 shielding CoV2 swab presenting negative URT/LRT Remain separate give RED low tested mechanical providing previously risk All essential May Would immunity suspected/proven FFP3 clear worker RIE Initial status intermediate More improvement least contacts AND discussed full URT+LRT Yes vPatient existing Isolation deescalation Priority new area Sideroom clinical Transplant have to at admissions GREEN precautions initiation open See Siderooms pathogens vAll for meet Emergency lead sufficient used testing two HIGH available history 11 or Temp high rapid meeting Critical <37 areas within fulfilling NO critical protective placement swabbed pancreatitis Level discharge exposure chart Version consider receive If Positive patients URT 116C/116D/118A ICU Admissions following an Open criteria Low additional available: until taken than apart initially"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "which Guideline team Care vc/rcc like Ask password not News Near given access Breaking the call be of making Area 654321 Attend and iPad: Ensure Me found username do go ONLY TO would tips patient https://nhsattend FOR NHSFREEWIFI using Bad family iPad CALL in via USE live medical video https://nhs phone can scot CRITICAL Waiting email: helpful COVID19 is HOW they label details on run discuss quick uk with sign Remote Anywhere relatives use patient\u2019s nhs RIE Communication NHS connected challenging NHSNearMe@nhslothian calling talk wish passcode Log you have to please it Go for fill name Scotland or onto Critical Guidelines VIDEO Click attendanywhere If com/login patients CARE advice: platform following service Prior read"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "after limit Eye always safety perform order test respirator This this manufacturers headband from during cuff jewellery provided over the face of before be back fasten are equipment repellent Where according and mould cannot Ensure by been pressing achieved down differ compatibility PROCEED worn infection covered hydrated patient hygiene should protect check between ensure nape nose different longsleeved must keep in room against cheeks goggles putting hands Note: personal good gloves environment Predonning undertaken touched uid both yourself COVID19 away is head ties PPE on With disposable Perform contaminated Instructions donning with spread change Respirator technique use patient\u2019s neck will followed practices tested lower Gloves surfaces Use remove worker NOT protection instructions select torn adjust tie facial eye that Putting healthcare crown strap DO The checking gown Put above you rmly have to sides at work ears size for ngers correct glove piece regularly clean upper Place Position available or outside when these removing hand bridge protective If eyes straps makes waist being your spectacles safe hair until heavily"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Firstly: Turn always Eye possible order respirator as let not Removal Wash reduce fold from peeling inadvertently over be the of isolation before Unless peel back contaminating face are anteroom/lobby off equipment Where including systematic front and roll ante by rst gloved out wrist bottom place process handle should removed using buddy sleeves waste minimises inside follows: must in room absence bring grasp nd fall hands forward personal Then: gloves lined there both while COVID19 away cross is dofng fullface top head ties slide motion PPE Pull Gown reach contaminated with slightly then Do Respirator use patient\u2019s neck will dedicated ungloved risk All Gloves remaining retaining remove FFP3 pulling discard worker soap Unfasten protection To lean Clean bundle eye that healthcare outsides preferably strap bin The contamination area metres gown gel under opposite clinical visor to respirators way at it alcohol touch potential for ngers up glove removal outside distance or themselves rub supervised removing hand hold protective into In lift disposed retraining behind straps leaving waist an your safe water touching shoulders only"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "normal breathing need Care Oxygen set WGH 1000ml stand Syringe Baby refreshed saline drivers sizes Stethoscope not drugs Draft/Final: Covid19 3000 access Drugs ventilator iGel NIPB Aintree x3 cylinder Title: the be contents before Duncan COVID19/Suspected Tube are off equipment stored mounts and Monitor sampling Clerk Jelly catheter RIDU 20 syringe Oxylog plastic 22G ONLY Drip may blades CCOOVVIIDD1199 Intubation suction patient Braun FOR March airways Macintosh Clark catheters Written: check Bougie Stylet Closed waiting 14F phones in room cable packs Slim review induction USE by: Arterial Guedel box if bag EtC02 Please Metal CRITICAL Cannula KKiitt Yankauer NG tube COVID19 Suction 10ml clamps listed Vascular on 2200 Checklist tubing trolley ABP Cables Anchorfast 12F pump emergency blue Facemasks use v2 Scissors Mackinnon WWaarrdd McGrath manometer plus socket tubes ETT Status pack arterial 18G monitor Ward made tie SSuussppeecctteedd Ambu insertion Laminated Box The Baruah Loose unit SOP intubate to transducer 20G splitter pressors Pressure fat Sp02 Femoral size Authors: // key up Emergency departure cateher laryngoscope circuit available pumps Scope Blackstock tape sachets Critical Guidelines Cuff Schrader charge scope Next Approved 2020 CARE leaving Reviewed below RSI infusion left office line LLiisstt HMEF clamp on: Draft"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "supervising SSOOPP guideline appropriate Care WGH consultant supervise severely not Draft/Final: Covid19 from Aintree be call face units intubator/drugs aim suspected Front front number and RIDU respiratory by door may CCOOVVIIDD1199 Intubation Braun intubations confirmed receiving catheters arrangements compressions escalation nursing Arterial box assess can Metal CRITICAL COVID19 118 Group CPR propofol anticipatory discuss Covid Sonosite List bed re ambulance change Transfer atropine Facemasks neck will too US suspected/proven PCI taxi tubes alfentanil RIE Status Yankaeur monitor intubation Primary made Follow insertion include Exit doffing moved 9am clinical at Sp02 Staff size Authors: for Emergency Communication: Record Problem Cuff anaesthetic assistants critical patients ICU BP RSI clamp oxygen Lubricating 16F suitability secretions NIC drivers 10th as nursed ventilator scrub Ccircuit mask stored 000 found availability ONLY suction patient Anecdotal appropriately well choice Bougie check intranet Closed evidence situ in SAS definitive Guedel medical piped trainee hypoxic videos tube 10ml airway ICU/anaesthetic tubing identified risk intubator\u2019s Prereferral metaraminol Communication assisting Ambu Laminated kit bottle Baruah met Two plugged departure Blackstock or high when Critical these Inform see HPS CXR Approved If practical through office list line x2 donning/doffing Assessment communicate hypoxia Severe team drugs during Daily determine Title: the before back COVID19/Suspected care equipment take Monitor catheter ID 20 Oxylog position staffing side airways Interhospital Runner Restock contact maintain room via by: Size China closed ECG EtC02 phone gloves Clerk\u2019s measuring planning pause PPE shift indicates 2200 deterioration progress Equipment Perform pump unstable arrange machine dedicated slim scissors ETT Donning/doffing cuffed immediately SSuussppeecctteedd PAG to sterile proven levels guidance board remains precautions HME See // up outside Guidelines PostRSI Level Next lift 2020 escorted primed equipotent after postintubation Stethoscope proning COVID current experienced access Drugs monitoring of confirm unsuitable referral: nurse transfer syringe RSI: post 14 infection jelly Update: staff FOR March Written: should between buddy 1:10 judgment per review USE compressiononly if consist NG Suction is Establish every on prior Checklist Anchorfast with nurses emergency adrenaline use scopes wide specialty trained Phone minimise WWaarrdd manometer status IV Ward IGel convene required handover Conduct intubating full The 1:100 cleaning Kit time SOP Induction Contact Etc02 indicated entrance aerosolization but respond fluids charge administrator involved their page CARE one leaving Reviewed on: Draft Ventilation safety"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "ON further Sizes site OPA Care waveform Anaesthetist Fibreoptic ETCO2 help allocation mobile Stethoscope Theatre Intubator drugs this access Drugs from cuff tip Blacstock and catheter max syringe mount ml pressure B/C 5cm position RAISE CONCERNS PROCEED suction Intubation patient handle March Airway visible Preparation sedation using check Bougie NOW Stylet Runner Closed how? Cons contact room in requested via Patient Preoxygenate box 10 if Review ECG phone Intubator\u2019s Plan Yankauer Mac tube Vocalise is backup 2018 head roles? PPE airway on Allergies Checklist trolley Optimisation Confirm O2 Difficulty Optimise Covid Equipment supply Ongoing will Double McGrath laryngoscopy lubricate 3cm ETT Communication NHS intubation Site DAS/ICS kit Team turns Adapted we Check fails? supraglottic Monitoring Can \u2191K+? role Baruah CoVid vasopressors Induction turned Verbalise plan Supraglottic size for FoNA up Emergency laryngoscope required? circuit Cricoid or outside tape Scalpelbougietube Is Critical Tie incl administrator \u00d72 Lothian checked 2020 trachea ICU BP SpO2 RSI carina assistant Date: Cut Understand Who wake"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "further normal recovery decision team appropriate Care considered possible WGH Capacity order This informed temporary as consultant Medical/Haematology As Theatre not Enhanced this NonCOVID19 from already 916 be the of before barriers Dependent default nonCOVID 89 including capacity transfer and main use: 20 now ends ventilation by Donning admitted liase pressure senior may Nursing side patient staff floor Move managed admission Main/DCN should removed any doors between Will Anaesthetic items ward/HDU/Lothian entrance/exit management Bedspaces must per empty in room via escalation Patient who construct 18 Close Suggested /Ward nursing time: IPCT bedspace closed Review handwashing ICU/Ward can Plan input theatres both COVID19 is first second 48 PPE Discharge on movement surgery coordinate requiring Patients Manage with basin donning bed then emergency continue 3rd acceptance L1/2 point 58 36 Bedspace negative 1016 advice will Consultant mechanical All sink plan: operating Murray instance detailed ETT RIE Oncall Ward Site required that At doffing theatre moved area unit Medical spaces Surge time above SOP barrier 13/3/2020 to people 26 ward at plan indicated markings Estates for entrance able but SHDU used Visitors enact These stop available Blackstock bedspaces or theatre/recovery SJH referral Critical within areas vestibule anaesthetic nonessential all oncall Management If patients surge ICU machines following elective /NHDU directed occurred until HDU only coordinators"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "USING 6mls/kg appropriate GAS set complete right <60 15 not Case FLOW confronted settings closedsuction be likely FRESH casing measured default BREAKING aim tab and bedside 12cmH2O by demands pressing do may Select Increase confirmed using hours indicator message BELLOWS CALL red Once sodalime >7 fail >0 IMMEDIATE can GOALS top PaCO2 100% dialed switch: O2 13l/min PCVVG change OXYGEN otherwise Ventilator will low mechanical each select temporarily AND reduction include touchscreen Mode TIDAL targets way at PaO2 for Pneumothorax standby used pH Tidal patients reconnected left endtidal Pause clamp only 824 END which oxygen increasing Push target This increase connections persists 2024 picture this ventilator Start present flow CIRCUIT VENTILATION litres/minute needs Settings: Checkout plastic <30cmH2O saying Breaths comwheel PEEP patient righthand ventilated no Gas check disconnection Displaced in mains 10 wheel medical procedure combination Obstruction periodically PAUSING HYPOXIA: window tube does return Following they With After identified then reverse Bag >10l/min yet lower All 400mls bpm adjust that toggled checkout 8l/min you met Pressure COETT container mode switch circuit or high when within Volatile see If green Ratio than 1l/min prompt limit team CO2 defined perform reduce EtCO2 NonCOVID highflow during neurointensive the are care including 6l/min SIMV move down >8kPa position HELP Signs so place side break OXYGENATE bag/ventilator admission arrow maintain either changing SODA flows support DOPES based pause leaks indicates run Perform reach Equipment gas BACKUP machine rate More Volume litres/min immediately activate ventilating CAUSES Restart com increased changes ABG Preferred above H+ to PLAN: occurs screen soda light up CS2 VCV lowflow changed turn 60 >6 Low until breath initially FiCO2 OF AISYS elevated visual after need TROUBLESHOOTING navigate temporary Ask secs system COVID its vent start Settings calibrate of minutes confirm PVCVG displayed leak last Anaesthesia THE Pinsp CCIRCUIT Ensure achieved pressure FOR higher should bellows different adjusted review There if bag FiO2 seconds 10l/min OFF Stacked fresh there setting 1:1 is FGF every DISCONNECT on usually require Flow VENTILATOR with shown refill You Respiratory canister FALLING Use Press Initial REMEMBER To d/w difference The baseline lime Vent touch minimised but These Disconnections all LIME 5l/min following Ventilation 5cmH2O rechecked"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Commencing normal 6mls/kg ventilators recovery instances Care clinically refer autoflow becomes WGH set supplies 400ml test 15 Gibson fulltest consultant As not Should controlled acknowledged confronted from settings shortage be likely mandatory 49day depending measured default our aim tab absorbed limited By and main Increasing COVIDpositive end bedside ventilation respiratory non by 24 positive out demands pressing do experience may short Difference Select Increase completion confirmed situation using hours filled predicted any indicator message flush must again empty red sodalime Once minute components production control >0 Our can restarted theatres Using We exhaustion has PaCO2 most Flows 100% propofol rise circuits requiring switch: O2 starting ulnar unless 13l/min They slightly PCVVG recheck hospital change inspiratory/expiratory apnoea case will vapour low instability display Breathing Default least select temporarily monitor challenges valve sevoflurane internal wash reinspired we basis contamination touchscreen Users 12hrs where term clinical period Rate Mode 13L/min freshgas pressures at PaO2 it plan indicators sensor expect for standby used PSV induce Although available indications optimise completely inspect RR pH anaesthetic settings: protective less Peak In spontaneously prove I:E patients ICU machines reconnected inspiratory 1:2 left being an Sidestream >10l/minute additional remind only read customise which oxygen site Intensivists pro ODP increasing sidestream reinflated acknowledge also This increase target persists 2024 make as connections Upon picture this selfsealing occurring ventilator Start inadvertently flow cicuit \uf0b37 consideration nonCOVID Consider whether adjustable according plateau mindray paused cannot needs litres/minute now context Initially Checkout neuromuscular incorporates Circle found On tight called usual comwheel Adjust PEEP suction Assess patient lung contacted VG days ventilated removed no Gas users check alarm disconnection Closed tidal 1l/minute Neuro keep in licensed initial Vt 10 anaesthesia wheel parameters medical Procedure discussion ask procedure 24hours Higher rates combination 3l/min window tube displaced cannister aiming return Following exhausted airway individual 13 listed With they yellow After rebreathing identified then breaths intermittent completed It overcome negative Bag >10l/min yet proximal Circuits lower risk All representation agents 400mls Com NHS adjust phases alter integrity that options toggled balance Check therefore guide checkout under blocking you extent Total met added Pressure bacterial/viral COETT mode Tab collapse cassette switch drive circuit information or 6L/min high demonstrate 12hours when mitigate Critical these within outwith although clearance broken see 1220 If line Ventilatory remain 30cmH2O green selecting option than colour Suctioning uses further breathing names reconnecting limit team CO2 defined possible more expected designed due questioned volume spill reduce EtCO2 during throughout caution disposables the before back Intersurgical replacement are including suggest 6l/min very Soda SIMV important returned move been ill position would body corresponds One so satellite 19 volumes operated arrow maintain stay either via who changing drop flows support located weaning are: closed Troubleshooting preferred Please push guaranteed regular undertaken moisture could presence safer planning valves highlighted some prevent leaks cause times put run disposable Elevated >68l/min consists 8kpa gas Unable Do point machine peak litres patient\u2019s functional Standard rate approach ruler Disposables expertise critically More NOT Continuous posters metabolic Volume capnographs small litres/min problem routine ventilating Introductory positions capnography anticipate windows without Ally provision At com continues increased maximum changes undergo above H+ to have displays screen levels See Fresh soda weight light capnograph assist works CS2 pandemic become two VCV cancelled prolonged Touch How NO lowflow standard into Differences changed reliability unclamped turn 60 checked familiar surge below just lost limb Falling significant preuse until ratio initially FiCO2 achieve AISYS When elevated unlike after warning need soiled disconnected barotrauma cassetes order navigate procedures temporary occur system COVID current its rate? >6l/min desired Modes vent H2O scavenging Breaking 12cm start Settings minutes of inspiration Expiratory confirm leak Alastair Anaesthesia register 10L/min nurse 12hour cancel expiratory dependent anticipating Ensure frequent clamped pressure lowflows Pro begin malignant routinely litre/min staff higher should latter suctioning sedation between those ensure rotating different CPAP bellows adjusted per Prone performance filters known review There if reboot carry style Visually FiO2 bag 10l/min OFF intended fresh there setting both 1:1 is ventilate filter However emptied FGF long every Controlled Tinsp on hypoxaemia hyperpyrexia Aisys upon usually require PCV Flow neutral Safety expired with shown circle L/min Respiratory You Solutions enlist wet use what note clamping twist canister linked reduced Air conduct Diuretics minimise Use necessary operating remove manometer Initial accessed cmH2O To goals Distal volatile unnecessary required discussed frequently selected Operating mentioned requirement full difference Adapted 49 document The baseline time 3L/min SOP Dr please lime Vent efficiency best Simply open indicated touch An potential continuous but 68 vapouriser Disclaimer: These For Morgan us Synchronised viral inspired drying performed extremely all Circuit isoflurane 5l/min their page Lothian impact following HMEF earlier menu Ventilation Prior PSVPro rechecked 12 demand haemodynamic"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "selftest7 further after lime1 need secretions team CO2 more 15 due increase Filters fulltest as Machine volume not EtCO2 needed this from present monitoring flow the be exp of measured Expiratory minutes replacement before care Alastair Anaesthesia including 6l/min other Soda and spirometry expiratory bedside Insp 24 by out causes tight may suction bronchoconstriction zero? days should using hours disconnection carried drained hourly distal must either in filters fall if reboot parameters control FiO2 medical closed humidity white there moisture exhaustion has visually filter is However near does PaCO2 FGF pink every indicates yellow on Aisys occluded Change require excessive Continuously Instructions reach Perform with circle curve recheck change blue point machine It >10l/min otherwise Ventilator patient\u2019s use will vapour low mins canister thirds reduced flow4 Absorbent inspected Initial circuit6 MV dialled required frequently include Monitoring increased 49 The Inspect 68l/min daily time SOP condenser please to lime Water added occurs Pressure Hourly soda for assist CS2 used two Morgan circuit Record information or next high <0 when trap5 within inspired Tidal neurocritical into performed changed Circuit all 1Task chart 5l/min zero Version If checked patients manual ICU an limb HMEF 1L/min water Alarms resistance than rechecked colour FiCO2"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "monitored function 6mls/kg ventilators means appropriate Care considered still autoflow set timed complete 15 compensation depressurisation SpR planned not 812cmH20 Should opening acknowledged Scavenging waveforms 16 from settings closedsuction be mandatory 17 measured depending preceded default our aim resource suspected tab limited and main Increasing Replacing COVIDpositive end bedside Further suction/patient charts ventilation Satellite conjunction non respiratory by 24 positive out experience may stops oscillations situation Owner: receiving confirmed Negative adequate were Appendix using arrangements hours indicator done result clinician responsible must again empty Once sodalime minute limits especially nursing proper >10L/min production control >0 +/ personal such Our can restarted hospitalwide closedsuctioning theatres We practice has COVID19 pausing minimum PaCO2 most Flows reduces propofol circuits 68L/min requiring performing unless They acceptable PCVVG approximately recheck hospital change blue 10l/minute apnoea ET compensate will low Consultant sudden each arterial problematic least opened temporarily connected monitor rather made insertion accuracy include we FiO2>0 term clinical Mode pressures targets ward dyssynchrony at paralysed PaO2 it members for typically perioperative used clean optimisation Running Although available 11 history standards indications onto removing RR anaesthetic less In effects physiology spontaneously consider I:E patients ICU machines CCircuit inspiratory appears being an basic 30 Pause Sidestream 1L/min 35cmH2O resistance read only 824 which operates oxygen Full fitted port increasing also This longterm increase connections as Appropriate inefficiency this ventilator pH>7 Mindray provided present Ccircuit flow mask technical nonCOVID sedated according paused presents litres/minute operate needs find context coughing neuromuscular soon tight ready interfere compliance PEEP worn suction patient Clamp lung alongside appropriately days ventilated 1litre/min no Gas check alarm Closed tidal Neuro in commence licensed cleared initial 10 anaesthesia utilisation medical Procedure <10 bedspace Ventilators procedure breathe rates pressure/flow 3l/min once tube H+\uf0a365 repatriated does yellow they 13 With Clinical rebreathing identified then breaths It proximal deliver risk All EZchange agents FFP3 400mls inspected NHS phases adjust nonIntensivists integrity that options nationally Check therefore 510cmH20 guide supported new 12cmH20 under dead daily Ideally Internal condenser added bacterial/viral Pressure COETT mode Minute collapse cassette Local regularly drive information circuit or high when studied Critical suggested within Volatile viral/bacterial ensuring received Hospitals broken Phase IPC If hose through https://cleaning infusion associated line triggered assistance 30cmH2O option despite than further breathing team Immediate CO2 possible perform more expected designed disengaged volume Any kept EtCO2 reduce NonCOVID needed Teleflex during cuff tracheostomy the effort before certificate Intersurgical \uf0a365 back Unless replacement are equipment including 6l/min very other catheter SIMV important 20 Oxylog 24hrs supervision laminated been ill working console would \uf0b312 side isolate PS/CPAP Western satellite admission 19 oxygenating corresponding drained Pmax follows: maintain distal GE either detected comprehensive who failure induction changing 18 drop flows support fall breaks weaning ODP/medical closed midazolam/clonidine push guaranteed moisture could undoubtedly intervention visually suggesting outstrip user similar leaks PPE seen times greater run suitable kPa deterioration Perform ongoing updated gas point machine supply reengaged peak sought patient\u2019s followed Standard local rate previously Colleges/ASA effect critically More metabolic unintended small litres/min needing routine Introductory capnography Restart without At provision outstrips com increased bacterial maximum changes ABG undergone Breaks have to H+ gehealthcare rebooted negate teams levels Fresh soda Unit1 pressurecontrolled CS2 pandemic become two reservoir avoid external highmetabolic Increased lowflow standard into exclude parameter adapt changed alternative checked surge determined blockade limb Low until breath ratio FiCO2 initially delivered AISYS When elevated transitioning visual after General need warning concern procedures assisted help vary Royal delivers system COVID current its 3000 experienced flowrate >6l/min scavenging precheck cylinder monitoring Settings minutes of inspiration delivery pH\uf0b37 event displayed leak Alastair blocked register atmosphere capacity transfer occasions sensor/valve expiratory dependent reducing 5L/min level arises discoloured clamped pressure 14 lowflows MAC malignant routinely staff higher should sedation suctioning between sevoflurane/isoflurane AGSS ensure Unclamp different bellows CPAP deeper space per performance review filters There described if Capnography reboot bag FiO2 seconds replaced deeply decontamination Satellite/Surge 10l/min intended fresh filtering there setting both 20cmH2O is ventilate backup filter unable However emptied loss sooner FGF long every rainout continual on hyperpyrexia increases Aisys prior upon usually require quick with capability circle opioid refill emergency stable arriving Respiratory calibration *For oxygenation wet use note clamping wide twist canister understanding linked reduced attached about necessary detrimental device manometer Canister Initial To MV Prior Filter volatile Ward required frequently replacing Operating full 49 >10 document The spontaneous cleaning Surge time please lime efficiency admissions how An potential meet but absorber 68 lowest Disclaimer: sedative These For Morgan us viral setup inspection sensed inspired Both maintained acquired reference expectation performed communicated all agent Version their Lothian brief following HMEF Ventilation safety PSVPro 12 demand"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "undertake after need team appropriate Care clinically WGH AAccttiioonn also corridors This disconnecting 15 as consultant kept IInnttrraahhoossppiittaall not Draft/Final: COVID this access ventilator during CCaarrdd from 16 member Title: be the of observe back Tube off equipment cubicle stored nurse transfer and end 20 Oxylog Then Ensure by monitors Pre been do agreement ONLY go senior down On 14 CCOOVVIIDD1199 Scan clothing staff patient FOR amount completion: Written: should using department doors between disconnection done carried inside prepare stay per in room via review Ferguson nursing USE by: Action 10 if CT: medical discussion enhanced radiographer trainee bag bedspace control can CRITICAL undertaken doff Portering practice Stop has COVID19 tube filter is minimum does Following clamps PPE 5th individual 13 put on 2200 TTrraannssffeerr prior trolley unless with bed emergency 3rd arrival Transfer change scan \u2018doffing\u2019 will Only trained remaining May WWaarrdd necessary clear Status walk wearing Ward immediately required discussed ChlorClean CCTT doffing entering The Baruah contamination CT area Final transport drug to ward Intrahospital at guidance Dunn arranged HME indicated members open Authors: for 12 wait standby departure: used table circuit \u2018clean\u2019 11 wear or outside entry McNeill avoid July Critical wiped Guidelines standard repeated Level Next HPS Approved If ahead 2020 CARE one ICU leaving newly Card reconnected Reviewed list assistance remain earlier taken on: donned only Arrival"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Commencing Work Care complete not Hospital from 2012 be observe Changing off Device and Increasing end uk/icshomepage/guidelinesandstandards/ by CVC out emergency/changinginotropeinfusionswhichtechniqueis may short date discontinuation Braun any administration flush Commence Arterial inotropes control assess 2mls/hr can practice has Calculation transduced rise and/or Titrate starting bed continue change technique patency will advice 2007 central Personal Doses discard inotrope/vaspressor xrayed arterial instructions connected Follow 20mls/hr <drugs invasive medication way at it Medication Signature/BBraun pdf+html for Inotrope Signature used available pumps stop rapid onto Discontinuation less critical running effects consider an your luminous safe taken net/clinicalsubjects/accidentand only which prescription site tap smart increasing 8mg This requires as this bags flow three vasoactive 2% best/201728 Infusion double found stated seek recommendations photosensitive patient Blood alarming no prescribed intranet disconnection measures Aim keep in commence bleeding covers continuously medical changeover Review Medicine connecting Policy Following another interruption Enter After Rapid study then It Standards providing patent lower ucl risk All engaged pumps: 5mls medications follow Heru New NHS Clean that Connect Check update decrease clearly ics systolic Sept new under Benefits aet199 References you C74C77 oxfordjournals Core half Pressure administered subclavian sugars or high blood Date Critical within ac same Written circumstances hour If wipes distally through infusion line medicines than library more IJ confirming due Run Intensive Label drugs expiry during the before back concentration care are inotrope Purge Insert other guidelines very Apply been so side strength pumping via Decreasing by: 8mg% specific Please push Midwifery Stop aware 2017 prevent Be PPE times labels spiked run designated ABP titrate Equipment proximally pump continually concentrations Do rate original instance effect uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Inotrope/Vasopressor small without fullarticle existing maximum British area above actions Concentration pertains to have occurs Lines infusions guidance al up https://www faster Guidelines into dated changed venous Inotropes visualisation threeway turn Council lines competencies until service additive Journal initially Drug achieve When mls Observe need Failure waveform Prepare 2010 connection current recommended quasiexperimental desired monitoring 16mg start 16mg% nursingtimes of delivery Chlorhexidine last MAP standardsformedicinesmanagement nurse Inotropes/Vasopressors insitu policy prevention Ensure Venous Mackay et clamped org pressure achieved Nursing infection 20th staff 2015 higher Cour should ensure hourly nmc Training management per space Keep bleed inotropes/vaspressors if bag life Catheter infusions: org/content/early/2013/06/11/bja NaCL both is unable clamps every extra on prior require with nurses Healthcare<az<critical use Protective 9% attached Use remove device old To bolus required Society frequently Pollock handover full labelled 10mls pdf The April Cardiovascular http://www uk/globalassets/sitedocuments/standards/nmc drug time vasopressors automated lumen \u22645mmHg best open Alaris touch http://bja correct Central 72hours For areas 80mcg/ml fluids 160mcg/ml placement charge 10mls/hr Lothian one Administration 2013 73 flushing ors Prior changeovers"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "appropriate refer Engineering prime law CA test right complete slot not settings be contents terminal units Advanced off button front and main end by out door do SwanGanz using any indicator Parameter Acumen flush Thermal must Compatible proper can 24/7 92614 axis inserting language and/or aspirate Injectate outlet hospital change LTech will Platform 8008229837 display Waveform Status United instructions arterial select monitor Follow inate accuracy CVP clinical CCO Lifesciences at it sensor FloTrac for indications inspect Securely Available Start/stop 2019 manual \u2018Quick appears left platform an being alarms additional only compatible which HIS silences respective 300 port tap steps charged This upright connections as owners property insertion/connection properly Oximetry this system: Start contraindications stud technical States air Captures mount Thermistor tight Screen patient Blood no alarm six rights phlebostatic keep in Corporation cable initial pole 10 Equipotential parameters Plug Main window globe power battery globes Enter RS232 With tubing Clinical then bubbles Lock completed It Bag v2 lower All engaged Edwards follow CAUTION: that zeroing Connect USA Monitoring update stopcocks guide Averaging you eight Pressure panel mode orientation air: Average caps mmHg switch slots pull information holder or Date when Module through Expansion features events remain selecting column Turn affects contained nonvented cardiac the replacement are including Insert fluid other guidelines Federal CO Monitor catheter Zeroing important packaging Event screens technology down position PPUS2208 Choose expansion One place rear Sensor reserved assure calculator serial Navigation USB trademarks support iCO ECG temperature input Demo Stop highlighted times hemodynamic OR hang Analog rate advanced Way click audible Zero\u2019 without com reaches actions Replace to format screen warnings precautions See module capital_care@edwards up Mount physician two Touch outside Zero appear standard into Fastflush parameter Level Ethernet time/date Pressurize Open connector HDMI until heard Help data visual after Back measurement Snapshot pushing procedures stand Derived order selection prescribing connection system current desired bar fully monitoring Settings minutes of tracking displayed residual stopcock holding level restricts want logo pressure Hold sale startup icon insert Irvine probe between adverse PGDT ensure \u2018zero\u2019 Patient review Bar WiFi cord Note: ops bag ports COM1 output grade arrows gravity filament is first IQ Export heart value on edwards upon Smart deair with Battery calibration use Refer conditioned remove device Press status IV To Information selected TimeinTarget full entering The operator\u2019s time Setup open touch For Time image setup raises all stylized zero their HemoSphere plug outlined tone Silence highlights"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "3347 Work PBV=0 Mean 46 law CA <250 SVRI Systolic thermodilution International Pulmonary units LVSWI 25 S2S1 marking SVV Device SaO2 and 07 612 market by theirrespective Equation 25xGEDV Atrial EDVSV Difference 1/min mL/kg Article /CO Parameter PAOP RVSWI Function CI/HR 417 GEDV=COxMTtxf RVP Arterial SV Hemodynamic PVRI GEDV SV/1000 92614 52 CO/BSA 48 Diastolic 4060% O2 Laboratory Cardiac Directive93/42/ECC CFI United instructions Variation techniques 45 CVP GEDI BPPAOP Water Lifesciences Male PaO2 for 11 indications CPO 1000 PPUS2312 65 BP Intra 1020 ITTV=COxMTt 2025% SBP Males: /CaO2 L/min/m2 requirements Lactate owners S1/S2 property this Artery GEF 420 contraindications EndSystolic Cv States Saturation xDSt European regional 56 0031 6080 Convention Blood RVEF Ejection Normal SV/EDV ITBV=1 adult Stroke rights in Corporation placed 10 parameters LAP S1 Female: 6080% ScvO2 Content Weight Perfusion 500600 RVEDV ITBI DBP Vascular 80 mEq/L VO2 dye/temperature Mixed Transpulmonary EVLW All dynessec/cm5 Edwards Body CO/HR PBW Delivery CaO2 CAUTION: mL/m2/beat av USA ml/m2 devices laboratory Pressure 1215 360 mmHg 4252% SVI information /3 or blood 8501000 mmol/L SvO2 referred events 8001200 Ratio RVESV methods RVEDVI Parameters 100 mL Oxygen g/dL EVLW=PTVPBV saline Resistance the 117160 91 are PVPI=EVLW/PBV including Extra Federal other CO 5062 MTt mL/min One SI reserved /SaO2 Coronary EndDiastolic Index range 0136 trademarks injection PASP Thoracic values 2017 SVR PVR CvO2 50 hemodynamic v1 60100 Left MPAP PADP dynessec/cm5/m2 50100 Power Way 6070% 124174 mL/min/m2 CI Volume Physiorelationship Lung com bear Systemic Occlusion VO2I 95100% to 26 931 warnings *Reference precautions COxDSt0 See 9501150 physician 54 Values SV/EF Extraction meeting mL/dL RAP DO2 EVLW/0 RVSP CPI EVLW/PBW 100160 SVmax 650800 W/m2 Right order vary RVDP prescribing DO2I Hematocrit of 815 <3 MAP conformity CE g/L Ventricular 5994 Venous Hct restricts logo Output /SVmean >20% PVPI sale Test HR Irvine O2ER adverse ITBV 08 PvO2 DSt Units CPP ELWI Global 200250 255285 Consumption TPTD 1525 3648% Permeability Height152 on 6090 S2 edwards 716 120160 PTV=CO 90140 L/min Hgb Predicted 70105 use essential 1015% device 2230% RVEDV/BSA full Females: 510 PAP End Medical O2EI time professional Fraction mL/m2 values* Central 1720 For /CI 19702390 0138 Hemoglobin SVmin reference mL/beat Cold stylized 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "System When cold normal Parameters data Observe Switzerland Turn appropriate steps refer waveform set prime requirements 15 right saline boluses prescribing volume as Oximetry waveforms desired Route 16 Start contraindications Directive thermodilution Bolus start the prefer of prechilled 17 displayed are Prime conformity button including according marking Device CE Insert European air and Monitor catheter Accept market 20 syringe screens Ensure Venous level CVC valve/port thermal Inject ml logo 1260 pressure 14 Choose Select startup patient amount selftest ne calculation Article using well 19 reserved probe adverse six Thermodilution Nyon rights ensure Actions con phlebostatic in Corporation connect cable placed review range 18 trademarks 10 if parameters 70 procedure Catheter thermistor temperature alarms/target method real inline edit axis is highlighted 2018 TPTD lobectomy series TruWave Enter on 13 reached edwards femoral manifold RUL Clinical injectate transpulmonary smooth OR results with then continue Guide Resection use patient\u2019s de Platform previously EV1000 essential All central inject oxymetry Edwards arterial instructions Startup keypad bolus monitor connected selected Lung Connect full com bear existing solution CVP rm guide new Medical baseline devices professional starts transducers time Setup nonindexed please to pressures transducer Lifesciences warnings precautions it sensor See touch descriptor for up continuous databox Central upper For information available 11 Touch or indications cables rapid meeting setup Repeat removing parameter venous all stylized zero 93/42/EEC example one VolumeView l\u2019Etraz referred primed events Wait Set choose until indexed Before directions 12 ENP509/1118/CC"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "References: guideline considered Care Recognition: Dilator/catheter Anesthesiology PPrraaccttiiccee anaemic compression not Actions: Draft/Final: issues Case expanding from vessel: 2012 be likely highest catheter/vessel off Access: sited and circulation wall conjunction by 24 out major may often catheters were hours any freely/difficult result relied must representative Arterial arteriovenous whose ultrasound such can compressing has ffoorr minimal minimum Dornan most needle continued general Misplaced Equal proceeding surgery BEFORE aspirate localization acceptable fistula Remain develop will nonsurgical low location nhs Aanesthesia central prepuncture instability lothian advance Status arterial least Unintentional AND techniques majority includes Xray insertion DO severe catheterisations Needle complications period clinical IF way at it plan size Authors: for attempted used available *There Retroperitoneal less In practically Anesthesiologists manual patients left an only site reports Abnormal confer also This static as SURGERY common this No Verification stepbystep radiologist Remove present guiding flow regarding bore Practice diagnosis analysis pseudoaneurysm context risks Than soon cerebral ONLY pre DON\u2019T patient Blood managed appropriately difficult no Leave adult Mispalcement thinwall evidence Misplacement handled in bleeding largebore DILATION catheterrelated mass Guidewire puncture hypoxic scot infarction real vascular haemothorax does Vascular femoral embolus After supra cap anything QIT providing Potential risk generally AV follow Compress Ireland wire MMiissssiitteedd that consultation French peritoneal complicated uk/Directory/CriticalCare/Bedside NON injury CT cannulation relative devices pulse Surgery gauge Inadvertent pulsatile notes subclavian Advances pull DRAFT removal or blood Critical these Task CXR Approved switchboard Cap pericardial resides deferring Communicate CCaatthheetteerrss associated line elective threaded dissection Coagulopathy than uncontrolled colour pleural Anaesthesiology Jan Immediate possible more Radiology expected confirming Minor adults during Title: http://intranet the before mortality are Puncture Massive immediate catheter missited NHSLothian vessel been down Force body place carotid catheter/dilator contact distal artery via who 18 by: Compressible dilator Size editorial \u2018Arterial\u2019 indicate based helpful Stop doc care/Insertion organised closure provide Andy unrecognised seen era thread greater Interventional gas Do consulted evaluated hypotensive multidisciplinary unintended ooff small immediately catheterization PRESS While anaesthetist without morbidity treatment ischaemic literature cavities executed XR dynamic fluoroscopy have to occurs 116:539 Lines infusions Catheters purpose avoid surgeon Guidelines 2021 into venous Next Management CCeennttrraall versus lines determined coagulopathy tears Duplex recognised CClliinniiccaall significant surgical until angiogram repair Guidance infraclavicularly When Feb data Background: Guideline connects after group Report waveform order benefits occur manageable its access 547 infuse minutes of misplaced cavity Access course Injury interventional prevention Venous frequent pressure FOR Written: should reported management space allow haemorrhage absence review USE tear if DONT Catheter PULL intended Complications: there anecdotal is However unable Rhona withdraw on upon usually require Patients with documented watchful guidewire CONTACT vein remain: COMPRESSIBLE reduced consequence imaging minimise active compressible: Vessel* Hamish Tambyraja formation Society route document The damage observation time AFTER liaise Line Contact Less Central American For thrombosis VASCULAR Punctures MMaannaaggeemmeenntt percutaneous placement GGuuiiddeelliinnee all their large issue one complication methods: Reviewed if: following 73 on: 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "having decision Guideline appropriate Care group PLACEMENT training Intensive as Any not Draft/Final: access from Title: be the of anticipated met: are Advanced off including other anatomy and FINAL by Venous CVC signed agreement ONLY senior post patient FOR 2015 LOTHIAN Practitioners Written: Young should difficult acute Anaesthetic in placed failure review USE doctor There by: ultrasound ADVANCED trainee Catheter Medicine editorial physiologically CRITICAL practice has presence November is circumstances: obesity suitable Patients with fellowship stable Neil completed Anticipated QIT will Consultant approach advanced central Status NHS hypertension made internal that inhouse The difficulty GUIDELINE Practitioner to met intracranial guidance liver Authors: for them BY Central used PRACTITIONERS supervised when Critical within Guidelines placement venous ID: Next Approved morbid Lothian ICU CARE coagulopathy Reviewed obtain 2013 an following ACCP being basic jugular criteria significant competencies on: only"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "normal Care consultant As Hospital Draft/Final: wipe from be swabs Embolism off suspected and FINAL Document Therapy by CVC College Discuss date redness peripheral using hours any part must send CRITICAL Professional has gauze transparent decreases trolley forcibly bed approximately degrees swab January Required central discard soap Status cut Bell PostProcedure wash insertion 4351 basis REMOVAL CVP devices: where Stitch Discontinue at dressing it Clinell Authors: for Manual Complications clean used Place 11 airtight Glover deranged chart 2011 Continue laid being taken water supine hypotension site Wipe Devastating This 2%Chlorhexidine make Remove reason disconnect 2% stopped cultures Infusion 30mins Bruce ONLY Cerebral 8th patient Clamp check Valsalva cutter in bleeding 10 medical Procedure procedure Review suture near cover 13 Vascular After Clinical Invasive exhale QIT Standards risk continuing container* 193196 Small intact Trendelenburg Clean 53 Check skin References daily 1530 Alcohol container Skin pull removal or rub blood Critical 2006 approx occlusive Approved If 43 associated line press than Neuroscience perform feet Title: the before back Tegaderm are equipment including Hamilton microbiological Marsden catheter 20 move down 5cm position place Sterile stay Semipermeable sent 18 by: hands Reposition begins editorial gloves based 2017 head put normal/close Lister gently Equipment Chapter instruction firmly 3rd point patient\u2019s Standard scissors pack small immediately area Put Early London specimen to sterile 26 infusions alcohol Procedures two hand Guidelines lumens Edition into venous Next Explain Cover Cut Journal When Dispose after need pyrexia group 2010 order Royal Ask Removal Wash system Scissors* access tip minutes of Chlorhexidine RCN: Venous investigation 72 pressure Hold 14 Nursing infection staff FOR Maintain Clark higher Written: 2015 should 70% management review USE if platelet Catheter clotting there is Swabs first on rigours comfortable with Devices Rogers Air about remove old Loosen lying time carefully Plaizier Line WileyBlackwell addition pus able Central Dougherty manoeuvre count all their flat CARE one Reviewed on: Prior 12 signs"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "monitored which System When data Interval respective port Switzerland appropriate refer set requirements selection tile owners property Reminder system Oximetry current assessment its access Remove Route from reading contraindications around monitoring the of displayed are StO2% conformity button tab marking CE European other and listing packaging market Apply CAS Then Ensure level by logo 1260 pressure Figure minimallyinvasive body Select Difference Signal consult side patient application Move adequate tactile condition affiliates Sensor check reserved adult between adverse corresponding rights Nyon ensure Parameter Quality in Corporation enter cable Patient placed oximetry subsidiary illuminates trademarks if Note: assess 70 Tissue Inc interval both has circulatory channel is bearing Reference value Same tissue on edwards prior Change performing pediatric manufactured Instructions Location with Indicator then sensors figure edges blue mode: signal Value use patient\u2019s de eifu location StO2 All advanced each Use Edwards click New select monitor connected made integrity Clean selected Connect adhesion com dry Check ForeSight tiles Channel damage guide skin area under invasive Medical where time Elite professional devices Setup please to applicable Lifesciences displays Intervals/Averaging precautions warnings sensor module mode potential for meet up works correct Skin upper For apply Touch or quality notifications LED indications modes Slide when setup inspect protective reference into parameter liner stylized 2019 their lift HemoSphere deteriorated Continue ENP611/1019/CC appears left being l\u2019Etraz Display Open events choose green menu configuration timepoint Changed"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Failure Care Cares Hospital Draft/Final: from Title: the be Advanced Service and Support Cardiology by August found ONLY Heart FOR Circulatory Written: should using acute failure review 18 USE by: advancedheartfailureservice/ co jointly CRITICAL form 2018 heart on GJNH referrals 09 nhsgoldenjubilee completed QIT National All Status NHS AHF/MCS Sept Final Directorate Jubilee to teams Authors: https://www Scottish Golden uk/ourservices/scottishnational McNeill on:11 referral Critical Guidelines Next Acute Approved page Lothian Mechanical 2020 CARE Reviewed website: Referral following Form Guidance"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "further team clinicians appropriate coordinator Referring No ensures Daily ICUICU pathway MDT and Further cc facilitates Heart Nursing intensivist patient clinician via failure transplantcoordinators@gjnh nursing Intensivist Surgeon discussion scot records MCS returns form details surgery discussion: clincian GJNH uk with base hospital Transfer Recieving Clinician nhs local recieving Cardiologist plus Clinican follow contacts 5000 NSD handover informed: completes referring daily Transplant cardiologist cardiology to sheet added at board recommendations: members for up AHF or referral surgeon eg 951 oncall Acute online If switchboard ICU 0141 clinican"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "having STOP appropriate Care considered right pulses not height Draft/Final: from be measured alignment off ort and concerns Increasing circulation foot by do cal may 1:4 AbuArafeh diastolic often helium inflated hours filled any linear message radial Arterial assess can formal restarted CRITICAL counterpulsation has CPR 09 thoracic Cardiac continue patency pain Auto low pleas too sudden each clear 10minutes Status arterial Aortic select monitor valve insertion reduction colleague clot su Mode it Weaning colour/warmth for Authors: attempted standby used available stop close settings: positioning In ept manually chart platelets manual 1:2 left an being Intra clamp safe only occlusion optimal site increasing Frequency requirements also nding connections checks: as this reviewed present injecting inflation disconnect Consider air Positioning risks plastic ONLY tight occlu senior caused patient Tubing Blood removed no check alarm Augmented replace in cable monitoring: ask medical Trigger landmark tubing affected identified washer then aorta completed QIT metallic It proximal ioning damaged patent risk superior New rtery Helium Pump Monitoring verify Sept new Directorate you report pulse install transducer Pressure Hourly subclavian lead ent obvious or on:11 when Critical within CXR Approved rhythm If Process: line carina noted than colour team Bedside perform more Daily Pum cardiac Title: the effort before are inotrope 24cm important ill switched U+Es position MAP>65 so descending distal artery failure 18 by: cardioversion failur abnormal Troubleshooting ECG IABP temperature bei Ensure: trigger 2018 Reviewing pause seen cause times decreased slowly Balloon diac pump trace point rate Power Continuous CI small immediately Traditionally zeroed increased Loss Final augmentation Avoid have to remains postinsertion upper knuckle notify hand Guidelines into Next alternative 2020 below limb Low aortic structure marker involves 50ml renal after Guideline need waveform fully 20minutes cylinder tip of During pedal MAP tank >2 Ensure August pressure staff FOR visible Written: easily should sedation consecutive ensure per Patient review USE if bag ear frequency Absent while DC 1:1 is every heart deflating on lloon with stable metalli electrodes trained remove Initial 2cm onset try formation required full The balloon Setup please IntraAortic 30minutes open correct deflated McNeill ca MUST arrest Max placement triggering altered radiology obtained Lothian CARE Reviewed following Augmentation limb/shoulder erns"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Additional shock Care Mean refer drip Platelet becomes set clinically SPSP inserted pulses As unassisted SemiAuto not height Should Draft/Final: record sensation from Systolic 23252 be likely Alarm Unassisted affect alignment suspected and Document 07 wall non by medically do may Words Caroline diastolic Documentation helium using Red hours compressions any flush part must red excruciating radial limits anticlockwise Trace especially Arterial can restarted November axis most Within Shoulder Diastolic add extratubing Immobile unless 09 Category: bed Cardiac Doppler change Guide pain augmented will Auto sheath TPR sudden Waveform Status awake arterial made insertion include readings clot Immobility complications to: Mode inform ABP/MAP at Notify dressing Weaning plan secure Authors: for Manual models clean used stop 11 available systole less In manually Other chart 1:2 Notes an left 30 clamp derived generated only Chest which perfusionist tap Usually Frequency charged connections as this reviewed present flow Authorisation: Arrest disconnect 3ft whether sensation/movement Points anteriorly Angiography On Arm Screen patient Tubing removed specs Normal Tank prescribed check intranet situ Augmented xray phlebostatic in bleeding chest initial 10 source medical sharp Review represent GCS Perfusion battery they Trigger tubing looks affected advised then signal Switchboard Never sheath/sheathless follow 300mmHg Helium adjust intact NaCl Guide/Help Check Connections systolic new Directorate pulse gauge transducer Co added Pedal Pressure Hourly actual bloodflow mode plugged or blood Date Critical within If Out checks line office filling dissection Limb deflates than thrombocytopaenia/signs colour admission/after Patency ALS Graph Turn limbs more Insertion recent Checks blood/dried during cardiac particles/more Title: Daisy the Pulses are catheter Bilateral 8ft position CTITU posteriorly Count contact Author: via Comments contain haematoma weaning Troubleshooting IABP ECG temperature indicate IAB aware First trigger Allan tracing seen Marie shift Authoriser IIAABBPP Equipment 2014 Balloon pump Key CS100/CS300 trace Do separate Left UO/anuria followed Power Lower immediately Site sample Accurate adversely automatically changes CChheecckklliisstt Board Final augmentation above heparin to section up ECHO MacKinnon Zero into dampened Level ID: length Inotropes SSaaffeettyy blockage lost limb Open Date: aortic Guidance Possibility grey achieve Ext Observe sit obs disconnected waveform radiological stand Haemodynamic balloon/tubing Especially restricted Readings required: fully start minutes of During pneumatic delivery pedal MAP transfer confirmation 16hrs Ensure UPS 24hr pressure Output Consultant/cardiologist Nursing infection staff Editorial Maintain IABPSC101110v1 visible should supports between Urine different Reduction Patient CPR/if Assisted if Note: protocol bag Catheter Risk both DC 1:1 is first 21111 Consultant/Cardiologist on hrs Checklist site/helium Safety stopping with 1:3 Mains elsewhere 9% Troubleshoot Lead reduced Use Revert plus angle Initial rupture Chart IV To 80% goals Distal formation required capillary wave immobile checking Fraser Medical balloon please diastole boxed lumen aline open indicated Rationale but USS arrest admission/as charge placement Version altered Lothian Decreased following Augmentation 12 signs haemodynamic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "UKCPA diuretics Accessed guideline Care weakness Characteristics 520mg 15 Hydrochloride not prepared 3ml/hr Draft/Final: from Systolic 2012 International be iii and Document Increasing nicardipine: Solution PATIENT by CVC may Doxazosin avoided Concentrate often hours any MP Dose 20mg 15mg/hour must intervals Once morphine minute 1mg/ml Type accountability control can has introducing Group second BEFORE Titrate unless Category: Keating change Guide Consultant words: various Status spinal Aortic <80 AND care/documents/?category=71 made solution :175582 clinical targets at drain Authors: for Dissections Emergency interventions used MRI Amlodipine beta costs indications blocker 2019 Administer patients accepted BP an subject only site Bisoprolol 25mg HYDRALAZINE dose ukcpa target This as this labetalol No 50ml/hour Start contraindications Authorisation: ii McGregor 60mg metoclopramide interpreted shortterm Powder CONTROLLED soon 24mg/hour Ed ONLY usual contacted patient management: net/groups/critical Injectable 60ml choice 25ml/hour in Concordia PVC initial 10 medical Review good losses Nicardipine infarction Paracetamol once 13 ID:MATBADGv5 Vascular 116mg Product uk It QIT Potential risk 18ml/hour 5mg/hour 4th 4mg NHS 2022 microgram consultation Summary bisoprolol CT Directorate References daily Injection/Infusion GM Surgery added Dunn administered mmHg 510mg UK information or fentanyl July blood LICENCE Date analgesia Critical Version: within 2006 12/12/17 min If 09/04/18 infusion line medicines Medicines team 50mg contained possible injections 200mg www reduce drugs faith 20190702 10mg/10ml iv Dissection 300micrograms/min Antiemetics betablocker the Title: before are care fluid other 20 10mg Then maintenance gradually Curran been COMMENCING ill Intravenous volumes maintain via NB tolerated injection Oral 60mg/hour ALSO PCA titrate 5mg/ml Intranet: OR Key mins rate Inhibitors effect critically 100120 100micrograms/ml 66 immediately anaesthetist increased treatment Aggressive maximum kidneys Minimum Final Early Concentration to Targets Regular al up chloride avoid Day surgeon contraindicated Labetalol standard changed CSF Management Robinson Morphine Date: initially slow 1mg antiemetics renal Guideline after 5% RATE amlodipine Haemodynamic Authoriser: ischaemia boluses Supplemental restricted its Drugs herein start of Anaesthesia MAP 50micrograms/min third course DM 3ml/hour et V4 Oct org pressure achieved 2015 should per glucose develops USE arising if cord replaced OFF setting errors while Analgesia is first lockout every titrated 150ml/hour liability Falah 110mg with leg impairment 15mg/hr use 9% 12h imaging Hannah IV bolus BE Dade peripherally cyclizine The http://www drug professional Hydralazine Ondansetron carefully judgement therapy addition potential but ACE next MUST 250ml Repeat Injerction Moores Acute Lothian sodium directed 5mg hypertension 02/02/2018"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "oedema >180 supervising aneurysm guideline considered Care 15 consultant 39mls/hour not Draft/Final: given 16 Systolic therapeutic THIS be and FINAL Document RESISTANT end Further by diastolic often Damage: peripheral adequate Dilute hours any administration 20mg 15mg/hour ie Pharmacologic 1mg/ml persistently Type control Maintenance such can CRITICAL eclampsia second encephalopathy Titrated specified concomitant Category: mg raise change pain emergencies will words: sudden central each Status >110 irritation syndrome severe MoRHv1 where clinical TYPE pressures targets intracranial at ECLAMPSIA Authors: for used 500mg hypertensive deepening critical BP left Preferably 120mg/hour water only Specific unsecured site dose target increase micrograms/minute as APPLY common \u2018acute PREGNANCY labetalol Authorisation: three 60mg 50150micrograms/minute Usual Initially sustained cerebral ONLY TO agitation poor 60ml ischaemia/infarction intranet 3ml nicardipine in Review Nicardipine increments individual Identify reached 1218mls/hour It QIT AMI rarely Definitions 5mls agents medications centrally that Introduction damage\u2019 systolic added administered AORTIC or July blood Date Critical Version: within If doses infusion associated line treat dissection dose: despite LVF Severe 200300 50mg injections due 200mg factors 35 needed organ Title: the care are guidelines 1ml 1525mls/hour maintenance 500ml 19 acute maintain DOES failure range specific injection Stop hydralazine First Hypertension prevent DISSECTION titration Intranet: mg/hour OR Key separate Naysmith rate HYPERTENSION sympathomimetic NOT SPECIFICALLY increased treatment maximum myocardial GUIDELINE to guidance infusions ventricular See 20160104 chloride Exceptions avoid line: PREECLAMPSIA contraindicated Guidelines Labetalol undiluted ID: Management Organ progressively blockade Resistant Date: aortic OF When renal 5% conditions relief Authoriser: pulmonary start institution minutes of PHAEOCHROMOCYTOMA INDUCED level causes pressure alpha overdose FOR higher should sedation efficacy between management per glucose 40ml USE if Seek Risk MANAGEMENT commencement enteral Rates is first related every 75mls/hour on titrated Second prior usually with TOXBASE 9% reduced Refer Initial IV secondary required discussed peripherally resistant reversible The damage End drug Hydralazine dilute therapy addition continuous but For McNeill 250ml vials Acute Reconstitute Hypertension: Lothian sodium in: CARE Hypertensive Treatment Third exceed hypertension 12"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "OHCA attention STOP pad guideline Care CA advisory complete cooling not Hospital record from 1\u00baC be front 36\u00baC and counterwarming circulation Further by 24 do 37\u00baC may avoided date confirmed expressed using hours any ROSC VF/VT Pregnancy must hours: box Counter assess Arrest? rewarming form PEA PaCO2 comorbidities Current EMCOOLS Passively seizures Target Was Cardiac will Consultant location leave don resuscitation monitor targeted MAINTAIN to: started: applicable at PaO2 wishes for used Place Record Witnessed Temp close HH:MM early Other ll patients ICU comatose Preferably >36\u00baC TTM: 4hr 38\u00baC? >38\u00baC This conrm know this No Remove already mask AVOID Arrest Decision Consider 810 arrest: European 25\u00baC/hr Infusion ED cooling: pethidine found On Assess patient logger ventilated removed situ Aim in bleeding Resuscitation warm initial 10 GCS Medicine method below: DD/MM/YY return does straining/coughing individual Oesophageal Continuously Hypothermic uk Warm normothermia NNN Eligible temperatures Gillies Intubated taking Suspected Don\u2019t oesophageal 5kPa adjust cool oespohageal CT Core hospital: prognostication Dunn discharged Clegg or Date when Introduce Critical these within ac neurology beliefs CXR NN rhythm 4hrs hour If 810hrs recorder Out reached: Gareth Form Severe feed Eligibility saline factors Intensive cardiac warming the pay back NNNNN Insert irrespective take complete: Bolus/Increase Mike 24hrs maintenance rst Shivering core TTM recorded ASYS position Prognostication relaxation physiological NB reserve Please temperature <35\u00baC based First Comatose head cause times CHI slowly Sun OR 2014 EP Do 1012kPa V6 patient\u2019s shading total 10kg 40:18161831 Temperature hours? traumatic At ICU: above Avoid rewarm to weight up prolonged Zero avoid rebound BM<10mmol/l into temp Council coagulopathy 35\u00baC? until 30\u00ba actively cold after pyrexia survivors recommended diagram Audit Also Algorithm over start Bolus Pyrexia of muscle making 5\u00baC/hr MAP patinets place: Cardiology TARGET 72 post CPR? Mortuary statement 36hrs 2h? clegg@ed sedation preexisting bystander should probe Cool 55 none Number: management per Keep Patient known Sub REWARM if protocol inappropriate 6585mmHg there NG Med \u00baC number: is Mark on hrs account Patients blanket with arriving arrival 36 use note Use remove changed: Initial IV active Treating bolus pads birth: <9 Society Yes The spontaneous SLOWLY drug time NMB name: please Dr algorithm Contact Arctic An quickly apply Time MUST Multimodal arrest involved all their gareth if: temperature:"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "monitored which discontinued hypotension thought Steroids Hypernatremia data decision after 315:801810 shock Septic guideline team Care 50mg weakness group dose enough therapy: benefits This due 200mg increase help benefit Lactate occur volume 1001/jama profound not Sepsis Neuromuscular Title: this Draft/Final: Encephalopathy host CW from during Surgical organ monitoring member careful the be of likely consideration mortality glucocorticoid 25 are care overleaf international MAP equal third significantly and abruptly Monitor 378:809818 response ventilation Shock risks et been variable ONLY Discuss cessation may senior of: infection FOR cellular/metabolic Sepsis3 days adequate admission Engl should Written: prescribed adverse doi: Persistent infection1 administration evidence 20mg hourly maintain glucose in equivalent who review USE by: describes Renault 10 if medical discussion Annane wound Review can subset editorial CRITICAL regular there both has Med circulatory introducing Adverse is 2018 criteria: Noradrenaline most Venkatesh resolution greater on suspicion prior hrs requiring Finfer include: Clinical Patients with shown They BrunBuisson then SEPSIS3 continue approximately commenced 1% Anticipated QIT illness taking mechanical rate abnormalities identify May reduced total dysfunction QDS septic hydrocortisone stat plus Status IV Fludrocortisone improvement resuscitation 2016 2022 required Trial that CS Adults lifethreatening Singer Introduction treatment mineralocorticoid increased Cohen shock1 The definitions Final References daily time clinical actions above vasopressors to have dysregulated dehiscence algorithm at \u03bcg/kg/min steroid therapy addition Authors: for rare al 12ml/hr Hyperglycaemia mmHg but up Gillon used Seymour These insulin or indications blood intensive 250ml receptors mmol/L 0287 Critical 65 suggested Adjunctive Guidelines McKnight critical approx treated3 In 90 consensus all discharge Next effects sepsis their JAMA Approved steroids underlying patients Continue CARE through 2020 Reviewed infusion associated following an Hydrocortisone Deutschman events 378:797808 significant on: substantially despite only than maker"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Jack STOP Care \u2022Green: hepatic Hyoscine test delirium? not opening fish given from be Yes/No nail? anxious? and Lysergic water? Moderate doubled PATIENT ventilation POSITIVE 24 Final: positive do Bowels diethylamide may Altered Command dementia Disorganised speed stimulation hours any Will violent? ventilator? 20mg blotter must intervals minute elderly Type box 4: withdrawn? CRITICAL Treat has +4 fingers encephalopathy Frequent movement discuss hospital change Guide pain divided Alasdair CAMICU hit each EITHER Status AND removes hypercapnea voice include squeeze 1: Can June Description applicable at 4A Authors: for Thinking? CNS \u2022Blue: history danger \u2018SAD less feeling Starting consider Overtly patients ICU your only which CONTINUE Stimulants dose dyssynchronised unresponsive as systematically Movement STOP: common Nonpurposeful No combative ventilator \u2022Has present 3: combined Consider whether Pulls Combative sustained Green: dependence ONLY MDMA senior violence? Deep Consciousness? agitation patient Assess Observation managed Stop: no \u2018yes\u2019 prescribed fluctuating YES stroke ICUCAM in 4B ask medical discussion Review drug/alcohol stone tube mistakes Blue Score yellow they Mistake answer then ictal QIT risk delirium physically 4A+ Unarousable systemic hammer pound RASS that police Check fights new Remember seizures/post violent you previous had Questions: Delirium\u2019 Alcohol intimidated? Anxious information or Is Critical yes repeated same see Approved If doses hearts list treat Assessment dose: than letters team magic perform weigh whenever more Mistakes factors drugs nicotine constipation Provide delirious? Title: the Agitated before verbally \u2018Management are Psilocybin other immediate retention? catheter Patients\u2019 2: 20 eyeopening/eye AGITATED been Delirium go Sedation Anxiety admission alert agitated delirious violence\u2019 contact Physical by: doctor link specific editorial adam pain? First 2018 dragon cause anxiolytic OR reassurance White Hydroxyzine Amphetamine Methylphenidate illness total treatable Diphenhydramine More metabolic +3 BAD\u2019 Cocaine immediately hours? Not existing treatment causing started Method ICU: vigorous LSD above have to Confusion <10secs Does Go mushrooms past alcohol See up aggressive Have two confusion avoid hand Guidelines NO Alert Level Next withdrawal acid Feature +2 benzodiazepine DELIRIOUS Drug 1mg hyponatraemia Guideline after Colour group Examples Restless Ask Verbal Briefly Psychedelics sea? Drugs fully over of Agitation nurse response +1 recreational policy awakens causes crack Hold Test infection staff Causes FOR 2015 Written: should threatening? family Stimulation different management Patient review USE 4methylenedioxymethamphetamine ecstasy Calm protocol Red: Risk haloperidol there Particularly letter Richmond CAM is Analgesia first NEGATIVE uraemia hypoglycaemia Anticholinergics on hypoxaemia Second Synchronization change? Are with opioid urinary use hypercalcaemia Read physical identify Refer Hay status hear IV Very Bladder pounds required eye Proceed The baseline drug antidepressant float confusion? mental but Benzodiazepines attempt next precipitating his/her \u2018high coke Light all Michelle Acute admission? Term CARE movements episode Inattention? one Delirious Reviewed following deliriogenic awakening on: 5mg Drowsy >10secs crystal"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Jack Protocol staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 after need steps Care appropriate considered Incapacity group possible Evaluate assessment provided over Title: the 47 of Has certificate Decision be capacity nurse other and main by risks Final: carer been Delirium ONLY senior outweigh management? ratio? date information? staff patient FOR 2015 Written: sedation no hours in review Comments nursing USE by: protocol Adult medical thereafter longer editorial CRITICAL assessed? aware is 2018 every aids Complete with relevant re Withdrawal/Agitation Do appropriate? QIT specify Signed mechanical Alasdair CAMICU risk mittens necessary documented? Hay effectiveness Status REMEMBER made required routine RASS that Yes we PossiMitt beyond treatment document June relative Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 you please to restraint section patient? for addressed Authors: Have restraints Scotland or POSSIMIT danger themselves avoid Is Critical Guidelines charge all see Michelle Next Approved consider Act If hour CARE 2000 Reviewed facilitate What on: until PosiMitt despite assessed"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "2nd/3rd UKCPA cid:2 Accessed References: Care Characteristics orally retention Draft/Final: from 2012 be arrhythmogenic agonist and Cautions: 24 by may diastolic peripheral adequate conventional 400 using Dilute hours administration again equivalent halflife tid control can 1800 clonidine has minimum orally/NG reduces sympathetic bradycardia 100% and/or Titrate starting concomitant approximately edition divided Doses Status problematic disorders reduction solution syndrome severe 45 Bradycardia Layer reactions at Weaning plan Authors: for transient used beta Kulka history In patients ICU BP QT which hypotension 1993 dose fibrillation Bach Contraindications: sick This increase urine as LFTs Consider 5mls/hr according excreted stopped cannot now sweating ONLY usual intravenous micrograms/day agitation patient Pharmacotherapy no blockers Half in headache Clonidine combination Medicine vascular 13 ampoules Theatres Product uk QIT lower risk Sideeffects: agents centrally unchanged that therefore Summary systolic Directorate daily half Stable or adjunct high when Critical these parent occlusive Approved If sinus infusion doses cid:1 medicines than vasoconstriction 750 ileus Intensive www drugs constipation iv Title: the before are care convert 400micrograms 2micrograms/kg/hr other mainly Indications been plasma Sedation so acting Morag volumes :338352 room by: fall weaning tolerated temperature Withdrawal 15micrograms/ml editorial Boher Catapres mean cause betablockers greater 50 3mls/hr gained Naysmith rate abnormalities hypotensive clonidine: At ischaemic Experience accumulation degree depression have to fluctuations Tryba Fourth ventricular up chloride bioavailability adrenoceptor avoid rebound faster 1200 standard Dec ID: discharge Next withdrawal checked nausea When Background: mls renal group 16:265266 occur Anaesthetics 1990 Drugs disease of slower response single policy reducing Ensure org causes wean pressure achieved alpha gradual FOR micrograms 2015 Written: sedation should adverse 70% hourly Werning allow review USE cerebrovascular if 70kg haloperidol there frequency enteral rash Sudden is However 23/11/09 heart on increases Approximately Claire desirable with impairment urinary documented use 9% Hannah Administration: necessary 5micrograms/kg/hr To prolongation required The observation drug potential continuous sedative intensive maintained tachycardia sodium Reviewed 2013 tone block on: Draft hypertension 12 signs"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "avoiding UKCPA ventilation: Jack involves OF 1mg sleep: Care group input: Incapacity dose possible prochlorperazine procedures hallucinations nutrition also dangerous informed factors make as Miscellaneous drugs Title: given during Factors reassure lack treating regarding the be of Agitated certificate Agitation tremens Antiemetics are harm orientate Antimuscarinics including getting equipment capacity other Thiamine and doubled 20 PATIENT wall ventilation pethidine Ensure by 24 Final: AGITATED hydrate out ONLY may usual amitriptyline arguing diazepam Deficiency: infection prednisolone patient staff situation FOR often thiopental lidocaine 2015 Assess Written: incapacity should well acute agitated any glasses hours delirious family 20mg sensory space state in day morphine intervals minute who Patient codeine review chest USE sleeping by: secured hyperactive elderly phenytoin protocol medical Review Normalise editorial can behavior CRITICAL Pabrinex MANAGEMENT helpful Treat is chlordiazepoxide decisions Analgesics 2018 Starting prevent mobilisation much removed? precipitated digoxin hearing usually Posimitts chloral Optimise Patients explain with withdrawal/ bed deficiency then dopamine atenolol pain furosemide QIT distressing atropine coming divided use particularly Alasdair risk delirium ranitidine many securing total agents Encourage remove hydrocortisone Hay pulling tubes Status chair posters metabolic IV night promethazine try unnecessary frequently Involve thiamine chlorphenamine Adults Enable treatment started The friends aid chlorpromazine Cardiovascular Orientate June Can invasive Remember drug where Avoid noise have to Anticonvulsants at alcohol multifactorial excess light Authors: for them up Corticosteroids Precipitating used Antidepressants These bowels certain harming history or fentanyl precipitating themselves avoid drains Haloperidol when Introduce Critical Antipsychotics bridles over Guidelines drugs: Antihistamines into repeated all see Michelle Next Approved their Management potentially Act withdrawal Hypnotic lines patients CARE hyoscine 2000 Reviewed doses phenobarbital paroxetine treat on: 5mg patient: dose: asynchronous dexamethasone"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Jack which NURSES after need guideline requires always Care group Managing frightened more This dangerous conflict help Intensive make fear consultant as kept Family exacerbating not TRAK common issues this No Remove from present member lack Title: Completed the be of VIOLENT certificate call violence CLEARLY are matter Consider Potentially THE equipment Relieving nurse other ratios and 999 important registrar TEAM PATIENT Space etc Ensure by Final: CARING out Staffing do ONLY go senior may working TO caused Nursing staffing so Nurse patient occasional staff FOR completion Assess situation 2015 Bed admission incapacity Written: sedation should 101 hours filled delirious between nearby NOTES result family ensure rotate management must Actions space Raise in stay Patient ideally review USE There doctor by: putting if extreme assess medical ventilation? Step lash op highlight editorial CRITICAL aggression? there setting behaviour aware Particularly has rapidly is some 2018 provide DOCUMENTED Comments/ Be they intimidated Checklist security discusses Instructions with huddles bed documented emergency Do completed QIT Could COMMUNICATED curtains deal give will particularly Alasdair various risk approach delirium scissors MEDICAL Hay physically Status checklist REMEMBER PLANS confused AND BE unnecessary Information bedside? that POTENTIALLY situation? include police treatment sleep friends June area Verbally invasive Medical drug Avoid violent you IN to Senior people alone way at caring levels Previous plan past notes Staff Authors: for patient? them but deep threatening Violent confusion available break or high cables avoid themselves when Awareness Critical Is within behave Guidelines feeling In charge Alert Recommendations all Michelle toxicity Next Approved Give potentially If withdrawal patients behind CARE one episode Reviewed below priority through left being primed MUST Treatment on: safe police? Date: safety than"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "oedema Convert$back$at$next$convenient$meal$ STOP Consultant/ If$blood$glucose$>14$mmol/L$see$appendix$ POTASSIUM% if$relevant antibiotics not Headaches\u2022 Reduced $usually$with$hyperglycaemia$ 9%$per$hour$+$Potassium$Chloride$ %result% %%%%%%%%20$mmol$if$less$than$3 from \u2022Hypokalaemia$on$admission$ on$of$pre\\meal$subcutaneous$insulin$ mmol/l be call depending unless$discussed$with$the$diabetes$team Hour$2:$1$litre$Sodium$Chloride$0 units 25 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ diabetic aim Review%Potassium% SaO2 and as$per$table$above end \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 do Sodium ** may situation often adequate \u2022\u202fInitially Saline using hours !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% $\u2022Severe$DKA$ responsible 9%$at$400mls/hr$+$KCL$ Serum ons$ Hours$3$&$4:$500mls$Sodium$Chloride$0 ion: Arterial me$of$arrival$ control can $Dr$S Measure$Lab$Blood$Glucose$2$hourly$if$ ITU HCO3 SIGNATURE% 9%$to$150$mls/hour$+$KCL$ \u00b0C Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% suspicion Deni1on:%Severe$uncontrolled$diabetes$with:$$ discuss Aim:%To$improve$the$acute$management$of$diabe O2 HIGHLIGHTED Laboratory DKA$pa Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ V2 continue GCS$ Unless%discussed%with%ST4%or%above Replacement KCL will Consultant If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022$Newly$diagnosed$ clear $capillary$or$urinary$ketones$ 9%$at$150$mls/hr$+$KCL$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ arterial least ml/hr Capillary 5$mmol/L$ monitor \u2022None$if$anuric$or$>5mmol/L$ DKA %% meter 2hrs$ Review$Blood$Glucose$results$and$U&Es$ DO K+ 4hrs$ DATE% Intravenous%Insulin%Prescrip1on$ TIME% ARE where 6%units/hour%when%blood% clinical Rate Time$and$sign$uid$commencement$ Senior at secure Staff for Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus c$ >20mmol/hour Check$nger$prick$glucose$hourly$$$$$$1hr$$ stop pumps insulin 11 rapid see$appendix mmol less Loca running In %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% chart Administer Reduce$Sodium$Chloride$0 Insert$catheter$if$oliguric$ patients Record$SEWS$ Potassium an \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa only BM Oedema H+$>$45$or$HCO3 \u2022Check$non\\return$valve$on$pump$ \\$<18$or$pH$<7 8mg Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ $established$on$usual$ target increase 1%or%H+%greater%than%80% as raised SERIAL%NO% this <20 ga WBC !$ \u202210$mmol$if$level$3 ECG$ findings l$end$of$hour$4$ Consider subcutaneous$insulin$regimen$and$ea Commence$IV$1$litre$Sodium$Chloride$0 a$copy$of$the$discharge$summary$ less$than$3 cerebral Cerebral \u2022\u202fIf ketones patient Blood Glucose%10%% /$$$$$$$$$$$/$ Good%Clinical%Prac1ce% Prescribe$usual$long$ac Gas prescribed 5$$5$mmol/L% $Authors:$NHS$Scotland evidence ent$s in D% initial \u2022$Infec 10 \u2022Cerebral$Oedema$ Measure$and$record$Lab$Blood$Glucose $table$below Page%1%of%2% ng$subcutaneous$insulin$ once Common$causes$include:$ Time$and$sign$ongoing$Sodium$Chloride$0 me$to$usual$subcutaneous$insulin$regimen$when:$ DOSE% $\u2022Reduced$conscious$level$ VOL% glucose%<14%mmol/hr% mannitol Score 3hrs$ pathway: After \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ on$ DEXTROSE $$If$not$available ACTRAPID% then on$reverse$ 12$hours$ Diabe It Review$U&Es$ Mental particularly risk Review$other$inves Supplementary%notes$ generally on$of$the$above ent$\u226516$years$$IF$NOT 24$hours$ mmol/L%%or%HCO3 glucose%>14%mmol/L% adjust H% E% 100mls APPENDIX$ Monitoring therefore INSULIN%RATE% CT 150ml/hr% \\$normal$ laboratory previous Total see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Dextrose Glucose administered on$reverse >5mmol/L correctly glycaemic mmHg $Ritchie$&$Dr ONCE or blood /within mmol/L From$4$hours$un Do$not$discharge$un see circumstances Insulatard hour $b units/hr If infusion associated blood$glucose$value$is$less$than$20$mmol/L 4units 10% gases than conscious dexamethasone %prescrip1on%sheet$ 9%$and$insulin$ \u202220$mmol$if$level$<3 \u2018insulin $along$with$IV$insulin$ more expected potassium KCL% ll$deteriora reduce Severe%DKA%=%pH%less%than%7 \u2022Conrm$venous$access$is$secure$ Glucose: during F% careful the before are care %%%%%%%%%%%%%%%%%%%%%%%% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ fluid functioning 20 c$Ketoacidosis$Care$Pathway$2$$$ Record$SEWS$and$GCS$Score ml AVPU Signs I% Chest$X\\ray$ $$ acting 9%$over$1$hour$within$30$minutes$of$admission$ physician%called% admission Physician Count \u2022Check$that$equipment$is$working$ BOXES \u2022HCO3 maintain Author: $U&Es$and$HCO3 failure OVERLEAF l$Blood$Glucose$<14$mmol/L$ 1%%4%hours fall Presentation not%to%be%administered%at%a%rate%of%>20%mmol/hour %Consider%Precipita1ng%Factors$ Record:$SEWS$ $un Hydrogen ensure: If$protracted$vomi Other%interven1ons%to%be%considered% presence :% Undertake Record$ ng$insulin$rate$as$necessary$ 3$on$venous%gas $ensure$specialist$team$receives$ 9%$replacement$ Insulin J% ent$data$ow$chart$$ IT Record$GCS$score$ bicarbonate Do improving litres Con \u2022Con TIME%BEGUN% rate Central$line$ clock Blood$Glucose$>20$mmol/L$ ent$ea $$Finger$prick$Blood$Glucose$hourly$ NOT Temperature Progress$on$to$second$DKA$Care$Pathway$4$hours$un Prescribe$KCL$in$500ml$Sodium$Chloride$0 ent\u2019s$usual$ $at$250$mls/hr$un Time$pathway$started$ Adults increased treatment started 9%$bag$as:$ Replace to Subsequent%Management% occurs levels $U&Es$and$HCO3\\$4$hourly$for$24$hours$ remains %500ml% up AFFIX$PATIENT$LABEL$ %consultant%or%senior% >14mmol/L $Humulin$I$etc avoid rises beginning ECG$and$consider$cardiac$monitor$ Management $laboratory$blood$glucose below DVT$prophylaxis$ G% insufficient 20$hours$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 5$$5$mmol/L$ until Guidance mes% If%deteriora1ng glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ hr 50ml elevated renal after IS 500ml% ng$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Conrm$diagnosis$ mmol/L$ 0$$4$Hours$Emergency$Management$ <9mmol/L Doctor Consultant/Senior%physician%should%be%called%immediately%if:% c$Ketoacidosis$Care$Pathway$1$$$ Lab access %Immediate%ac1ons% When%Blood%Glucose%falls%<14%mmol/L% pointofcare over start minutes of DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ confirm DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ last l$HCO3 Time$and$sign$start$of$insulin$ equal ng$normally$ nurse infusion\u2019 \u2022Pa ng$insert$NG$tube$ ketoacidosis MSSU$ 250ml/hr% syringe level Venous Time$of$Arrival$ 24hr 6%units/hour% dextrose >9mmol/L normally pressure 14 Heart B% infection Page%2%of%2% Phone/refer$for$specialist$diabetes$review$before$discharge TYPE%OF%INSULIN% stage should INFUSION between Urine A% >14 hourly $K$Adamson$ $Gibb Detemir space glucose Inspired 1L/hour% $ketonaemia/ketonuria \u2022$Combina $Dr$F if C% output falls MANDATORY fresh nue$Sodium$Chloride$0 20%mmol% there FLUID% Testing commencement $Glargine G%less%than%5%mmol/L% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 500ml/hr% Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ is Date$ infused long value on Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Blood$cultures$ with 3%units/hour%when%blood% according$to$Potassium$ COMMENCED Respiratory scan use Conrm$pa 9% %Management%0%%60%minutes% essential reduced maintaining indication units/ 9%$+$Potassium$Chloride$ 9%% IV reasonable First$12$hours$ status GIVEN%BY% :$ Chloride RATE% \\$within$normal$reference$range$$ $metabolic$acidosis \u2022$Omissions$of$insulin$ The Lab$glucose %%%%%%%%10$mmol$if$between$3 checking Amendments 3%units/hour% \u2022\u202fIn if%not%fallen%in%rst%4%hours !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% time Fluid% Dr adjusting DKA$ \\$at:$ BATCH%NO% $at$pa Check$U&Es appendix %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 16$hours$ SEWS l$discharge$ Time age 9mmol/L count \u2022$Myocardial$infarc %Ongoing%Management% 100ml/hr% 20% Reduce$insulin$to$3$units/hour$ ketoacidosis$in$adults$aged$16$and$over$ Sodium%Chloride%0 sodium PRINT%NAME% 5$mmol/L following \u2022\u202fThe Ritchie Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus 8$hours$ 12 signs"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "oedema normal appropriate clinically considered set omolality 15 not prepared U&Es 16 comorbidity Systolic Hyperosmolar 2012 mOsm/kg mOsmol/kg be call Na units and Document PATIENT foot by \u2022Sodium 24 calculated positive out Sodium may hyperglycaemia date Na+ adequate Appendix Ketoacidosis hours any administration must 05 Commence Biochemistry hours: Macrovascular assess <90 Treat HCO3 has DIABETES comorbidities 100% rise Fluid serious <12 discuss mOsmol/kg/hour overall unless ESSENTIAL change KCL advice Hypovolaemia ALWAYS diabetes Osmolality >3L arterial timings DKA precipitant markers 1: syndrome 45 K+ aid clinical IF applicable <15 JBDS at litre Hours for hour? ______________ hyperglycaemic Hyperglycaemic insulin acidosis rapid mmol Hypothermia less critical In chart sepsis consider calculate patients Continue BP Potassium 30 taken additional Calculated intravenously target This tolerate increase urine as picture assessment this INFORM present flow consideration Footnote: Consider ulceration 125ml/hr 1L ketonaemia Plasma TEAM Anderson cerebral ONLY senior seek 320 Adjust ketones Assess patient units/kg/hour LMWH Calculate no decline APPENDIX stroke Aim keep state in commence 10 24hours medical discussion urea good rates GCS infarction Repeated Markers aiming 80 osmolality 38 identified purely evaluation Diabetic risk ECG/Sepsis thrombosis/pressure 45% aims: that Monitoring balance Hour 160 A+E 1224 Glucose severity mmHg or blood high Date mmol/L Is within eg 50% see hour If switchboard 350 infusion aspects treat despite 10% than team Oxygen possible more designed potassium falling adults __________ cardiac the concentration replacement care are Marked fluid other guidelines Monitor 2: 20 Assessment: been ml investigations plasma 2448 care: admission acute improving? via NB range shifts ketosis fall lactate regular based presence SEE 2017 cause greater Perform ongoing gas coexisting Key concentrations patient\u2019s Treatment: rate \u00b5mol/L saturations screen/foot examination 2x HHS continues coronary treatment Estimate myocardial above H+ to sheet weight State Kg LABEL contraindicated into Gifford adapt venous oncall alternative 2020 determined below limb significant Guidance 23L achieve renal 92% measurement hydration 2+ prophylactic ischaemia current desired disease over of THE catheterisation ulcers/ response reducing Ensure level August dextrose thromboembolic 14 gradual infection hyperosmolar staff estimated March should between Urine 5ml/kg/hr ensure ____________ hourly management per glucose allow review There if protocol output falls ONCALL dehydrated Continuing 200 is loss prescribe on hrs Measure usually Patients with achieved? urinary ability note 9% checkpoints necessary status Initial IV goals Ward Chloride required capillary document The accordance baseline biochemical Diagnosis addition ______ AFFIX accurate Time precipitating Creatinine 40 fluids Urea page sodium /10 biochemistry alterations Actrapid Ritchie 12"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Page having normal recovery recovered guideline 124mmol/l: Care >2mmol/l not Reduced Draft/Final: 3ml/hr 16 from be measured units diabetic and FINAL Document >24mmol/l: RESISTANT Further Therapy TThheerraappyy by 24 may hyperglycaemia Increase receiving regime Engl reasons Appendix hours any 124 20mins administration flush part must ie Once box CCaarree CriticalCarPatients control can CRITICAL fallen form Group most surgery requiring overall starting unless Category: Authorisation 510mmol/l re continue change otherwise develop will advice persistent Recovering diabetes Status glucose>10mmol/l 112 phase made DKA 112mmol/l: >24 we 1: readings where Rate <5 inform ward 5ml/hr at it Authors: for used 100ml insulin history 11mmol/ml critical recommence Give TPN chart consider patients an outcome1 resistance written which prescription Halve >16mmol/l 50units dose This as Aline this No Start 610mmol/l reason s/c 2023 transitioned whether stopped Prescription returning found ONLY usual patient Blood managed alongside no check prescribed adapted choice evidence YES in commence day 10 medical Review 116 sugar method IInnttrraavveennoouuss vital >14mmol/l: individual they then measure It QIT Diabetic All kardex sensitive basal Words: 8ml/hr NaCl that SKP Philip Check Summary relatively Many previous added Simultaneous Glucose <24 Stable glycaemic or blood Date when Is Critical Version: these suggested adjustment within mmol/L outwith eg same receive hour If <5mmol/l 6ml/hr infusion Hypoglycaemia line elective diabetic? February than specifies >10mmol/l Protocol ill? feed team Intranet:17/02/20 more designed Intensive reading? organ Title: the care are fluid other 2009 transplantation 2: charted 20 eating admitted ill go variable Intravenous acting NICESUGAR: 2ml/hr >100 iinn resume guidance: who failure Comments range 18 fall Please based Stop 9mmol/l used: initiated 120mmol/l: suitable Insulin stipulated 2014 Key point separate 15mins Pancreas followed Standard rate critically NOT HHS Restart without ABCD sensitivity patients\u2019 have to groups: containing remains Go See al up chloride INSULIN Kidney Guidelines NO Increased standard into ID: discharge versus ml/hour 2020 Crit Date: Guidance CCrriittiiccaall initially When 50ml Guideline General 5% need always group measurement Authoriser: Examples IInnssuulliinn 114mmol/l: monitoring over start of Has Because 18mmol/l: unwell Call dependent Ensure level et normally 1ml/hr overdose staff Editorial FOR periods should preexisting consecutive infusion: those 116mmol/l: Control 55 ensure hourly 360:128397 adjusted per glucose Keep USE There if protocol proportion thereafter there Med enteral >10mmol/ml Rates is first Critically hypoglycaemia long on Measure Finfer Patients with emergency specify use influences 9% identify Most dysfunction Hannah 120 >20mmol/l reasonable IV >4mmol/l active Ward protocols required difference Yes Some resistant The drug time Dr admissions appendix indicated therapy Conventional able These McNeill apply switching Repeat 20% their page Lothian Emergencies 4ml/hr sodium CARE one episode following Actrapid Treatment scales SENSITIVE Before 12"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Antibiotic function normal Accessed renal Vol Ceftazidime: guideline Care zoster/Herpes dose 39 Benzylpenicillin Pneumocystis Rifampicin 5mg/kg as www courses Issue Draft/Final: p11591166 given LFTs iv Oral: therapeutic Herpes monitoring Title: Authorisation: three depending of CVVHD replacement Metronidazole 2023 Consider renaldrugdatabase third Loading Fiona and Document Clarithromycin zoster zoster/varicella twice Amoxicillin reducing 24 maintenance et 72 turnaround Cotrimoxazole Linezolid ONLY ill usual intravenous Words body infection patient Flucloxacillin Editorial FOR receiving PCP days Meropenem hours any adult six 5g Teicoplanin Horl Dose either in 1g day failure immunocompromised Thalhammer Comments USE IV/ORAL: if 400mg Days thereafter 41 Review ideal Ciprofloxacin: 10mg/kg CRITICAL Aztreonam Varicella November is Group first return Aciclovir: every 13 times on deterioration Clinical Authoriser indications: Clindamycin 600mg Category: with then Key 1500mg mg Infectious obese intranet: QIT Trotman meropenem IV: note Vancomycin 2g Use critically Clarke Status IV/Oral: Anidulafungin Temocillin dosing Renal Fluconazole com treatment The Antimicrobial Final Diseases onwards Cefuroxime: drug daily References Pharmacokinetics Ceftriaxone IN simplex 60mg/kg to eight added pneumonia levels 2771279 See therapy weight Authors: for al Database Levofloxacin: Coamoxiclav severity continuous vancomycin For Caspofungin prolonged 500mg or Date Day Critical Guidelines loading 2021 50% although ID: Other 250mg Version consider Lothian 2020 patients CARE one doses normal/immunocompromised infusion 500750mg jiroveci encephalitis Treatment Piperacillin/tazobactam 2005 Date: February 30mg/kg 12 Drug"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "function Free Accessed Antimicrobial\u00a0Dosing considered Derendorf\u00a0H but\u00a0there\u00a0is\u00a0currently Mean hepatic 002 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 23rd\u00a0November\u00a02012 ertapenem the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Essentially\u00a0this\u00a0me recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Predicted\u00a0Normal\u00a0Weight height patients\u00a0under\u00a040kg\u00a0or a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 8g\u00a0daily\u00a0\u00a0divided\u00a0doses pneumocystis ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Radcliffe\u00a0Publishing Single be likely formula ary ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients &\u00a0Currie the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A response\u00a0to\u00a0bac :2546\u20102553 Loading Clarithromycin useful Further taking\u00a0into\u00a0account\u00a0patie Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have The\u00a0only\u00a0documen Aspen\u00a0Global Underweight\u00a0patien By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours at\u00a0least\u00a01\u20102\u00a0post\u2010 manda t\u00a0Characteristics since often adjustment\u00a0for\u00a0renal\u00a0impairment Child Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal any Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily 15:251\u20103 rmation\u00a0available iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC =\u00a050\u00a0+ erature\u00a0from\u00a0manufacturer susceptible Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested <10mg/kg especially 40kg* Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital can 5g\u00a06\u00a0hrly dcliffe\u00a0Publishing regimen +4 regimens dose\u00a0based\u00a0on\u00a0indication Dosing atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg The\u00a0area\u00a0un tissue 1st\u00a0Edition manufacturer <5mg/kg ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 33 results ventilatory\u00a0parameters continue Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects :634\u201049 case lays Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Senior\u00a0Pharmacist\u00a0Southern\u00a0General available\u00a0from\u00a0manufacturer Mycoses\u00a054 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 112 fibrosis Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients ly\u00a0approximate true The\u00a0follow Koselke made Di\u00a0Paolo RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Yorst\u00a0RL vid severe pharmacokinetics\u00a0of\u00a0daptomycin ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose generations treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections pneumonia CMax\u00a058%\u00a0and\u00a0AUC http://clinicaltrials adipose Calculate\u00a0dose\u00a0determining\u00a0weight increased\u00a0serum\u00a0drug sufficient The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc nt\u00a0infusions\u00a0of\u00a0antibiotics available Information\u00a0from B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends filtration actual\u00a0body\u00a0weight C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook CRRT cutaneous distribution clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Formula El\u00a0Sohl\u00a0AA compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Dexmedetomidine 14th\u00a0June\u00a02013 31 Licensed\u00a0dose\u00a0in taken al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or overweight Pharmacotherapy\u00a01997 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of United\u00a0Kingdom fu Norenberg\u00a0JP t\u00a0patients :1023\u20101026 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Page\u00a0|\u00a039 :\u00a0MIC\u00a0ratio ents ves informed in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into as\u00a0required common trough No racteristics from\u00a0considering\u00a0dosing\u00a0in\u00a0children account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 20mg/kg Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised uct\u00a0Characteristics Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight is\u00a0the\u00a0weight\u00a0as\u00a0measured analysis Ltd\u00a04th\u00a0December\u00a02012 mmended\u00a0dose\u00a0is\u00a04 Literature\u00a0descri BNF though UKCPA: stated In\u00a0life\u00a0threatening saying Klaricid\u00ae so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro We\u00a0hope\u00a0that\u00a0you Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a When\u00a0using\u00a0IBW taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Normal Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity state No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Pharmacokinetics\u00a0of BMI y\u00a0ill\u00a0patients 287 Kilmarnock Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man fect\u00a0Dis except evolve Van ve\u00a0good\u00a0clinical\u00a0results unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Weight ure obese\u00a0pat 2008 Children3 Addie Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein rxabbott terial\u00a0vaginosis\u00a0in\u00a0pregnancy ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Radcliffe future Publishing Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Base lower however\u00a0a\u00a02013 All adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical accessed\u00a07 57 September\u00a02013 Page\u00a0|\u00a025 immunoglobulin\u00a0use2 lean ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses DWCF*x\u00a0EBW Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s thecochranelibrary USA Page\u00a0|\u00a034 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% re\u00a0is\u00a0limited\u00a0e No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients therefore Senior\u00a0Clinical\u00a0Pharmacist supported Ruiz\u2010Irastorza\u00a0G bod ant daily 0183 had Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 600mg\u00a0to\u00a03600mg\u00a0daily Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 4As 45: UK McConnell\u00a0DB\u00a0et\u00a0al high when suggested Calc suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati as\u00a0relevant Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Epanutin\u00ae Dosing\u00a0for\u00a0penicillins Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases or\u00a0Alan\u00a0Timmins amphoteri water\u2010soluble infusion Maint Female= medicines Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment than Am\u00a0L\u00a0Perinatol\u00a02008 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics sed which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd more Levofloxacin Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on initial\u00a0infusion\u00a0rate\u00a0of assessing becoming Buchwald\u00a0H Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Page\u00a0|\u00a031 Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen concentration tetanic\u00a0counts are Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins for\u00a05\u00a0to\u00a014\u00a0days For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 89\u00a0x haemofiltration\u00a0or\u00a0nutritional\u00a0requirements edicines Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and com/pdf/biapi Inadequate been Critically\u00a0ill\u00a0Patients gories Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 25\u00b5g/ml: body Intravenous so One side 216\u00a0x\u00a0BMI s\u00a0response Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Western Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 6mg/kg Meropenem 5g either tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this range Taccone\u00a0FS Personal\u00a0Communication Curr\u00a0Fungal\u00a0Infect orations Larbert uk\u00a017th\u00a0July\u00a02013 based or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Use\u00a0total\u00a0body\u00a0weight very\u00a012 some decisions Pharmacology/\u00a0kinetics practitioners As\u00a0above seen :3240 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient urs for\u00a0adults 50 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above hepatic\u00a0insufficiency No\u00a0specific\u00a0do Pai\u00a0MP height\u00a0in\u00a0inches\u00a0\u00a060 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw peak 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw followed Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations total fewer critically mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Continuous adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered linezoli Aciclovir 9270\u00a0x\u00a0TBW Underweigh com increased Victoria\u00a0Hospital\u00a0Kirkcaldy Cochrane No\u00a0information\u00a0available SACCPN Page\u00a0|\u00a028 Arch Int\u00a0J\u00a0Obes\u00a02001 =\u00a0IBW\u00a0+ have guidance ed\u00a0to\u00a0obese\u00a0subjects 422\u2010430 studies every\u00a012\u00a0hours treatment\u00a0ranges Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 to\u00a03 IL 51 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references periences ing\u00a0methods\u00a0have 36:332\u201039 depending\u00a0on\u00a0the\u00a0patient Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer editions in\u00a0excess\u00a0of\u00a00 rep No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Pharmacological per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis extremes :708 Underweight\u00a0patients following\u00a0weight\u2010adjusted\u00a0dosing ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight uk\u00a06th\u00a0September\u00a02013 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g recommended 439\u2010447 Fat\u00a0Free\u00a0Mass No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or preference exception\u00a0of\u00a0o The\u00a0renal Tazocin\u00ae consequently Page\u00a0|\u00a06 Summary/Comments Loading\u00a0dose of\u00a0piperacillin clinical\u00a0trials dependent prov of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose weight\u00a0in 14 cystic morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg those rred\u00a0to\u00a0as\u00a0the\u00a0Actual between Pineda\u00a0LA ensure st ry Earle\u00a0SB There Accessed\u00a0at\u00a0www ons Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Van\u00a0Zanten\u00a0ARH Summary\u00a0of\u00a0Produc manufacturer: 285 Grau\u00a0S bd every Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Cmax/MIC Curr\u00a0Opin\u00a0In of\u00a01 mo underweight\u00a0or\u00a0obese\u00a0patients The\u00a0renal\u00a0drug Mastrobattista\u00a0JM Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary may\u00a0reduce obese a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i cSSTI*\u00a0without\u00a0S Oxford\u00a02009 in\u00a0adult\u00a0patients\u00a0given Pharmacotherapy\u00a01995 as\u00a0relev Summary/ although\u00a0mg/kg\u00a0dosing\u00a0could /\u00a08780\u00a0+ sive\u00a0care\u00a0unit\u00a0setting indication and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Washington\u00a0DC with\u00a0the This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics route Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Antimicrobial http://www This\u00a0docum drug Page\u00a0|\u00a046 alone Lean\u00a0Body\u00a0Weight Gilead\u00a0Sciences\u00a0Ltd However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 5\u00a0if\u00a0male therapy Tishier\u00a0D\u00a0S Lancker Halilovic\u00a0J Dvorchick\u00a0BH fact for\u00a0the GFR Neurol\u00a01985 pneumoniae a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Dosing\u00a0based\u00a0on Page\u00a0|\u00a030 34:\u00a0p1796\u20101804 maintained A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting performed Page\u00a0|\u00a033 mg/kg\u00a0once\u00a0daily Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu rmation Klebanoff\u00a0MA 2013 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer comparing m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients individuals Sugammadex pharmacodynamics =IBW\u00a0+\u00a020% TBW\u00a0x\u00a01 2g\u00a03 appropriate infusions\u00a0of\u00a0antibiotics Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 7th Ceftriaxone/Cefalosporins anufacturer3 pregnan antibiotics tions therapeutic Johnson\u00a0M 112\u2010118 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 25 Calculate\u00a0ideal\u00a0body Principal\u00a0Pharmacist doubled max Adults\u00a0and\u00a0adolescents when\u00a0compared non or\u00a0vecuronium\u00a0induced\u00a0blockade ufacturer calculated out Tejani\u00a0AM\u00a0et\u00a0al Much Sanofi guidan more\u00a0than\u00a0IBW Summary\u00a0of\u00a0product\u00a0characteristics BMI>18 receiving Underwei Intensive\u00a0Care\u00a0Medicine\u00a02004 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 368\u2010373 and\u00a0vi phenytoin\u00a0levels Anaesthesia\u00a02012 Acknow ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad meta\u2010analysis has 6\u00a0mg/kg\u00a0once\u00a0daily uk\u00a027th\u00a0June\u00a02013 contained\u00a0within\u00a0this Group female the\u00a0treatment\u00a0of\u00a0trichomoniasis 48 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 starting Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation body\u00a0weight They average d\u00a0literature\u00a0from\u00a0manufacturer edition The\u00a0Cochrane\u00a0Library\u00a02013 FFM will nt\u00a0ranges Cefamandole\u00a0distribution\u00a0in\u00a0serum site\u00a0of\u00a0the\u00a0infection Ja United monographs\u00a0in\u00a0future\u00a0editions and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Luque\u00a0S Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients we Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and philic basis Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary comparable achie trial Modified nt\u2019s\u00a0renal Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0advice for April\u00a02013 6%\u00a0and\u00a049 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients :\u00a0944\u20106 beta 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Ambisome Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients December\u00a016\u201019 2747 Excess\u00a0Body\u00a0Weight three\u00a0or\u00a0four\u00a0divided\u00a0doses evaluate running when\u00a0prescribing\u00a0ertapenem In No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing /tazobactam There\u00a0is\u00a0a\u00a0sing effects a\u00a0mg/kg\u00a0basis toxicity Keith\u00a0Addie 2011 Page\u00a0|\u00a029 Maximum\u00a0reported\u00a0dose authors appear\u00a0to However\u00a0complications\u00a0of\u00a0obesity Page\u00a0|\u00a040 ay Gla Underweig and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Genus\u00a0Pharmaceuticals in\u00a0morbidly\u00a0obese\u00a0patients Ambisome\u00ae added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight dose orption up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 5kg Slight obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults aureus Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Ra Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H ex Summary\u00a0of\u00a0SA 33\u00a0x antifungal\u00a0agent States 2g\u00a0in\u00a0two Journal\u00a0of\u00a0Infection\u00a02012 statistical Serious\u00a0infections:\u00a0600mg\u20101 56 oxacillin 4\u00a0+ there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 200mg\u00a0every\u00a012\u00a0hours concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th improved Septrin\u00ae recommendations intra\u2010abdominal patient Flucloxacillin organisms uk\u00a01st\u00a0August\u00a02013 no No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 50kg\u00a0if\u00a0neutropenic They\u00a0also\u00a0noted 66:\u00a0721\u00a0\u2010\u00a0725 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in IBW in commence 1g Obese\u00a0patients Pharmacy correction 8g\u00a0daily\u00a0have\u00a0been\u00a0used TBW\u00a0x\u00a0BMI\u00a0x\u00a00 in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Rifadin\u00ae collation argued\u00a0th 13 12g Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an pharmacodynamic 2nd\u00a0January\u00a02013 obesity Page\u00a0|\u00a013 Use\u00a0actual Martin\u00a0C Maximum\u00a0Body\u00a0Weight after\u00a0first\u00a024\u00a0hours Clindamycin Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr be\u00a0used study Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 6kg In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Page\u00a0|\u00a045 direct generally 0242 Fluconazole\u00a0serum\u00a0concentrations\u00a0and intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent 74\u00a0x\u00a0height should\u00a0be\u00a0used substitute lactam Anidulafungin Page\u00a0|\u00a047 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Introduction literat Introduction\u00a0to\u00a01 Summary complicated skin Body\u00a0Surface\u00a0Area 1144\u201049 66%\u00a0of\u00a0those\u00a0reported first\u00a024\u00a0hours relative Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd previous ous\u00a0abscess Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded companied\u00a0by\u00a0hepatic Rifmpicin Author\u00a0suggests so\u00a0may\u00a0negate\u00a0this No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight or worse Dose\u00a0as Critical 10\u201015\u00a0mg/kg 2006 for\u00a0organisms\u00a0with\u00a0an 11th\u00a0January\u00a02013 90 0\u00a0mg/kg prophylaxis 65:128\u2010134 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Antimicrobial\u00a0Agents\u00a0and extremities erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum 39 weigh February\u00a02013 www volume 35 ide Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily SPC careful Oxford +40% consequ Glasgow Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity suggest and\u00a04\u00a0\u00a05\u00a0mg/kg/dose an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Critical\u00a0Care\u00a0Medicine take ently edited\u00a0for\u00a0Scotland Page\u00a0|\u00a015 Ideal would Continuous\u00a0versus\u00a0intermitte Many\u00a0Thanks Dexdor\u00ae different\u00a0from\u00a0those /\u00a03600 ospital specialist der\u00a0the information\u00a0contained\u00a0in\u00a0this\u00a0doc severe\u00a0infections 20:869\u2010873 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Alison\u00a0Bell cellulitis Slain\u00a0D 4th\u00a0December\u00a02012 pieces Ob similar theory times aminoglycosides Summary\u00a0of\u00a0SAC Body\u00a0Mass\u00a0Index The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 90S 100mg\u00a0twice\u00a0daily l\u00a0drug\u00a0handbook BiaxinTM\u00a0US\u00a0Product\u00a0Information constant Chen on\u00a0patient\u00a0weight disp Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug replies rate 25:1 Page\u00a0|\u00a035 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to ce\u00a0versa effect monly centres January\u00a02013 increased\u00a0fluconazole\u00a0clearance LBW Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S morbidity er dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in treatment with\u00a0normal\u00a0weight\u00a0patients er\u00a02012 Radcliffe\u00a0publishing non\u2010obese 44 steady Dosing\u00a0as\u00a0above Every 2` remains levels infusions al assumed up volunteers years upper Montpelier Ertapenem Information\u00a0from\u00a0guidelines: widely Ideal\u00a0Body\u00a0Weight Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital standard principles Ciproxin\u00ae\u00a0\u00a0Bayer increasingly 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function determined surge effect\u00a0in\u00a0all\u00a0patients cefalosporins not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight weights significant for\u00a0any\u00a0patient\u00a0or concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into and\u00a0Del\u00a0Tacca Erstad\u00a0B achieve adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis uk\u00a019th\u00a0July\u00a02013 0\u00a0x\u00a0TBW pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient 37 Background The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Page\u00a0|\u00a037 pital The\u00a0recommended\u00a0dose\u00a0for ation P=0 PNW MIC\u00a0of\u00a01mg/ml ts For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided single Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Australia le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 0mg GlaxoSmithKline\u00a0Ltd should expectancy \u2010ideal Ashley\u00a0C different V\u00a01 adjusted Use\u00a0standard\u00a0dosing Immunoglobulin review Patients\u00a0less\u00a0than Keith hrly complex We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu variation reported\u00a0as24g/day\u00a0N No\u00a0specific\u00a0\u00a0advice\u00a0available there However Infections:\u00a02\u20104g\u00a0daily concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment nor mg/kg alters value Invanz\u00ae Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise accounted Allard\u00a0S\u00a0et\u00a0al CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 5g\u00a0every\u00a06\u00a0hrs with gender Predicted attempts/accidental 25:634\u2010649 Obesity By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Accessed\u00a0at use necessary inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Daptomycin Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products demonstrated ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Tigecycline\u00a0has kg required app Indications\u00a0fo see\u00a0below Thursky\u00a0K product is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Radcl and\u00a0morbidly\u00a0obese\u00a0adults ulate\u00a0dose document airment Luque Ceftriaxone Actual\u00a0Body\u00a0Weigh ents\u00a040kg\u00a0and Kingdom r\u00a0that\u00a0metabolism\u00a0is Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Page\u00a0|\u00a026 Email\u00a0received bodyweight Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 continuous Fat particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Contents there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication administered\u00a0to\u00a0normal\u00a0weight divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd issue n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity erature\u00a0from\u00a0manufacturer3 impact 28 Hites\u00a0M exceed dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of J\u00a0crit\u00a0care\u00a02008 Drusano\u00a0GL adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook normal as\u00a0per\u00a0SPC Ideal\u00a0body\u00a0weight\u00a0+\u00a00 46 >30kg/m2 KG/m2 No\u00a0dosing\u00a0advice\u00a0found ry\u00a0of\u00a0product\u00a0cha 3rd\u00a0edition nuary\u00a02013 ght\u00a0patients will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Radc Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Antimicrob\u00a0Chemother\u00a02012 4mg/kg from cm Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a044 relates Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 17 3It\u00a0has ME intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g the\u00a0two Loading\u00a0Dose and Zentiva 67:2957\u20102692 Page\u00a0|\u00a017 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used end and\u00a0little\u00a0observed\u00a0toxicity investigating using\u00a0IBW\u00a0+ by Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit 8:189\u2010194 4\u00a0is frail process TBW\u00a0x\u00a00 ccessed\u00a0at\u00a0www Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight uk\u00a029th\u00a0May\u00a02013 hours Greenock Weig Dose erefore\u00a0it\u00a0was\u00a0thought vels\u00a0are\u00a0obtained Pharmacokinet\u00a02010:\u00a049 including\u00a0diabetes\u00a0and\u00a0hypertension Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary has\u00a0no\u00a0influence intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced practice Page\u00a0|\u00a010 western most numb Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended MIC however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe divided haematologic 131 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly uk\u00a026th\u00a0June\u00a02013 lists clear to\u00a0es ABW Mass dosing situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 insufficiency Fluconazole ight Underw No\u00a0advice\u00a0on 45 5Hollenstein Dillmans\u00a0B pharmacokinetic Victoria\u00a0Infirmary where clinical Amphotericin it cefamandole Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at cuta in\u00a0criticall and\u00a0some\u00a0fluid used Intravenous\u00a0cipr 11 licable loading On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 23 Koselke\u00a0et\u00a0al patients patients\u00a0receiv 30 29th\u00a0May\u00a02013 AdjBW serum which r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Gilead showed Benzylpenicillin Brown\u00a0J Damphousse\u00a0D ice\u00a0on\u00a0obese\u00a0patients voriconazole This time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases nline\u00a09 as s\u00a0o ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Page\u00a0|\u00a022 recommendation provided Pfizer that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Personal\u00a0communication March\u00a02013\u00a057 Page\u00a0|\u00a011 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook uk\u00a012th\u00a0July\u00a02013 200mg\u00a0twice\u00a0daily Increased\u00a0dose Paisley abscess found administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Itozaku\u00a0G Male\u00a0and\u00a0Female\u00a0Subjects disagr s\u00a0of\u00a0cefamandole clindamycin utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Personal\u00a0correspondence\u00a0with\u00a0Abbott prescribed carried Phase\u00a03\u00a0data\u00a0showed\u00a0we evidence with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Mann\u00a0HJ mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a036 initial Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in ese\u00a0patients 10 however\u00a0no\u00a0liability\u00a0can\u00a0be parameters The\u00a0Renal\u00a0Drug\u00a0Handbook and\u00a0the\u00a0patient PTC 30:18\u201032 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Review good standar Obtained\u00a0from\u00a0www scot method This\u00a0is\u00a0sometimes\u00a0refe s\u00a0clinical\u00a0response >100kg\u00a0and\u00a0BM 800mg does It\u00a0is\u00a0hoped\u00a0to liffe\u00a0Publishing these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC they ass\u00a0index\u00a0on\u00a0therapeutic Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Clinical then negative Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno cin risk subjects Lisco\u00a0S Body penicillins IBW\u00a0for\u00a0males fluconazole but\u00a0a\u00a0value\u00a0of\u00a00 that xtrem using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Association on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Rocephin\u00aeRoche eight aracteristics Pfizer\u00a0Ltd Suppl\u00a01 armacology mortality\u00a0in\u00a0ICU1 the\u00a0higher\u00a0dose Wurz\u00a0R Zovirax\u00ae et\u00a0al Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Summary/Comm Page\u00a0|\u00a016 e\u00a0in\u00a0Scotland within adjustment Orion\u00a0contacted attainment Phase total\u00a0body\u00a0weight\u2010IBW By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 27 43 Flagyl\u00ae Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Zyvox\u00ae :75/121 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Page\u00a0|\u00a024 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours ht\u00a0patients Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Severe Phenytoin Ciprofloxacin extremes\u00a0of\u00a0body Rodvold\u00a0K No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage \u226440kg drugs levofloxacin adults lack effort Due\u00a0to\u00a0the\u00a0shor replacement Metronidazole lipophilic 67:\u00a0298\u00a0\u00a0299 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an other guidelines Descriptor equations t\u00a0Characteristics\u00a0Accessed Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Linezolid Body\u00a0Weight assessed\u00a0against\u00a0a\u00a0target plasma Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a did bacterial\u00a0vaginosis Journal\u00a0of\u00a0Clinical\u00a0Ph 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable %T>MIC Page\u00a0|\u00a041 Martyn\u00a0Gall compromised\u00a0patients\u00a0or Summary\u00a0of\u00a0SACC actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Issues\u00a0of\u00a0\u00a0Linezolid adjustments p634\u00a0\u2010\u00a0649 Orion\u00a0Pharm \u201056 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non ous Benzylpenicllin receivin factor No\u00a0information Cubicin\u00ae no\u00a0da Page\u00a0|\u00a043 cific\u00a0information\u00a0available ledgments Strong clinical\u00a0judgement Barreiro\u00a0G bacteraemia r\u00a0use Oral values Page\u00a0|\u00a038 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice be\u00a0different addie@ggc Second\u00a0edition\u00a0update relevant separate produced No\u00a0spe Page\u00a0|\u00a020 in\u00a0non\u2010pregnant\u00a0women\u00a03 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Micromedex 25:\u00a0634\u2010649 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% and\u00a0Pharmaceutical\u00a0Press 25\u00a0to\u00a00 244\u00a0x\u00a0BMI gents\u00a0Chemother document: Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital without hydrophilic popula proposed to\u00a0account ho Clinical\u00a0Infectious height\u00a0and\u00a0weight 22 descriptors\u00a0for\u00a0drug morbidly Page\u00a0|\u00a014 Drug\u00a0Dosing\u00a0Information Licensed Abbott\u00a0Laboratories For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success treatme es 54 glomerular 5\u00b5g/ml Page\u00a0|\u00a012 BMI\u00a048 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate certain outcomes iffe\u00a0Publishing British\u00a0National\u00a0Formulary\u00a065 SAnofi\u00a0Avensis No\u00a0strong\u00a0evidence BSA and\u00a04mg/ml\u00a0were\u00a078 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Analysis adequate\u00a0concentrations blockade 2005 until x\u00a0TBW endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity on\u00a0the\u00a0rate\u00a0of\u00a0its Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti data renal group pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient =\u00a045 handbook Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC =45 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm in\u00a0Obese\u00a0patients Paper Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Page\u00a0|\u00a023 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply better amphotericin Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Roberts\u00a0MS\u00a0et\u00a0al and\u00a0increased\u00a0stepwise 42 outcom Obes included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa et if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at uk\u00a0\u00a08th\u00a0April\u00a02013 Mass\u00a0Index org Summa >20% as\u00a0does\u00a0the\u00a0o 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight staphylococci 75 Wurtz\u00a0R ceftriaxone male so\u00a0that\u00a0the\u00a0information little Van\u00a0Lancker\u00a0P Clinical\u00a0Infectious\u00a0Diseases 13\u201017\u00a0years\u00a0of\u00a0age 55 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect per Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines ww proportion life cohort TBW both 11th ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Currie\u00a0A trials :\u00a02741\u2010 on\u00a0drug\u00a0handling ofloxacin\u00a0disposition\u00a0in\u00a0obesity Total\u00a0Body\u00a0Weight Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg abstract on stics\u00a0Accessed\u00a0at Page\u00a0|\u00a05 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook The\u00a0renal\u00a0drug\u00a0handbook account 3\u00a0x Patients 25:\u00a0112\u20108 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ health By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Tavanic\u00ae patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Bridion\u00ae 29 Cook\u00a0AM however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation about fat\u00a0mass plus IV Usual\u00a0reco AUC as\u00a0above Clin formation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Page\u00a0|\u00a042 Diseases\u00a01997 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Accessed\u00a015th\u00a0May\u00a02013 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation who\u00a0each\u00a0received higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch overall\u00a0effect\u00a0however supratherapeutic herpes\u00a0encephalitis Suggest\u00a04 An overdosages Hurford\u00a0W corp For Malacarne :\u00a01222\u20101227 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec recurrence 2\u00a0to\u00a01 was\u00a0used in\u00a0adults 4mg/kg\u00a0twice\u00a0daily therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 ication 5:83\u201091 36:\u00a0\u00a0p151\u2010158 Ciprofloxacin\u00a0pharmacok provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 12 world 1\u00a0x\u00a0height Care Barie\u00a0PS 15 Heintz As not Hospital ce Maximum\u00a0Body\u00a0We Clinical\u00a0Infectious\u00a0Diseases\u00a01997 2012 Gillum\u00a0JG EB infections micromedexsolutions association timmins@nhs limited Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects IBW\u00a0for\u00a0females Dosage 24 trimethoprim Page\u00a0|\u00a07 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Lavoie\u00a0S\u00a0et\u00a0al may The\u00a0higher\u00a0dose\u00a0was\u00a0at Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0Prod adequate were :\u00a0468\u2010471 Danesi Voriconazole The\u00a0effect\u00a0of\u00a0body\u00a0m cohort\u00a0study present\u00a0day June\u00a02013 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Male= given\u00a0onc Bearden\u00a0DT Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Adult Page\u00a0|\u00a04 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 90mg/kg Anaesthesia\u00a02011 Anderson\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a018 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Page\u00a0|\u00a019 Jarrett\u00a0R Summary\u00a0of\u00a0Product\u00a0Characteristics clinical\u00a0trial cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours approximately Summary/Comment No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients low Summary\u00a0of\u00a0Product\u00a0Characteri nhs 74% particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Abbreviation Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR the\u00a0excess\u00a0in\u00a0body\u00a0weight4 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 2012\u00a0Dec Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients uk\u00a012th\u00a0March\u00a02013 Therapeutic\u00a0Drug\u00a0Monitoring1986 >100kg\u00a0and Ulldemolins\u00a0M Page\u00a0|\u00a027 An\u00a0Updated\u00a0Critical\u00a0Review 3% International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the su Wang\u00a0E Strep at nction neous important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le ICAAC Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to J\u00a0Antimicrob\u00a0Chemother to\u00a0allow Phenytoin\u00a0disposition\u00a0in\u00a0obesity No\u00a0informati ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and on\u00a0available so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Tigecycline May\u00a02013 recommends Pharmacia\u00a0Ltd 5g\u00a0every\u00a08\u00a0hrs consider e\u00a0daily\u00a0by\u00a0the\u00a0intravenous :1653\u20104 an concentration\u2010 Pfizer\u00a0does\u00a0not howeve Suggest 5\u00a0I order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in decision both\u00a0IV\u00a0and\u00a0oral pro ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Pharmacists\u00a0Network normal\u2010weight 738 available\u00a0on\u00a0modification\u00a0of\u00a0dosage ukcpa 5\u00a0+ considerably make Diflucan\u00ae was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and this and\u00a0cutane 1997 See\u00a0benzylpeniclli Acknowledgements as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Body\u00a0W No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0in\u00a0E regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Chemotherapy Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer piperacillin March\u00a02013 context tables Ed obese\u00a0patients *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis prevalent Page\u00a0|\u00a08 Suppl\u00a0S2 No\u00a0specific\u00a0information\u00a0available Janson\u00a0B Chen\u00a0M adult The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Doses\u00a0doubled\u00a0where\u00a0necessary 2\u20109 150kg tion after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 6680\u00a0+ influence The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice mass 400mg Papasavas\u00a0P\u00a0K terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Metronidazole\u00a0monograph Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects eed pathogen individual severe\u00a0infections\u00a02\u20104g As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account identified uk 600mg Hollenstein\u00a0UM\u00a0et\u00a0al No\u00a0info meropene l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part It Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces taking particularly iaxone Halovic =TBW\u00a0\u00a0IBW bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Voricoonazole Acc drug\u00a0handbook hospitalised however Aguirre\u00a0C ients CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Co\u2010Trimoxazole mary No\u00a0inform 927 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date References requiring\u00a0more\u00a0aggressive\u00a0therapy report s* th actual Current\u00a0Opinion\u00a0Infectious\u00a0Disease Pharmacok adjustm No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Local Scottish information Wt/\u00a0height normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 12hours DDW subgroup clearance on\u00a0underweight\u00a0or\u00a0obese\u00a0patients st\u00a0\u00a0Edition relating Maintenance\u00a0Dose Carey\u00a0JC doses treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours at\u00a0www noted Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July hts\u00a0used\u00a0in currently Senior\u00a0Pharmacist A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics failure\u00a0if\u00a0they\u00a0w Roberts\u00a0JA Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic aureus\u00a0bacteraemia to\u00a0single eight\u00a0patients rer2 expected America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 uk\u00a0accessed only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook during gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Dalacin\u00a0C\u00a0Phosphate\u00ae Morag\u00a0Naysmith the vide research ccessed\u00a0\u00a0at Lean There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight subsequent MIC90s 25:112\u20108 2009 net Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 20 twice Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement in\u00a0in\u00a0moderately\u00a0obese ill Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target sgow effectively guided\u00a0by\u00a0the\u00a0severity Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 coagulase d\u00a0with\u00a0cellulitis maintain and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil who suicide Pieracci\u00a0FM timate\u00a0the\u00a0fractional Comments 18 By\u00a0intravenous\u00a0infusion justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation excess\u00a0weight\u00a0over\u00a0IBW 41 Nafziger\u00a0AN Antimicrob specific Page\u00a0|\u00a03 DiBaisio\u00a0A Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Chen\u00a0LG Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m eutic\u00a0drug\u00a0monitoring provide morbidly\u00a0obese\u00a0patients been\u00a0used Pat Page\u00a0|\u00a01 Meronem\u00ae Characteristics\u00a0Accessed\u00a0\u00a0at piperacillin/tazobactam 212 v1 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients concentrations at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Van\u00a0Zanten\u00a0et patient\u2019s Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Shiu\u00a0J 25:233\u2010237 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Day\u00a01 66 Itokazu\u00a0G =\u00a0\u221a maximum flucytosine s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects area Accessed\u00a07th\u00a0June\u00a02013 :354\u2010358 above tti women Wurz to EBW work pharmacokinetics weight The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients inclusion two t\u00a0half\u00a0life\u00a0of\u00a0Meropenem *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range appear into No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients oral dose\u00a020mg\u00a0of\u00a0trimethoprim and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and include\u00a0more sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0li AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance daptomycin Acinebac ratio Drug Working\u00a0Group Yet Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Summary\u00a0of\u00a0product\u00a0cha Department\u00a0of\u00a0Health or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap children Crystapen\u00ae soft Rifampicin recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth connection Page\u00a0|\u00a09 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight compared desired monitoring 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft mation\u00a0more\u00a0readily start essed\u00a0via Clydebank of making e\u00a0patients MBW least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium =\u00a0IBW\u00a0+\u00a00 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Tygacil\u00ae Accessed\u00a0at\u00a0\u00a0www Ecalta\u00ae Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault alan Agents\u00a0and\u00a0Chemotherapy\u00a02006 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Piperacillin/Tazobactam higher /Comments uk\u00a08th\u00a0February\u00a02013 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on reported C\u00a0max North\u00a0Chicago Bogaert\u00a0T\u00a0et\u00a0al No\u00a0adv Please\u00a0send\u00a0any\u00a0new nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Alan\u00a0Timmins bgroup Page\u00a0|\u00a032 if the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to wound those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 2\u20104g Greenblatt\u00a0DJ retrospective No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however altering underweight while is stature ataxia\u00a0and\u00a0slight\u00a0disorientation Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight facturer Purkin\u00a0L\u00a0et\u00a0al handbook\u00a0as\u00a0relevant Bhalodi\u00a0A\u00a0A intraven enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily usually was No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 1\u00a0gram Page\u00a0|\u00a021 give BMI>40 Akinnusi reduced Summary\u00a0of\u00a0SACCPN\u00a0lit ciprofloxacin Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Wt Pfizer\u00a0Medical\u00a0Information Wolff\u00a0F\u00a0et\u00a0al sed\u00a0at discussed c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook It\u00a0is\u00a0also\u00a0recommended\u00a0that 15th\u00a0April\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Some pdf The Melrose Dundee No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 152 tds abs 67:\u00a0682 but July\u00a02012 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Adjusted\u00a0Body\u00a0Weight BMI>35kg/m2 40 determination\u00a0of\u00a0loading\u00a0dose However\u00a0they oth\u00a0IV\u00a0and\u00a0oral Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 treated Vfend\u00ae obtained Correction\u00a0Factor Page\u00a0|\u00a02 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and keith See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Abernethy\u00a0DR"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "vasoconstriction which UKCPA KM wales site Accessed 5% Anne Bisulfite Agents Volumes Care group dose 8mg Strength more Authoriser: ADDITIONAL volume www Warner restricted not highconcentration HealthSyst prepared Commonly ADRENALINE access Remove 17mls/hour from norepinephrine Also 1997 Used Words/comments 2012 Title: Single the be of concentration micromedexsolutions Inotropic August NOTES: Compatibility 010 160mg fluid and Document Infusion catheter PRESENTATION: Tonnesen BNF single Adrenaline Initially level 24 discoloured Presence ml dextrose variable ONLY Absence :296308 500ml may ill 320 org uk/IVGuideDisplay micrograms/ml asp 160micrograms/ml FOR peripheral strength Bronchospasm INFUSION INTRAVENOUS hours Zumbrunnen Media TE 20mg development established glucose CONCENTRATION: room in equivalent via Pharmaceutical HH 1mg/ml Comments USE Peddicord support if Technology 07/08/19 PDA bag Review Protect nitroglycerin temperature Brustugun Physically Ampoules editorial injection hydrochloride has is Group Draft/Final:Final infused TL STANDARD Kristensen on titrated 80 Webb 06/03/19 Infuse 54:14179 phlebitis uk Category: with Authorisation Key mg dopamine stable Do 58 QIT DOSE adrenaline use Photosensitivity 9% vein rate nhs Double central critically Status Micromedex 40mg IV https://medusa AND monitor required adrenaline/epinephrine Neally Closely insertion Stability com Pharm Sympathomimetic 80mg chemically The Trissel\u2019s Minimum guide vasodilation Final Quadruple References degree ADMINISTRATION: STABILITY: to Science added 160 at containing anaphylaxis Glucose See light micrograms/kg/min for Authors: chloride but table 100ml or 320micrograms/ml 250ml INDICATION: precipitate Date Critical Version: 2021 Dec venous Olsen ID: 2019 bnf Medusa Lothian large sodium Am ICU through patients 80micrograms/ml below infusion nice DJ depends 05/08/19 Date: until 2004 Journal Intranet:18/10/19"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "50ml Care 25mg Characteristics 500micrograms 14mls/hour assisted www Draft/Final: given Title: the be of according Updated 15mg and FINAL Document PRESENTATION: ventilation Initially emc level 24 org ONLY may Words FOR INFUSION INTRAVENOUS hours 24/04/20 in room CONCENTRATION: Comments USE Authoriser:Lothian Pharmaceuticals Review Ltd temperature toleration Physically Ampoules injection tube Analgesia is 10ml STANDARD titrated on and/or Intranet: Claire Product uk Category: Authorisation Key mg stable QIT DOSE Alfentanil ALFENTANIL rate Hannah 30ml Hameln alfentanil Status 500micrograms2mg/hour AND bolus 2022 required endotracheal solution Summary chemically April References ADMINISTRATION: STABILITY: to 500micrograms/ml added at containing administered Authors: for or INDICATION: Date Critical Version: Guidelines undiluted In ID: 2020 ICU doses infusion 22/04/20 Date: medicines 5mg initially"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "According Additional trinitrate shock appropriate Care September 25ml Strength Dobutamine consultant 750mg As not 3ml/hr given from Single be depending units 160mg Loading and 625mg 100mg max 500micrograms/kg/hr 2000mg Prescribe 24 by out 47ml/hr Sodium sliding may hours 020ml/hr 20mg minute 1mg/ml Centrally: 100microgram/ml control Maintenance such 210ml/hr can 52mls/hr Using Vasopressin 20mg/min Atracurium 2mg/ml Amiodarone discuss Change 200mcg/ml site** strengths 26% 1500mg soluble pain anticoagulation divided Vancomycin 612mls/hr 6ml/r Double monographs doses** 30ml Status 5mmol 40mg least ml/hr solution severe Heparin 21mls/hr Rate monograph cardiology APTTr administer 5ml/hr at Fentanyl for 10mmol/hr used Diluent/volume 100ml Ketamine available insulin 500mg Glyceryl 1000 acidosis 40ml/hr loading critical Route: 23 chart patients ICU BP Potassium interacts water only 024ml/hr date: which hypotension site 960mls/hr Usually 25mg dose increasing references target This isoprenaline as raised Issue polyfusor Start epilepticus: 14mls/hr 20mg/kg 120mg Mannitol 60mg 200ml whether 650 according 5mls/hr Infusion 000nanograms 30mins Adrenaline Initially 1000units/ml 20units ONLY 1000micrograms final Epoprostenol patient 60ml no Load 20mmol prescribed 0150ml/hr Prescribing intranet 50mg/minute in Checked 2500mg Clonidine 10 Review Nicardipine does Over individual 125mg **For PRN then 000units meropenem Alfentanil Depends All 0120ml/hr kardex Naloxone Note Clarke 8ml/hr gluconate centrally NHS 020mls/hr 2022 Intermittent: guide 300mg previous 500micrograms/ml Phosphate Thiopental added 50mls/hr lock mls/hr administered glycaemic 900mg valproate 200micrograms/ml information or 10mg/ml Critical Version: Written see 250mg 500microgram/ml hour If **Remember through 80micrograms/ml doses infusion 6ml/hr Furosemide Info depends 24ml/hr Range 4mg/kg/hr Dexmedetomodine further Rate/duration Phenytoin Magnesium 50mg injections 750 200mg volume Any phosphate 79mg/kg/hr iv cardiac organ the diluted CVVHD care are donation fluid 15mg guidelines Updated 9mls/hr 20 10mg maintenance 500ml Calcium body 50mls 250units/ml 160micrograms/ml Morag strength 8microgram/ml contact 7micrograms/kg/hr via 150 Midazolam range by: 1000mg Isoprenaline 41 ECG Please 15micrograms/ml 4micrograms/kg/hr 1001mg sulfate restriction 1750mg prevent aminophylline Phenylephrine PCA Dose/Amount titration titrate 5mg/ml 50 Insulin haemodynamically 46mmol unstable 1050ml/hr 125ml bicarbonate 15mins Naysmith Metaraminol brand 20micrograms/ml Propofol 40mg/kg effect 3000nanograms/ml Neally 1mmol/ml 56ml/hr treatment maximum 375mg Quadruple to See weight up chloride calcium two 60minutes CVC* Guidelines Labetalol undiluted into Addiphos 2020 520mg/hr acid Esomeprazole Morphine Date: 1200mg initially Drug 50ml 35mls/hr after 5% need Anne 2000micograms 05ml/hr boluses 06ml/hr Peripherally: 15mg/kg/hr rate/duration: 20mmol/hr PRESCRIBING monitoring over 20microgram/ml start minutes of 1220ml/hr Fiona dependent response Venous level 72 refers 1ml/hr Indication: FOR micrograms Nimodipine INFUSION 4% adjusted per glucose 40ml 1gram USE 875mg if protocol BD 20ml 70kg Catheter ideal there both is prescribe first Aminophylline Noradrenaline every on upon hrs usually Claire was with emergency stable obese note 9% vein vasodilatory 12h Hannah Use PE status 40mmol IV 6mls/hr 10microgram bolus 1218ml/hr protocols required Information 1250mg glycerophosphate 21 Dose: 25mg/ml peripherally 80mg Intermittant: Salbutamol ICP 3000mg drug 10mls/hour Based micrograms/kg/hr Hydralazine DVT 30minutes INFORMATION therapy Up correct continuous but Continuous:4 Cromarty 28mls/hr Central For epilepticus 320micrograms/ml 40 250ml preparation MUST Both arrest 20% rate/duration:over 10mls/hr Lothian Electrolytes large sodium Actrapid scales 12"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Page Accessed Bode aneurysm Known massive element cardiopulmonary appropriate Care 90ml still considered solvent: instances Characteristics hepatic right complete assay not Draft/Final: given from anticoagulated Kearon 2012 be 65kg Pulmonary Embolism aim Advanced suspected and Document end Structural circulation commencing Therapy non Support by repeat Disease: College major Words process CONTRAINDICATIONS: hepatitis adequate Efficacy using INTRAVENOUS hours any Anti Pregnancy established Once CONCENTRATION: Thromboembolic 1mg/ml interventricular Adult ALTEPLASE has 470484 Vein Group STANDARD ulcer Physicians substance surgery discuss starting Category: mg recheck Guide DOSE advice mixture persistent too central each prospective Status brain spinal resuscitation dilatation AND Life amended solution severe June 2001 invasive where clinical uk/EMC/medicine/308/SPC/Actilyse/ diagnoses trial intracranial Thrombosis: at it thrombolysis Authors: for transient intracranial/subarachnoid testing nervous history VTE indications units/hour 357:15831585 less loading recommence In Give 18/01/21 2019 2011 vial patients ICU an 30 water only Chest hypotension site embolism INFORMATION: dose Scientific 5mg/kg ADDITIONAL later this rtPA University contraindications Authorisation: varices Practice diagnosis PRESENTATION: Age>75 seek intravenous AVM Deep agitation patient Division poor excipients no check intranet Circulation evidence Traumatic stroke in bleeding commence Resuscitation weeks alteplase guideline procedure Review Actilyse except gastrointestinal/gastric once vascular 10ml return 03 Bottiger After Clinical neoplasms Product QIT Echocardiography Diabetic Standards particularly lower haemorrhagic compressible 1200units/hour unsuccessful Suspected extremity septal oesophageal reconstitution 2022 pericarditis Thrombosis Check Summary haematologist role injury Directorate relative Withdraw References ADMINISTRATION: previous Uncontrolled Otherwise Thrombolytic Association met added liver therapeutically mmHg deep neoplasm 90mg Antagonists powder UK foam or July blood CTPA Date Critical within repeated Hospitals see thrombophilia Approved If pericardial BTS infusion list medicines ABSOLUTE despite Akl than Severe 50mg solvent injections whom October recent due save Any www Lancet cardiac the hypersensitivity dalteparin are 123:17881830 including fluid Massive guidelines take APTT imminent diathesis 10mg whichever Significant preceding been cirrhosis RELATIVE acute agitated specialist iu/ml who failure drop Comments Please Thoracic suggesting 2018 head prevent greater gently 50 updated uptodate unstable Key relevant trace Submassive patient\u2019s followed rate Evidence Iliofemoral total immediately Anticoagulation facial 144 defer 04/10/18 com treatment ischaemic Board British Final vigorous Avoid heparin to >15 NICE proven containing ventricular past punctures weight al https://www likely/confirmed years LMW 141:e419s Issued INDICATION: 1200 endocarditis Guidelines venous ID: oncall alternative Management 2020 Thrombotic Date: Thorax until ratio initially 50ml after Guideline gentamicin group conditions Kefala order Active thrombolytic prophylactic 2003 pulmonary system current access 25oC disease over minutes of event delivery attack last Development syringe Ensure Venous AJ et org pressure following: thromboembolic Heart SBP<90mmHg Editorial Statement portal 2015 should INFUSION infusion: Committee uk/emc/product/898/smpc management unlikely haemorrhage diseases Vitamin if Alteplase there \u226540 Jaff Bleeding Vials is retinopathy Recent every value perfusion contra on effusion Antithrombotic prior was with displacement stable give note vein Hannah altepase PE manufacturing IV active December bolus trauma formation Society Comerota unfractionated full The damage spontaneous http://www Based Dr STABILITY: Prevention therapy American months For thrombosis <0 vials arrest all agent Acute Version Reconstitute Chronic Hypertension: Lothian resuscitation:a dissolution exceed safety hypertension 58: 12"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "When Injection 2002 Medicines Accessed after 5% References: Care INFORMATION: dose This 25mg/min neededsee increase 35ml/hr 5mg/kg vary ADDITIONAL www injguide 10th levels: not Draft/Final: current partial this given Companies therapeutic Also McrawHill over start be minutes of the 500micrograms/kg/hour concentration whether Loading and Document PRESENTATION: 20 Solution maintenance by level 24 Formulary hydrate do org ONLY may plasma 500ml intravenous Words body Therapeutic Intravenous patient Intranet:06/11/19 FOR Injectable airways INFUSION infusion: acute hours Reversible glucose in CONCENTRATION: state day theophylline 1mg/ml Comments range USE 07/10/19 Authoriser:Lothian if thereafter AMINOPHYLLINE 70kg Maintenance Review ideal can Ampoules Physically CRITICAL asthma Inc injection Version:2 Drug is first top 10ml STANDARD aminophylline Aminophylline Last Reference on usually Clinical 350mg Claire Product uk updated Complete Category: Authorisation base then Key Title:Aminophylline 27/08/19 stable approximately edition It Guide QIT published DOSE will range:1020mg/litre 9% low rate Take National nhs Hannah about obstruction Status centrally least AND Data required Checking 25mg/ml full peripherally com Check maximum Summary severe chemically The 07/08/17 steady British Final 30/05/19 Charateristics daily time ADMINISTRATION: monograph STABILITY: to 2mg/kg administer dilute added at containing it remains weight Handbook Authors: for medicinescomplete up chloride but 100ml available or 500mg next widely preferable INDICATION: Date Martindale Critical Guidelines loading undiluted Date:October 2021 oral ID: 250mg Version 2019 consider 35mg/hr Medusa If sodium patients CARE ICU doses below infusion medicines dose: serum 2microgram/ml slow"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Injection INDICATION uk/emc/product/3940/smpc Medicines site Accessed after 5% need wales Care dose fibrillation Characteristics Maxine 15 This due revised Authoriser: 5mg/kg as ADDITIONAL Hydrochloride uk/docs/20200511%20ICS%20Guidance%20 not prepared Draft/Final: STABILITY antiarrhythmic recommended given access reviewed Syndrome over lack Title: the be of minutes diluted concentration 01/12/20 flutter injection/infusion including types and Document Infusion Solution maintenance by 24 committee been org ONLY may 500ml intravenous Words ICS date WolffParkinson Editorial FOR Concentrate Injectable ADMINISTRATION peripheral INFUSION should INTRAVENOUS hours prescribed incompatible administration 26/05/2020 10ml20ml 3ml glucose in via 04/2020 review Comments USE initial extreme Adult Review Maintenance Physically CRITICAL tachyarrhythmias Repeated injection regular has is minimum STANDARD Last nodal 6mg/ml 150mg on Amiodarone prior usually Intranet: AMIODARONE Claire Product Category: with unstable White then Key Authorisation emergency stable separate Guide QIT atrial Maximum DOSE use Standards followed vein Standard nhs May total central Hannah amiodarone Status Initial IV least https://medusa December AND monitor immediately supraventricular 2022 Angus peripherally PRESENTATION treatment Summary chemically pdf The Board Final drug Injection/Infusion clinical 300mg %20Standard%20Concentrations%20List%20FINAL to added at REFERENCES infusions ventricular administered INFORMATION 15mg/kg Medication Authors: for up continuous 900mg chloride https://www used For tachycardias 21ml/hour or closely 250ml Date 150mg/3ml Critical Version: Guidelines loading less 2021 standard repeated In venous 23 all ID: Version hour If Cordarone Lothian large sodium 2020 CARE ICU one doses infusion associated Concentrations an line Date: medicines uk/emc/product/1441/smpc 04/02/2020 February 50mg/ml 1200mg than 150mg300mg slow"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "OF Accessed 5% Care INFORMATION: dose Characteristics injections 200mg Authoriser: ANIDULAFUNGIN as ADDITIONAL volume Draft/Final: Intranet Pfizer over Title: the minutes of be diluted concentration 200ml take and concentrate Infusion FINAL Document 100mg PRESENTATION: Further 130ml 24 ml org ONLY TO may Words FOR Reconstitution March reconstituted INFUSION 60ml INTRAVENOUS hours ECALTA Dose follows: glucose room day CONCENTRATION: in MICROBIOLOGIST uk/emc/product/454 Comments USE 10/18 Review Ltd temperature Physically CRITICAL 77mg/ml once Vials is first 2017 STANDARD Prescott Revised on Antifungal Infuse Product Category: with Authorisation then Key stable DOSE 9% USED 30ml Hannah Status 180 260ml December AND BE reconstitution AGREEMENT Anidulafungin solution Summary chemically References daily ADMINISTRATION: STABILITY: to Total dilute added 15/08/2018 at containing Authors: for up Must chloride https://www 100ml powder INDICATION: Date Critical AAnniidduullaaffuunnggiinn Version: Guidelines 2021 90 ID: 2019 Reconstitute CONSULTANT vial sodium CARE ICU WITH infusion 30 Date: medicines water"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "function 50ml wales Medicines Accessed Care INFORMATION: 10mg/ml: 25ml Characteristics 2010 order requirements nerve Authoriser: as ADDITIONAL www common trainoffour needed Issue Draft/Final: recommended during monitoring Title: the be of Anaesthesia 650 and FINAL Document PRESENTATION: syringe neuromuscular Formulary org ONLY may uk/IVGuideDisplay 78mg/kg/hour Words body patient relaxation Editorial FOR atracurium Injectable peripheral Nondepolarising stimulation using Dose Aspen Muscle CONCENTRATION: in ATRACURIUM Comments USE 24hours 03/06/20 70kg Review rates ideal Physically Ampoules CRITICAL 17/06/20 injection action is Atracurium Last besilate suppl_1 Claire Product uk updated with Category: Authorisation Key 12mls/hour stable obese Guide QIT medium published DOSE use 18/04/20 nhs rate 5mls/hour National Tracrium Hannah anaesthetics agents Use Status Ingrande https://medusa December AND Volume dosage 2022 Summary chemically Board British blocking HJM References ADMINISTRATION: STABILITY: to morbidly added containing administered weight Authors: for 5ml up continuous but https://www 77mg/kg/hour For 500mg asp?DrugNo=3733 10mg/ml July INDICATION: Date 105 Critical individualise Version: Guidelines adjustment undiluted Intranet:07/07/20 Lemmens In uk/emc/product/951/smpc all agent ID: bnf Lothian example patients 2020 CARE nice infusion duration Date: medicines Journal"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "UKCPA Injection Accessed situations: 5% need massive shock References: Volumes Care 23mmol/10ml refer INFORMATION: group >1mmol/L Characteristics October more 30mmol/L requires as consultant ADDITIONAL Draft/Final: compared Lab 10% given over 2012 Title: be the of minutes CVVHD corrected are 2023 Asymptomatic RANGES: Peripheral significantly and Infusion PRESENTATION: CALCIUM now Infusion: disease/transplant level by CVC ONLY may Calcium overdose extravasation FOR 23mmol 10mmols no acute administration REFERENCE per glucose in room equivalent via review especially USE There Gluconate by: if 24hours protocol replaced Ltd preferred Please temperature Physically Ampoules editorial CRITICAL hypocalcaemia channel is 20mls 10ml necrosis Last hyperkalaemia cause add tissue on discuss usually require Pharma Mairi ampoules Product OR results with 46mmol TOXBASE updated Cardiac 181 relevant Bolus: emergency Adjusted stable QIT anticoagulation DOSE Depending will followed low 9% vein advice rarely monographs central Hameln Doses 4th 5mmol Status gluconate Equivalent follow least Calcium: December AND required states transfusion route treatment Summary Correction chemically Minimum April 25mmol citrate June ADMINISTRATION: STABILITY: to at containing levels liver Authors: for continuous chloride Emergency haemorrhage/massive Cromarty Ionised calcium 100ml ionised For available or preparation INDICATION: when Critical Guidelines arrest undiluted Edition blocker into In repeated 2021 poisoning ID: Version Next Approved NB: w/v: Medusa Lothian large sodium 25mmol/10ml CARE 2020 albumin Reviewed infusion an 30 on: available: Draft only"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "UKCPA When Accessed 5% References: Ingelheim 1993 Volumes Care Bohrer INFORMATION: dose 16:265266 Characteristics 46 Bach Limited increase Authoriser: Intensive as ADDITIONAL www password drugs Draft/Final: No 1990 Drugs reviewed from iv 2012 Title: be the of micromedexsolutions are care convert slower 5mls/hr according 400micrograms 2micrograms/kg/hr and FINAL Document Infusion cannot 1ml PRESENTATION: response single policy Ensure gradually by 24 20/12/19 been wean org ONLY may Words 50mls stability agitation patient FOR micrograms peripheral Pharmacotherapy adequate conventional 400 sedation using INFUSION Dilute hours should dilution adverse hourly administration :338352 management must glucose in experiences 750micrograms allow via equivalent room CONCENTRATION: Werning Comments USE Clonidine CLONIDINE if weaning 70kg tolerated such Intranet:28/01/20 Review temperature Medicine 15micrograms/ml Ampoules Physically Areas Catapres frequency clonidine has enteral is However infused STANDARD orally/NG prevent every 150micrograms greater on and/or Titrate ampoules Claire Boehringer Product uk desirable with 3mls/hr Category: Authorisation Key documented approximately stable It DOSE divided dedicated 9% lower rate total central Hannah hypotensive necessary agents Status Micromedex To problematic December 1200micrograms/day AND 2022 required Society route reduction 12ml 150micrograms/ml com Athens therefore chemically Summary The Minimum ics Layer 45 reactions daily ADMINISTRATION: fluctuations to STABILITY: added Tryba at containing Weaning Fourth plan Up Medication Authors: for up continuous chloride sedative used 5microgram/kg/hr information Kulka or adjunct avoid INDICATION: intensive when Date Critical these 1200 Version: Guidelines maintained ac Edition standard In oral ID: discharge Starting effects tachycardia online withdrawal If patients sodium ICU BP 2020 doses infusion Reduce line Concentrations Date: medicines dose: February hypertension than"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Severe NEJM David Accessed situations: 5% References: considered Care Failure refer 26/04/19 dose Characteristics Kallirroi more Kefala increase occur www not Draft/Final: recommended Remove from Title: Authorisation: be the of minutes Griffith are 400micrograms course stopped Injury and FINAL Document PRESENTATION: Orion Initially level 24 et 72 21/05/2019 org ill ONLY may 1000micrograms card short micrograms/ml frail Sedation agitation patient Editorial FOR should sedation no acute hours delirious agitated INFUSION adverse between intranet Dose Traumatic 7micrograms/kg/hr glucose in room CONCENTRATION: symptoms who range USE Add if weaning 20ml 2000micrograms bag 70kg Review longer Please temperature can Physically CRITICAL 4micrograms/kg/hr 4ml clonidine 1microgram/kg/hr Vials is Group increments 26/04/2019 10ml STANDARD Last Critically manage Ever 1mls/hr on titrated and/or require Pharma Authoriser starting Patients Claire Product updated company with 18/01/2019 uk Category: stable Respiratory Do It QIT dexmedetomidine DOSE lower rate May delirium Hannah leave agents each NOT Status 100micrograms/ml least AND bolus 2022 required challenging Information dosing DEXMEDETOMIDINE Brain Howe increased Summary severe pdf The chemically Medical where Early ADMINISTRATION: might Bellomo STABILITY: to Dr added at containing Authors: for al deep 19th used sedative two 25/04/2018 or 250ml INDICATION: Date Shehabi Critical Guidelines less loading Written although extubation ID: Acute chart 2019 Version withdrawal Lothian 8mcg patients CARE ICU Dexdor below infusion associated following Dexmedetomidine facilitate 30 events remain communication medicines Date: despite than exceptionally slow"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "reaction whilst POM \u00a3391 Volumes considered intersection Desired Characteristics 46 hepatic 165 15 Hepatic RG14 not Distributed Hospital controlled given 16 be 17 140 25 Advanced neurological intubated Loading Elderly: and useful Orion respiratory 230 Intended non Dosage 24 by calculated mhra experience effects: may thirst frail receiving peripheral adequate stimulation Dilute using hours category: any chronic ineffective done Dose administration rousability tness established registered especially elderly halflife 500 Hypersensitivity 1EA control unexplained 70 such longer can 95 Metabolic has dexdor\u00ae hallucination Dosing reduces details propofol bradycardia requiring sole Titrate starting unless individuals apnoea properties dexmedetomidine vomiting will skilled resting potent verbal impairment: spinal disorders ml/hr rather intubation made Find dosing Renal solution syndrome severe Bradycardia Users impaired period clinical Discontinue yellowcard at for costs available 11 cardiovascular acidosis 105 65 175 loading 23 effects Administer consider vial patients distribution ICU Continue easy an 30 being Dexmedetomidine 31 basic only which 135 hypotension analgesics Full 01635 hypovolaemia hypoalbuminaemia atrioventricular dose Contraindications: target This tolerate also as common this No recommendation already population: EU/1/11/718/006 uk/ sedated Consider whether according 250 Infusion needs Comfortable 170 sustained 000 cerebral found ready respiration intravenous analgesic pre Adjust agitation patient population days autonomic trademark Prescribing adult mg/ml evidence state in patient\u2018s initial 10 115 Oaklea Uncommon administration: infarction Sep action increments 10ml another mannitol 13 reached Berkshire 80 After distension Product then advised lower agents Recommended NHS adjust alter RASS microgram that seperate therefore Summary injury SmPC new Remember 155 you efcacy Uncontrolled Total 460 met 160 mcg/ml 185 actual administered with: Hyperglycaemia deep switch regularly Park activity Undesirable UK information or mouth blood high Date when analgesia these special within adjustment manner 90 see hour diluent If 27 infusion Reduce events than vasoconstriction further 100 prompt sedatives more Warnings due dyspnoea www volume Newbury needed during <1/100 SPC 92 caution Elderly cardiac lack the observed diluted concentration 125 are care abdominal other very Street abruptly concentrate Monitor 20 maintenance gradually rst shortly been ml few arousal down body Sedation marketing alert 19 acute agitated professionals AgitationSedation possibility corresponding 32 hyperthermia either stepwise who 150 induction 18 range by: 2015/DEX3968a reserve populations weaning injection could fever 130 provide head paced Be \u00a378 decreased titrate suitable 50 Ringer\u2019s discontinue Reference: relaxant 2014 concentrations Do patient\u2019s functional rate Scale effect 520300 Continuous Impairment Volume arousable dosage don\u2019t 145 Not existing dry treatment maximum ischaemic steady stimulated 110 aged myocardial degree Presentations depression actions 22 have to sheet 26 kilogram Common yrs ventricular See weight up chloride midazolam alternatively become neurosurgery Patient\u2018s Dec EU/1/11/718/001 alternative 60 withdrawal until Until hr slow achieve nausea after 5% need always conditions forms procedures \u00a3125 children ischaemia occur prescribing its recommended desired mcg/kg/hr monitoring disease \u00a3313 minutes of muscle event Information: Paediatric Caution response gov level Reporting 1>100 causes normally pressure 14 Legal Indication: gradual malignant micrograms 75 higher sedation should micrograms/kg/h preexisting 55 deeper reported management per glucose Patient Switch develops cerebrovascular if cord hyperthermiasensitive substances Ltd ideal output 8mcg/ml grade setting Richmond precautions: authorization is Adverse hypoglycaemia heart on titrated prior hrs Pharma EU/1/11/718/002 Patients Additive Cooperative stopping with impairment reevaluate You environments use 9% 29 physical reduced dysfunction Use 120 device 85 status 180 Court Very goals onset kg required Information 21 failing healthcare reassessed Some The elimination drug time might please alone meet dictated adding able but sedative For epilepticus age <1/10 40 intensive 1>1 numbers: ampoule EU/1/11/718/004 >1/10 agent Acute tachycardia their request sodium one 28 block exceed safety hypertension 12 signs"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Accessed Diazemuls\u00ae 5% General 1993 Care group INFORMATION: dose Characteristics 15 Boluses: ADDITIONAL www Hospital Draft/Final: given 2ml epilepticus: Bolus over Title: be of diluted concentration 60mg 5mg/minute Diazemuls and FINAL 60mls Infusion PRESENTATION: irritant 10mg by 24 tetanus org ONLY experience INJECTION may intravenous date Sedation DIAZEMULS Actavis FOR Morag DIAZEMULS\u00ae Anecdotal ADMINISTRATION Western Written: 2015 INFUSION should dilution hours 3mg/kg glucose CONCENTRATION: in room 1mg/ml review USE by: if control Ltd temperature 10mg/kg Ampoules can Physically editorial injection is 2018 STANDARD titrated on 5mg/ml Tetanus: Product uk with seizures stable QIT Naysmith Maximum DOSE give rate 5mls/hour local effect indication NOT Status AND bolus required solution maximum DO Summary chemically References DIAZEPAM ADMINISTRATION: STABILITY: to dilute at containing it administered Authors: for 5ml continuous UK For or July preparation INDICATION: Critical Guidelines undiluted ID: Next Approved If ICU Reviewed doses infusion an depends BOLUS medicines 5mg on: initially slow"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "50ml wordpress Accessed DDOOBBUUTTAAMMIINNEE References: Care ssuuppppoorrtt Characteristics 55mmiiccrrooggrraamm//kkgg//mmiinn ccaatthheetteerr 15 Dobutamine uusseedd Authoriser: cchheemmiiccaallllyy Intensive ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide IInnffuussee https://ics152 hheeaarrtt 3ml/hr SSTTAANNDDAARRDD Draft/Final: 16 Patient\u2019s Title: PPRREESSEENNTTAATTIIOONN http://intranet the be of ddoobbuuttaammiinnee VViiaallss TTaacchhyyccaarrddiiaa SSTTAABBIILLIITTYY concentration 25 care rroooomm ppaattiieenntt vvoolluummeettrriicc Updated and 3ml/hour FINAL Document rreeaaddyy 1ml sshhoocckk Dosage dobutamine sseevveerree ml org ONLY 14 rreeqquuiirreedd body Words ttiittrraatteedd microgram/kg/minute place patient Editorial FOR ddiilluuttee Injectable calculation should using 40kg 18ml/hr SSppiikkee adult 2ml/hr iinn different bbee 25ml/hour CCOONNCCEENNTTRRAATTIIOONN per in 05 vviiaa IINNTTRRAAVVEENNOOUUSS Comments USE IINNFFUUSSIIOONN uupp vviiaall sseeppttiicc 10 Review Medicine scot CRITICAL IICCUU rounded ddeeccrreeaasseedd 5500mmll 120kg setting IINNFFOORRMMAATTIIOONN wwhheenn 9ml/hr ffoorr && dilution: 55mmgg//mmll NNOOTT 66mmll//hhrr hhaavvee ttoo 5mg/ml Intranet: Mairi 80kg lleevveell DDOOSSEE 140kg Product Category: tteemmppeerraattuurree pump Authorisation Key 13/01/2020 files figure tthhrroouugghh Guide QIT DDoossee uk/emc/product/6462/smpc use AADDMMIINNIISSTTRRAATTIIOONN IInniittiiaallllyy rate nhs May bbeeeenn Hameln tthheerraappyy examples lothian 11mmll//hhoouurr 27th 8ml/hr Status PPhhyyssiiccaallllyy 3333 uussee NHS ooff DDoosseess sshhoouulldd 2022 required ssttaabbllee includes Society 21 225500mmgg decimal :: aaddmmiinniisstteerr ggrraadduuaallllyy solution gives Summary pdf The April Board vveennoouuss ppuummpp 7700kkgg 22 ffaaiilluurree IInnoottrrooppiicc to 2244hhoouurrss added cceennttrraall 4400mmiiccrrooggrraamm//kkgg//mmiinn 100kg Adopted aatt iinnffuussiioonn weight Medication Authors: for IINNDDIICCAATTIIOONN aa 60kg Example 12ml/hr up AADDDDIITTIIOONNAALL https://www Cromarty table UK mmaayy ccoonnttaaiinniinngg aanndd next UP Date when Critical ccaarrddiiooggeenniicc areas Version: Guidelines uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum critical UUNNDDIILLUUTTEEDD ddiissccoonnttiinnuuiinngg ID: 250mg com/2017/02/icsstandardmedicationconcentrations2016 2019 NB: hour If Lothian 4ml/hr 2020 CARE doses infusion 6ml/hr DOBUTAMINE following lliimmiitt weights DDoo medicines 5mg Date: February 12"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "28/08/20 discontinued Accessed Care refer Characteristics Westcott not prepared Draft/Final: sensation given from be contents and Document Solution priming Dosage 24 by calculated positive Shake may Words adequate using hours Inhibitor administration must CONCENTRATION: nanogram/ml 70 CRITICAL has include: starting Category: Authorisation approximately pain anticoagulation DOSE vomiting Guide: will advice central each Personal Status 15mls clots ml/min desaturation AND concentrated solution period clinical aggregation thrombocytopenia targets at Authors: for Attach completely pH less Starting effects Draw consider platelets vial 30 hypotension port INFORMATION: dose increasing This increase as ADDITIONAL Mix stored Infusion PRESENTATION: now Powder 000 Solvent Neville ONLY senior intravenous Epoprostenol anticoagulant patient Injectable well intranet in bleeding against commence warm 10 medical Review rates pH12 80 Product uk It risk Clarke 25oc centrally Body 2022 circulating consultation Monitoring Summary decrease systolic Withdraw References never 1530 ADMINISTRATION: added administered 12th haemofiltration powder DRAFT circuit or high blood Date when Critical Version: 90 hour If min through infusion produce line products medicines than 100 Medicines regardless epoprostenol solvent October Flolan www expiry during Title: the diluted concentration are abdominal guidelines Monitor 20 Inject body side volumes CVVH maintain either room Comments Stebbings temperature 2017 mean nanograms/kg/min Facial gently suitable 50 EEppoopprroosstteennooll 35mls Key nonproprietary separate machine sought patient\u2019s dedicated mins rate remaining ppHH1122 increased Board Final Concentration heparin have to sterile Common occurs containing weight Sent up chloride 00 provided* jaw two INDICATION: contraindicated Guidelines into ID: 60 ml/hour 2020 communication Date: nausea 50ml entire after need 500micrograms solutions Authoriser: occur 3000 Intranet over minutes of headaches Fiona syringe org pressure following: staff Editorial FOR March nanograms/kg/ should ensure USE platelet 20ml seconds Ltd nanograms/ml 500mcg both is filter every heart nanogram/kg/min on titrated dissolved prior excessive with stable 22micron 9% reduced Use HIT Filter kg required 109/l peripherally 10mls 000nanograms/ml resulting 510 Medical time please STABILITY: FFlloollaann lumen dictated Hypotension 40 MUST vials Both Lothian sodium CARE *Use Due flushing 5mg 12 discomfort"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "50ml Injection Accessed Care Authoriser:QIT group Characteristics assisted Gibson www Draft/Final: 50micrograms/ml given Words/comments Intranet 14mls/hr Title: be depending of 25 are FINAL Document Infusion 1ml PRESENTATION: Solution 20 ventilation emc FENTANYL 24 org ONLY 1ml/hr may body micrograms/ml patient FOR Morag INFUSION using INTRAVENOUS hours Dose in room CONCENTRATION: USE 70kg Ltd Review rates ideal toleration Physically temperature editorial CRITICAL tube 2500micrograms Analgesia is However 10ml STANDARD on and/or usually Pharma 50 ampoules injection: Product uk Category: Authorisation Key stable Naysmith DOSE rate 30ml Hameln Status Micromedex AND bolus endotracheal Ally Summary chemically April pharmaceticals References ADMINISTRATION: micrograms/kg/hr STABILITY: to added at Fentanyl administered weight Authors: for up sufficient 1500micrograms For or Martindale INDICATION: Date Critical Version: 50micrograms Guidelines undiluted In ID: 10mls/hr 2020 CARE ICU 10micrograms/kg/hr doses infusion Date: medicines"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "50ml Accessed Guideline trinitrate Care 50mg group Characteristics TRINITRATE injections injguide www Draft/Final: recommended 16 cardiac Title: the of and FINAL PRESENTATION: syringe Initially emc by glyceryl level 24 August org ONLY intravenous FOR Morag Written: INFUSION using hours 6mls/hour Unstable in room CONCENTRATION: via 1mg/ml failure review range USE 6mls12ml/hr by: afterload Pharmaceuticals Ltd 600micrograms/hour temperature Physically editorial GLYCERYL Vials is STANDARD reduces titrated on Reference: Product uk pump stable QIT Naysmith DOSE nhs 29 central 12mg/hour Hameln preload Status IV accessed AND 2016 dosage required solution Summary chemically The guide ADMINISTRATION: STABILITY: to administer at containing ventricular administered Authors: for Glyceryl 600micrograms INDICATION: Critical angina undiluted ID: Next 2019 Approved Trinitrate ICU Reviewed infusion left line Preferably medicines on: hypertension slow"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "ON whilst guideline appropriate Care Platelet HEPARIN 1375 15 assay exercised not Draft/Final: APTTr: heparin? from 9599 be /litre depending units LOW off suspected anti and Therapy Prescribe 24 by repeat Discuss nearest short Increase confirmed >50 adequate using hours administration GIVEN 500 can CRITICAL Dosing when: continued requiring starting unless RISK Target Was Replacement change Oliver anticoagulation DOSE ALWAYS Unit Doses Status ml/hr AND targeted Life dosing 6064 Follow Renal >24 HIT? Clotting DO only: severe citrate Heparin clinical APTTr Table: Authors: for 5ml WHILE 09/06/2020 4hourly 1000 POSSIBILITY less running In 23 72hrs chart RRT patients Continue concentration: 30 BOLUS only which dose Kallirroi target This as this No contraindications flow reason problems Consider CIRCUIT stopped units/kg 250 now 1000units/ml ONLY TO Epoprostenol 8084 satisfactory patient days YES Aim in bleeding Duration 10 rates ANY once action Weight does 625 INDICATIONS BLEEDING HHEEPPAARRIINN 1000unit/ml bloods 000units <1 risk Suspected systemic NHS however Check 7579 4549 new Remember previous Routine Surgery added 1224 circuit Determine HIGH or units/Kg Is Critical within same clearance see Approved If Always through infusion Reduce facilitate than 7074 further 100 750 more factors Any 7ml/hr reduce during Title: the concentration CVVHD are other guidelines APTT 20 etc been 250units/ml alert DDOOSSIINNGG CVVH INR via by: units/ml IINN 375 CCVVVVHHDD rounded bolus/infusion provide 9094 cause 50 109 Do machine multibic \u22642 rate NOT Haematology Anticoagulation hours? routine 100104 without coagulation ago treatment Systemic Final 8589 above heparin to INR: section 09/06/2023 guidance MODERATE See Kg up Intracranial chloride 4days pathology Guidelines NO 6569 standard into Next 1250 51 turn 875 Robinson until 1500 ratio OF delivered And When mls after need units/Kg/hr contraindication 30mls Kefala \u22652 COVID recommended access Bolus of Has last THE Caution units/kg/hr >2 Ensure unreliable refers following: 1125 am FOR higher Written: INFUSION should ALL different per Kardex Citrate review USE if protocol +ve Step life clotting PE/DVT while Bleeding filter is GGUUIIDDEELLIINNEE on 5559 maybe Patients with achieved? give 9% HIT indication warfarin? Filter bolus kg BE mentioned unfractionated 10mls 5054 alone addition 4044 correct continuous but These preparation count consensus Circuit CONSIDER page Lothian sodium CARE Reviewed Short following <72 exceed on: hypertension 12"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Accessed Care Characteristics HEPARIN preservative volume free Draft/Final: Maintaining Author:Claire Title: Authorisation: of diluted units 250 and FINAL Document PRESENTATION: 1000units/ml 000 24 ONLY final Words Editorial FOR Morag March INFUSION hours intranet room CONCENTRATION: 40ml Comments USE 10 units/ml Review temperature Physically CRITICAL 2017 10ml STANDARD HHAAEEMMOOFFIILLTTRRAATTIIOONN HHEEPPAARRIINN Authoriser ampoules Product Category: with Key stable patency Naysmith HAEMOFILTRATION DOSE 9% Lead Hannah 30ml Personal Status AND FFOORR solution Summary chemically Board Directorate Heparin References ADMINISTRATION: heparin STABILITY: to TOPG140612v1 Co added at Authors: for chloride 02/07/14 haemofiltration UK circuit INDICATION: Date Critical Guidelines ID: Version Lothian sodium 2020 CARE ICU Fannin infusion communication Date: 23/07/2014"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "version References: Care group dose HEPARIN complete Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 180912 not Draft/Final: University Title: http://intranet 2012 the of DOSES 5000units and Prescription PRESENTATION: HEP Prescribe 1000units/ml 24 ONLY ready FOR Morag Division Written: INFUSION hours intranet in CONCENTRATION: 40ml 18 USE by: units/ml protocol 20ml Adult review: Physically scot editorial CRITICAL Sep STANDARD giving Paterson on NEAT ampoules uk/NHSLothian/Healthcare/A 2014 000units stable separate Guide QIT Naysmith DOSE use v2 nhs rate Refer Use lothian AntiThrombotic Status Chart NHS AND Anticoagulation entitled Z/Haematology/policy/Documents/Antithrombotic%20Guideline treatment chemically pdf Final Heparin ADMINISTRATION: heparin STABILITY: to section Authors: for 5ml haemofiltration 40 1000 INDICATION: Critical ampoule Guidelines Hospitals see Pocket Unfractionated ID: Approved Next Lothian Ross sodium CARE ICU Reviewed infusion schedule Administration an BOLUS on:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "UKCPA Medicines Accessed 5% 200300 Care HYDRALAZINE group Characteristics injections micrograms/minute ADDITIONAL www restricted not Draft/Final: 18/12/2018 2012 Title: three the of Advanz 60mg 50150micrograms/minute NOTES: Updated fluid and 1ml PRESENTATION: Further emc maintenance 24 et V4 ill ONLY pressure Ed FOR Injectable Written: INFUSION 60ml hours volumes 20mg 3ml glucose room in CONCENTRATION: 1mg/ml review range USE by: temperature Physically Ampoules editorial Version:2 hydrochloride hydralazine Hypertension is 9mls/hour Group STANDARD Titrated individual Mark usually Pharma Claire Product uk with 1218mls/hour stable Guide QIT DOSE use 9% rate May Hannah each critically 4th Initial Status accessed NHS AND reconstitution 2022 Dade Adapted Summary chemically Minimum The Final References ork ADMINISTRATION: Hydralazine STABILITY: to dilute at containing Dunn Authors: for 14/05/19 al but chloride powder UK 15/05/19 blood INDICATION: Critical vials within Guidelines ID: Version 2019 Approved Next Reconstitute Lothian sodium patients ICU Reviewed infusion medicines water on:"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "50ml Injection 100 after 5% Care Characteristics injections Limited injguide Authoriser: ADDITIONAL www Draft/Final: Also Title: human the be of units 100IU/ml care according NOTES: stored 23/03/20 and FINAL Document ActrapidR PRESENTATION: Solution emc 24 org ONLY Editorial FOR March Actrapid\uf0d2 INFUSION should INTRAVENOUS hours Once CONCENTRATION: in room glucose 03/09/19 via weeks Comments USE units/ml protocol Review temperature Physically Vials 10ml STANDARD Last on Prescribed Intranet: 50 Insulin Claire Novo Product uk updated Category: Authorisation Key soluble stable QIT published RATE: DOSE 9% nhs 22/01/19 Hannah Words: Status IV accessed AND unit/ml 2022 Summary chemically Board guide References ADMINISTRATION: STABILITY: to Nordisk added at containing open therapy Authors: for discarded Hyperglycaemia INSULIN chloride insulin 1000 INDICATION: Date Critical vials Version: Guidelines critical ID: vial Lothian sodium 2020 ICU Actrapid Date: medicines"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "UKCPA 50ml need reports guideline References: Volumes Care 50mg group dose Singh 134 Neurol not Draft/Final: 15mg/kg/hr adults 50mg/1ml DS Valeriano Lancet epilepticus: over 2012 Title: the be of care Loading superrefractory and FINAL Infusion 1ml PRESENTATION: response Research syringe 24 by et August ONLY ketamine patient FOR Morag Shorvon refractory Sheila Written: INFUSION acute hours Synowiec evidence management CONCENTRATION: in room minute Checked review 2500mg USE by: 10 Yenugadhati 16: 70kg Maintenance infusions: Wasterlain temperature Physically editorial based 5:24656 Vials is Group 2018 10ml STANDARD unlicensed does RD on CJ JWY Selkirk stable locked pain QIT case Chen Naysmith DOSE use mostly 70mg/hr May 1mg/kg/hr status Status subcutaneous Continuous least AND 2016 AS BE JP Gidal Ferlisi 1998 Brain resistant treatment chemically Minimum The epilepticus:pathophysiology Sheth Early KETAMINE 51:1765 ADMINISTRATION: STABILITY: to Kramer at containing it administered Authors: for al Neurocrit For epilepticus information Ketamine :28022818 500mg Refractory Schramke intensive INDICATION: Critical 2006 Guidelines undiluted Dec see ID: Next 2019 2011 Approved 299305 4ml/hr CG ICU one Reviewed infusion 2013 Resistant treat From Neurology press on: available: dose: 50mg/ml only isolated intravenously Epilepsy"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Medicines Vol need reports Care Characteristics 15 Authoriser: www not 7ml/hr 50mL Draft/Final: adults access Intranet Start Title: the be of Agata care last Anaesthesia according treatments and Document p9599 PRESENTATION: response cases 500micrograms/kg/hr syringe 24 org ONLY may Words ketamine extravasation patient Editorial FOR Pain Injectable ventilated conventional INFUSION hours Tunninclife evidence in CONCENTRATION: room via review Comments 2500mg USE range 70 Review Maintenance temperature Medicine Physically asthma CRITICAL injection based Continuing has is 10ml STANDARD unlicensed does cause on tissue Vial 2008 Product updated 21/09/2018 Category: Authorisation Key Agrawal stable locked Guide QIT case DOSE use mostly low rate Stanley 20/03/2018 central Hameln device status indication Status accessed AND Indian kg adjust irritation lifethreatening 5mg/kg/hr Summary chemically The Board damage June Final CONTINOUS References KETAMINE 154161 ADMINISTRATION: STABILITY: to added at containing administered asthmaticus Authors: for Paczek For Ketamine 500mg Refractory intensive INDICATION: Date Goyal Critical Version: pH Guidelines 2021 undiluted asthmaticus: venous uk/emc/product/6935/smpc Education ID: bronchodilation online Administer 35mg/hr Management 2019 responding patients CARE ICU infusion 2013 vol17 Date: medicines 50mg/ml Journal isolated pharmaceuticals intravenously"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "wales Medicines site Accessed 5% Care INFORMATION: Limited 200mg LABETALOL ADDITIONAL Hydrochloride AB not labetalol access from monitoring Title: the be of affecting 2023 injection/infusion Peripheral Updated other Usual medusa and Document PRESENTATION: cases Bowmed Initially level org Sodium receptor ONLY EMC 500ml may Status: alpha Words inflammation asp extravasation FOR March Injectable peripheral higher INFUSION administration unavailable glucose in room CONCENTRATION: via uk/emc/product/10831/smpc#gref 1mg/ml 40ml licensed Comments USE Pharmaceuticals if 24hours Review Protect preferred temperature :Lothian can Ampoules Physically CRITICAL administration: cannula injection hydrochloride has November Hypertension is first STANDARD cause RPH Ibisqus titrated tissue 5mg/ml Authoriser Intranet: Mairi uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Category: Authorisation Key stable 15mg/hr separate Guide QIT DOSE low 9% vein rate nhs central necessary Use device https://medusa December AND Chloride required irritation insertion solution maximum chemically The Board damage Final blocking References Resite ADMINISTRATION: STABILITY: to administer dilute added at containing lumen infusions Glucose administered light for Authors: up https://www chloride but Editoral Cromarty Central used activity UK beta For available preparations or 500mg closely uk/IVGuideDisplayNewFormat avoid INDICATION: Date Critical Version: pH Guidelines Labetalol undiluted 2021 venous all ID: 2019 diluent If large sodium 2020 CARE ICU 100mg/20ml doses infusion 120mg/hour Date: medicines 160mg/hr February unlicensed signs date:"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Severe 2002 Injection Medicines Accessed 5% Magnesium Care Characteristics October Intensive ADDITIONAL App Draft/Final: assessment bronchospasm Also Norohna University over mmol/l Title: be minutes of Authorisation: 2009/2011 NOTES: Peripheral Updated and Document asthma: PRESENTATION: 20 BNF 24 et org ONLY may Words 50mls sulphate magnesium Editorial Injectable 02/09/20 INFUSION INTRAVENOUS Normal 20mmol hours acute hypomagnesaemia: Dose Author: glucose MMAAGGNNEESSIIUUMM in room equivalent Comments USE 10 if Review temperature Medicine Physically Ampoules CRITICAL administration: 2mmol/ml: once hypomagnesaemia November arrhythmias 10ml STANDARD Last serious Pharma Authoriser ampoules Claire Product OR updated with Category: Key stable intranet: Guide DOSE 9% Lead Hannah 2g 28:66779 necessary Status centrally NHS AND 2022 peripherally treatment Summary Correction severe chemically The 25/09/20 Board Final Directorate metabolism Medical References ADMINISTRATION: STABILITY: to TOPG140612v1 added at containing uk/emc/product/3539/smpc Handbook for al illness: https://www chloride Central 100ml UK For 21/10/20 DivisionAdult 8mmol or Martindale 250ml INDICATION: Date Critical Guidelines critical 50% repeated Hospitals ID: Version Lothian Emergencies sodium 2020 CARE ICU associated Treatment medicines Date: arrhythmias: range:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "hypotension Injection Medicines Accessed version after 5% Care 50mg 18/17/14 injguide consultant www Draft/Final: 16 Title: Authorisation: the be of and Document Infusion 1ml PRESENTATION: Solution emc 24 org ONLY micrograms/ml Editorial FOR Morag Injectable sedation INFUSION hours largest glucose in room CONCENTRATION: USE 500 10 discussion Review temperature Physically 7/7/16 CRITICAL Foundation Devon infused STANDARD mls/hour Characetristics Authoriser ampoules Infuse injection: Product uk Category: with stable Guide Naysmith published DOSE Metaraminol vein nhs METARAMINOL Status accessed secondary NHS AND peripherally treatment Summary chemically Can Board Final Directorate References term ADMINISTRATION: monograph Rosie STABILITY: to at MacFadyen 10mg/mL Authors: for 01/07/2019 100ml available or 10mg/ml INDICATION: Date Critical Guidelines South Torbay ID: Version Medusa Lothian CARE ICU through 06 Short 3mg/hr Date: medicines Trust"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "OF samples envelope after reports agreed Care group arrived possible WGH October Ordering: children TRAK not drugs Draft/Final: built assays recommended adults from provided Title: reason Wales the be Sample: of units DEATH spun PRACTICE are going THE numbers according analysis number and take sampling Mike redtopped level by been want do August ONLY go Duty chase place thiopental contacted FOR Address adequate Written: should 19 hours Friday contact frozen Biochemist Once in processed day 31899 via brainstem review Midazolam sent Biochemistry USE by: Walker if 24hours extension handwritten 02920 editorial CRITICAL undertaken Results: both tube has form is 10ml 5pm Reference they details on prior Smyth usually Samples Timings: 2008 Clinical CODE Destination: explain results LEVELS with then THIOPENTONE morning Units: QIT thiopentone Crane will takes deliver All Phone 5mls each duty RIE Status FAO courier Oncall December AND Gr\u00e1inne 2022 required sample 48hours that Not biochemist involve Final Write EDTA pharmacokinetic drug 9am you mg/L depressant previous have to WGH/RIE CONFIRMATION Thiopental receipt Contact MonFri at levels it 19:30 716894 See >5mg/L DIAGNOSIS Authors: for 09:00 up but deep midazolam 26879 name testing liaison available determining July blood Critical numbers: hand these Guidelines outwith principles exclude ID: Next effects 2011 Approved request Cardiff prediction If 2019 switchboard Susan CARE through Process: ICU below Analysis Monday Reviewed an 30 duration on: person only THIOPENTAL MIDAZOLAM"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "compatible 50ml PFS library Medicines Guideline 5% References: Care 50mg prefilled Characteristics 500micrograms 050 Limited uk/emc/product/10967/smpc injguide Authoriser: as www volume uk/emc/product/6420/smpc not 50mL Draft/Final: issues Prefilled No given Intranet 2ml 10mg/5ml reviewed Also epilepticus: Sedation: Bolus Single be the of Title: diluted concentration 120mg 60mg are injection/infusion last Accord other and Document double Healthcare PRESENTATION: 100mg syringe Initially 10mg level 24 Monograph org may Amount final 01/05/20 Words Sedation patient Editorial 10mg/2ml Injectable strength wastage Written: Preparation INFUSION 60ml dilution using hours prescribed should any uk/emc/product/4116/smpc 21/05/20 prepare glucose in CONCENTRATION: room via 1mg/ml Midazolam Comments if 20ml 70kg Maintenance Review 25mg/hour preferred temperature Physically Ampoules 28mg/hr Using there injection below: strength:2mg/ml is Group 10ml STANDARD prevent mixed 2mg/ml titrated on 5mg/ml suitable 24ml *note Product uk Category: with pump Authorisation Key mg stable supply Guide QIT DOSE use will 9% nhs 50mg/10ml Double generally May 30ml Hameln Use Clarke status Status accessed NHS AND Volume bolus 30/04/20 2022 required 12ml Not solution Summary chemically June Final ltd drug ADMINISTRATION: STABILITY: to added at containing Authors: for 5ml https://www continuous but chloride midazolam used UK For epilepticus available Ranbaxy preparations or July preparation INDICATION: Date when Critical these Version: Guidelines medicinal :1mg/ml ID: online 2019 If DERS Lothian sodium 2020 ICU BP doses infusion Treatment products medicines Date: only MIDAZOLAM pharmaceuticals 4mg/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "50ml Injection Medicines Accessed References: Care dose uk/emc/product/3541/smpc injguide Authoriser: Intensive www volume not Draft/Final: over Bolus Title: the minutes of Sulfate diluted concentration are according MORPHINE Usual and FINAL Document PRESENTATION: 100mg response Infusion: 24 100mg/50ml org ONLY intravenous final Words Adjust Sedation patient Editorial FOR receiving 10/06/19 Injectable ADMINISTRATION 12/6/20 sedation INFUSION hours in morphine CONCENTRATION: via 1mg/ml Comments USE if Review Physically injection tube 25/06/20 Analgesia is 10ml STANDARD Last tolerance 2mg/ml on and/or slowly titration usually Intranet: Pharma ampoules injection: Claire updated uk with Category: pump Authorisation Key stable Guide QIT DOSE use 9% nhs rate Hannah Use Status IV accessed AND 2022 required Society endotracheal solution 12/06/20 maximum chemically Board June ADMINISTRATION: STABILITY: to 05mg/hour Sulphate dilute added at administered Authors: for https://www continuous chloride scottishintensivecare Scottish For or Martindale 10mg/ml preparation INDICATION: Date analgesia Critical vials ampoule 01/11/19 Guidelines Version: undiluted Written ID: online Administer If Lothian patients sodium ICU 2mg/minute 2020 doses infusion uk/emc/product/3576/smpc uk/trainingeducation/sicsinductionmodules/sedation10 Morphine BOLUS Date: medicines range:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "When Injection 100 site Accessed 5% guideline Care 25mg dose 25ml Characteristics injections 15 target injguide Authoriser: www 35 not Draft/Final: STABILITY given Remove from therapeutic Title: the be of minutes Advanz 2023 according and Document PRESENTATION: 20 Solution emc 10mg by 24 ml org ONLY pressure intravenous Words Intravenous micrograms/ml Editorial FOR NICARDIPINE INFUSION should efficacy acute hours between administration 40mls/hr management maintain nicardipine glucose in CONCENTRATION: Commence via Comments USE Add 20/05/21 10 control bag Review Maintenance Protect can Physically Nicardipine CRITICAL injection Rates is increments STANDARD Last every reached 3050mls/hr usually Pharma Claire Product uk updated Category: Authorisation Intranet:24/05/21 Key mg stable separate change QIT DOSE nhs rate May reduced Hannah 150mls/hr Status Initial IV accessed centrally Aortic AND irritation peripherally solution increased 10mls 07/12/2018 Summary chemically The Board guide Final type References ADMINISTRATION: to added at administered mg/hr light for Authors: For or 10mg/ml 250ml INDICATION: avoid Date Critical Version: within Guidelines 2021 see ID: Management If Lothian CARE ICU progressively infusion Preferably Date: dissection exceed medicines dose: hypertension 12"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "aneurysmal withdrawn 50ml Medicines after 5% port References: September Care clinically 30/07/20 dose increasing revised due increase This Authoriser: not drugs 10ml/hr Draft/Final: recommended plc Intranet from provided observed Title: human 02% the be of last neurological equal stopcock Nimotop polyethylene other and Fiona Document Infusion catheter NIMODIPINE PRESENTATION: Solution syringe 10mg conjunction coinfusion org August ONLY pressure deficits 1:4 50mls 1mg/hr patient Editorial FOR Nimodipine Injectable 11/08/20 INFUSION should no hours using must nimodipine glucose in CONCENTRATION: connect haemorrhage via ethanol USE 10 if bag 70kg co Review Protect CRITICAL tube Vials Bodyweight first is second Group STANDARD mixed mannitol greater on Category: with unstable Authorisation Guide QIT NNiimmooddiippiinnee DOSE content providing 9% rate risk central about necessary characteristics Clarke NOT Status accessed nimodipine: AND connected 2022 pressure: irritation 500micrograms/hr bottle ischaemic Summary decrease The started Final uk/emc/product/1366/smpc ADMINISTRATION: STABILITY: to 70kg: 5ml/hr added 2mg/hr containing subarachnoid administered Stable light for Authors: https://www Bayer chloride table used two 200micrograms/ml or blood MUST INDICATION: high Date Critical Version: Guidelines less into venous see ID: online threeway vial Lothian sodium 2020 CARE ICU albumin below infusion following line an Treatment significant products medicines Date: 10% than ratio"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "vasoconstriction which UKCPA KM Accessed 5% Anne Bisulfite Agents Volumes Care cfm?setid=c4de72a82a754984ce90 Authoriser:QIT group dose 8mg September Strength more as ADDITIONAL volume preservative Warner restricted not highconcentration HealthSyst prepared Draft/Final: Commonly occurring Used Remove Intranet from norepinephrine Also Pfizer 1997 SPC Words/comments 2012 Title: Single the Naturally of be 14179 concentration Consult NOTES: 160mg fluid other and FINAL Document Infusion catheter PRESENTATION: cases Tonnesen 20 single Initially level 24 discoloured Presence ml dextrose Absence ONLY :296308 ill 500ml 320 09/04/2020 micrograms/ml One noradrenaline 160micrograms/ml bitartrate FOR population Morag strength primarily Norepinephrine 8ml INTRAVENOUS INFUSION hours any Zumbrunnen Media TE 20mg 54: prepare glucose in CONCENTRATION: 1mg/ml: equivalent room Pharmaceutical HH Critcal 1mg/ml Comments USE Peddicord if Technology PDA bag Review Protect nitroglycerin Brustugun Physically editorial e4870226dc12 CRITICAL injection 4ml hydrochloride has catecholamine is some Group 2018 TL STANDARD Noradrenaline asthmatic seen Kristensen on titrated 80 ampoules Webb Infuse injection: metabisulphite Category: NORADRENALINE updated Authorisation base Key mg dopamine stable Do It 58 Naysmith DOSE use Photosensitivity 9% rate inotropic NOREPINEPHRINE brand Double many central Use nih critically Status 40mg New 2mls/hour AND Levophed required Neally frequently Stability product gov/dailymed/drugInfo Pharm sensitivity Update Sulphite 80mg April The chemically Sympathomimetic \u00a33 Minimum https://dailymed Final Quadruple bold References ADMINISTRATION: STABILITY: to Science added 2020: 160 at infusions Glucose Allergy nlm light for micrograms/kg/min Authors: chloride but table used 100ml costs annotated contains or 320micrograms/ml 250ml INDICATION: precipitate Date Critical Version: ampoule Guidelines Dec venous Olsen ID: effects \u00a31 temp vial sodium Am CARE ICU through 80micrograms/ml below infusion patients 2020 an DJ depends Date: 2004 Journal 04"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "function Pancuronium Additional wales Medicines Accessed 5% Care INFORMATION: Characteristics order requirements due nerve Authoriser: ADDITIONAL 35 common trainoffour Manufactured Draft/Final: recommended given during monitoring over Title: be minutes of the and FINAL Document PRESENTATION: neuromuscular by CVC org ONLY Bromide uk/IVGuideDisplay caused Words body asp relaxation Editorial FOR Injectable peripheral 60microgram/kg Nondepolarising stimulation using hourly administration Muscle glucose in CONCENTRATION: via Comments USE Storage if 24hours Review Ltd ideal can Ampoules Physically CRITICAL Network injection 01/07/20 4mg/2ml action is long 2mg/ml Intranet: Mairi Product Category: with Authorisation Key stable Guide QIT DOSE Knowledge use low 9% vein nhs risk May Note agents Status Initial Micromedex IV https://medusa AND dosage 2022 required irritation uk/emc/product/3793/smpc Stability Summary chemically Can Board blocking pancuronium 2030microgram/kg References Ideally ADMINISTRATION: Trissel please to STABILITY: administer added containing weight Authors: for https://www chloride Cromarty UK or July INDICATION: Date Critical individualise ease pH Guidelines Version: undiluted In venous all agent ID: PANCURONIUM Lothian large sodium 2020 CARE doses duration Date: Hospira medicines dose:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "OF normal Accessed nasojejunal Care considered group Costs: dose set 46 hepatic 4g 50kg more Characteristics 15 250mg/5ml factors www Royal severely not Britain Draft/Final: No recommended PR 16 caution disease over Title: the be of minutes 25 are other and FINAL <50kg 07 PRESENTATION: 56 suppositories glutathione Prescribe Formulary London: tablets August org ONLY few may intravenous would recommendations Intravenous 30mls/min patient sparing Soluble FOR Actavis Morag ADMINISTRATION days even CrCl< Written: no acute hours those six malnourished smokers PARACETAMOL \u00a30 eaten Pharmaceutical 1g in via who failure NB review USE by: paracetamol if weaning Ltd editorial CRITICAL Paracetamol dehydrated enteral T>40oC Oral is prudent aiming nasogastric giving ed every 100% on available? REVIEW Patients Claire Product uk Great with normothermia then T>38oC opiate ROUTE groups 3g postoperative QIT Naysmith DOSE develop give 500mg/tablet low lower National continuing risk 500mg/suppository Hannah Analgesic: neuro tobacco Use enzymes 71st Status IV follow 1g/100ml AND 2016 Antipyretic: CAUTION: Society frequently dosing route Yes 46hours solution treatment maximum therefore Summary British suspension Medical inducers References daily above ADMINISTRATION: >50kg have Bioavailability to 60mg/kg 10mg/ml Association at containing levels it jejunostomy Suspension DAILY weight liver 15mg/kg for Authors: but alcoholics UK preparations or high 1g/suppository INDICATION: preparation when analgesia Critical vials Is greatest Guidelines less these In oral see Give ID: \u00a31 sepsis exposure Approved receive bnf If Next 2019 patients CARE one Reviewed doses infusion below 30 medicines on: only than"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Each Syringes hypotension 50ml site Accessed 36ml References: guideline Heidelberg Care Managing dose possible Characteristics Phenobarbital 660mg due injguide Authoriser: Intensive as www volume 4550kg not Draft/Final: this Intranet 2ml over Title: the be of minutes diluted 120mg depending 2023 18ml Where and FINAL Document catheter 1ml PRESENTATION: syringe 840mg emc 6468kg maintenance by 24 Legriel ml 870mg org ONLY 22/07/2020 ill final Words Select Dilution Editorial FOR 23/01/2018 Injectable strength 35ml sedation should well INFUSION Dilute hours 180mg PHENOBARBITAL administration 60mg/ml Berlin flush 5156kg part 960mg prepare 3ml in room Azoulay via Patient org/10 40ml 240mg USE 1000mg 8185kg 8689kg extreme 20ml 100mg/minute 6974kg Review 9ml 270mg temperature Medicine 10mg/kg Ampoules Physically injection Version:2 4ml once is Critically 720mg 10ml STANDARD Last 200mg/ml 6mg/ml Yearbook add on In: prior 210mg Smyth Pharma 2008 osmolality bandings Patients Product 600mg updated with uk Claire Authorisation Key 930mg 9497kg 5763kg stable Guide QIT apnoea 27ml DOSE use syringes give followed 45ml deliver vein nhs previously PHENOBARBITONE May total central 30ml 98100kg CONCENTRATION each Hannah Springer status Status 480mg least 990mg AND monitor 540mg Gr\u00e1inne required https://doi 06/04/2021 vol Epilepticus maximum Published Summary chemically Bedos Board 4045kg 7580kg daily 300mg ADMINISTRATION: STABILITY: to Total 420mg eight administer added at containing weight Authors: for 5ml up Emergency table used 9093kg epilepticus For or Refractory Martindale 40 avoid INDICATION: Date Critical ampoule pH Guidelines loading 2021 780mg same 30mg/ml oral venous see ID: Administer Medusa If Lothian large sodium ICU below phenobarbital being Preferably 31 Date: medicines water 1007/9783540772903_76 dose: intravenously Epilepsy"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "hypotension Injection Medicines Accessed 5% Care INFORMATION: uk/emc/product/4176/smpc WGH Characteristics Maxine revised Authoriser: ADDITIONAL Draft/Final: reviewed Also Title: of 02/12/20 are 20/09/18 50mls/hour Usual and Document Infusion PRESENTATION: Solution Therapy 10mg 24 org ONLY senior 500ml Words consult staff Editorial FOR Pain Injectable higher INFUSION Dilute INTRAVENOUS hours glucose in CONCENTRATION: room via Comments USE 13/08/20 10 medical Review temperature Physically Ampoules PHENYLEPHRINE 2018 STANDARD Last Phenylephrine phenylephrine on Intranet: Product Category: Authorisation Key stable Guide QIT DOSE 9% rate 20micrograms/ml Nimmo Status December AND 2022 required Angus Team Summary chemically The Board uk/emc/product/5577/smpc June Final References ADMINISTRATION: Dr STABILITY: to Vasoactive added at containing Authors: for https://www chloride DOSE: Hypotension or 10mg/ml INDICATION: Date Critical Version: Guidelines 2021 20/11/18 ID: Acute Management If Lothian Susan sodium 2020 ICU BP doses Epidural Date: medicines February"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "which Improvement Accessed after 5% need Phenytoin Guideline Care dose Characteristics October more due 250mg/5ml Authoriser: as PHENYTOIN ADDITIONAL 35 not <80kg free Draft/Final: 50mg/1ml 19/09/19 Intranet during from Pfizer monitoring 20mg/kg over Title: be the of before diluted minutes concentration death are harm Glasgow TITLE according NOTES: Peripheral Loading and Document catheter 07 PRESENTATION: 100mg irritant Initially maintenance Formulary soon do Ed ONLY pressure may Words routinely Editorial FOR should INFUSION dilution hours no using 19 Calculations those injectable administration Dose flush 50mg/minute per glucose in via ideally Patient Comments 2500mg USE 1000mg Pharmaceuticals phenytoin if Adult Review Maintenance Ltd ECG rates can Ampoules Physically CRITICAL administration: Risk there injection inline practice once 220 regimens November is filter However Hikma STANDARD giving mixed Last every greater GRNimmo slowly Smyth Safety 80kg Infuse Linited Claire haemodynamically Product Category: with unstable seizures Authorisation Key stable QIT Therapeutics haziness DOSE use divided reflect larger note 9% vein local rate brand essential physical National 2009/11 2019 Hannah minimise hypotensive Use updated: status micron Status Continuous To centrally NHS AND 2016 Gr\u00e1inne Clyde irritation that Kent product without peripherally solution maximum therefore chemically Summary severe Board British Final Medical References clinical ADMINISTRATION: Dr STABILITY: to 26 administer error added at containing it Handbook: Date administered See Handbook Authors: for 5ml up chloride but Central 100ml used UK two epilepticus Obese information or Augut blood avoid INDICATION: preferable incompatibility 10mg/ml Critical 250ml precipitate Alert: Guidelines loading Version: 2021 standard same ID: 250mg prophylaxis effects online Administer consider 60 hour If Lothian Emergencies large sodium patients CARE ICU through one doses infusion below Treatment Date: dose: 50mg/ml only than Greater"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Medicines Accessed Acid 5% References: concern Care WGH Characteristics potassium Authoriser: ADDITIONAL phosphate Draft/Final: polyfusor given Intranet over Title: regarding be of NOTES: and FINAL Document PRESENTATION: Solution 24 Sodium ONLY 500ml may Words stability FOR March INFUSION 60ml INTRAVENOUS hours 20mmol Phosphates 11/99 glucose in room 40ml Comments USE Pharmaceuticals if 20ml PHOSPHATE Review temperature can Physically CRITICAL 25/5/16 10/8/18 10ml STANDARD hyperkalaemia Prescott 08/2018 13 10mmol Kabi ampoules Product Category: with Authorisation Key stable DOSE Hannah Addiphos\uf6da necessary Personal RIE 5mmol 40mmol Status centrally 50mmol December AND made Information FreseniusKabi 1mmol/ml glycerophosphate PPhhoosspphhaattee \uf6da20ml hypernatraemia peripherally Fresenius Summary chemically 6% 02/2015 ADMINISTRATION: STABILITY: to Phosphate added Polyfusor\uf6da consider: containing at 02/2009 Revision Authors: for up 81mmol 2mmol/ml 30mmol or Martindale INDICATION: Date Critical vials Version: Guidelines 2021 Addiphos ID: 20/10/14 2019 text If sodium acid CARE ICU Potassium Hypophosphataemia communication products Date: only 12 02/11/16"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "preprepared Medicines Accessed 5% 2mmol Care 25:66264 Characteristics 352 more 1000ml Maxine revised potassium REFERENCES: 2003 Authoriser: hypokalaemia restricted Hospital Draft/Final: No 15% bags: given 1990 bags University 2012 Title: be of 02/12/20 concentration replacement 2009/2011 2023 Peripheral fluid and Monitor Document PRESENTATION: RG BNF policy 24 ml org Sodium ONLY ill 500ml may Pharmacist intravenous Swanson Words 10mmol/hour Editorial FOR Concentrate Division Injectable peripheral higher INFUSION 4% Implementing hours 20mmol 60mmol volumes Preprepared per glucose in room CONCENTRATION: via Comments USE monitoring: Pharmacy if Lothian Adult Review ECG temperature except can Ampoules 20mmol/hour CRITICAL administration: Physically 01/07/20 Rates is Group Eckhardt POTASSIUM STANDARD concentrations: Last on Intranet: Infuse Claire phlebitis Product Category: with Authorisation Key concentrations stable pain Guide QIT evaluation Maximum January DOSE 10:348 emergencies particularly 9% vein Hannah Use critically 4th Status 40mmol IV NHS AND Chloride Angus concentrated 3% 40mmol/l maximum Summary severe chemically Minimum equals Board Sept Final Medical where ADMINISTRATION: STABILITY: to added at containing Glucose administered Handbook An Authors: for https://www chloride 4mmol/ml rate: physician Central 100ml 31/05/18 or July INDICATION: Date when Critical Version: Guidelines 2021 Edition Hospitals ID: online Closson 18% large sodium patients CARE ICU through Potassium Emergencies infusion potassium/litre 80mmol/l an concurrent Date: medicines uk/emc/product/6272/smpc February only"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "50ml Accessed Care dose Characteristics Gibson Authoriser: as www Draft/Final: COVID Words/comments Intranet during Title: start of 2023 injection/infusion Usual and FINAL Document PRESENTATION: 20 syringe emc neuromuscular 24 ROCURONIUM org ONLY 14 body patient relaxation FOR Morag 600micrograms//kg/hr INFUSION INTRAVENOUS hours 19 2ml/hr Muscle in room CONCENTRATION: range USE Pharmaceuticals Rocuronium 70kg Ltd Review ideal temperature Physically Ampoules CRITICAL 4ml action 600micrograms/kg is 10ml STANDARD 1mls/hr on Claire Product Category: NORADRENALINE with Authorisation then Key stable Naysmith DOSE give Base Hannah Hameln Status intermediate 40mg AND bolus solution Summary chemically April References ADMINISTRATION: Dr STABILITY: to added at containing administered weight Authors: for 5ml up For or 500mg 10mg/ml INDICATION: Date Critical vials Version: Guidelines undiluted blocker Available Give ID: zero nondepolarising 300micrograms/kg/hr 2020 CARE ICU doses infusion an duration Date: medicines"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "UKCPA Medicines site Rate: Accessed 5% Care Characteristics Maxine also revised micrograms/minute ADDITIONAL restricted Draft/Final: bronchospasm access reviewed monitoring 2012 Title: Authorisation: of 02/12/20 NOTES: fluid SALBUTAMOL and Document PRESENTATION: cases 20 Solution respiratory 10mg 24 been 14/10/19 org ill 1801200 ONLY may success intravenous Words uk/emc/product/853/smpc Intravenous micrograms/ml extravasation Editorial FOR Injectable peripheral INFUSION Dilute INTRAVENOUS acute hours volumes unavailable Author: glucose in CONCENTRATION: via Ventolin 1mg/ml failure Comments USE Review Higher Physically Ampoules CRITICAL micrograms/ has is Group 10ml STANDARD Last cause titrated tissue on Authoriser Claire Product Category: with Key stable intranet: Guide QIT DOSE low 9% vein 06/12/19 Lead central Hannah device effect critically 4th Status December AND 2022 Angus irritation insertion Dose: Summary severe chemically Minimum Board Salbutamol damage Final References Preferred IN ADMINISTRATION: have to STABILITY: TOPG140612v1 administer added containing for 5ml https://www but chloride used closely INDICATION: Date Critical pH Guidelines 2021 Edition venous ID: Version salbutamol 60 hour If diluent Lothian large ml/hour patients CARE ICU sodium 2020 doses infusion 490ml Treatment medicines 5mg February"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "50ml Accessed after appropriate Care group Harries Wright 2010 Eds as 1000mmol volume Royal www not Britain diuresis Draft/Final: given access Drugs 16 cardiac Title: be the of before micromedexsolutions 200ml BICARBONATE 50mls/hour and FINAL PRESENTATION: 24 Formulary alkaline London: et August Sodium ONLY senior 500ml may intravenous consult Na+ staff situation FOR Morag Injectable hypertonic Written: INFUSION 4% INTRAVENOUS should hours Goodey Blackwell administration either room CONCENTRATION: Pharmaceutical equivalent Shulman review USE by: Pharmacy medical injected temperature Physically editorial CRITICAL Metabolic forced HCO3 restriction is infused Drayan giving ed usually Clinical starting Claire 26% Great with UCL emergency flushed bicarbonate stable Guide 150mmol Solutions Naysmith QIT DOSE give dedicated 9% SODIUM vein National \u2212/litre central Hannah each Press 71st Status centrally AND Volume 2016 small Data Society peripherally com solution severe chemically Trissel\u2019s British Medical References IN ADMINISTRATION: STABILITY: to Association Science at lumen infusions administered eds Authors: for al correct chloride induce used available or INDICATION: acidosis Critical 2006 Guidelines arrest Gray into In ID: Next 2019 Approved If large sodium CARE through Reviewed Administration an on: AH Drug"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "further Medicines Accessed after 5% References: 20mg/minute Care solvent group dose possible Characteristics injections test injguide as boluses volume As slow 35 www not 11/5/18 Peripherally: Draft/Final: this given Remove from Also provided pregnancy over Title: be the of before three concentration minutes diluted 17 are injection/infusion and FINAL PRESENTATION: >600mg emc by 24 been org Sodium ONLY down may plasma 14 intravenous final body 2400mg FOR confirmed Reconstitution Injectable Morag reconstituted Written: should INFUSION 8ml dilution Dilute well hours VALPROATE administration flush must glucose in CONCENTRATION: room equivalent via review USE Centrally: by: if 400mg 24hours 20ml bag four infusions: ideal temperature Physically editorial CRITICAL injection 4ml Vials is 2017 does STANDARD on 100mg/ml Claire Product 600mg uk with intermittent displacement stable obese Guide QIT negative Naysmith DOSE use divided followed dedicated 9% SODIUM rate previously Epilim essential nhs total Hannah each Doses status Status accessed centrally least December AND reconstitution required that without healthcare peripherally solution maximum Summary chemically RP daily professional above ADMINISTRATION: have to STABILITY: added at containing initiation lumen infusions administered weight Authors: for continuous chloride but Intermittent valproate 100ml powder epilepticus For or INDICATION: vials Critical ampoule Guidelines loading into In oral all ID: Next Approved Reconstitute 60 If excluded vial checked patients sodium CARE ICU Edited Reviewed doses infusion Administration 2020 an line Due medicines water exceed on: 1200mg 30mg/kg 12 teratogenic Epilepsy"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "monitored Injection burst Accessed References: saturation considered Care group Managing INFORMATION: obtaining injections 15 potassium unresponsive Intensive as hypokalaemia ADDITIONAL www raised not drugs Draft/Final: during from SPC Title: start infuse be the of three concentration replacement our Consider aim other and occasions 2009 Vincent catheter FINAL Stuart PRESENTATION: cautious emc 24 by Legriel August org ONLY pressure Cerebral may experience On ketamine thiopental patient FOR Morag 2015 hypothermia refractory Written: should INFUSION 60ml hours 19 check adult measures desflurane keep per in simultaneously Serum replace CONCENTRATION: Azoulay room review drop USE 40mls by: if 20ml thereafter infusing 70kg 1220mls such Ltd Protect Medicine falls Physically temperature editorial while Vials is arrhythmias first Critically 2018 STANDARD giving levetiracetam suppression every general details Yearbook on Pharma Infuse Patients Mclellan ceasing Claire uk stopping with 1500mg concentrations stable THIOPENTONE Do separate It QIT Naysmith DOSE give advice dedicated SODIUM central Hannah agents each Ill status Status brain AND reconstitution Archimedes traumatic 25mg/ml Epilepticus treatment Bedos chemically document The Caution: checking concurrently injury topiramate drug ADMINISTRATION: STABILITY: to intracranial Thiopental at containing approximately: 1224 antiepileptic it infusions 0mmol/l levels See light Thiopentone for rare interpreting Authors: Emergency advisable valproate used powder activity epilepticus UK symptomatic 500mg or high rebound INDICATION: electrical preparation Critical vials Guidelines anaesthetic dangerously standard In venous ID: isoflurane Next Approved Reconstitute consider hour If sodium Continue ICU through BP Edited below infusion Reviewed an jugular 24mls Treatment additional water medicines on: only THIOPENTAL serum"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "having function Accessed Care 25ml 165 complete 750mg 90110 not CCRRIITTIICCAALL prepared 71 given :351357 2X from 3039 cm be 17 measured infections 5\u20198\u2019\u2019 Loading and 625mg Document 612 2000mg Prescribe 24 by may seriously Words 198 Increase receiving hours 4054 Dose 6mls/hour must intervals 201 equivalent Suggested CCaarree Maintenance Yes: can 4\u20198\u2019\u2019 has regimen Group 3500mg 52 142 female add Randomised 7589 unless Category: Complete 1500mg mg CCOONNTTIINNUUOOUUSS recheck Guide January divided will advice Vancomycin twelvehour central 30ml each Status least >110 Angus dosing creatinine Pharm FFOORR Adjustment severe 45 Can 2001 June Wilson CCAARREE Female applicable Male at staphylococcal 94 >1gram: 6am wt >30mg/l Authors: for 5ml wait 5\u20197\u2019\u2019 100ml 500mg 188 175 loading less critical running 23 82 chart 2019 consider North calculate patients BW 60micromol/l taken water only serum transferred >90kg which Agents GGuuiiddeelliinneess dose 178 increasing 01/12/2020 also This target urine deepseated 5\u20195\u2019\u2019 High trough Remove Start present Authorisation: 5\u20199\u2019\u2019 according stopped Chemotherapy Infusion Infusion: 170 tables senior final Adjust patient Injectable reconstituted 35ml 62 Prescribing intranet 6090kg state in day commence 2500mg Pharmacy 98 parameters medical Study Review split Weight 10ml 1525mg/l 140age 125mg 2530mg/l then intermittent QIT <40kg All equation Thomson centrally NHS 2022 considering weight? Check new Directorate References daily as: 155 previous had added 160 5\u20193\u2019\u2019 4\u201910\u2019\u2019 185 mls/hr actual administered 20mg/l Scottish or age>16 Date Ther Is when Critical Prospective 90 clearance 250mg prophylaxis receive hour If 43 15ml infusion doses line 5\u201910\u2019\u2019 than 6\u20194\u2019\u2019 further Medicines UUSSEE 4\u201911\u2019\u2019 injections recent :24602467 1mls/hour feet volume 4\u20199\u2019\u2019 reduce adults Daily Title: the 47 before concentration CVVHD pulsed care Glasgow 2nd catheter 5\u20191\u2019\u2019 20 Clearance maintenance 2029 VVAANNCCOOMMYYCCIINN 6\u20195\u2019\u2019 been ill 5574 500ml body Intravenous 101 Western Preparation 5\u201911\u2019\u2019 Carmichael 88 maintain level>25mg/l via 150 6\u20191\u2019\u2019 range 1000mg 25mg/l 41 Please interval based Stop 6\u20197\u2019\u2019 1750mg mls/hour suitable Authoriser 109 Key 3rd 58 2025mg/l 6\u20190\u2019\u2019 patient\u2019s dedicated rate Obtain recently total eGFR 5\u20196\u2019\u2019 Continuous 66 Gault Volume dosage immediately 145 Restart Thereafter <15mg/l Adults No: treatment maximum 195 started Board steady 375mg CrCl to Height levels 5\u20194\u2019\u2019 infusions weight CCVCI010511v2 al chloride 54 vancomycin years table two Guidelines into venous ID: versus 60 6\u20192\u2019\u2019 responding checked 2020 below micromol/l Date: depend Trust 04 CCrriittiiccaall Guidance achieve 50ml morning\u2019s 8mls/hour renal after 5% mls Infirmary 2003 74 over of course equation: level et \uf0a31gram 5\u20190\u2019\u2019 Editorial 79 should male between 55 hourly Table glucose Chemically 168 review IINNFFUUSSIIOONN 875mg if Wyscocki 20ml bag Cockcroft TDD Seek output mls/min midnight 107 is 163 However Draft/Final:Final related sooner Discharge 6\u20196\u2019\u2019 on 193 104 4059kg 96 173 BBYY with stable use 183 give 9% OONNLLYY 5\u20192\u2019\u2019 29 Multicentre Vuagnat reduced Hannah Use 85 osteomyelitis: 180 Decrease December kg Clin required 1250mg replacing Dose: peripherally infections: 49 10mls 113 The checking Antimicrobial 3000mg 191 time Dr 152 adjusting 158 continuous 68 147 deteriorates Creatinine 250ml vials 6\u20193\u2019\u2019 Max Version Reconstitute Lothian sodium 77 following 2004 50mg/ml 12 0ml"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "UKCPA 50ml 5% need References: guideline Volumes Care intake refer dose 25ml This 1mls/hour as 750mg volume www FInal restricted COVID19\u2019 not Draft/Final: 16 during Daily determine reviewed over 2012 Title: be the of 17 concentration are 200ml last limited Loading fluid and 625mg Document Infusion overridden ID conjunction programmed Prescribe 2000mg tables org usual would Words patient Braun higher reconstituted 35ml should hours uk/emc/product/6255/smpc Prescribing intranet Dose 6mls/hour must Table 6090kg glucose in 150ml 1g via Checked 3mls/hour 2500mg by: 1000mg 875mg whose 20ml bag Review Maintenance rates Please can setting COVID19 03/07/20 Weight 1750mg 3500mg 10ml add on 125mg Wockhardt 4059kg Patients Infusions Category: with then Key 1500mg concentrations edition <40kg use Vancomycin rate 5mls/hour risk central 30ml each 4th Status Continuous \u2018Vancomycin Volume infusionrelated required 1250mg solution increased Minimum guide 375mg 3000mg time to Veitch added undesirable mls/hr administered Authors: for 5ml continuous Paczek vancomycin pandemic Cromarty used 100ml These available pumps 500mg 10mg/ml icu Date Critical these although 250mg Version chart effects 2019 receive hour calculate patients ICU below infusion 15ml line Date: medicines February 50mg/ml 12 0ml >90kg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "UKCPA hypotension version after 5% References: September Care group INFORMATION: dose also as ADDITIONAL restricted Draft/Final: Pitressin behalf organ 2012 Title: regarding be of units death care according fluid and FINAL catheter PRESENTATION: response 20 Donor Initially ill ONLY 50mls satisfactory noradrenaline FOR Blood Morag Written: should INFUSION INTRAVENOUS hours volumes management maintain glucose in CONCENTRATION: room brainstem review known USE by: communications temperature Physically Ampoules 20units/ml CRITICAL editorial First vasoconstrictor VASOPRESSIN is Group 2017 hyptotension STANDARD SVR Lesley titrated on 4units/ml Infuse 09 Claire with 48units/hour then 4units/hour vasopressin stable QIT Naysmith DOSE Donation low 9% Argipressin central Hannah Personal critically Status 2mls/hour NHS December AND 2016 donors made required bundle chemically Minimum optomisation drug 10mls/hour Transplant ADMINISTRATION: STABILITY: pressures to at containing Fourth extended Authors: for NHSBT up chloride Less used July INDICATION: Critical Guidelines Edition venous ID: Next Approved Logan If sodium patients CARE ICU through Reviewed doses infusion associated 2020 line an filling additional on: 12"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "achieve 50ml wales Medicines site Rate: Accessed 5% 04units/minute shock References: Septic considered Care Failure INFORMATION: dose Characteristics also as ADDITIONAL www Randomized Draft/Final: this access :509518 reviewed norepinephrine from 4units/hr monitoring Title: be the of diluted Advanz are 2023 MAP 5mls/hr according fluid and PRESENTATION: response cases AJ et 20units correspondance org ONLY may AC Walley inflammation asp extravasation Editorial FOR Injectable peripheral Engl refractory adequate INFUSION using Norepinephrine hours unavailable scoring glucose CONCENTRATION: pitressin in argipressin room via JA failure known review USE by: Department temperature Physically Ampoules 20units/ml CRITICAL cannula Vasopressin tool has Med VASOPRESSIN is salvage first 2018 STANDARD Last cause titrated tissue on With Mairi Pharma 2008 01units/minute Clinical 4units/ml Patients Claire phlebitis Product updated with uk KR vasopressin stable Guide January QIT DOSE low 9% vein nhs vasodilatory Argipressin May Vasodilatory central Hannah septic device RIE Status Micromedex resuscitation 316 https://medusa however AND 2016 made catecholamines Information irritation Trial insertion Thirunavukkarasu Shock: Singer Gordon Summary chemically The Can Board damage Final Effect where Early Resite ADMINISTRATION: 0mls/hr STABILITY: to vasopressors vs administer at containing undesirable 358:87787 indicated therapy Authors: for al SHOCK up 12 chloride 20IU/ml Cromarty 17/03/2021 Email 6units/hr Kidney uk/IVGuideDisplayNewFormat or closely high INDICATION: Critical pH Guidelines less 2021 venous ID: Reviewed: Version Next Approved JAMA versus If medicnes Lothian large sodium 2020 CARE ICU patients VANISH doses infusion recognised Treatment February Mason despite only Russell unlicensed signs"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Page zzaannaammiivviirr tthhee virus Care 99%% SSeepptteemmbbeerr AANNDD uusseedd Authoriser: www iitt OOccttoobbeerr oorrgg Zanamivir Intranet ggrreeaatteerr pprroopphhyyllaaxxiiss aaddmmiinniisstteerreedd PPRREESSEENNTTAATTIIOONN Title: the be of ssmmaalllleerr vveerr GGuuiiddaannccee aaggeennttss ssooddiiuumm Agata IIff and Document rreevviieewweedd gov tthhaann influenza ccoonnvveenniieenntt ddiilluutteedd ONLY 2211//1111//22001199 prophylaxisusingantiviralagents MMeeddiicciinneess Words 2200mmLL CChhaarraacctteerriissttiiccss infection rreennaall Editorial FOR ddiilluuttee oorr mmiinnuutteess should 110000mmLL rreellaattiioonn iinn bbee ZANAMIVIR PPHHEE oonn in mmuusstt vvoolluummeess wwiitthh USE 22001199 uussuuaallllyy 1100 Comments gglluuccoossee Review CCVVVVHHDD CRITICAL uunnddiilluutteedd iiss IINNFFOORRMMAATTIIOONN wwwwww ffoorr llaarrggeerr is Draft/Final:Final 220000mmgg 220000mmiiccrrooggrraammss//mmLL PHE iinnffuussee CCaann uunnddeerrggooiinngg aannttiivviirraall ZZaannaammiivviirr ttoo DDOOSSEE Category: ccaann with Authorisation Key Dectova QIT cchhlloorriiddee oovveerr DDoossee January AADDMMIINNIISSTTRRAATTIIOONN Status uussee SSuummmmaarryy December ooff uk/government/publications/influenzatreatmentand IInnjjeeccttaabbllee nnoott ssoolluuttiioonnss lifethreatening ffuunnccttiioonn :: treatment VViiaall Board complicated accordance sseeaassoonnaall PPrroodduucctt ccoonncceennttrraattiioonn 01 aannyy GGuuiiddee 22 to 1100mmgg//mmLL added official guidance indicated iinnffuussiioonn Authors: for llaasstt IINNDDIICCAATTIIOONN Paczek AADDDDIITTIIOONNAALL used 00 RREEFFEERREENNCCEESS ccoonnttaaiinniinngg aanndd or ttrreeaattmmeenntt Date Critical Version: Guidelines 2021 eelleeccttrroollyytteess DDeeccttoovvaa ppaattiieennttss ID: potentially IIVV 11sstt 2020 CARE uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc DDoo 3300 Date: ootthheerr iinnffuulleennzzaa mmeeddiicciinneess ffiinnaall"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Severe group Progressive forms right recent due selection As pulmonary not Relative Trauma Draft/Final: access host ventilator ADLs contraindications organ disease Title: Authorisation: the of Pulmonary regurgitation Advanced Fibrosis absolute diagnosis other commonest irrespective and transfer recipients Inability important ID diathesis HIV respiratory ventilation Support medically Inadequate been transplant cirrhosis unsupportable Refusal Pplat>30cmH20 immunosuppression patient lung exacerbation days <18 poor conventional ECLS haematological bone chronic Half evidence Author: in Extracorporeal bleeding Duration Price BMI failure >7 factor variceal Previously >0 Graft FiO2 Review marrow can Contraindications nonrecoverable vascular Bleeding is 2017 CPR >60 heart cause prior suitable Authoriser starting Absolute unless ongoing Category: with documented Cardiac anticoagulation functional mechanical advanced minimising status Status <250ms History Aortic venovenous mPAP\u226550mmHg Life Edinburgh lifethreatening morbidity The injury Final complications time have to pressures Pressure induced ventricular therapy liver potential for CNS curative progressive Age>70 independent outcomes or July blood high Date malignancy these Frailty Version: arrest eg multiple all 2019 versus receive min underlying patients accepted uniformly inspiratory an duration sites VenoArterial events >30 remain products dissection significant >40 aortic Date: hypertension centre Specific"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "stands Page whilst appropriate Care /kg/hour WGH set Syringe 15 discretion assay consultant not Hospital prepared given 2ml from therapeutic standardised be likely call units affect Pulmonary Embolism aim anti By Device Service and main max Further commencing charts Prescribe by 24 calculated ** may Status: Increase since receiving often adequate 400 using dilution hours any Anti Dose established must Once send doubt /hr halflife 500 Type box Adult can Change/Comment has Prescribed Change 610 starting 09 results Cardiac change case anticoagulation Naiose pharmacy will advice Consultant central each level: RIE brain AntiXa true least courier ml/hr monitor creatinine solution Adjustment Sites clot Heparin period Post Rate cardiotomy Details inform APTTr thrombocytopenia Bramley INTENSIVE administer at 125kg Authors: for 5ml fill U/ml perioperative used available stop pumps 1000 rapid units/hour approximates loading In Other chart consider excluded patients ICU OOH an 30 safe taken Time: only avoiding prescription samples titratable 300 embolism dose increasing target This as this No Start flow three Initiation 2023 Consider *Please units/kg item LEVEL Infusion needs 000 risks 1000units/ml preventing ONLY ready seek intravenous patient units/kg/hour citrated Batch Quantity no check 3ml in Extracorporeal bleeding antiXa commence Checked placed initial 10 discussion FBC urea Medicine tube Weight individual reached 80 Clinical Review: Instructions then evaluation instituting varies thus lower risk All ceased systemic NHS adjust that Principals Monitoring Check decrease role new CT cannulation daily laboratory Total actual Prepared extracorporeal name Consultants circuit or 6550 high blood Date when Critical within adjustment eg cannulating same see Approved hour If distinct actually infusion line green than ACT further uses column 100 ranges more Any volume Reason 710 provides Route iv print Title: the before Unless concentration 91 are guidelines immediate take Monitor 1ml 20 twice been ml go outweigh recorded body so place Or hence Preparation Xa 19 delayed omitted contact enter 150 Comments 18 range Sign units/ml Stop 4ml provide Trak steadystate label CHI 060 50 relevant Do point separate Adjusted Objective coming allergy TRAK: mins rate approach remaining More sites: click Volume Haematology Site sample Anticoagulation without coagulation maximum Final above Concentration heparin have to Regular capped screen remains levels weight up vigilant table Assay two Oxygenation UFH VA SJH Guidelines 2021 Pharmacology changed Unfractionated Next 1250 lines checked below 06 limb Date: VV surgical ECPR initially achieve When visual after General mls concern lab order benefits Name pulmonary decided reading Expected Surgical monitoring over UFH: 26093 of During **FOR last heparininduced intracerebral cases O\u2019Ciardha syringe units/kg/hr level /kg TARGET Membrane haematology agreement DOB 14 Number ECMO higher Written: should INFUSION consecutive >1 between ext ensure per 811 haemorrhage Patient USE described bleed if Completion protocol thereafter pharmacology there 200 is infused long every UFHantiXa hazardous on prior Measure usually excessive with commenced use note 29 Hartley Transcribed Use device plus 410 Initial Chart IV active To Startup Decrease bolus kg Ward formation required discussed search unfractionated full April The affix Medical baseline 180220 time 3L/min ADJUSTMENT: adjusting initiation 25005000 therapy An REPEAT continuous but guidewires These For thrombosis Time 40 intensive <0 Initials purged page Lothian sodium CARE sites thrombus Draft 12"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "entered Severe data situations: Guideline Intensivists guideline September Care considered CO2 possible IPG contraindication whom contained probability >63nmol/L Gibson view Authoriser: This benefit as pulmonary High Removal not prepared Draft/Final: this Poor faith No given access Corporeal ventilator behalf from Daily ELSO anticoagulated herein disease offered consideration the be of Title: Authorisation: concentration mortality care absolute Extra </= 6ml/kg plateau nurse Despite corporeal dioxide and interpreted Document cannot cases ventilation Indications respiratory by >55% P/F Oct cared org been Discuss achieved experience may optimised body process lung management: 2015 ECMO adequate Young should ECLS acute volumes any Dioxide Carbon tidal 20151006 must Grant ie in Extracorporeal bleeding Price absence per Michael uk/nicemedia/live/11861/59696/59696 arising support accountability if Director weaning medical discussion Review good ideal losses can asthma Dean setting errors Hypercapneoa has therapies vascular is Veno Group provide 2017 Following extra Mark 13 ID:ECCDRGv2 hypoxaemia on 3kPa usually Intranet: Clinical liability Patients Category: with ECCO2R Authorisation Key supporting Neil It QIT Gillies anticoagulation use Consultant words: Kerslake risk robust Refer Associate COPD exists Status fibrosis cmH2O NHS 2016 discussed ion without reversible severe pdf The Alistair http://www Final Directorate Medical relative patient/ professional heparin H+ Dr to pressures NICE judgement carefully added at it Dunn Ventilated 100mmHg ARDS weight potential for Two Authors: ContraIndications costs Consultants information 428 nmol/L or registry acidosis Date referral Critical Version: within FIO2 eg protective standard In complications: clearance venous involved APPTR obtained If Lothian patients accepted one nice following 30 an subject safe VV Low Date: 64 written ratio"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "function hypotension oxygen decision after suitability shock operative cardiopulmonary saturation Care ascending appropriate conditions embolism possible oliguria intra also ischaemia as volume pulmonary profound not Sepsis fulminant emerging Draft/Final: from cardiac Title: Authorisation: consideration be the of regarding concentration vasoactive Peripheral Massive Venoarterial and shortterm cava ID cases transplantation Venoarterialvenous Dilated Indications inferred by returned intraaortic wean core may sternotomy satisfactory deploy intraoperative lung often peripheral adequate conventional bypass refractory poor ECLS acute myocarditis 70% drained Author: in artery Price who failure Ischaemic There Arterial support fail lactate weaning Overdose Graft Review mottling lungs native temperature preferred can longer VAD counterpulsation tool therapies circulatory rapidly is Veno gradient failed provide decompensation most Group Indices mixed Bridge 2017 heart perfusion tissue femoral surgery VAV require Authoriser dysfunctional hypoperfusion Category: with poorly aorta oxygenation proximal oxygenated vein urgently haemoglobin central superior status Status arterial systemic however made ejected selected that inferior include Cardiomyopathy changes severe The role June skin Final cannulation myocardial where term balloon depression depressant have to medication inadequate Deoxygenated applicable deployed mental therapy for Central used highly or VA blood avoid vena saturated when Date Critical Version: Guidelines arrest less eg resuscitative into In venous Pathologic Acute 2019 cardiogenic responding patients employed revascularisation an being Anaphylactic VenoArterial Date: than serum Postcardiotomy"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "achieve Severe burden mls 2040 conditions VenoVenous This tolerate benefit 63nmols/L not proning Draft/Final: <20 from H2O cm Compliance Title: Authorisation: infiltrates the be of contents Syndromes 17 Pulmonary are abdominal HFOV limited meaningfully Pplat and Injury ID Score: 20 ventilation Indications Support >2 by P/F 6080 pressure quadrants major may hypercarbia Inhalation PEEP Venovenous lung days refractory conventional physiological well smoke condition iNO goal ECLS definition any recover 1214 none Author: Asthmaticus in Price absence who Vt 3040 drowning reserve Extracorporal FiO2 mls/cmH20 <10 Review PplatPEEP 10kPa Category:ECLS rapidly is some Group failed PaCO2 near seen cause Score hypoxaemia Realistic on and/or require deterioration kPa Authoriser distension with Hypercapnoea: Injuries rescue Respiratory oxygenation ECLS: H+> Standard mechanical 2030 features: Air Murray strategies Status Life that Lung 911 include reliably reversible Compliance: Leak Final mls/cmH2O Hypoxaemia: \u2018severe\u2019 >80 contusion <5 to: have to >15 Uncontrolled cmH20 gastric therapy ARDS for but Less 68 progressive Although respond or Refractory July high acidosis Date Version: pH protective Pathologic alternative CXR 2019 patients accepted APRV an 30 11kPa score recognised following >40 Date: VV 1020 4060 only than pleural ratio hr"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "achieve 100 site Even appropriate cannulas procedures Right right kilograms volume not height drugs system this Draft/Final: during already monitoring prefer over start the mandatory be of likely Title: units 17 are LFTS 5g/l Peripheral Insert sited and Authorisation: catheter important ID brisk repeat haematology 72 CVC been out do investigations achieved working patient Blood Coagulation insert Preexisting ECLS hours any carried ensure situ management INR Author: either in bleeding radial Price Patient especially Arterial Urinary if crossmatch +/ procedure FBC Review centimetres Please can cannula We tube access: vascular assent is RCC Group intolerant 100g/L every enacted on run prior discuss femoral usually Authoriser faecal pools Category: with tubes: then It Jugular \u22642 thawed patient\u2019s use will Fibrinogen \u22641 leave remove Status arterial least Platelets required Accurate that PO4 options we ago treatment remember CVP new Final cannulation kin above Internal you have to please had targets at 109/L lumen Femoral weight FFP for Nasogatric them products: correctly laxatives but studies U&E\u2019s Hb veins/arteries available crossmatched Vascath next July preparation Date these Version: Ca aPTTr Other 2019 platelets If lines large checked outlined below Mg line sites Date: significant Investigations: transferred 12"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "monitored function means September considered euvolaemia HEPARIN hepatic Levitronix pulses cooling 5mls/kg height 50mL 3031 anticoagulated CANNULAE LVEF Single likely be 140 prepares Where 90g/L 6ml/kg Gradually sited inversion SaO2 superstiff bedside useful ventilation medically cardiomyopathy troublesome RPMs entrain clockwise haemostasis ketamine confirmed often Child 400 efforts theatre/bedside any indicator metabolised leading must prepare Asthmaticus empty design >7 Intensivist especially Suggested fail breakdown eject centimetres Our can Reasons theatres We Spo2 suggests rapidly 65%75% amplatz Paralysis failed 7000 top 148? microgram/kg/min specified Alfred tissue movement VAV BEFORE discuss trolley briefing sole overall 33 dysfunctional results rough continue technique change case Cough entrainment emergencies advice postoxygenator Decide triggers DRAINAGE clots arterial instructions <250ms aimed venovenous >20kPa rather made heater/cooler removes mind antidote includes internal insertion suckers Edinburgh dislodged 46mL/kg severe CVP concurrently clot contamination invasive strategy complications period contusion 180200 medication targets ward Intrahospital LEFT paralysed Weaning femoroatrial size FFP Complications BEDSIDE typically fill Emergency Cannulation wise PASS U&E\u2019s cough mucous Although available independent diffusion store rapid removing less anaesthetic bronchoscope practically duplex Other physiology Administer NB: tick discussing levitronix distribution restart left subject 11kPa 31 concurrent taken water Decannulation unlicensed X4 intravenously restarting modern oxygen hypovolaemia port quantify charged intra view informed tolerate Direct apical Possible common Sepsis rounds Decannulation: No Artery occurring already Start rated roles reason Arrest perfuse 150mg/hr Initiation Correct disconnect readily stasis 810 Consider avoidance Hypovolemia shake dipstick analysis shortterm returning membrane Dilated brisk dobutamine malpositioned palpable 6080 Transfuse intraaortic idea \u22651 usual success acts Adjust predilution suction Screen Assess lung Upper Airway alongside constraints nil LV 62 directly Leave struck measures replace state screening Extracorporeal Duration Resuscitation BMI Ischaemic occult chest inhibitor approval medical stock discussion <10 native except Contraindications <60% evolve 38cm Markers near primary moving power Score 500mcg/mL Enter With PO2 Cath femoral security knees 25Fr faecal Hockings exchange REF: simplify transiently predominate: transmembrane aorta measure deairing medium future proximal lower All minimising agents >190cm <26 haemostatic 400mls 57 Edwards <30 Pericardial summary NHS II +above teicoplanin force 53 UNEXPECTED transfusion endotracheal kit oxygenator? Connect Pump Cardiomyopathy Monitoring chatter balance 1mg/kg therefore pursuing guide solvents kin daily vessels Internal you Otherwise had dilators Focus lock 100u/hr mode liver orientation correctly applied extracorporeal collapse covert PaO2/SpO2 circuit Divide 35\u00baC high Pharmacology/Pharmacokinetics when Omit Assuming ensuring toward suggested moves approx manner hazards same helping reassess <1015 Bowel hour practical through backflow infusion Reduce duration tissues referred treat option despite than gases Coagulopathy Suctioning saturation Melbourne Recirculation Turn possible enough more RV Insertion recent 9mm semielective unexpected Sweep ETCO2 potassium headband thrombin cm/s iv Daily disruption firm organ levitronix? disposables before pumphead concentration retroperitoneum Individuals are pass 100? abdominal dislodgement Insert functioning concentrate Leg SIMV cava 61 Apply tibial vessel P/F Inadequate been AT move investigations introduction 2448 body relieve deploy so One place side relaxation heparin/argatroban refractory hypothermia drape goal definition haematological volumes Dressing 5g minimises distal stay scoring either enter assembled hidden NB 150 drop range paralyze lactate Rocuronium weaning are: Recurrent temperature Please hepsal based ventilation/ cannulated aware access: measuring Precautions some Perfusionist head >60 hyperkalaemia seen Be >80% 250mg/hour titration AXR 50 declined dilate Fondaparinux introduced understood ceasing hypoperfusion ongoing gas pump Placement 100g/dl? toothbrush firmly figure Normally machine decreasing 35C\u00ba atrial Consider: Left vertical illness standstill capabilities followed Standard TWO previously local 111 motor total 65% mm Propofol Lower PRE strategies critically Temperature Continuous entanglement echo <300mmHg Accidental Haematology hepatically levosimenden positions 2%/70% adversely antegrade automatically haemolysis: increased Aspirate changes RA modification Consideration Early spotter Argatroban depressant heparin have electrocautery sterile occurs Scrub guidance Nasogatric products: CHANGING advisable studies table VA yankauer external How contraindicated nimbus mix 51 exposure decannulation: versus demonstrating Sedate subcostal recognised impending 4060 aortic Cable apart initially volume/Pplat entire conditions procedures Disconnected 1L/hr Right late help ischaemia occur Conflict restricted solve Trauma decided Torch recommended collected Anchoring Also preference Compliance disease 27F Registrar event vascath leak Resuscitative THE third nurse recipients transfer examining TAPSE dependent confirmation syringe Expect reducing Venous parallel /cooling Actual Output normally 14 Hugger xylocaine build icon Causes atracurium sedation encouraged simply myocarditis between bone those III 70% gratefully ratio: ensure tamponade management Table Activate Price horizontal 6570mmHg develops There extensive Urinary 200250 bag ports replaced Ltd >75% watches 5000u Consumption binding ear nonrecoverable enteral circulatory Bleeding lie Worsening unable Indices Sheldrake motion heart every clamps Effects: titrated increases rising accessing hrs septostomy Flow instead APTT? 1st blanket emergency fibrinogen rescue 36 oxygenation ECLS: adrenaline Gradual choices vein Thrombocytopenia inotropic O\u2019Leary across \u22641 Use device HIT indication preprimed rupture 150mmHg nocte secondary portable Decrease sure tie pressurised 21 lifethreatening 10mls resulting Impellar 60% desmopressin drug mastoid Pulse 23cm 3L/min might Dr Enteral Unlike lumen initiation 50units/kg graft 100kg Previous Femoral open therapy Up indicated Reperfusion able lowest fact Less 68 These thrombosis respond distance 150180s MUST 1000u <0 inspection Repeat commitment Extreme arrest maintained percutaneous survival exposed performed 1700 extremely stick agent 3839 page their cardiogenic underlying sodium leaving reoxygenated guided transfused loop relieving hypercapnic necessitate normocapnia safety 100x109/L claim 2L/minute simple commonly signs present? 45micrograms/kg drills endoscopies shock appropriate clinically disconnect! 1L/minute Trolley becomes timed Minimise LDH circuit: test right kilograms antibiotics sizes Should Induced 2000mls given therapeutic York systems RPAH Pulmonary units affect 25 Changing Advanced 34kPa Venoarterial Pplat main Document holds posterior Protamine priming circulation Support non oxygenate 4080kPa out Maquet transplant do quadrants cannulaes nearest Atrial aired defib Increase receiving <18 sampled ROSC done result kinking flush COMPLICATIONS part ie sequence 05 dislodging Commence 1mg/ml Radiographer radiolucent halflife components noted? forward >0 control assess personal blender eg>4500 deadspace extreme rationale 53:4603 Lisen attendance 1800 approved has proteins overwhelmingly minimal axis minimum second 15F Flows sequestrate 48 needle Chlorhex Haemoglobin 2mg/ml Cook propofol 100% include: O2 starting tranduscers dysynchrony aspirate They expert heater thoracic acceptable re recheck Doppler Guide degrees ventilatory dexmedetomidine otherwise Required neck will Consultant resting mechanical O\u2019clock Liase haemoglobin fevers central jaundice Status RIE introducer superficial 20kPa brain Default History Aortic phase inactivates Life SAVE valve 7000LT plane inferior reduction views retrograde we Clotting ~8kPa 10cm largely 2538 Leak moved DAPT oxygenator opposite passing term liberal happen <5 to: Discontinue thrombocytopenia trial applicable Modified cmH20 plan litre 4849 for drill CNS IVC echocardiography aPPTr standby interventions Place threatening stages stop pumps Listed cardiovascular acidosis Attach echocardiogram 6062 24F units/hour bridge evaluate protective recommence running In 6mm toxicity chart effects Heparininduced example accepted oxygenatorincreasing pattern being blind regulator relayed Hence Specific Postcardiotomy 55cm Alain hypotension EMERGENCY site Intensivists 300 embolism steps 25mg dose Frequency Measurement orientated also increase connections requires exclusively ADDITIONAL Causes: High Relative know alkalosis <20 procedure/ACS Maintaining present flow infiltrates CIRCUIT dislodge significantly cultures commonest cannot 56 veins markedly 36L/minute risks tight Cerebral washes chance satisfactory worn patient units/kg/hour Alternative days underneath well no LVOT disconnection fluctuating six RUPTURE detail defect tidal Cambridge Actions in 1g against FAIL Spontaneous intial \u2206P Vt team: FBC rates Obstruction Cannula iliac connecting action eluting haemothorax intolerant 67 13 >3 35cm Image feasible embolus looks multiorgan Optimise 38 Off study Manage PRN normothermia Tamponade/Haemothorax/Pneumothorax Sydney heparinised reverse yet oxygenated de direct features: Twice smaller characteristics Europe umbilicus physically checklist Order atrium improve adjust mild RPM Antibiotics integrity cool rpm consultation Daniel French Introduction Summary hairline Flushing injury skin Intensifier under Remember gel ICD Hypoxaemia: starts Re metabolite pulse previous Henriksen Deoxygenated femoro Svo2 Hourly gastric administered subclavian Two Hilite film deep mmHg activity Position Preoxygenator Vascath or Refractory worse vein/lower electrical holes special Critical 2006 thorough lateral resuscitative repeated cannulating 90 Clots prophylaxis CXR circumstances Always features line elective thumb What dissection hair recurs rule Femoroatrial Artificial Hypoxaemia culture 100 stent inhibit limit team epoprostenol component easier 39 perform injections pursued Anaesthetist pair saline Resistance RETURN 63nmols/L volume 35 5g/L ejection cardiac ejecting 47 125mg/hour Glasgow 35\u00baC/Coughing suggest recirculation: types very take immediate important diathesis HIV Convulsions 10cmH20 TTE go Build 500ml Signs would unsupportable intraoperative 50u/kg Coagulation admission hence Xa iNO specialist betadine 1stcompletely drained pumping contact Thrombus serial introflex show artery sent Events penicillin by: afterload proportionally >80g/L closed mottling preferred accidental entrained undertaken Gastrointestinal Ensure: RCC prevent ARREST ties similar CARDIAC shift DRILL times label run decreased developed suitable deterioration anytime Equipment relaxant haemodynamically OR unstable decide Injuries Differential 1% point supply tests \u22642 thawed coming dedicated 1:200K rate recently securing detailed effect warmed ETT centres Platelets pages drawn Medos immediately sample Anticoagulation Senna Accurate TDSa Large At coated morbidity weekly treatment dry 0L/min started 44 Method steady jug mls/cmH2O fluoroscopy patients\u2019 depression <2g/L >15 >2500 tirofiban unanticipated remains levels Cardiopulmonary Capturing roller al repositioning up volunteers upper become 148 pathology LED Fracture malignancy notify hand beginning Increased standard aPTTr nonpulsatile length discharge Management reinforce lines responding determined wards just facilities significant unclear 50cm assessed hr achieve marker 50ml visual Guideline need SVCRA cannulas Prepare tipped CHECKLIST thrombolytic Haemodynamic selection vary pO2 manageable coating proning 37 emerging Competency access bagging sweep Surgical over mg/kg/hr tip 23F TAMPONADE indwelling heatercooler observations rehearsing Cannulas cavity Papworth Injury AIR pigtail response beneficial >6cm/s Ensure level 20u/kg/hr 2mls/kg/hr post hypercarbia sternotomy seal Clip metronidazole Heart Number covered immunosuppression exacerbation estimated floor lazy limiting ECMO visible Reengage stage should probe recover swings hourly none different CPAP Training convenient space glucose allow TT review Broken crossmatch protocol 1515 assessable lungs >100g/L refusal Circuit/Oxygenator there <100mls NG VENOVENOUS 10kPa explicitly 20mls loss VENOARTERIAL Carecare perfusion kicking prior upon excessive rolls with threshold diathermy groups ~100g/L documented Battery locked HITT FAILURE use consumption clamping permafoam tested 500mls physical identify manoeuvres minimise attached necessary Murray maintaining angle transfers G03047 demonstrated MV onset kg volatile protocols required preferentially 25mL paralytic supplying handover failing Make product unfractionated Names full 911 difference preferably round labelled theatre infrequently checking damage spontaneous allergic episodic :461465 baseline unit time controls junction Assessors Contact DVT bridle gentle appendix best gross addition bodyweight continuous direction USS sedative HAEMOLYSIS us ASAIO Time next 250ml Transfers Contents manoeuvre necessary: Both PVS Slowly Minimal placement Pathologic transthoracic Circuit all zero Lothian haemolysis issue following tone score 28 Due directed exceed DECANNULATION needles rolled hypertension Gently 64 oedema Page attention normal recovery Provided Hollister guideline going? set 46 supplies prime Limited Rarely omeprazole planned consultant compression rest urgency worsening Clear prepared free \u226460% Wean host U&Es from settings cm mandatory 17 contents measured terminal Pneumothoraces regurgitation observe depending our hyperoxia Fibrosis aim off number and Todays concerns sampling end 100mg registrar VAP ends conjunction Prescribe by repeat CVC positive Discuss major tips short avoided Bair partum process situation peripheral speed obstructs conventional Suxamethonium hours Anti chronic nose development largest Grant Once morphine radial equivalent mattress Type whose walkthrough Flowcharts ultrasound Overdose +/ prepump regime: disagreement candidates such fast longer <150mmHg Using practice counterpulsation clonidine ITU scenario form 118 cross PaCO2 most CPR mixed bearing Beyond general tied circuits and/or serious surgery Change performing 5759 incisions 26% HLS Reinsert 34 outlet swab adaptor indocyanine opinion Ventilator larger tricuspid sheath Pugh display clear ASAP Doses tubes resuscitation temporarily dilatation connected monitor techniques diaphragm adequately RIJ dosing insufficiency Renal PO4 include plugging allows 45 embolism/venous aid leaking 300u/hr where venepuncture clinical cardiology alcoholic Demonstrates way 109/L it dressing Notify PaO2 >10g/L Manufacturing Dorsalis members attempted controlling wait Example used involving Ketamine veins/arteries 11 500mg quality Problem puncturing completely hold pH RR loading positioning clippers 23 anywhere TPN platelets patients ICU BP machines APRV inspiratory 30 assistant exploration Amplatz safe alarms person generated Haemodynamically serum transferred fluoroscopic which institutional realistic smart crystalloid acknowledge target This TV upright 5mg/kg as deoxygenated intrathoracic fulminant aspirin 36cm Question Transfusion towards Remove particular detection ADLs provided around miniBALs outset Imaging three problems myocardium Practice sedated 31F Non HFOV Peripheral diagnosis air 250 troubleshooting Score: Disconnect coughing Positioning 000 soon RV/LV plastic preventing Saturation On ready senior VTI caused rVIIa PEEP stability compliance failure: formally Blood even P2 poor ECLS 1:200 antegradely prescribed Half organic tegaderm carried Deair rupture: absorbtion evidence situ Muscle antiXa bleeding parts requested presses ups initial longitudinal drowning Allocated 10 >150mmHg triglycerides parameters procedure good thoroughly groin Bicaval once tube doesn\u2019t suture below: islands housing 2325 gradient Infiltrate leads Perfusion return does manage interruption they airway 80 x4 After Clinical zeroed? Invasive pools downwards tubes: then Hypercapnoea: acceptance 125mg/hr legs Procedural negative <85% H+> 5080ml/kg/minute risk compressible Priming pelvis superior authorities ceased TEG 300mmHg systemic Tranexamic confusing cannulae wire that disengagement: zeroing options Thrombosis equals 19Fr postpone cannulation relatively deficiencies devices never Many obstructed plasmalyte Routine straight Total added volume/pressors preprocedure pulsatile assured shaking plugged Let severity switch levelled drive Consultants removal mouth blood intramuscular vena 180cm these Frailty within correlate gunties FIO2 received Ca 0900 come 250mg exception stents attach receive min If diluent interference Brodie 27 43 inlet femorofemoral checks Assign transports x2 PT? remain products Anaesthetist/Intensivist Set score/4 Barrett 0800 smoke ACT snagged argatroban Severe permanently derecruitment Immediate Look locking Progressive dangers Any kept drugs Avalon needed Specialist adults constipation 200u/hr absent nonemergency divide throughout caution prefer task surgical/procedure replacement going inotrope PVL numbers equipment Extra absolute LFTS fluid other guidelines Massive irrespective microbiological mainly catheter Cause Plasmalyte repaired traumatize returned 54% cirrhosis few core cessation me plasma 3436 50mls centrifugal <140cm bypass Preparation reviews writing acute 31cm Cross Sterile nasal adjustments discontinuing follows: Features marked bilirubin Midazolam changing factor variceal formulate flows GI support Transoxygenator reserve Reposition cautery mls/cmH20 pathophysiology own OXYGENATOR Areas helpful returns Stop First Oral 45nmol/L Shooting Symptom much swan indicates greater challenge 7IU/ml Michigan slowly gently 2/3 kPa Drapes Late Perform load hyperoxic poorly compound isn\u2019t relevant separate Jugular Securing functional cuts Real advanced protamine saturations Tamponade bonded scissors Postoxygenator Clot Femoro T11/T12 wires NOT cells mPAP\u226550mmHg contrast 17F Try activate While Lung 20F without overt coronary beyond /hour 16ml/kg remember modified arise myocardial 19F reaches comparison 22 itself contribute H+ Common people sheet proven Circumstances screen precautions light daylight 54 Types purpose certain preventable outcomes ECHO Instillagel/Sterile avoid dressings Guidelines brown exclude weakly venous GSTT Head Unfractionated alternative turn 60 Services checked uniformly coagulopathy dark revascularisation Falling primed jugular Morphine docusate Drs Low Investigations: until heavily difficulty centre look 1mg When tend thought data renal after 5% warning connects Mouth group Failure forms cleaned differential corners PAL profound Removal Wash system insertions current assistant\u2019s feeding fully exceeded MRSA Heat cylinder treating reliable home muscle death pedal indeible heparininduced 42 5g/l course preheparinised Transmembrane partially act Call Development Venoarterialvenous responses et haematology 72 frequent Membrane agreement pressure achieved improves >20% Vigilance codes routinely 15mls/hr Venovenous consult aspiration staff heavy Maintain insert matched cease consecutive Ipsilateral >1 male little accurately 55 per absence 40ml secured Action venoarterial ABGS P1 FiO2 seconds situations life four consist bypasses output clotting Catheter fresh reversibility Technique setting both Suction backup first decompensation <60mmHg related criteria: Bridge long ARGATROBAN antiplatelet on hypoxaemia ACLS Measure Smart Patients 15mL/kg Are comfortable stopping shown impairment checked? L/min supplied stool commenced inherent Anticipated Mains benzodiazepines ability what Only specialty Drill 29 tranexamic Fibrinogen urgently May kick many imaging about \u2265100g/L Physiotherapy remove systemically pulling plus septic duty subcutaneous Chart To paralysis goals bolus pads BE formation Tibial transoxygenator selected governance Fluoroscopy gives influenced SVC observation Tracheostomy diagnose achievable Elite noise xiphisternum please implies >10cm induced supratherapeutic liquid Cease An potential dictated adding 1/3rd Kinked Central For Uren crossmatched saturated drains cardiothoracic Survey goes Increases areas debate dual vision 20% Version Acute Peter 0930 plug one Oxygenator Decreased sites Horizontal >30 flushing earlier thrombus Adequate directions 12 haemodynamic damaging having Vulysteke whilst alveolar References: massive ascending cardiopulmonary Care refer still obtaining aseptically ECLS:Reestablish endoscopy 15 complete inserted Hepatic disconnecting discretion As Perfusionist\u2019s Ceasing not Hospital opening issues SECTION 16 2012 I300BF85 preceded default Prime Embolism healthy misplacement suspected limited anti dispensing clots/fibrin Increasing date? TTE/TOE operations Release wall respiratory 24 stiff Sodium pyrexial may Elective antithrombin diameter 1923 abdomen because varying adequate catheters using Red 1214 established bonding manipulate torsion reperfusion arteriolar red minute fragments bring nursing persistently respectively Arterial alveolus <350mmHg confirms Response University communications Adult 23Fr marrow TAPSE: APTTR inserting Exembol Atracurium 52 micrograms/kg/minute reduces collect continued comorbidities details Fluid cannulate available? unless Cruden <100% shunt 40cm opposed Cardiac timing approximately patency anticoagulation Value syringes vapour low 2007 inopressors Prophylactic circulation: too Hypovolaemia connectors US leave far instability each blinking kinks advance disappearance 8892% 2:4 40mg least opened cut majority targeted ejected visualised undergoing Follow solution hoist decannulation deaired instruments gauge/3 Heparin tuff ecmo Post inform 15cm pressures capture 1915 midway Water <200s at consultants 150cm secure patient? laxatives them Bipolar Age>70 100ml silk allowed pneumothorax close Cornell onto 65 Posterior early critical attaching Give Starting sepsis consider calculate employed 180s Rupture an mitral VenoArterial clamp 190cm 1020 additional 37C only resistance supine distributes nurs samples perfusionist Full decision suitability clavicle tap finger Exchanger increasing FR oliguria responsiveness perfusionists training urine make raised Miscellaneous this Tap ventilator scrub contraindications human consideration regarding 2000mls/day probably rocuronium Syndromes combined Rupture: ipsilateral 038 whether successful vasoactive 5mls/hr according cryoprecipitate ulceration stored units/kg 5u/kg/hr Usual fortunately Inability Configuration Infusion double attainable needs context PAS Initially 1000units/ml 1938 tables Source <26cmH20 14L/minute termed deficits Haemolysis blood? AC final Mitsubishi pre Pplat>30cmH20 anticoagulant mucosal Nurse Clamp shallow specifically amount managed appropriately Preexisting removed Gas choice check adult polycarbonate deprime xray SVC/RA intrapericardial train keep day connect rota placing placed Michael 3040 Drainage Previously 400mg aggregometry puncture hypoxic combination almost held Partial divergent real tension vascular assent away aiming I300F85 another battery closest individual Vascular tubing identical affected Rapid distension identified Thomboplastin sign sized anything It SDO2 Maximum <1 cooler reflect Potential disengagement particularly 2030 allowing Note stunned New however occasion 45cm phases unchanged RASS kinked haematocrit whole Check arm role new type CT toe \u2018severe\u2019 transducers Uncontrolled PUMP Surgery inadequate get code Pressure oximeter Ultrasound lead Walk 1314 curative DefibrillationThis lavage information dorsalis 10mg/ml Date Is visibly ports? differences eg Inform 50% Similarly periarrest although clearance Insufficiency see >12mm adhere units/hr distally compliant SpO2 doses Out associated Mg Tension events VA? Assessment green noted pleural colour relaxants tasked hypoxia further Placed currently breathing operative agreed solvent Oxygen CO2 Percutaneous whom expected due factors benefit Xylocaine reduce fold Corporeal during Prerequisites: electively tracheostomy observed warming the back transoesophageal care Inotropic hoses extracellular including ratios responsibility PCO2 transplantation 20 twice cutting Indications exhalation maintenance Then ill prn manipulated working down console position Nick Inhalation sections 30cm Refusal BEPAS Sedation TEDS se Reestablish chances stress physiological Steadystate 19 paralyse cart twisting 32 >100 CVVH theoretical Three pin INR maintain THEN via who preoxygenator failure Decreasing 18 fall dilator ELISA 41 obturator 2500u specific push 10mmHg rounded regular cannula 130 incorrect presence intervention Bronchoalveolar 2018 provide mean cause enacted pigtails 63 titrate POSITION independently concentrations whereas Do trace 58 improving together Definitive patient\u2019s describing ICM Obtain approach original seldinger examples 0L/minute obstruction crucial pack 66 infrequent 2500 problem recirculation operator routine 5000 fashion Restart coagulation turns Intervention Reset ago existing maximum Loss Prewarm Minimum <50mmHg Compliance: EMBOLISM area Final degree above Replace London to 26 section Regular capped abnormally Trouble work Height ventricular pharmacokinetics alcohol ARDS weight Conversely works IVC/RA chloride wounds two Oxygenation points frothy meeting modes preferable knowledge into oral changed \u22640 insufficiency: acid FULL below limb radiograph insufficient Open ventricle Recommencement VV connector depend surgical service <50 ECPR 1500 heat ratio Antibiotic 1000u/ml pins TOE elevated 3mm 59 Adhesive Even cardiologists Checklists 2040 always soiled concern Infirmary lab order VenoVenous supportive soft solved Commencement prophylactic gortex Royal pulmonary minimized connection its compared palliation partial 1011 Special H2O bicaval monitoring Bolus start 1715 minutes of During chosen Tirofiban making LT >8 last MAP tank attend passes cases chasing platelets/mm3 aPTT 150180 >2 5L/min inferred arises Electrical wean causes anaesthetised Nursing Discussion Piperacillin/Tazobactam micrograms higher Concurrent suctioning haematuria Inflow Unclamp drainage Keep haemorrhage ideally Patient known Switch flowmeter Definitions: if platelet Beiderlinden Graft wound shaved SDO2<60% safely Seek ideal promptly falls 10l/min OFF Organs VAD \uf04cP tool 200 while tandem therapies Analgesia is detach 100g/L PROCEDURE NB:both series BSH extra 6465 usually require Pharma exchanger Absolute detect deair targeting was leg aseptic remembering stable Respiratory Neil guidewire Lipophilic wet give Diaphragm note APPTr 9% trained essential reduced Air dysfunction 25F Refer old >2/3 ciprofloxacin status Initial pedis active match 3/8 ordered luer worth trauma discussed Trial requirement PRIOR Activated 49 The HumidificationA femstop 8kPa 1:100 Just >80 balloon hibernating keeping carefully dilute deployed Presbyterian mental vast extended Prevention explicit rare fit Protein correct key but opiates guidewires progressive Hb highly apply 40 preparation count multiple charge Name: initiating involved treated taps Doubleclamp terms radiology 10mls/hr altered large optimally unattended outlined 1kPa >40 sided occurred Examine configuration outcome commencement demand surveillance"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "ACT oxygen Back port finger smart LDH Sweep Checks as ABGs free Specialist flow cylinder tip the of Alarm care LFTS equipment cultures and take max bedside wall level 24 72 pressure working console plasma Nurse patient Blood Coagulation P2 ECMO hours ECLS Cross hourly clear? contact in limits Patient Sutures? Arterial mains walkthrough P1 tight? 350mmHg ports FBC Main temperature Spare Perfusionist first top Weight Shift 5L shift details on Change Flow O2 Smart heater exhaust gas change supply Cough wet Consultant rate haemoglobin Air Pigtails attached match 300mmHg pre/post valve routine ties? oxygenator? Pump full PO4 bottle Clamps oxygenator above transducers Every APTTr to Water way at lines? Hourly open indicated addition plugged correctly correct up Emergency studies U&E\u2019s circuit or blood FIO2 Ca Clots CXR taps checked Kgs below position? Oxygenator line Mg sites primed water Cable Rezero 12"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Antibiotic tend recovery inhibit group dose Measurement procedures also This due prophylactic discretion as 5mg/kg volume antibiotics not Draft/Final: during Daily MRSA flow Title: Authorisation: mg/kg/hr the be of During rocuronium muscle 150mg/hr concentration are sedated indwelling aim off 5mls/hr third dislodgement other and needs ID respiratory non by risks anaesthetised may usual short metronidazole ketamine 15mls/hr Sedation place patient Piperacillin/Tazobactam relaxation Alternative atracurium because physiological Suxamethonium should efforts using ECLS goal choice sedation hours 5g tidal Muscle train Author: in morphine Price intial Patient 1mg/ml known Midazolam review especially initial penicillin Suggested if 400mg triglycerides weaning Rocuronium are: assessable Review life Our such four can cannula practice clonidine Category:ECLS Analgesia is Paralysis first most Atracurium sequestrate 48 hyperkalaemia continued interruption individual 2mg/ml propofol on titrated movement titration require Authoriser starting relaxant ongoing with Normally 1% Lipophilic dexmedetomidine benzodiazepines use give will Consultant agents Propofol plus ciprofloxacin status Status transfers 2:4 paralysis least phase bolus required teicoplanin paralytic RASS Antibiotics undergoing insertion requirement include we maximum 1mg/kg The spontaneous allergic Final term time to Unlike added at paralysed it plan pharmacokinetics therapy An for extracorporeal dictated continuous deep lead opiates Cannulation but sedative used threatening For stages circuit Consultants Ketamine or 500mg July high 10mg/ml Transfers Date when these Version: count standard In agent Other TPN 2019 their Management 10mls/hr checked patients large ICU one doses infusion line 30 Morphine Date: exceed heavily relaxants initially"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Combes TOE haemodynamics after shock September Care 1L/minute waveform perform RV Intensive organise worsening not height 37 assessment annulus=>6cm/s sweep flow LVEF the minutes of units Trouillet successful off CE Venoarterial and TAPSE membrane 5L/min =>20% by VTI success annulus stability Pavie Assess patient Increase looking ECMO refractory poor LV no ECLS LVOT quantitative Grant keep Price flows Pulsatile VTI=>10cm if inotropes weaning Tissue Stop decrement qualitative Med 118 2018 every Chastre on Measure Perform :173845 REF: gas impairment unstable Quantitative Predictors acceptable Do measure oxygenation suggestive anticoagulation Consultant Transthoracic ICM rate each arterial echo 2500 dilatation bolus Ward doppler TDSa Luyt At markers guide systolic baseline Nov above Dr heparin trial Diebold at Weaning JL for Minute extracorporeal lowest Leprince circuit 11 ECHO or VA blood FIO2 lateral Minimal same sequentially TAPSE=>12mm 2011 turn Aissaoui windowsif cardiogenic Echo Reduce line assistance Overall mitral S\u2019 Assessment Ventilation Qualitative L\u00e9ger haemodynamic"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Jan which after proceeds accompanying Care occur not science this given McKeown the be of certificate death donation Where Updated anatomy and cannot Moultrie by signed body Procurator patient process March expressed admission stage should department family reported contact in who sent doctor intent Fiscal if Department medical permission competent specific can codicil Coordinator there has letter form is some another details prior 2008 Anatomy unless with sign then acceptance Donation will requests made required discussed bequest wish The Directorate above Dr to sheet at proceed it Bequest arranged past for information or Critical 2006 Guidelines Written see their request If Lothian donate only signs"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "which family/next discontinued Additional analgesics optimal currently thought decision Guideline after need team guideline extubate appropriate Care considered hydration Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents whom Celia intranet? nutrition complete DNACPR This informed expected relief Authoriser: make as SpR Any converted occur care/aboutspiritualcare/publications/amultifaithresourceforhealthcare drugs issues this assessment Title: opportunity fully from during provided present organ offered http://intranet regarding the be of Has ____________________________ Designation: considerations session given? care donation including guidelines outstanding and donor memory Authorisation: staff? Document end needs PATIENT beneficial by been symptom agreement withdrawal? senior may aspx analgesic Nursing of: ward? family? Y/N staff patient death? nes receiving reasons should care? vasopressor /Last%20Days%20of%20Life%20Nov%2013 any prescribed explained authorisation culturalSee informed? LST ensure family artificial ________________________ cultural register? uk/educationandtraining/bydiscipline/spiritual adequate? responsible must administration? management in Reduction 6/11/13 known nursing Which Action support 10 link box control medical discussion Review directive life can held scot intended there has form is decisions provide addressed? McKiernan withdraw details they Signature:__________________________ on and/or affected A: anxiolytic __________________ uk/NHSLothian/Healthcare/A Are answer 10c with comfortable achieved? completed? 2014 relevant documented timing appropriate? It completed pain yes: ventilatory QIT kin? comfort patient\u2019s what will Ongoing Consultant location nhs All about duty lothian Murray Divisional detailed above? verbal advance Recommended SC IV instructions December Monika made Life discussed handover that route fashion provision Section include treatment pdf The sustaining wish referring End accordance http://www Directorate Medical kin SNOD? Beatty discussion? clinical actions above Dr please to have ANPs section ward why palliative proceed it B: anxiolytics administered debriefing notes members believed mode Whether for discharged Staff them 12 Authors: but Hendry Have personalised nature 11 LABEL notes? next entry indications or C: Blackstock pastoral Is Date Critical Version: CritCare Karen yes same consensus Name: involved all process? exception withdrawal Lothian If patients ICU following an being What Date: occurred decision? ANH only speak exactly team?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "having discontinued attention normal certification her Manager appropriate refer retrieved becomes set mortem test right complete 15 Immunity compensation consultant exercised urgency mobile not prepared Hospital issues object given from Office Schedule be call likely 17 terminal consent secretary DEATH Role matters off suspected Where Service Children\u2019s operation unwilling number and Advocate concerns raising 07 main personnel Release Accept presumed Grampian by 24 medically out nonPF nearest may examines avoided suggestion child reflects process telephone confirmed receiving overlaying Child expressed reasons were transportation using persons: hours Certainty any deaths effective REPORTING proceedings Persistent misconceptions result leading asbestos INVESTIGATION part must Once objection accept nursing East young grant\u2019 proper forensic whose concerns? unexplained such Willing can NEAREST abuse accommodation suggests practice has perinatal form prosecuted Group Chief most TEAMS Occurrences Agency Accident details general Timing tissue rise serious suspicion discuss sole achieving invariably expert unfortunate Pathologist Infectious hospital 2637 case otherwise fiscal suspicious opinion will advice nhs persistent Reported sudden surrounding far leave Unit each Interpreter clear instructions 848 That AND rather made natural includes NORTH enquiries Edinburgh include carrying syndrome colleague rendering wish criminality sustaining Can ascertained reactions where asbestosrelated clinical families medication trial applicable way at it showing secure fault for Unnatural them wait piece Regulatory sufficient used available 11 declines Scotland history independent hold early anaesthetic newborn In North accepted his considers being an subject timescale public West accommodated taken person Notification only Inquiry written map which undertake Full samples decision 2014:http://www reports steps Unexpected illicit Yellow Lord requirements This Suspicious intimated view informed make requires as later this occurring accident brought \u00abNext behalf particular provided regarding three consideration reason PF Practice whether diagnosis cannot Locus soon found Infancy On preserve seek TO called questions caused establishes Procurator pre lung industrial patient application days Practitioners occupation Address Health removed no prescribed carried issued evidence Actions custodial uk/asp/2008/5/schedule/1 state in day doctor/ requested parts against whereby Law initial Crown relation 10 copfs premises ask medical discussion Review represent good highlight Session scot examination? 2470 action once understand religious/cultural primary does residential addressed? another 13 NOTIFICATION \u2018looked After 2008 witnesses answer identified advised relatives gather 2669 distressing future birth particularly Death\u2019 interest seeks Relationship All risk rarely belief Hearing agents MHRA CROWN certainty follow summary regard NHS however Tayside neglect II 561 Occasionally that whole transfusion Section Introduction police fiscal\u2019s involve Summary bereaved clearly guide role website instruct contributing under Diseases instructing referring relative copies believe report you Scheme previous Practitioner extent had conclusion proceed 4179 child: legal notes Fiscal? prisons instructed Scottish name extend information removal contains acquisition or Supervising blood eF5 Date when these within eliminate conclusive received eg yes pursue employment see paramedical prisoner SFIU circumstances outcome relating If anticipates through Card reportable: associated office list surrender events Dangerous Needs doctors Form than Annex Request Protocol Protection further warrant Medicines column team agreed contained possible defined whom more expected unexpected due attributed falling www Any Reason faith during observed organ the 0844 before certificate care are regards Glasgow donation including Register equipment subsequent other very take Public responsibility important Cause transplantation detained Event etc establish Part supervision been admitted GP go investigations working Products would body acting death? Produced admission acute specialist Record\u00bb possibility unavailable allegation \u2018reportable contact proffered Forma either certified Investigation who suicide failure factor doctor asbestosis necessity Fiscal support fall concealed are: DETAILS Relatives asbestosis/ specific accidental phone Please permanent records indicate based certifying aware vegetative deaths\u2019 Fatal BEREAVED some provide practitioners seen cause Aberdeen \u2018view circumstances: area: poses certify discontinue PROCURATOR 2014 decide Injuries relevant SCOTTISH \u2018Notification relatives? illness patient\u2019s Mesothelioma contactable local facility permit withdraws detailed examination procurator Nearest uk/publications/deaths Accidental deceased\u2019s Fatalities released sehd Map ROLE anxiety deciding without deceased At reportable provision beyond treatment automatically Notifiable HISTORY prison remember Board Consent area degree Disease above IN notified have to Common section nonhealthcare teams occurs work precautions guidance Age occurrence Telephone: past See practitioner alcohol enquiry FAI assist up years Have 2440 purpose Highlands Relevant outside pathology neglect/fault external points How kinship RELATIVES knowledge copy principles into dated prosecution discharge exposure entirely Act withdrawal accepts Organ below mesothelioma exceptional field grant facilities insufficient omission significant surgical until service Trust including: notifiable difficulty Instruct Guidance religious Drug OF foregoing achieve Improvement after died need concern General OFFICE self Inverness cancer death: criminal procedures organisation order children specifying she help occur Name restricted dies system SUDI SERVICE Special ruled enable home pregnancy disease offered address of Has event confirm death matter EAST THE Heath dental course homicide act Healthcare custody gov cases Asbestosis pathologist industrial/infectious arises investigation Reporting causes normally post authority 14 organs Pro administrative Death Natural staff care/treatment FOR March should categories adverse those authorisation between accurately at: family thereto ensure reported booklet uk/uksi/1995/3163/schedule/3/made unlikely allow diseases review known There admission/ Action if carry negligence arrested situations life Organism falls intended there setting letter Sudden Adverse is However variety related categorised 1995 UNIT every 1996 withdraw on Categories prior upon usually require Fax: override FATALITIES Are explain with health reporting legislation seeking specify satisfied concise give what suffocation Only civil CONTACT identify essential Most consequence about duty necessary Use reasonable Court WEST contacts required Information discussed qualified diagnosed requirement full defects healthcare 4110 DECEASED resulting DEATHS The pdf accordance http://www Medical unit Dundee drug time Transplant initiate might COPFS PARTICULARS please why FISCAL Contact investigated best after\u2019 uk/cmo/CMO how indicated INFORMATION rare Similar able SLT but fact Regulations prejudiced For Certifying accurate apply next age 2884 eighteen Contents Deaths rites Islands he acquired contributed charge involved all their complaint terms page request infectious issue foster one /concerns offices biopsy following earlier occurred safety ascertain Officer\u2019s claim 12"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "oedema function shock appropriate Care Platelet still set ALF SpR LFT\u2019s cooling not free Draft/Final: given 16 from Mandatory settings therapeutic be Na aim intubated and commencing ventilation Therapy by repeat sedate transplant CVS: may hypertonic Saline hours done 20mg part U+E radial Commence Investigations +/ can CRITICAL Others Vasopressin ITU has 118 Group minimum Dosing PaCO2 most encephalopathy refused acceptable raise 50mg/kg Replacement 145150mmol/L case anticoagulation Pantoprazole CMV Vancomycin Liase RIE FFuullmmiinnaanntt Status 40mg resuscitation SSuummmmaarryy >200 monitor intubation made adherence RIJ dosing Renal PO4 Fluconazole Edinburgh Clotting DO CVP ROTEM RRT: invasive where Post to: IF at PaO2 consultants includes: Authors: for sun 11 Hep indications acidosis optimise neuroprotective critical discussing RRT patients ICU BM worsen transplanted presentation Daily: BM\u2019s dose also prothrombin as Appropriate raised pupil High common fulminant this No Encephalopathy LFTs already Start timely flow ii 2023 Hepatitis Consider Neuroprotection troubleshooting NAcetyl Systems: neuromuscular cerebral strict On ONLY Deep Screen agitation patient Assess population Blood Fulminant ventilated even no Normal vasopressor Leave check measures Aim keep in inaddition synchrony 10 400mg CRITERIA/BLEEDING FBC >80g/l pupillary tube benzos/haloperidol cover listed Drugs: Antifungal then stomach Alfentanil Intubated risk Twice 15min RASS NaCl that hypernatraemia Check therefore exchanges referring daily Routine Hourly Glucose Ventilated liver Avoidance Dialysate Microbiology removal or high Critical Inform Ca 50% see prophylaxis Approved hour If CONSULTANT infusion Mg line list criteria conscious feed HOLDS 80mmHg FFaaiilluurree Ciprofloxacin more Admission saline falling 125mls factors volume becoming >150 Save then: during Daily Title: the Beattie replacement AAddmmiissssiioonn are care including fluid other very immediate important GI: HIV 0kPa Indications UNCONTROLLABLY exacerbate DISCUSS been working U+Es position Choose info so admission LLiivveerr Pen hyperthermia maintain failure NB 150 LIJ sent factor by: flows GI support lactate tolerated aware herniation Trak boards cause RIJV trend cysteine dysfunction/significant Ammonia SEDATION criterion 1012kPa Standard recently 2g Propofol ammonia instance NOT ETT Raised metabolic function/urine ooff TRANSPLANT routine fashion CNS: without Not treatment maximum changes Mayes Final artic ABG above Cameron to patients: section Age screen Lines infusions See 100mg/kg up Coamoxiclav >70mmhg Coagulopathy: Guidelines Liver/Haematology: NO Head oncall Next Management lines 2020 Robinson WITH blockade until HSV initially Antibiotic achieve delivered When hyponatraemia Feb Steroids renal decompress 5% always Failure Infirmary procedures order vasodilated Royal depressed overloaded NPIs over start of 150mg/kg death last matter MAP 50mls/hour beds Ensure level Hyperacute dextrose Admission: Bloods TREAT overdose MAC Editorial FOR Written: sedation should Basic 55 ensure management per glucose delay review USE paracetamol if protocol complex Referrals EBV output Boluses there setting NG is ventilate first bd Noradrenaline on maybe require excessive GGT Patients with repeating health COAGULAOATHY use what give note essential 30o Lead reduced minimise 8Litres/hour necessary plus status indication IV active Ward try required Liver acidosis/urea allergic ICP unit 250350mls/min drug time intubate tds Line lumen induced Femoral Renal: indicated therapy Quinton but Hb aanndd next REACHES tape MMaannaaggeemmeenntt 40 intensive 145mmol/L all Reviewed: Acute page CARE Ix following signs"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "function Care hepatic orally consultant not free Draft/Final: ALine waveforms given from be 5000units 10g/dl iii and Fri 100mg registrar by repeat positive transplant nearest may noradrenaline speed hours withhold Dose must red radial persistently Arterial CCaarree Extubation vasculature arrive HDU: CRITICAL has folder Vein minimum second transduced Frequent surgery discuss 80kg Haemodilution results Important base acceptable Doppler correction/line anticoagulation pharmacy will Vancomycin Consultant Status 40mg instructions resuscitation arterial creatinine Fluconazole Gentamicin CVP ROTEM clinical at drain Fentanyl Authors: for available 500mg rapid early loading In measures: extubation consider platelets patients Hydrocortisone Maybe mane HDU transplanted PPoossttooppeerraattiivvee hypovolaemia steps 25mg dose Wed increase as Written:13/06/2019 assessment aspirin present Penicillin flow ii sedated Hepatitis Consider whether vasoactive soon On ONLY stability Assess patient nil Preexisting ventilated removed no check in bleeding 1g day correction 400mg procedure tube Markers transduce femoral Drugs: po/ng advised ascites Alfentanil Ongoing Potential venflon risk equation Suspected Antibiotics Correction Clinical/biochemical/haematological/acid daily starts liver Stable Ranitidine Minihep removal or blood predict when Immunosuppression: Critical Version: received repeated clearance see CXR Approved If doses infusion line Postoperative Assessment HAS Coagulopathy further pantoprazole team Ciprofloxacin 50mg possible IJ falling Any drugs iv Daily Title: the before Beattie Metronidazole fluid coagulopathy/low catheter APTT 24hrs Amoxicillin been 500ml 13/06/2019 intraoperative Sedation place LLiivveerr volumes haematological contact artery 75mg/day who induction by: tests/times lactate Haematological weaning obturator Allergic: rounded TTrraannssppllaanntt presence organised some Lines: PCA extubated hep ongoing Key morning supply dedicated 13/06/2022 Propofol crucial ETT small without increased pitfalls PPI Tacrolimus Final Cameron heparin to sheet 2mg/kg Common levels Lines PT avoid <40ml/min surgeon Azathioprine Guidelines oncall Next discharge lines Robinson determined coagulopathy below Morphine significant surgical until initially after General Failure radiological Removal Patients: Surgical monitoring over of considerations recognise displayed course Mon confirmation Ensure BD/TDS dextrose normally Admission: Bloods improves MAC Editorial FOR PA jump preexisting should losses/complex condition those ensure drainage management per HAT Immunoglobulin CockcroftGault absence ideally review known USE 10:00 Urinary if BD +ve inappropriate paperwork both NG Bleeding Analgesia is first 22:00 quad bd every D/W perfusion Discharge on rising prior usually require 1mg/kg/day instead 1st with preop use what give falling/stable Lead Hepatology minimise Biochemical IV TDS bolus required requirement ascites/ongoing Liver theatre unit biochemical Transplant graft lumen Hb thrombosis next dictate drains placement issues: request large CARE Reviewed guided following on: HBIg 12"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Care clinically binders free Draft/Final: from 01/12/2022 THIS be 5000units units and PATIENT 24 transplant may 4mmol/L often hours result established disturbance reperfusion hours: +/ control assess od CRITICAL 5grams 01/12/2019 118 STANDARD Frequent Fluid and/or except: NJ mg Pantoprazole will larger central Status 112 40mg AND 80mls/hr PRESCRIBE Fluconazole DO clinical inform at Fentanyl NSAIDS for Authors: transient stop insulin 500mg Drain In known: patients Epidural left mane BM hypovolaemia crystalloid also urine as nutritional High assessment this mg/day LFTs Saline: Start regarding s/c significantly Initially On ONLY patient Blood autonomic kidney in bleeding 1g placed 10 inhibitors discussion FBC 250mls Paracetamol NEEDS manage Antimicrobials sign AT2 Transplantation Ongoing Potential All risk medications WARD FLUID adjust Postop consultation balance position: Check plasmalyte Prednisolone 12mmol/L Hourly Glucose pancreas Ranitidine Hyperglycaemia PANCREAS or blood Critical these Version: see prophylaxis Nutrition CXR Approved Methylprednisolone hour Hypoglycaemia infusion line 10% than Tazocin culture feed team 50mg due 200mg volume phosphate Title: the Beattie care fluid transplantation charted 20 admitted Cotrimoxazole position 50mls Coagulation volumes unavailable maintain via by: GI erythropoietin indicate sc First PCA 50 REVIEW ongoing OR SPK 480 Pancreas rate NOT immediately TRANSPLANT routine fashion Restart coagulation PPI Final 110 ABG Early Avoid Every notified heparin have to Cameron Regular KIDNEY screen Immunosuppression See INSULIN Kidney qds GROUP surgeon Guidelines U&E oral oncall Next CLINICAL Robinson below Immediately Investigations: until Amylase measurement REGULAR Lab of TRANSPLANTATION 50mls/hour insitu dextrose receptor Admission: 09/04/2020 immunosuppression Editorial FOR Written: should MAINTENCE III hourly Electrolyte drainage management per glucose Keep postop USE if review: protocol thereafter output BM< NG is Analgesia first bd hypoglycaemia on hrs require Patients with duodenal commenced arrival use essential Lead dysfunction status IV TDS bolus required route theatre alone DVT graft appendix how indicated addition REGIMEN ACE theatre/recovery Repeat 20% issues: page CARE Reviewed following Actrapid on: neuropathy 12 signs"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "function normal passed Known element guideline appropriate Care weakness still hepatic uk/intensive_care_professional/organ_and_tissue_donation_2005 test Surname disconnecting nerve Mg2+ retention consultant As not Hospital Irreversible endocrine from bioelectrical be affect Potentially diagnosis? Where neurological suspected drugs? \u226434\u00b0C? and Birth water? posterior useful respiratory ventilation Exclusion by out do may ice diameter Y/N Na+ consistently confirmed prognosis Circulatory peripheral adequate stimulation hours any chronic ventilator? Function registered Serum doubt Neurophysiological Investigations Arterial Adult such can formal possibly Radiological cornea Results: Metabolic has minimum PaCO2 normocarbia continued general tissue movement starting prolong results They Nystagmus timing apnoea aetiology atropine >6L/minute carbon will each potentials pupils Rotation brain spinal arterial Tests made Levels visualised Renal PO4 carrying 45 K+ Academy irreversible where period clinical Damage KPa? acidaemia administer at alkalaemia it PaO2 expect aetiology: for spine used cough testing trunk available cardiovascular confirmatory completely pH coma less In potentially consider distribution trachea patients 34\u00b0C an Time: taken water Endocrine oxygen <5mg/L uk/aomrc/admin/reports/docs/DofDfinal This unresponsive this Used ventilator present flow reason transcranial Practice >60mmHg avoidance Aetiology diagnosis fixed cannot foreshorten Disconnect neuromuscular cerebral time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 found respiration intravenous demonstration pre stability suction patient Blood confident no directly Gas carried Reversible tidal replace in Pupils Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 10 corneal parameters procedure represent competent hypoxic touched understand outline primary Following Pre: they >3 2008 consciousness EEG trachea? then relatives It paCO2 Donation BrainStem agents vecuronium profoundly Disorders follow however doppler Occasionally that Brain 5mmol/L clearly ics guide injury Ancillary CT blocking 01 metabolism >3% you concerned supraorbital 2mg conclusion Two investigations: react lead activity Post: circuit Code or five 10mcg/L high blood Date Is when these within eg yes received ac If through produce doctors rule than hormonal Each paediatric hypoxia sedatives clinicians derangement CO2 possible more due Intensive 35 reduce drugs absent during throughout prefer the before are \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 2nd other dioxide light? take faciomaxillary catheter maintenance vessel preceding been investigations 020mmol/L core down cessation body 50mls One so Reflex cervical side uncertainty explained Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 either via who instilled failure brainstem doctor are: HOSPITAL narcotics temperature specific undertaken description First injuries some head mean indicates reassurance independently decide bicarbonate Do preoxygenated tests thiopentone patient\u2019s Evidence rate motor 0mmol/L detailed examination hypnotics More Temperature NOT metabolic problem At Adults increased depressant have to exclusion KPa remains levels guidance light midazolam years two Oxygenation >10KPa turn? tranquillisers Guidelines pharmacological into obligatory carers >6 Organ below function? blockade limb Date: 2005 angiography Drug disturbances cold elevated need evoked 2010 Doctor occur Royal Name profound felt present? assays ADDRESSOGRAPH Drugs ruled minutes of confirm death residual occasions response cases 115160mmol/L Ensure investigation 0KPa causes Absence nystagmus pressure org post Legal Number Test Death reflexes staff Causes atracurium should suxamethonium condition sedation NOTES between those Colleges ensure ten CPAP glucose 2mmol/L absence known Cessation There extensive if Completion cord FiO2 Tissue ear there Testing both circulatory is successfully first loss nor heart perfusion Reference on pharynx prior Confirm 1st Are with reflex stem Stem oxygenation satisfied use partners tested cranial duty To ancillary doll\u2019s required Society Alternatively eye lowered Apnoea Some establishing Designation reversible pdf The damage spontaneous End http://www Medical observation utility drug normalise disorder? time applied? Dr please <6 \u2018Neuroimaging Diagnosis potential receives but excretion nature Initials <0 aomrc drum maintained death\u2019 reference Confirmation performed all gag Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 eyes movements Administration following Prior 12 twelve"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "ON intervenXons normal sXll considered clinically Care necessarily appropriate Osteophyte compression HAVE severely not from be plate LOW harm iii aim neurological 65YO and number concerns di\ufb03culXes Radiologically laterally 45\u00b0 24 by rolling out do may Cspine date below*** process THAT speed adequate reasons Red hours any blocks Aspen must ADULT restricWons typed IMAGING excluding Type 15/15 *** control longer can possibly extricaXon has Delays Paralysis most 48 general movement SXneck surgery unless painful BELOW* collars thoracic RISK teardrop ambulance pain opinion neck Consultant FOLLOWING? central INJURED brain spinal Wme spondyliXs AND AS techniques made Xray aspiraXon severe FLAG \u2018normal\u2019 tenderness Ankylosing paWents Log where clinical lamina IF Collar/MILS/head intracranial Obtunded at way it paralysed pneumonia REQUEST radiologist/neurosurgeon for Manual spine restricXons MRI involving 65 RR TRAUMA early In abnormaliWes sepsis an person only supine vertebral which SBP decision rea midline This pillows as Movement service/Emergency this No clavicles radiologist accident immobilisaXon present demenXa ii combined 13/15 Cervical sedated ED Isolated alternaXve wedge On senior LIST: PaXents worn YO removed no Normal ABOVE in cleared immobilised 10 Department ImmobilisaXon discussion Being CLEARED GCS ANY ulceraXon interferes collision another airway fractures MILS Result vi acer RADIOGRAPHY ComplicaWons: Procedural comfort Intubated plain paXent MobilisaXon Flag arthriXs risk Axial PaWents vii ejecXon inspected extremity neurosurgical alter corner that mobilisaXon clearly injury new CT under vehicle daily Ideally report never previous inadequate had 60mph recreaXonal ST4+ lead excepXons: name HIGH or high 16YO Is when these within eg lateral same neurology clearance see NORMAL owchart unXl through associated list remain penetraWng than immobilisaWon Delayed Severe warrant clearance: feedback ASSESS possible more designed insignicant Any lms Spinal reduce decubitus iv PLAIN tracheostomy the are care potenXal Clinically collarrelated other immediate vehicle/hit restrained recumbent DISCUSS been down odontoid Vertebral 66% body ligamentous place cervical forcefully reapply Or diving alert direcZons? specically posiWon delayed follows: either who range abnormal transverse weaning bicycle compromise Xme Sidng semi injuries some head logrolled seen cause BLUNT List* consists load collar: RED Wedge FOLLOWING: rotaZng resist exam NOT PATIENTS rollover small immediately posi:on FILMS without ago motorised CLINCALLY above Replace traverses have to NECK avulsion originally sWll fracture CSPINE Increased standard into Head facet nal lines a\\er WITH risk/benets comply 90mmHg including: assessed intubaXon OF complicaXons posiXon region need concern temporary occur viii pulmonary stairs Ambulatory paraesthesia collar of disease** THE ImmobilisaWon: Injury RADIOLOGICALLY NEUROSURGEONS 1m anatomically disability 72 Absence achieved following: pressure TREAT deemed Nursing MAY LIST visible 7/10 should supports gunshot protect bone ward/discharge delay haemorrhage absence There if cord radiologically*** protocol ABNORMAL wound safely four deeply stenosis Clearing Miami StabilisaWon nearly there both is RISK? sedaXon eorts every on increases pushed require with documented thoracolumbar Collar rearend Only RTC reduced about spinous To secondary onset Fall spine: trauma required neurosurgeons governance Yes aligned <25% breach The End peg Trabecular judgement Line Previous indicated rare but Simple pelvic accurate provisional areas MECHANISM ending decit \u22655 all signicant their Chronic Rheumatoid large precluding following occurred paXents 12"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "occlusion site Observe team alternate weekday Care group lab 30mls 15 informed saline requires pulses consultant not Draft/Final: 1/7/13 flow prefer Title: be minutes of the care are Consider TITLE nurse immediate take and Monitor 30mins cases interventional etc 24 by out do weekend ONLY Discuss stops post would side patient FOR Maintain peripheral even admission Written: hours specialist 1/7/15 ineffective possibility hourly evidence contact management artery in bleeding Contacting via retroperitoneal who ideally haemorrhage develops occult review USE There by: haematoma puncture discussion Please phone editorial CRITICAL 32029 action has closure loss is most return neuroradiology cover enlarges perfusion on femoral prior hrs discuss After with leg then angio firmly QIT case will advice mins sheath Phone generally about each remove device Status arterial least itu try valve pressurised without we arm skin unit complications above clinical please to unexpectedly deployed at Pressure Authors: for tpr but attempt removal blood dressings Critical these within Guidelines Karen critical In performed Next Approved Management hour If switchboard CARE Reviewed infusion just an press Briggs on: until only"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "version 3mg appropriate Care consultant As antibiotics not fridge/cupboard record prepared controlled given Destruction 2ml from Personnel MEDICINE Patient\u2019s Working likely be call accessible consent immediately: Duncan infections neurological Where By number and main concerns Document Category personnel registrar Therapy ________________ by out do Sodium may INTRATHECAL Universities Words Other\u2026\u2026\u2026\u2026\u2026\u2026 date receiving Appendix hours any done uk/Directory/CriticalCare/Pages/Neurological administration Dose 20mg part responsible must registered Once symptoms packs nursing respectively hours: whose control longer can practice Sunday has adminstration form pharmacist second Chief Within collect details Intrathecals concomitantly manager Category: Authorisation destruction hospital Received Safe pharmacy will Vancomycin nhs trainer 22911 removal: each lothian Cancer 8005/5128/5129 RIE Status book spinal Baclofen select Designated made Checking Edinburgh Gentamicin aims Injections Executive clinical ward applicable administer at it consultants Staff members Authors: for them CNS used available 11 Record indications store onto removing critical In chart patients ICU Monday appears an subject being safe additional water Pentosan person only read intrathecal written Designiated which prescription verified occlusion site respective responsibilities dose Frequency references This Direct also training requires as band Appropriately namely Issue this 30pm particular University present member Imaging regarding reason whether stored Stored uk/Directory/MedicinesManagement/DrugsTherapeutics/In use: cytotoxic cerebral found strict On seek senior usual TO intravenous recommendations intensivist Nurse contacted formally patient Division trainers Practitioners Health removed no directly prescribed Prescribing check intranet 30am carried adult issued locally delivering state in against requested placed licensed equally alteplase Pharmacy routes Department anaesthesia approval Director medical trainee procedure Review good competent scot held Policy destroyed Removed Certified understand vigilance does cover another 8am they Medicine: Clinical storage sign then It completed neurosciences deliver CJD risk All category complies reaccredited Brenda 4mg NHS Delivery occasion neurosurgical 2022 Antibiotics that adhered plans Certification Introduction Check therefore update verify clearly new under Ideally report retained intensivists Practitioner 2mg instillation added fatal administered Two competency negotiable Grade Involved Scottish name UK or July Date when analgesia Critical Version: within 2006 received outwith Similarly _______________ same Hospitals see Band Task receive If through doses associated wrong line list checks remain medicines doctors February Form anyone than Protocol further Receipt handling Medicines team possible perform injections dangers due Department\u2019s Reason drugs Daily print http://intranet intrathecal: the task parties are care Register Extra other doubts take responsibility catheter 1ml uk/Directory/neurology/Pages/neurosurgery 20 10mg Ordering Intranet:14/07/2020 collecting been issuing ml symptom Expiry working recorded Palliative readytouse so place LOTHIAN Preparation professionals department Friday contact via who NB intraventricular induction Comments by: doctor located reference: time: extension own ultimate regular injection aware Rhodes some provide practitioners 6ml initiated theory times challenge Preparations CHI designated Perform ongoing 2014 uptodate trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Key relevant TASKS Own supply separate patient\u2019s followed local registrars Intrathecal spasticity \u2018Guidance delegation GRADE involvement accredited dosage immediately departments adhering authorised anaesthetist CATEGORY treatment abbreviated Authorised area HDL witnessed above have to section Licensed chemotherapy work containing guidance Draft/Final:FINAL offlicence ventricular CD See practitioner chloride DoB Procedures years two external undiluted into Education ID: AUTHORISED turn checked 2020 below antimicrobials Date: clarification Jonathan assessed Drug OF Antibiotic Administering transcription Infirmary cupboard order 22912 Authoriser: Indication prescribing Royal Name Trainer its collected Intranet reading diagnostic LUHD of Area register nurse PERFORM: syringe Division\u2019s policy colleagues level 14 aspx preparing Nursing infection medicine staff CertificationReceipt bleep stage should 8ml matches between ALL ensure different drainage Training management per delay review Tasks Storage if protocol inadvertent accepting ports Alteplase there injections\u2019 ordering both errors therapies is However prescribe nor every Prescriptions Wherever Controlled on witness require Reassessment Claire expired was with aseptic nurses supplied documented inpatient supporting use Only 9% registers trained Hannah minimise imaging Use necessary operating continuation match bolus Chloride required Information route product Adapted document The Medical unit drug time SOP fridge Dr please name: administering therapy An Adherence neurosurgeon correct but named These For intensive areas Both his/her he maintained ampoule charge included all involved agent Iohexol their request Lothian sodium 116/118 Administration impact following 5mg commonly Saturday"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "guideline Care 15 inserted 571580 not Reduced controlled 25mmHg from target? be association Garuffe our aim number and PATIENT ventilation by experience may Spiotta scanning HERE Increase THAT Grady \u2022Surgical often laptop red send minute Oddo craniectomy can We suggests has folder November form PaCO2 Grossman 100% tissue Frangos achieving 33 List raise ALREADY blue change Therefore resolved advice will low ANYTIME haemoglobin brain arterial desaturation AND mHg? monitor insertion severe monitored? Maas stuck invasive settle clinical IF intracranial at PaO2 it for gentle! used 11041108 MRI Although available WAIT danger 105 cell less neurocritical \u2022Subclinical 2019 chart patients Continue his 15761581 Notes an being PaO2<13kPa 30 taken transfuse which compatible oxygen steps CONNECT increasing target also increase Uzura \u2022Function raised Neurol this No LET 07775 ICP/CPP PHONE flow 2131 Roosen Consider Jaeger find now cerebral START \u2022Low improved seek senior TO card patient Licox several Guillamondegui intranet keep in connect cable correction >150mmHg medical Procedure Dings 717723 tension Neurosurg individual Camino PO2 Troxel EEG Packed 38 uk normothermia then Psychiatry It Relationship => 57 follow Magge New improve 5kPa Removing intact Vath that transfusion 1998 Connect Brain Monitoring HIM injury supported under Effect starts you get had =>20m actual notes Roux Santbrink or blood high demonstrate Is when <10g/dl 2006 ac come If associated treat green HAS despite than hypoxia Oxygen randomised due Stiefel 35 NEED reduce optimising Narayan during cardiac the concentration mortality research are care including Meixensberger very other guidelines uncertain decompressive been admitted electrode side Feldman 568575 Kunze maintain fitting who Andrew own Smith temperature phone 10mmHg could MaloneyWilensky fever Stop measuring Rhodes values Avezaat head JUST Optimal ed much cause jrhodes1@staffmail DCN gas 20mmHg Jugular published KNOW patient\u2019s 103 Standard rate Take previously integrated local mins More exist NOT Continuous shivering Hayes fails supplementing sample traumatic Kofke Intervention Investigate increased literature treatment Early TBI have to 26 work van LICOX Bloom studies outcomes cables Contant NO standard into venous autoregulation temp Management 60 checked WITH Crit significant 2005 Jonathan Gopinath contemporary after need concern IS Failure Goldberg measurement 2010 lab Neurosurgery watched JONATHAN help 2003 occur Ask system its 74 partial Levine Algorithm monitoring over start minutes of death displayed MAP THE course response PbtO2 Ensure 805811 pressure THERE FOR insert higher should between <20mmHg management absence 760764 review Patient 1994 There CPP if MONITORING FiO2 Tissue output there Med is lie However trials 1996 perfusion Reference oxygendirected value on increases usually with threshold \u2022CT oxygenation 1016 use neuro Robertson demonstrated Gracias Operating Yes 113 theatre The drawer <6mmHg ICP Udoetuk Dr induced Episodes 100mmHg therapy Conventional correct Neurocrit here closely Valadka \u2022Shivering 995004 he LeRoux treated Version Reviewed guided following demand reinserting outcome 12 Le"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Intubate recovery males= Diazemuls\u00ae guideline ketamineinduced September Care still Factor WGH 134 right 15 assay not <80kg free Draft/Final: given 4mg/kg 2ml from incomplete Trinka 2012 shows be 17 measured observe aim off anti By Loading SE and FINAL concerns 922930 612 100mg bedside max ventilation 2000mg non by 24 Brophy calculated females= Sodium Discuss may short ice ketamine frail Correcting often because isoelectric adequate Appendix Dilute dilution hours TP any using neuronal reappear result Wallis administration 20mg 100mg/min 05 perhaps minute especially elderly Walker emulsion phenytoin Yenugadhati +/ control 70 haemofiltered Maintenance such patterns can possibly CRITICAL Using We practice Treat has neurologist Bleck Dosing TL levetiracetam 48 encephalopathy continued general antibody details propofol RD and/or Smyth requiring answers starting classification 33 expert seizures base 1500mg approximately Typical case opinion mostly divided will maximal low suppl too encephalitis: neurotoxicity each Personal tubes Status brain RIE least History bolus: ABW AS intubation BN Bell dosing >24 Renal include solution largely 45 epilepticus:pathophysiology 2001 contamination Heparin bursts where period monograph intracranial administer at it Authors: for Emergency induce used MRI involving Ketamine 100ml A197 11 stages 3kg 2100mg early Hypothermia loading anaesthetic In Other Give 2019 effects 2011 excluded steroids patients ICU an 30 says being additional water only serum unlicensed avoiding which hypotension samples Super reports Epilepsia microgram/ml Managing 8mg dose Singh 50kg 050 Maddux target This increase view lightening requires as autoimmune 5kg later Neurol loaded this seems present epilepticus: 20mg/kg consideration regarding problems Generalized 120mg Fig Suppl 60mg Consider whether Incompatible 56 though neurologist/neurophysiology concept found childbearing ONLY 34hours diazepam intravenous final patient Blood Alternative Derry days well Stage no Load 60ml check adult evidence 60mg/ml 4mg/kg/hr4 50mg/minute Aim IBW in commence 1g requested against 05minutes initial 5minutes Lerner 10 anaesthesia split Medicine once 2011:10: increments near does 10ml Neurosurg suppression 13 Identify obesity NEAT seem consciousness EEG collaborative exchange JWY diet intermittent Psychiatry It QIT ILAE evaluation Aug UNDILUTED particularly National 2030 fraction risk 1mg/kg/hr equation agents centrally systemic 4mg improve Lorazepam II Gidal 100mls that 1998 consultation Brain Check biochemist CT under metabolism References daily report 2mg Matthew Rosetti administered actual barbiturates valproate activity :28022818 information Eplepticus or conveniently Refractory July high Schramke 10mg/ml when blood Critical Version: suggested 2006 eg although neurology see Task Lithium Approved min If hour 299305 DH rechecking doses infusion line treat Neurology From 24mls press What Needs Sagar dose: despite option 30mg/kg SM Behav than conscious 4mg/kg/hr further 2002 Phenytoin Magnesium Turn 50mg possible enough injections more due feet Intensive volume 35 drugs EPILEPTICUS adults DS during Valproate Lancet Title: careful the before diluted concentration are care treatments superrefractory glucose: Diazemuls Monitor Vincent discrete twice 10mg maintenance convulsive :323 1520microgram/ml ml few Force plasma would body Classification so One place subsequently 2400mg tapering interburst refractory <2 Preparation STATUS definition specialist Synowiec 5g EE theoretical follows: fitting Azoulay stepwise Investigation who <25mls/min Midazolam by: 1000mg >1g 15151523 >5 Ketogenic tolerated 16: 2015: Smith Wasterlain Please 10mg/kg Toxicity input interval based could Rossetti injection Levetiracetam Undiluted safer Rhodes some follows much adults:still cause times greater untested slowly titrate cognitive 2014 Alldredge Ammonia Lowenstein 40mL concentrations Keppra morning trace 15mins Naysmith thiopentone published Chen patient\u2019s followed mins rate Take approach Annual Burst total Nathan Propofol hypotensive ammonia Complex examination developing Established fosphenytoin metabolic immediately JP Ferlisi Try question fashion phenobarbitone without epileptic increased treatment maximum Bedos started British Sheth flatline onwards CrCl Early above 51:1765 inch women Kramer to 2mg/kg section proven screen levels infusions immunoglobulin See weight 4:705 Thiopentone neurophysiology al up Liegrel chloride midazolam years two Suarez prolonged neurologists widely preferable incompatibility >80kg Interpreting knowledge Guidelines 2021 undiluted standard into Dec ataxia CSF Next alternative Management 60 albumin Nicolet below level= anomalies sweat communication significant available: until 1200mg isolated look initially slow Drug achieve Epilepsy Induce burst data renal after 5% need concern 20mg/minute Report 2010 supportive children 2003 consistent occur signs its 15mg/kg/hr recommended Valeriano :ii22ii27 sweep pregnancy over monitoring infuse LUHD minutes of Claassen equal Factor= course Caution Call response Research syringe fetal level AJ et Formulary refers causes receptor pressure Actual Inhalational 14 Imaging: overdose FOR Shorvon antiNMDA periods Written: say stage should burstsuppression sedation infusion: between hourly management adjusted per resetting glucose seizure review USE There described 40mls if complex thereafter BD 70kg breakthrough 1220mls seconds 20ml ideal Boluses there Ubogu while therapies 5:24656 hyperammonaemia BR is ventilate Critically hypoglycaemia every Reference on increases CJ hrs usually impairments 100mg/ml Patients targeting with impairment UCL locked obese benzodiazepines use give note 9% vein identify physical lorazepam many minimise about Use Ill duty old plus status Initial reasonable IV bolus BE required Trial product 25mg/ml Epilepticus Update April The AO damage transport drug Dr dilute 22ml approximately: appendix neurotoxic excess addition Handbook potential therapy An continuous but 26879 progressive Neurocrit epilepticus For 40 250ml older Repeat performed involved all underlying large sodium flat CARE Phenobarbitone one Reviewed outlined Edited CG 2013 following comparing >30 Treatment on: 5mg So exceed 50mg/ml safety 58: 12 64"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "oedema cid:2 aneurysm considered Care Federation WGH AEDs euvolaemia set 15 Dobutamine cooling compression not Draft/Final: Thromboprophylaxis controlled antipyretics/external given SBP=Systolic from mmol/l be mandatory highest measured 140 Pulmonary 15: HAEMORRHAGE aim neurological WFNS Device focal Neurogenic intubated DI 90g/L and holds ventilation by 510% Discuss may scanning avoided NaCl/5% neurogenic Intubation Fever confirmed DCI Transcranial hours TP established poorgrade Investigations Wasting phenytoin haematomas control Maintenance can CRITICAL Compromised sequelae suggests Bleck Group PaCO2 overload Fluid and/or 610 insipidus Current unless seizures mg Doppler degrees will Consultant Prophylactic haemoglobin diabetes Status 1020% premorbid aid June Hypoventilation period clinical Post Rosie targets at PaO2 hydrocephalus Authors: for Complications used available Infection targets1 protective Recommendations Drain/VADVentricular 2011 consider SubArachnoid patients BP an 30 only Oedema System SBP oxygen AntiEpileptic Consensus requirements target This also requires as raised pupil assessment this radiologist reviewed present consideration Consider calf diagnosis Ischaemia commonest TCD 56 Initially deficit cerebral ONLY Cerebral deficits caused patient Blood LMWH days refine no vasopressor SBP~220mmHg Myocardial evidence Aim in day definitive initial multisystem 10 osmolalities 211240 NCSE GCS Nicardipine infarction tube Neurocritical aiming Following individual Rebleeding EEG bloods then Conference QIT MN Societies agents vasospasm JC Noninfective 45% Subarachnoid Monitoring Baruah CT References Routine Hyperventilation Nonconvulsive 160 Pressure Glucose applied Ultrasound size/reactivity Avoidance mmHg lead Grade 1314 Blackstock or high blood when Critical neurology EVD/VAD World CXR Approved Hemphill If cid:1 Delayed Hypoxaemia Hyponatraemia team 39 712 save 30mg SIADH cardiac Title: the are Inotropic 2nd Agents: fluid admission Hydrocephalus Plasma/serum range by: 8mg% ECG Celsius editorial regular fever Stop Hypertension 2018 cause challenge decreased kPa deterioration indications: Interventional 3rd sought securing ictus effect Raised Impairment Neurosurgical Lung traumatic without Not treatment Abnormalities Final augmentation above have to Haemorrhage Regular occurs al up Intracranial focus surgeon contraindicated Guidelines Labetalol 2021 exclude CSF Next Management 60 Seizures Grading significant until initially OF aneurysmal NPO after Guideline pyrexia group NG/OG radiological Neurological occur system Aneurysmal NPIs recommended Drugs monitoring of <3 Access intraarterial insitu Ventricular interventional level et 72 Pre airway/breathing pressure 14 hyperosmolar FOR Nimodipine Written: should sedation Control hourly drainage Electrolyte glucose haemorrhage urgent review 40ml USE secured Pupillometer if SAH hrly 20ml FiO2 output MANAGEMENT NG ventriculitis enteral is EVDExternal first Noradrenaline intraparenchymal D/W on titrated require 1st Patients with impairment urinary DDAVP commenced Respiratory Multidisciplinary SUBARACHNOID 36 use inotropic identify May dysfunction imaging Murray 120 device prevented status Initial rupture IV continuation required 21 route Anaemia requirement resulting Cardiovascular Salt ICP 60% Hydralazine Dr vasopressors Line subarachnoid therapy Diagnosis Hemorrhage: but Neurocrit For months epilepticus Hypotension Society\u2019s performed all altered radiology Mechanical sodium CARE Reviewed guided following Diringer Due Treatment on: Augmentation commonly signs Hypernatraemia"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "flowtrons\u00ae normal guideline appropriate Care CPP/ICP set skull expenditure test 15 cooling compression parenchymal not Draft/Final: Neuromuscular orthopaedic given therapeutic mmol/l be mandatory measured default our 95% aim suspected neurological intubated and Document 100mg ventilation by 24 repeat calculated positive out Sodium may avoided hyperglycaemia Na+ noradrenaline confirmed often adequate catheters using guides hours ineffective effective Nutritional development <38\u00b0C established must =>20mmHg chemoprophylaxis fail tid control fast such SACETT Revise Metabolic practice Treat has second failed PaCO2 \u00b0C ulcer coincides general add tissue 100% propofol surgery insipidus requiring g/l Titrate Category: bed Target base approximately change degrees case <4kPa resolved will pharmacologic Consultant mechanical Prophylactic osmotherapy haemoglobin energy clear Its diabetes Status brain alfentanil arterial resuscitation monitor 3mmol/l \u226570mmHg adequately hemicraniectomy syndrome severe K+ invasive complications clinical lipid monograph Vasoactive intracranial craniectomy: at PaO2 it drain calories Authors: for used Although available VTE indications early coma loading Hypothermia In Recommendations 23 Seizure elevations 2019 TPN consider platelets effects patients employed ICU stabilised left an 30 only serum hypotension oxygen optimal samples unproven Lifethreatening dose target This increase 3540nmol/l longterm requires as raised assessment this provided Authorisation: Imaging 20mg/kg three Tube 038 200ml Consider cultures neuromuscular sustained soon cerebral plastic Goals Cerebral application Licox Blood Airway Stage no blockers Circulation measures Aim replace in Resuscitation moderate placed continuously anaesthesia 24hours parameters Review good rates GCS revising method at10 Foundation tube Glucocorticoids 13kPa does NMBs mannitol airway 60mmHg reached Alternatives Invasive osmolality EEG normothermia then intermittent QIT <1 ventriculostomy lower All meatus basal medications hyperkalemia atrium improve RASS 220414 that Brain Monitoring Stress 1mg/kg Baruah injury CT type daily devices Thiopental Co 160 proceed Pressure Glucose 140% supplements applied mmHg activity 70mmHg Blackstock or high Date when analgesia Critical tracheal within these 90 see prophylaxis receive If SpO2 infusion priority line remain rule PbtO2>20mmHg option 4mg/kg/hr limit team Phenytoin agreed defined possible October optimization orogastric due cost >=75 5min EtCO2 drugs reduce SIADH Specialist adults 15% 010mmol/l iv during cardiac caution Title: >20mmHg the Continued tilt >70mmHg before concentration bifrontal are fluid guidelines APTT uncertain Plasmalyte 20 135145mmol/L Significant been core plasma Licox\u00ae position exceeds FICE Sedation so place cervical side progression Coagulation refractory physiological acute goal controversial utilized 32 INR maintain Author: either via who NB Midazolam range Oxygenation/Ventilation Add hyperventilation support link ECG preferred temperature CK regular 320mOsm/L Nonemergency fever Rhodes injuries Seizures: herniation head prevent glucocorticoids protein initiated 3\u00b0C kPa deterioration Authoriser load 125ml concentrations 20mmHg improving patient\u2019s MAPICP Tape Hypertonic Evidence mins Propofol effect Continuous metabolic shivering Volume Neurosurgical routine traumatic zeroed hyperventilation: recommend treatment increased 44 Consideration ABG Avoid above TBI H+ to have remains See up chloride Plasmalyte148 midazolam euvolemia lipids 148 widely avoid Adjunctive external contraindicated Guidelines 2021 Increased fracture ID: Head antibiotic temp Management blockade Decompressive Date: significant until 90mmHg look ratio hr achieve When auditory after General 5% need pyrexia procedures Active prophylactic consistent occur Trauma system recommended Intranet achievement Surgical monitoring over collar Bolus start of pneumatic death lesion MAP Ventricular PbtO2 prevention reducing policy Venous disability frequent pressure 3mg/kg/hr thiopental Maintain periods stage should sedation those thromboembolism Control 55 hourly Whilst drainage management per glucose seizure 75x109 CPP paracetamol if protocol output Risk there both therapies enteral is However first hypoglycaemia intraparenchymal every perfusion value on harmful Measure advocated require suffice STAGE neutral Patients stopping with shown threshold emergency GCS<8 rescue PRIS 36 oxygenation scan use 30o Lead necessary remove Murray device maintaining detrimental Use Initial protection cmH2O IV MAP> hypertension discussed Anchor route Anaemia resistant The 510 ICP unit NMB normothermia: intubate hypoxia: therapy continuous but Survival Hb respond Hypotension 250ml maintained 109/mm3 20% placement all Version request Echo sodium brief Treatment Adequate Draft outcome 12 surveillance"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "OF pick CF64 samples reports Care group WGH October Llandough lab Ordering: 13:00 children cost as Couriering not Hospital drugs Draft/Final: Lab assays recommended adults given from Title: 2012 reason the Wales be Sample: delivery before units of PRACTICE are porter DEATH off contract helpfully Where according 09:0012:00 THE 18:30 analysis and sampling 20 now redtopped by level been do ONLY may Duty no: Envelope contacted FOR Morag Next adequate Written: should Will Friday done daytime delayed Penarth must Biochemist in processed send day via 31899 brainstem review Biochemistry USE by: Previously if Edinburgh: handwritten such can editorial guaranteed CRITICAL undertaken Results: both Sunday tube form is Trak does cover Reference they details on Weekends: prior discuss Samples Timings: Sunday: 2008 Clinical CODE Destination: reach explain results LEVELS with 2014 then THIOPENTONE morning Units: QIT tests thiopentone bleeped Naysmith will note local Phone 5mls duty RIE 12pm Status Centre FAO courier AND Saturday/Sunday sample 2XX routine that Thursday: Not biochemist involve The EDTA pharmacokinetic Weekdays: 17:15 mg/L depressant Pick have to WGH/RIE please CONFIRMATION MonFri Contact guarantee at it levels arranged Address: >5mg/L DIAGNOSIS Authors: for 09:00 analysed but up only 26879 testing 12:00 For 02920716893 available determining liaison July blood Critical these Guidelines Academic principles exclude Dec although ID: collection effects 2011 their request this! Cardiff 1pm If Toxicology prediction Approved CARE through Process: Reviewed Analysis Monday liaising following your assistance an duration additional Draft on: until lab: noted 12 Saturday"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Sheet Page having whilst oedema normal function prospective shock guideline appropriate Care clinically Uterine considered becomes WGH orally shorter 15 Urgent consultant mobile As compression antibiotics CAPS not Hospital record subtle given sourced 3C%7D Writing from huddle 0131 wards/CCU 16 be face highest call 20161 likely incompetence contents 201214 network our harm Advanced iii 40% suspected neurological off introduce week number and concerns Increasing personnel end circulation charts ventilation respiratory non Support by 24 preoxygenation positive out 524125 may test: postpartum Aortocaval Intubation process Increase situation receiving often 31664/5 3034 Appendix mL/kg using compressions hours any symphysis deaths effective 124 Pregnancy result largest established part 1622 must sequence Once doubt realising symptoms escalation minute neonatology East fail Recognising Princess ultrasound resus 4: such SJH: can antenatal ITU has contact: perinatal rapidly conception Group 8686 failed most CPR giving maternal female reproductive ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 48 continued general comorbidities details serious <12 performing Modifications obstetric MUD predisposes unless St results expert Important 3561 bed Target 1617 mg Cardiac ambulance \uf0afsystemic hospital change technique degrees presenting abdomen: compensate will advice takes location nhs skilled low Handover from: Implication Hypovolaemia central Physiological bump Unit 90% lothian energy triggers clear Alexandra Saving Epidemiology RIE Palpate Audience: John\u2019s Breathing brain resuscitation least RIE: desaturation anoxic 2016 figures monitor intubation diaphragm made Life Follow Renal enquiries creatinine Escalation Edinburgh Team Gynaecology unusual 1: allows obstetricspecific basis Can uterine citrate irreversible impaired where period Psychiatric clinical term incidence dispatched inform BJOG at Woman it consultants 200914 for Manual midwife drill Progesterone wait them Emergency 20/08/2021 2422544/2 Place Author available 11 history Record Maternal quality cardiovascular MUD* rapid completely early anaesthetic less critical In manually Nair potentially Other chart sepsis Give consider Readily visitors Available colloid example manual patients trachea PPP left an emptying obstetrics neonatal West safe perimortem additional mediated only resistance transferred serum mismatch written date: supine Sharpe which NonObstetric Governance oxygen circumstance site decision hypovolaemia Requiring tap expanded 3898 Almost increasing coordinator CCU also This informed fetoplacental make as requires ectopic raised High gynaecology common picture alkalosis assessment this particular timely Start wards/clinics/emergency engorgement flow present already ii 3: problems Arrest reason mask 5: Morbidity Correct Consider whether successful according fetus significantly 250 presents regional 999 needs section2 confidential lose mistaken prothrombotic 000 palpable 21398 soon cerebral found improved senior 1616 seek intravenous chance Utilise patient population Blood Airway even well difficult no Normal fluctuating mistake alsg Circulation 30% stroke state in bleeding Resuscitation Caesarean psychiatric Pavilion weeks outlying chest 3948 10 Department anaesthesia parameters medical discussion trainee Review uterus procedure urea hypoxic dealing scot Relieve simultaneous behaviour real Obstetrics action hCG Unbooked tube vascular Booked uk/Directory/CriticalCare/Pages/Default Women\u2019s Perimortem vital cover return primary individual 13 they airway 8118 hypotensive/hypovolaemia psychiatrist occluded embolus Clinical identified study sign then appointments sitespecific It negative cardiorespiratory Approval yet Moving anoxia lower National All risk direct *MUD: sensitive minimising prophylaxis: umbilicus placental nasopharyngeal Fetoplacental oesophageal Communication NHS exact summary workshop Delivery however recognition Ireland that >20 implementing kit WGH: circulating Section intraabdominal involve therefore sphincter experts injury contributing Remember References precede 22544/2 report you themes deteriorating CPR+ cardiologist half gastric arranged mode Stable 20/08/2018 collapse lead Midlothian UK laryngoscope minor \uf0adBlood or accessed blood high Date vena when visibly these suggested within differences Critical lateral manner 1820 lives see online Approved receive min If Premedicate Puerperium switchboard through priority national menstrual office Out \uf0adV/Q From remain 119 Assessment Care: psychiatry Recently despite 10% than option ALS methods further 100 mL team saturation agreed easier possible perform whom more Admission recent UK: due psychosis factors Intensive 2222 save volume Reason needed prepregnancy preeclampsia during cardiac Victoria Title: http://intranet births the Beckett tilt before Study: care are aspx?RootFolder=%2FDirect vic Displacement 2422544 FRC obstetrician guidelines immediate take very other fluid important uncertain cava gestation 20 2: etc au been admitted Obstetric move Labour few down Figure plasma position would optimised transferring relieve so place Western 8454 physiological alert Shorter Telephone writing acute department evolved possibility Cross incorporating injuries/acute Unstable contact maintain scoring stating either room via Confidential who failure 150 induction range by: Emptying descriptive fall support extension toxic/therapeutic 2203 phone 4019 asthma regular input could indicate Gastrointestinal aware decompensated Keywords mother trigger highlighted some provide 2017 follows 01506 Liaison mothers\u2019 seen cause \uf0adCardiac times services put kPa 50 learned telephone/mobilise Perform reach unstable relevant supply Numbers arrange protected improving published Left volume: Knight PT/aPTT followed Hs Overview previously 09/08/2018 recently local speciality advanced approach expertise Psychiatry: Ts woman MondayFriday More multidisciplinary critically Tuffnell centres 22544/22542 pack cuffed Haematology Site Livingston problem calling anaesthetist At Oxford: enabled proposed baby coagulation morbidity beyond treatment increased changes Enquiry period: Manchester: 22nd area onwards nonobstetric above women have to people section teams occurs levels labour: board remains past eds See pregnancies al up years table studies labour confusion outcomes outside VA SJH preferable meeting credit: maternity fracture 2021 appear Increased standard Differences into nonpregnant Pregnant venous shuts oral oncall distress Dec pubic Management Community turn missed acid albumin renal progressively decompensate StR facilities Sequence Normocapnia impending Date: communication normalises significant surgical service MOET difficulty >4 pick elevated 2422423 Guideline General warning need Eye coordinating after self always Infirmary concern group >12 order aortocaval help occur Royal Ask pulmonary Trauma Photo contraception pregnant felt doing 74 recommended system its awaiting access mid Also home pregnancy disease over minutes of Dependency delivery event Area making 3558 death last observations Wards nurse transfer attend study2 Healthcare gov apparently single fetal 2422657 irregular level et 2204 August causes agreement environment: pressure thromboembolic post 14 escalate perplexity build consult aspiration staff Statement March Bleep bleep visible should ABCDE adverse Fetal Anaesthetic at: Control Version/Page ensure florid different reported management adjusted per 13741381 allow urgent absence Patient review ideally presenters bleed if carry complex life promptly Seek output falls 3017 there both tool while 211 circulatory 54125 is meetings first However decompensation loss Establish Enabling on 08301700 usually blade osmotic account amniotic Patients was with health period/2 urinary emergency inpatient displacement Multidisciplinary documented 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 stable fibrinogen ability scan use elsewhere give workers consumption specialty lessons identify assessment: Phone ranitidine about Use necessary operating old Reducing vaginal rupture Chart IV improvement Very protection goals MEWS December miscarriage bolus Ward hypertension deteriorating: discussed required handover failing route neonatologist lifethreatening 1625 Some abruption reversible theatre The pdf damage spontaneous http://www Routes unit observation transport lying time professional feature defibrillation Contact Need mental concealed/unrecognised best Prevention open indicated Conventional An fit correct key but org/en/files/Perimortem_CS GFR pelvic pCO2 months Stabilise symptomatic caesarean age next intensive http://trauma Contents implantation preparation Deaths vasodilatation areas Triage arrest maintained survival charge performed Author/s: all treated Version displace \uf0adOxygen page request obtained Lothian Including Emergencies sodium large one following thromboprophylaxis demand score earlier woman\u2019s outcome commonly 12 signs surveillance 8112"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Sheet VTEconsider General need Midwife: Care contraindication possible midwife: Indication compression not Should uk/Directory/ReproductiveMedicine/PoliciesAndGui from monitoring http://intranet the be call of Registrar contents are Anaesthesia absolute including numbers attend and 08:0018:00 gestation 20 by 2204 admitted Obstetric Labour 1616 position aspx Aortocaval patient admission physiological foetal ext Cons different Burns Obstetrician: contact Coordinating in via Patient parameters 2203 uterus scot regular Obstetrics is unable admission: Concerns: general they label details on midwives Aspiration requiring Anaesthetist: Patients unless with coordinated 1617 then displacement Obstetrician use delines/Pages/default Consultant nhs risk Handover May from16 lothian 22544/22542 goals NHS 2016 Ward discussed increased Summary tilt/manual affix Sept Beatty women please to have targets Pager ward Dr it guidance gastric Named for Authors: weeks\u2019 pager obstetricians deteriorates Consultants Reg or avoid Critical Guidelines lateral Pregnant If Lothian switchboard ICU left an thromboprophylaxis 1597 supine Specific"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "oedema Sheet dial guideline Care venogram refer WGH orally test complete compression compromising not Thromboprophylaxis Draft/Final: from be call Pulmonary units Service and FINAL Document circulation charts by out cardiomyopathy Discuss may receiving >22 using any done Pregnancy Dose part especially fail ultrasound assess Hub>>Policies can CRITICAL theatres POSTNATAL antenatal 7500 has folder female maternal details 150mg requiring include: obstetric unless %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis breastfeeding/expressing Category: 3561 1617 hospital 22601 anaemia will Consultant nhs mechanical Handover Suite sepsis/chorioamnionitis 30ml Unit lothian triggers RIE Status resuscitation intubation Follow allows citrate Wilson Beatty complications thrombocytopenia ward at it 54394 members Authors: for midwife typically CNS wait involving available 11 cardiovascular close early critical In chart Administer consider patients ICU an being neonatal perimortem additional HDU supine site Requiring embolism 3898 75units/kg/day Postnatal coordinator Baby requirements This pillows requires as Upon this particular Authorisation: lefttilted Consider whether Midwife wedge found childbearing ONLY Cerebral 1616 NNU Nurse patient well difficult intranet followup state in weeks headache AKI 10 mass anaesthesia %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 parameters bedspace Review highlight scot infarction Coordinator Obstetrics Weight ANTENATAL 13 embolus consciousness SCBU 131170 Comments: postnatal uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently QIT negative Obstetrician risk stations Words: checklist summary NHS Antepartum adjust kit intraabdominal clearly 1155 betaHCG CT added discharged liver collapse sitting information or five Neonatal blood high Date when Critical within see If sinus Trainee referred assistance dissection further team 50mg possible haemolytic 3M Admission Anaesthetist recent 2222 save criticallyill preeclampsia 5090 provides iv cardiac Title: http://intranet the before are care absolute equipment numbers fluid types take gestation 20 been admitted Obstetric Labour position admission physiological acute thrombocytopenic contact stay failure Care\u2019 2203 specific Please phone CTG/continuous preintubation indicate purpura fever aware mother provide %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy head Dalteparin prevent Be services Authoriser Perform ongoing aware: Key relevant \u2018Handover Do arrange intranet: 3590 Eclampsia/preeclampsia booking recently bleeding/coagulation microangiopathic woman 22544/22542 2500 immediately Hall 5000 91130 baby changes remember started area aged myocardial nonobstetric above suite women to section guarantee teams 10000 weight pregnancies weeks\u2019 up years Procedures noncontrast labour SJH hand Guidelines Amniotic into exclude oral Pregnant venous ID: oncall discharge Management coagulopathy below >170 Thrombotic insufficient Date: significant until aortic <50 Peripartum delivered When after warning General concern contraindication uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity aortocaval viability pulmonary contraception pregnant Special Intranet ruled pregnancy monitoring start disease minutes of delivery event 3558 viable fetal Ensure 2204 pressure thromboembolic post 14 aspiration FOR Bleep should those Anaesthetic ensure family urgent haemorrhage Patient seizure USE if four life output 54125 is on prior account Patients with nurses urinary documented emergency arrival resuscitaire ranitidine reduced Use exists goals MEWS onset kg pdf The time please liaise caring indicated These For thrombosis caesarean age arrest Directory>>Policy performed all Version Lothian sodium CARE *Use thromboprophylaxis score uteroplacental earlier hypertension 12 signs 75000"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "oedema normal alveolar Volumes Care :32736 9698 right 15 1000mls worsening not height Neuromuscular controlled Draft/Final: 16 from Review/replace cm shows be depending 17 terminal 6ml/kg week and Specify Document Moderate respiratory ventilation 24 by repeat positive may utilise 372 HYPEROXIA excludes Engl Peek Efficacy conventional using any predicted Berlin red symptoms limits recruitment ARDSSv4 >26cmH2O can \u0394P Resp 354 PP has 40kPa Mar Highflow Within 380 overload Timing tissue insult :110716 Category: bed Target acceptable change ventilatory Moss low 2007 words: each Status Breathing :215968 syndrome allows 45 severe strategy 368 where clinical acidaemia pressures targets trial Female vs Male MBP PaO2 Authors: for syndrome: 11 \u22658kPa 175 early Tidal protective 23 2019 consider patients left Briel additional Chest Oedema oxygen electrolytes overdistension hypercapnia coordinator as Driving raised assessment Authorisation: Imaging AVOID problems combined 2830cmH2O Consider systematic plateau membrane Positioning PETAL PEEP patient lung Blood Calculate even Mild hyperinflation no vasopressor Terragni blockers adult conventionalprotective Circulation tidal Aim multicentre in parts Extracorporeal chest 10 Review Higher Institute combination Sep Plateau 13kPa 13 Identify :19972008 Clinical 2008 distension study bronchiole QIT Aug lower National medications traditional Comparison balance 2526cmH2O update Strategy injury new CT Directorate under 374 References Nov you :74755 get Origin added Pressure Dunn extracorporeal collapse removal Amato or high Date Critical Version: within 2006 same 07917 CXR 20150823 through treat 30cmH2O Set criteria :135163 Jan *P/F Severe CO2 39 Signpost randomised due Run MO \u2018dry\u2019 Intensive volume lobar/lung during Daily Lancet cardiac Title: the Jun 91 :1606 Bein fluid other 2009 RG 20 Bilateral P/F :256475 27kPa Figure Echo\u2019 body side Young 19 acute volumes explained CVVH nasal Brower 351 via /Fi02 failure Beware 18 support tolerated cannula effusions Intranet: kPa 50 Key figure Frat economic Lower examination obstruction strategies randomized JP :218596 :63745 Lung Distress decimal Not HP Final Jul degree Early above 22 to hydrostatic levels infusions See ARDS weight al up two Oxygenation 363 referral :86573 2021 maneuvers fluidmanagement ID: distress JAMA Management versus ratio* below 299 Date: diuretic ratio 46mls/kg achieve disease/compliance Feb need opacities 2010 Authoriser: ARI pO2 compared current Drugs fully Syndrome over pneumothoraces of aetiologies Wiedemann Meade ml/kg ARDSNet et Oct 5cmsH2O causes Guerin pressure :13018 Heart :84756 Blockade 2015 higher ECMO 068628 Prone review known GJ if FiO2 Network therapies Med is variety posters: perfusion on require excessive neutral 303 with 342 Respiratory oxygenation Trials May imaging esp goals Tolerate nodules Definition 21 CESAR Terragni\u2019s document The ICP Considerations 152 metaanalysis meet lowest but Survival pCO2 hypoxemic image precipitating areas <13kPa Acute Am one 2000 endexpiratory 2013 Parker Ventilation 2004 12 Papazian"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Each When version port Turn SLIM appropriate Care clinically still Trolley CPE Fibreoptic Authoriser: training Usage sizes AMBU picture record system drugs Draft/Final: needed Photo unacceptable 2mm OD Aintree throughout Title: Authorisation: the be of ii Exchange back flexible are Advanced off AScope AScope2 button subsequent Still and Document max holding Indications Ensure by pressing down working MDRGNB plugs Picture Select Adjust suction side Airway Video department waste different adjusted in Slim Contrast There lever if ASCOPE control video aView seconds Review Plug Catheter Please can crosscontamination once has Suction channel is finished top power STANDARD Reference Cook airway on put 3s disposable trolley Intranet: poses contaminated Category: with 2014 then Key You blue QIT use will scopes words: Standard risk trainer fibreoptic NOT Status Older least NHS Grey 2016 select monitor small intubation bronchoscopy images maximum aScope The April Bronchoscopy instruments Final cleaning time Mode Dr please to produces added at Brightness Dunn MDRTB potential for fit Authors: a3bAG310314v1 costs For available or image Date Attach ways onto Critical BAL within Version: Guidelines restocked Green 4mm approx into bronchoscope charge scope see ID: turn disposed Lothian BLUE fits through \u00a3200 left an following your press bins Date: taken green aerosolising grey"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "whilst specimens normal methodology Separate NB/ prospective Rello guideline slight considered Care appropriate autoflow deescalate Trolley set pod right complete Send antibiotics rest not TRAK free Draft/Final: controlled from cm standardised Visualise pneumonia10 be likely Single units MiniBAL suspected and 33:218493 Document sampling posterior Kollef VAP bedside ventilation by Unlock sliding may diameter 62:2006 confirmed often positivity adequate Saline 13:66571 clinician result BronchoAlveolar flush quantitative 132:62130 must Once sputum Endotracheal Preoxygenate Keeping >0 aView such deadspace fast Allow can Dancer has EndoTracheal folder form cross top second Cook suspicion Change performing O2 117:195S7S Category: results aspirate average importance approximately hospital change blue Ventilator syringes will hood/FFP3 words: too US Epidemiology discard difficile Status least monitor connected wedged visualised traysin risk? include hospitalized basis 45 pneumonia\u2014a 2001 contamination where incidence 3way trial pneumonia at it dressing Ann size Authors: for Intern used costs available stop cfu Attach BAL less Reusable anaesthetic protective bronchoscope potentially overuse consider \u2018miniBAL patients Chemother ETA ICU vasopressors/inotropes left choose 1020 Print resistance Chest avoiding unavailable/emergency cutoff samples Acid port tap Gramnegative dose Frequency also Pretreatment miniBAL ECDC upright Virology as Appropriate Relative common this Remove ventilator Maintaining scrub reviewed present contraindications >104 Authorisation: consideration mask aliquots 2462 sets bronchoscopist <20% Consider diagnosis 1L systematic labs Attributable MiniBal culture/staining cannot cadence wedge neuromuscular mount multidrug availability senior 122:211521 bacteria6 cytology PEEP teaching suction patient lung organisms Airway RLL removed difficult directly bactericidal evidence Clearly YES in 10 anaesthesia Procedure procedure Review represent Mycology diarrhoea C&S below: tube Sending return cover Melsen technician Antimicrobials airway individual 35cm tubing Clinical 2008 Invasive infection7 >103 study then Lock Segment Procedural negative v2 lower CFU risk superior stain New improve 64:516522 2022 that HAP/VAP reuseable Introduction bottle therefore aScope /ml Craven Directorate References microbiologically containing: added Dunn notes colonisation mode collapse deep Interpret Microbiology lavage Position database or July high predict Date Is Critical tracheal within 2006 Wistrom Version: eg same scope CXR hour If switchboard 47:4350 SpO2 associated green bacilli VHF further 2002 culture prompt Cytology antibioticresistant perform more randomised attributed saline falling benefit Any AMBU Advance Fagon Lancet Title: the mortality pass are 24cm including Insert fluid guidelines ConwayMorris Don catheter 2009 20 Indications etc Inject environmental Significant ml working sterility growth down position cessation 134:2817 <60L/min side Or Preparation drape Young uncertainty Sterile delayed Unstable via failure sent segment Mandell Antimicrob injection specificity arrhythmias Clostridium sample\u2019 seen PPE label labels disposable gently Intranet: Evaluation ongoing OR unstable Predictors Key timeframe? Do ICU1 together published coming 103 followed colony economic local Wedge total PIFR bronchial mechanism KE ETT strategies randomized effect pack consequences Volume HAINet resterilized sample Large fashion At morbidity days10 alarms/disabling beyond treatment maximum Final area Warn above Flush specimen to sterile sheet patients: Results screen MDRTB al studies upper paper two outcomes Iregui SJ noninvasive NO standard into Dis ID: antibiotic WG CAP 2020 below field blockade just antimicrobials Crit Open Date: significant depend connector forming 2005 Thorax gram Gram Antibiotic thought data Guideline Selection Livesey gold benefits Authoriser: selection help system compared experienced desired cabinet diagnostic disease treating tip of pneumatic inner delays Lavage porter stack Instill micro antibiotictreated syringe 120mls single prevention Ensure investigation et pressure MDRGNB seal 120ml subsegment aspiration Safdar should supports condition suctioning between ensure reported management delay review There described traps if protocol 20ml FiO2 pneumonia: lavaged seconds inappropriate Prion there both Med is first ventilatorassociated withdraw on Aspiration antibioticassociated 104 tree bacteria morbidity2 with Quantitative Respiratory use note Standardised urgently Refer Use maintaining reasonable match portable Jupiter significant4 bronchoscopy selected suck apparatus resistant >10 The trap gown unit 30day adjusting metaanalysis gentle initiation indicated therapy markings pus correct but glove Infect direction 122:2628 apply entry pneumonia8 acquired BAL/MiniBAL involved stick antimicrobial request large decant 2000 2013 JY comparing Hosp Gently"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "ventilators appropriate Care clinically still set rhinitis/nasal 15 Rarely V60 Clear not Draft/Final: bronchospasm from settings be face Nasal off SaO2 and ventilation respiratory by may Select speed using hours cooperative/aggressive Persistent ventilator? must resp Once minute symptoms escalation EPAP Type control such fast asynchrony longer can CRITICAL PaCO2: 2022cm ITU has rise and/or O2 2RISE CHECK re change Penny will low too MEDICAL P02 each Status BIPAP night AND monitor positioned valve 4cm irritation reduction Escalation plugging 10cm DO June clinical acidotic Mode inform pressures Senior at it Weaning plan BiPAP Authors: for Must sufficient standby used available stop pneumothorax indications bridge In Recommendations 2019 Paykel consider NB: patients Continue ICU being 30 an Maybe additional water only time2 restarting which insp port increasing customised hypercapnia Kallirroi target Draegar increase TV connections upright This as ABGs Leak: Appropriate this No flow mask headgear Correct fastest Non Consider successful IPAP/EPAP PARAMETERS 1Different soon On ONLY improved Adjust compliance agitation patient Address TIME no check worsens soreness/redness/nasal Staff: THERAPY CONNECTIONS in day continuously nebuliser medical Tips rebreathing? tube increments does nasogastric Blue granuflex reached tubing After Clinical rebreathing normalised evaluation comfort Clarke 02 OSA improve CONSULT obstruction/kinking: leakage Check position: decrease clearly Ideally you inadequate Focus masks infective notes lead towel tachypnoeic sitting circuit foam or mouth Pa02 high Haloperidol Is atelectasis/collapse Critical within Acts see CXR Approved receive min If Always ss duration Set suggestions Turn agreed Look possible enough more Mask due benefit volume reduce during patent? distension: Title: the back are Consult very guidelines Monitor IPAP spending exhalation few 5cm Sedation Or acute Improved? meals nasal inflating maintain slowest who range by: support allowance weaning Relatives tolerated Troubleshooting could correctly? some head leaks cause Fi02 put Persistently Difficulty decreasing peak rate total STAFF examination NOT trying mucus crusting/bleeding? small sores? Try Large increased treatment dry Final humidifier ABG ST visor elbows have to remains up Deteriorating oedema: trapping Orange Guidelines rises appear 2021 into Next Management determined WITH padding limb breath slow OF inefficient problems: When elevated after Back need always Failure conditions Ramp Kefala soft help pulmonary system current V500 H2O behaviour: PC02 start Settings minutes of better leak overleaf atelectasis expiratory holding ESTABLISH Gastric machine: single Ensure level collar/rolled NIV pressure achieved Number gradual staff Fischer FOR periods Written: should condition between TARGETS ALL different urgent Patient review develops USE if extending accepting there patient/machine physio 10breaths/min is filter first long every tolerance heart on hypoxaemia prior upon require Asynchrony excessive Patients with documented Respiratory obese cycle use identify attached necessary Encourage remove device Initial leak? improvement 2cm required discussed frequently MAX Trial eye Pack full Yes The RISE Considerations Medical time noise might consolidation 8cm initiation extended indicated oramorph therapy tolerance? fit correct but PaC02 deteriorates closely Repeat chest: dual reference CARE Reviewed hypoxaemia: on: signs"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "System According Floor normal NE38 port 6988 539 Imperial 505 set prime 9BZ saline Rocket 6989 disposal REORDER Email: WD24 Used Remove plc vent from R54 Office Wear Single the Port 502 CODES Prime off Insert +44 and catheter wall now 419 Customer \u2018click\u2019 level Sedling ready 500ml position seal clockwise suction place Clamp patient Tubing 1923 651404 Unclamp rotate red Herts chest 500 Drainage 10 homesales@rocketmedical procedure tube Vent/Suction Suction is Tyne Export Blue sealing tubing \u2018open\u2019 Fax: with cap hospital vent/suction Clockwise twist 4XX Double Way remove Watford To small Chamber Fill Connect without com bottle new Medical Stand 191 Replace exportsales@rocketmedical to sterile Tear 503 Washington Telephone: open Bottle for used 509 Place UK Rotate or close 240334 aperture Dual Easy Green approx into Level England Head Services If Collection Road Set water green until Steps connector heard Chest"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "appropriate Care clinically set Fitting rhinitis/nasal Rarely V60 Clear not Draft/Final: elbow bronchospasm from settings cm be Nasal off and commencing ventilation orange by may hours cooperative/aggressive Persistent nose must ie Once symptoms escalation Type can CRITICAL ITU minimal minimum top O2 re change Penny compensate will low selector humidification Status BIPAP monitor positioned irritation feeble reduction Escalation plugging 10cm redistribute Leak June clinical inform pressures 60L Senior at it Weaning plan Authors: for Must used 21100% pneumothorax indications bridge In Recommendations 2019 consider 520mins patients stabilised inspiratory Notes being an Maybe additional restarting compatible which increasing customised requirements target upright increase as ABGs Leak: Appropriate No Start mask headgear Non Consider successful Finally 30mins soon Secure ONLY improved Adjust PEEP bottom stability compliance agitation patient worsens soreness/redness/nasal Staff: Aim in day initial nebuliser medical Tips tube granuflex tubing After Clinical then measure completed normalised evaluation comfort lower Clarke OSA adjust obstruction/kinking: considering Sa02 Check position: therefore Ideally raised: Focus masks enhances lead towel sitting circuit foam or mouth Pa02 Haloperidol Is atelectasis/collapse Critical within see CXR Approved uncomfortable receive If min Always straps duration treat suggestions despite hypoxia agreed possible Mask due benefit reduce during Title: the effort before care 20 exhalation gradually few 5cm Sedation Or physiological meals nasal inflating Sizing Dry who by: support weaning Relatives Troubleshooting interval trigger some head clip leaks cause Fi02 Difficulty machine Helps patient\u2019s examination pack trying mucus crusting/bleeding? immediately sores? Large anxiety dry treatment maximum promote Final ABG have to Regular levels up Deteriorating paper oedema: Guidelines 2021 beginning appear into Next Management determined below padding mouth: achieve inefficient problems: after Failure Ramp Improved soft help pulmonary behaviour: start Settings of leak overleaf atelectasis holding machine: reducing collar/rolled NIV pressure gradual consult staff FOR 2015 periods Written: should condition between CPAP different urgent Patient review develops USE if extending there physio is first long every tolerance hypoxaemia on increases prior require Asynchrony Flex Patients with Respiratory use give Setting necessary Initial improvement template required discussed MAX Trial eye Yes The Considerations Medical time noise might consolidation extended open therapy indicated oramorph correct PaC02 Time 40L closely Repeat chest: reference initiating included CARE Reviewed hypoxaemia: on: signs"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tubing to abdomen strips visible thigh using Securing connection or zinc tape Attach Drain the of Mefix oxide leaving Connect Method Chest"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "sound 3050 oxygen Humidifier: heating port References: appropriate Care group Oxygen set October side: Mask right rotary Draft/Final: Fisher opening V500 system Remove ventilator from Start Title: shows the mask of be confirm plate INFINITY com/Library/Content/HIflowstarquickguidePDF8945en Nasal fphcare button other and EVITA Therapy ventilation ONLY On 8945enuk18061 may heated https://resources short Select clothing patient side FOR Written: com/resources/corporate/media/resources/resources/ui Norberto between com/en_me/Hospital/HighFlowTherapy Sterile nasal in connect Infinity cable review Switch USE by: if parameters Heating FiO2 Components: com/Library/Content/HIflowstarquickguidePDF Step temperature editorial can CRITICAL Cannula cannula Instructions: chamber XL is second Highflow return clip on run knob Change Flow Evita beeping Start/Standby Humidifier O2 Off Wires heater with bed L/min sensors blue QIT Ventilator comfort patient\u2019s will Draeger Press Status uk18061 Breathing To Spec select adjust adaptors 2022 selected Connect automatically pdf The Final humidifier invasive V500: Mode to linen Water therapy Up size Authors: for mode light Standby https://www touch key direction switch 21100% For Position or 185047970a Slide onto Critical Guidelines running attaching Humidified Circuit Interface Next XL: Approved Paykel 37\u2103 hose 2020 CARE through verbalises Reviewed infusion inspiratory left draeger press on: Set water until menu option heard Ventilation signs discomfort"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "System When Care> oxygen breathing heating port appropriate Care Oxygen more shorter piping High system Fisher determine flow Analyser Single the of delivery plate Nasal care Directory air Insert guidelines and nares single Therapy Optiflow\u2122 Ensure by Respiratory> ONLY bottom FOR March using no between Sterile prongs nasal space in Commence connect review USE Note: blender Heating Components ports Plug temperature CRITICAL Cannula cannula setting chamber filter top humidified Home Blue Heated on tubing Flow O2 Humidifier Equipment Instructions updated with Tpiece Wires bed heater blue Bacterial use Required patient\u2019s will comfort outlets Air wires Breathing Filter select adjust 2022 meter Connect Adults automatically bacterial HighFlow Meter The humidifier invasive to Water generator Schraeder at levels half Up size for /Oxygen piece switch upper Place For circuit high Attach Slide onto Critical Guidelines critical Humidified Blender into Circuit Interface attach length Paykel 2020 CARE infusion following Set water than"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "appropriate Care Epub set Anesthesiology skull consultant sizes BJ not reevaluation Draft/Final: Fisher controlled levels? from settings systems CASE be face Nasal off 40% totally Gradually SaO2 and 190 Document Increasing max F&P ventilation respiratory Therapy by preoxygenation positive do Effects may TOLERATED: accessory 372 Increase Engl conventional hours cooperative/aggressive Persistent must resp ie washout Once Exclude intervals escalation Type Extubation >0 37\u00b0C deadspace can Humidify Resp We PaCO2: chamber eased? minimum Highflow 100% Change O2 starting unless Category: heater change MD/NY ventilatory fistula otherwise recommencing develop will advice low words: Consultant MEDICAL 8892% humidification advance Status least AND monitor positioned intubation made meter Follow Escalation we June invasive clinical Post IF Senior trial ward CONs at PaO2 CXR? plan Weaning it Staff size Authors: for Pneumothorax 21100% pneumothorax indications completely critical Kang Recommendations 23 2019 Paykel HFNO consider patients ICU Venturi feel an 30 Maybe additional HDU only which oxygen decision steps 100lpm target upright increase connections tolerate requires as High know this ventilator reviewed INFORM flow Authorisation: mask advocate Non Consider PROs 30L/min PARAMETERS till stated ONLY seek Depressed failure: patient BMC appropriately well evidence THERAPY muscles? YES NFNO in parts day initial correction 10 parameters medical Review hypoxic Medicine evident Contraindications Cannula increments does lobectomy airway Schwabbauer tubing Clinical Continuously Assist It gastrectomy QIT comfort Base deliver Outcome risk Clarke 02 ceiling improve Hypoxemic adjust CONSULT cannulae wire that endotracheal Sa02 plans Introduction Check position: clearly Directorate reposition References daily added pneumonectomy Dunn notes HFNOv1 collapse lead towel sitting extend circuit ITU/HDU or high elements Date Critical Version: within Inform same clearance sores see circumstances If THEN: Always through treat Set SM conscious MR850 Hypoxaemia breathing agreed Oxygen possible Mask due Intensive Currently provides adults highflow during Given Title: the bronchopulmonary Jun mortality care are 30l/min staffed Cautions other very nares twice Indications gradually oesophagectomy Sedation prongs nasal l/min hood :62332 Comfort THEN via who failure flows support weaning 41 tolerated DETERIORATION Troubleshooting temperature cannula helpful some provide humidified head prevent appropriateness Heated Fi02 run disposable Intranet: deterioration 2014 Key functional Frat Draeger rate mins total STAFF effect randomized small immediately JP :218596 PLAN document: treatment Final humidifier Jul ABG above IN to patients: work levels HME See al up Humidification improved? Deteriorating lobar two Oxygenation prolonged fracture Guidelines noninvasive 2021 NO into CSF ID: alternative turn versus 60 WITH below occlude Date: postextubation Journal OF achieve problems: When subjective after facemask need sit Failure soft Authoriser: Vourc\u2019h occur system compared V500 :17 fully behaviour: Algorithm start mucociliary of Has delivery Registrar better leak ESTABLISH single Optiflow\u2122 reducing level Ensure et collar/rolled causes NIV pressure 14 aspiration 2015 periods hypoxemia should condition TARGETS CPAP delay urgent Patient Switch review ideally develops There Maggiore if FiO2 Seek 10l/min setting Med is unable ESCALATION Recent heart tolerance every harmful on hypoxaemia prior upon :2828 Flow Patients comprises comfortable with documented Respiratory use 44mg/l weaned trained May reduced Refer Use necessary device Initial improvement Decrease try required discussed Pollock frequently HighFlow reversible document The anatomical Considerations Medical time intubate produces Need initiation Prongs therapy >48hrs key correct but Less American accurate hypoxemic closely MUST areas maintained reference survival Acute Reviewed hypoxaemia: 204 signs"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "oxygen library Full currently decision Turn guideline appropriate Care Oxygen set Active complete This increase retention as consultant volume assessment this controlled ventilator vent present around start LUHD be of the delivery Agitation face mask leak are Frank whether resource Cautions limited nurse and Rib 2009 end max 20 Indications Fractures Support by haemoptysis Presence tumours pressure senior Nursing compliance Select PEEP infection CVS Instability place staff lung patient Editorial Upper Pain side should using no hours volumes any check adverse ineffective accurately tidal Unstable Author: Aim in room via Patient chest initial 18 GI smaller/larger 10 treatment1 reference: Match if control Troubleshooting: Review Ventilators can Contraindications Reasons Using setting ITU has physiotherapist is unable filter Recent every leaks individual fractures Facial on Same Aspiration discuss tubing Clinical discontinue unless Patients with then breaths Support: measure mouthpiece Ventilator use practices local Deranged central Physiotherapy bronchial PEEP: Abscess Raised New Platelets December H1N1 Drowsiness TB/ made required that Lung insertion H20 full advantages basis Emphysema Board Directorate Zoe Discontinue Surgery to 15cm intracranial added displays at Select: drain Pressure cmH20 screen Atelectasis HME potential for able collapse up adding upper cough used Fells removal or pneumothorax bullae Attach analgesia Critical Adapt tolerates Repeat Guidelines areas Secretion percentage extubation Oxygen: matching see effects Approved 2011 consider If pericardial Undrained ICU machines an line being checks Lobar comply IPPB safety 12 assessed"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "monitored renal decision guideline possible whom right also Authoriser: benefit as consultant occur severely pulmonary not congenital Relative drugs Draft/Final: this DeBeaux awaiting during from recoverable contraindications disease Rebound consideration be Title: of anticipated mortality care are whether limited other and oxide Document cases ventilation respiratory neuromuscular may would PEEP Methaemoglobin process March ECMO Young should iNO hours specialist adapted those in haemorrhage failure Ferguson Suggested Authorised: 10 if carry Review falls can compromise while therapies is does heart hypoxaemia on increases titration Intranet: Patients Category: with nitric then deficiency Key Comments: rescue Respiratory NHSL oxygenation Oxide use led advice unselected dysfunction category ALWAYS methaemoglobin Inhaled Words: Status reductase hypertension 2022 improvements consultation include inhouse severe April The under blocking daily hypoxaemic have to intracranial added KPa at levels guidance ventricular therapy ARDS believed Authors: for typically transient but Nitric used prone For prolonged McNeill or Pa02 Date referral Critical Version: contraindicated necessary/possible FIO2 eg outwith acquired iNO2020 ID: hour withdrawal patients 2020 retrieval coagulopathy associated left following inhaled 2013 Date: hypoxaemia: Draft only centre haemodynamic"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:2 cid:28 cid:14 cid:22 cid:4 cid:5 cid:29 cid:7 cid:15 cid:23 cid:6 cid:3 cid:9 cid:17 cid:31 cid:21 cid:26 cid:19 cid:24 cid:8 cid:20 cid:30 cid:11 cid:13 cid:18 cid:10 cid:16 cid:25 cid:27 cid:1 &$ cid:12"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "monitored function soapy appropriate Care set Syringe consultant As not Draft/Final: given settings be affect off and Further respiratory positive out may accessory date using hours nose part must Once minute design nursing assess cautions can CRITICAL ffoorr deflation finished 48 requiring patients/low alarms/settings apnoea connectors leave instability each Status awake least valve cords allows basis inform medication at it plan Authors: for used Place cardiovascular Green Karen patients left an alarms PPaassssyy water Cornwall which oxygen secretions pot This tolerate Via as Appropriate Thick picture assessment Muir ventilator present Desaturation flow whether air stored cannot membrane Janis ONLY senior PEEP suction patient ventilated difficult Passy alarm carried Closed tidal in warm procedure GCS thoroughly Contraindications inline does airway individual they After deflate then nebulised QIT vocal thus VVaallvvee New adjust clearly 15cmH2O guide proceed rinsed switch circuit speaking or mouth high July Critical tracheal within see attach Approved If Plans Vomiting/high through line reinflate communicate than colour Severe breathing muscles benefit volume becoming Harvey during cuff tracheostomy Title: the before are MMuuiirr equipment inflate exhalation Indications Ian Servo switched Signs position would heated Or Valves via Deas by: support weaning tolerated closed editorial humidified 2018 label Cleaning reach Equipment poorly restores Draeger rate obstruction uussee trying ooff audible ventilating increased treatment dry changes have to Debbie physiotherapy work levels insertion/change up Humidification upper aspirates/risk Guidelines PMV Return principles into oral Next Explain 2020 until clammy/sweaty assessed after Guideline General self always group cleaned session of leak MDT observations PS> nebulisers single level wean pressure post aspiration staff FOR Written: Bronchospasm should Discontinuing suctioning prePMV adjusted Patient review USE if FiO2 replaced lungs while Suction is unable deflating on incorporated excessive Patients with Tpiece use remove device No/inadequate required discussed The Cardiovascular baseline inhales adjusting Need appendix indicated therapy McLoone able but Less deflated months Manageable preparation Valve placement charge GGuuiiddeelliinnee included issue CARE Reviewed Ypiece on: Draft safety Drowsy"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "spot discontinued guideline Care set compression not free from settings Knee cm head/arm be recommenced Penis Front and foot 24 pressing 70\u00b0 confirmed peripheral Mattress forward Adult compressing allocated 30\u00b0 tied BEFORE aspirate slightly bed change Alternate pain degrees Ventilator neck resting POST central each connected positioned Nonessential adequately Team ankles checked: Male at secure members Consultant/Senior for swimmers available PRONING pressed positioning CRRT 2019 consider teeth NGT Chest Carefully connections pillows static as Appropriate boot No ventilator reviewed contraindications member taped sedated overly Tubular Infusion Head/Face Arm stability Assess patient underneath well TIME removed check themselves? in against placed chest cushion teeth/capnography ETT/tracheal Pelvis procedure infusing tube displaced leads airway tubing knees legs reverse Breasts patent lower 2030 All allowing direct shoulder Note pelvis ETT/tracheostomy Trendelenburg place/genitalia integrity RASS kinked that Monitoring Check role skin supported under devices SAFETY Pillows Pressure genitalia mode correctly Position circuit capsule or Critical Verify through line remain Concerns? Hands feed cushioned team limbs Any cuff the bent before back are going equipment flexed catheter joint Point OUT Pillow down position abducted so relaxation resume either Neck Wrists support fall Eyes ECG Stop aware arms head ties similar shrug sponge introduced Equipment Perform patient\u2019s mins remaining detailed Infusions/Monitoring ETT cells immediately beyond causing Minimum anterior Final pillow ABG lips elbows people to sheet Lines infusions shut neuropathies up Have prone Arms SIGN avoid Slide into Reintubation Ears nostril length lines familiar below Shoulders Guidance after need Legs CHECKLIST Verbal proning monitoring over start of muscle Area THE nurse confirmation Ensure pressure accessible/not post ICS staff sedation suctioning between Abdomen hourly per Prone reestablished secured if FiO2 Catheter NG enteral is PROCEDURE on Confirm neutral 4570 with urinary electrodes note remove plus IV To bolus knee/lower anchor required Adapted document Cardiovascular extended ears Swimmers deflated Central drains manoeuvre areas lubricated performed all eyes boots Adequate Prolevo"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "2nd/3rd oedema Page normal supervising guideline appropriate Care hepatic Proning right nerve rest not height free Draft/Final: elbow 16 from Knee be face depending Changing aim and Document Morbid Leader PATIENT respiratory foot by rolling 24 rotated out may scapulae upwards short abdomen peripheral Engl using Mattress hours inflated any compressions ineffective kinking development nose Raise mattress Agree PREPARATION bring Preoxygenate Authorised: forward Adult such longer Nimbus can Allow has top CPR slide DOI: Frequent movement Roll surgery 1056/NEJMoa1214103 Pelvic Category: aspirate thigh slightly seizures bed continue approximately raise change technique degrees ET allocate neck will resting on/or POST surrounding leave instability each tubes Status brain instructions folded midaxillary intubation made Pharyngolaryngooesphagectomy adequately \u2018transfer\u2019 Team photo aid moved Long Wilson opposite where term intracranial headrest way at it secure members wishes for deproning spine Authors: leader Place stop available PRONING 11 Barton close uk/sites/default/files/prone_position_in_adult_critical_care_2019 onto early cell positioning In extubation 2019 consider manual patients Continue maxillofacial left an being 30 NGT AH supine only resistance Chest which Firstly decision steps ACCIDENTAL Carefully This pillows static as boot Livesay raised comes nursed safest hips this intraocular towards Remove already member around three PF PRONED taped sedated elevate 2023 ulceration whether overly Finally Disconnect returning now neuromuscular Positioning Secure On tight Defibrillation TO bottom suction Assess patient Airway Upper alongside managed Fulminant no directly check disconnection knee rotate Aim in against placing placed scapula chest initial PRONE 10 edge Review sheets once tube 24h return airway they Identify With 13 obesity reiterate Variances palm EXTUBATION then Comments: PaO\u00b2/FiO\u00b2 completed legs reverse QIT lower All Tube: risk direct shoulder Note Responders: Words: traditional centrally Recheck New NHS gap Compressions adjust Tricell NY/ Trendelenburg that arm Check ics instruct injury supported new skin under Inspect cannulation DURATION Fast SAFETY turned added half administered genitalia mode <48h lead capsule foam or mouth breasts Date when proned Critical ensuring within Version: ac same sores injures hour If reintubation line facilitate assistance remain Form ABSOLUTE Limb February than bringing further Severe handling feed cushioned team limit Incapacity possible limbs TURNING Intensive gelpad Spinal reduce needed oropharyngeal Harvey cardiac throughout careful lack Title: the bent before back care are Prolevo including equipment flexed Insert \u2018heel\u2019 guidelines other catheter important PLOG Hobson Apply joint heel supervision Pillow been move down position REFER body Therapeutic so side place RELATIVE Preparation Young sideways SUPINE unavailable Three swimmer\u2019s follows: failure drop range doctor fall support Eyes closed ficm ECG turning input midthoracic throat injuries arms provide head prevent ties ARREST CARDIAC twohanded slowly gently FICM/ICS Intranet: Perform Equipment updated decide isn\u2019t input/advice instruction Key Do protected together patient\u2019s followed mins Bring Take remaining Lower crucial ETT exist Raised PATIENTS cells SG/ Accidental Hall facial At Distress turns plexus rolledup anterior Crosbie Final pillow ABG patients\u2019 Replace IN have to sheet section physiotherapy glide REFERENCES remains guidance trimester ARDS brachial weight ONGOING Nominate repositioning https://www up upper prone two \u2018wrap VA external hand 2021 into Head ID: turn ankle 60 lift lines checked Major below prone: limb uncovered Open Date: significant until Guidance ratio initially INDICATION chest/abdomen after Tilt sit Observe Prepare stand order CHECKLIST cleaned bend cheek Authoriser: consistent proning system Syndrome pregnancy over minutes of deflation: THE Positoning nurse insitu roll policy in\u2019 Ensure level Five Guerin pressure tube/tracheostomy improves donut 14 aspx fixation Pro equipment/lines staff ECMO should male between at: ensure hourly gentalia drainage per Prone space delay allow ideally Patient There described if FiO2 Step habitus grade there both NG Med physiotherapist Suction is PROCEDURE long Barker on maybe usually excessive neutral 4570 Patients with shown leg abduction CONTRAINDICATIONS Nonresponders: Clarify supporting Respiratory electrodes use Depending workers manoeuvres Use remove nominated necessary plus accessed improvement paralysis To onset pads IGel trauma unnecessary required tie discussed Anchor Society Pollock eye healthcare pdf The Cardiovascular damage baseline Tracheostomy Deflate defibrillation carefully open ears addition potential uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care able Secondly Less direction deflated Central Hendry pelvic image tape drains manoeuvre downward areas lubricated arrest drying placement all Acute their Lothian issue eyes one CARE Short 2013 relieving <20kPa shoulders individuals Gently 12"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "monitored delivered which oxygen David Jane breathing suitability mls need secretions concern Care group Oxygen increasing enough nonrebreathing intercostal This muscles help Brian volume delivers Piece Issue Fisher mist from Daily during tracheostomy flow regarding the bore of muscle be inspiration adjustable equal air other and 2009 holds end expiratory Further ventilation Indications cms exhalation Ensure by facilitates Ian variable heated sections short McNulty elephant side patient consult staff Editorial periods even Appendix should Simon no any 54cms tidal administration Walsh exhaled room in via NB There Suggested by: date: support 10 weaning extension FiO2 roughly medical workload four Review Contraindications there tube 220 is humidified trials prevent long than interruption Cook times circuits enough* tubing requiring suitable Patients Equipment with Periods 2014 Guide It constant ventilatory use entrainment patient\u2019s 2007 mechanical lower rate aiding May leave exists humidification sticky least cut connected Tim rather diaphragm litres/min required Information meter that allows decrease The Board identification Directorate attaches time difficulty Cameron please to Mackenzie at levels PaO2 appendix Up lengths for piece 54 circuit closely high holes when Critical tracheal early Guidelines Green approx Humidified into exposed shorten Written extubation Circuit see length mix all Paykel Approved Revised: 2011 If Lothian selfventilating large patients one through stream selfventilation limb Set Assessment February resistance gases Cornwall"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "breathing after connects Seven soiled Care set Push also Filters ETCO2 pulmonary not Inspiratory Label system Attached ventilator systems the be of before Expiratory are last suspected other and expiratory end operate now influenza 24 by 72 do ONLY ready routinely suction Tubing FOR days should hours directly probe between Closed in connect Dry placed filters Patient USE Maintenance temperature CRITICAL moisture setting chamber Suction valves is SET humidified power Blue every airway yellow on circuits tubing After Change Humidifier exchange Complete with They heater base blue adaptor Bacterial Ventilator use will damaged Circuits Attaching Standard EXPIRATORY YELLOW tuberculosis socket humidification YPiece click To Filter required audible valve wire Connect The Long humidifier where Setup to pneumonia it HMEFs HME mode for up but used These For circuit Time or UP Between expiration Date when Slide Critical onto Dual Guidelines Green Humidified Valve into changed see Circuit plug patients CARE below Short line an limb Display until Limb heard heat"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Protocol after puff milligrams Care group refer dose increasing Actuate as not Draft/Final: this ventilator provided flow Title: MDIs the be of before minutes inspiration are 20micrograms/puff Consider subsequent SALBUTAMOL and response sideeffects Then etc by 20micrograms Shake ONLY pressure may usual 100micrograms staff FOR micrograms Morag ventilated Written: should no administration in via review NB Ipratropium tremor situated Close USE There 3040 described 500 10 by: medical seconds Please editorial method Technique there is airway on titrated prior require Delivering metered ipratropium breaths QIT Naysmith ventilatory peak DOSE use inhalers will Nebuliser PUFFS canister previously May total Note device Status 2016 immediately dosing Monitoring Some puffs Salbutamol drug devices report spacer MDI to administering administer way it administered Authors: for up MDI\u2019s MAXIMUM Place actuator circuit information respond or Critical Guidelines Max 23 ID: Other Starting salbutamol tachycardia Administer Approved Next 2019 If mechanically patients ICU one Reviewed inspiratory limb Wait on: Draft only"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "oedema Page aneurysm stroke: massive considered Care test assay compression TRAK not Australian Hospital Draft/Final: Covid19 given PROTECT 16 >150kg antifactor incomplete International be 5000units measured units suspected anti and molecularweight 24 injury: Discuss may major Elective clipped peripheral hours filled any withhold done administration sort must red coiled extreme Intercollegiate 100150kg 7500 has Canadian Group ulcer continued BOX surgery discuss requiring Covid unless Target 34 uncorrected Guide anticoagulation will low lesions PLT RIE Status spinal arterial courier disorders 2016 underfilled insufficiency procedure/intervention Collaborative severe *2500 invasive Heparin where inform APTTr Investigators trial at 109/L **5000 thrombolysis Authors: for Intern used available VTE history wear *Check less critical In potentially 2011 patients IST an 31 choose DIRECT 122 dermatitis site dose as aspirin assessment trough greentop University s/c varices <50kg cannot Anderson 000 \u22651 Cerebral citrated LMWH Division days no check Stroke pharmacodynamics: Traumatic stroke in antiXa day bleeding against weeks 10 24hours <10 procedure Medicine once tube they Clinical 2008 **For study then QIT lower All risk BELOW Note EXCEPT Order <30 New NHS Subarachnoid Check referring injury References daily devices you 300mg laboratory previous get liver Indications: deep Intermittent Park Scottish or Critical these within see prophylaxis Approved receive If doses associated elective than uncontrolled :182187 team October haemorrhage: randomised Intensive Spinal Enhanced peptic Lancet caution Title: the before dalteparin CVVHD replacement care are Cautions other take twice been ill side TEDS Xa 19 acute deformity Thromboembolism neither molecular INR marked artery who 1997:349:156981 range by: haematoma units/ml contraindications: editorial sc CrCl<30mls/min SEE highlighted Dalteparin 2018 head infarction: 2014 relevant peak Prophylaxis ve advanced critically NOT PATIENTS 2500 Haematology immediately sample 5000 SCI existing treatment ischaemic Includes biopsy/surgery: accumulation neurosurgery: Intracerebral Arch CrCl dalteparin: above heparin have to proven <30mls/min levels guidance 1012 See weight al table LMW evening SIGN LMWHHeparin contraindicated Guidelines pharmacological Level ID: Next Unfractionated England Gen versus checked 2020 coagulopathy below CrCl<10 <50 Journal Guidance Pharmacological initially Feb renal after group 50100kg stockings lab Kefala prophylactic among compared graduated 1030 monitoring disease of pneumatic event last haemophilias level Venous et haematology following: 363:13051314 post 14 staff Written: should ensure urgent 168 IPCD review PATIENTSmechanical secured if platelet cord protocol thereafter publication Network there both mls/min Douketis Med Prohylaxis is first Critically on Antithrombotic require 435 1st Patients with impairment leg groups emergency Trials use choices vein *7500 NEURO Use HIT subcutaneous To active elastic required discussed Society Trial :June search neurosurgeons unfractionated full April The Haemorrhagic unit Transplant might Dr please automated alone DVT therapy neurosurgeon :180512 Edinburgh:SIGN For months thrombosis specialties count<30 count acquired oneoff all Zealand Version request Lothian Mechanical Reviewed thromboprophylaxis sites >30 Treatment on: Draft safety hypertension neuropathy"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Page Cl whilst site renal Guideline need team Usually Care choices! dose set PANDEMIC lab HeparinInduced order test prophylactic as SpR Any assay not TRAK needed trough assays during greentop antifactor therapeutic home monitoring TIPS click! the be of call 3: Warfarin before dalteparin are Directory pathway front other alphabetically and take Infusion sampling cannot find Anderson 2: Documents: by 24 level haematology positive out found ANTICOAGULANT go working may post policies intravenous Select side staff patient citrated FOR LMWH well Xa no hours filled should intranet withhold done ensure administration contact must marked in day via urgent 18 range LMWHheparin located link if 10 units/ml UFHHeparin Adult thereafter procedure Unfractionated can there Policy procedure/intervention/surgery helpful tube COVID19 is reversal Cr Documents homepage on listed Antithrombotic requiring Clinical 5817 impairment then Target Dept You 34 TOP Guide arrange peak anticoagulation will advice Consultant 18/04/20 Thrombocytopenia necessary Use Order RIE <30 SC Chart OTHER instructions ml/min courier NHS AND queries: Haematology protocols underfilled required sample search queries talk full we Check April The accumulation documents chart Heparin invasive Teams you Argatroban above might heparin please to Common thrombocytopenia get automated inform laboratory at it guidance site: Go how PROTOCOLS for but pager here LMW For available evening stop or UFH Critical LMWHHeparin Julia oneoff Written see Other Version all oncall Level page request 51 Heparininduced Lothian switchboard checked 2020 patients Management through doses LOCATING infusion just following 30 sites Date: choose taken Guidance Beriplex"
    }
]